0001493152-23-009866.txt : 20230331 0001493152-23-009866.hdr.sgml : 20230331 20230330195351 ACCESSION NUMBER: 0001493152-23-009866 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 96 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNIQ Corp. CENTRAL INDEX KEY: 0000278165 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 020314487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40768 FILM NUMBER: 23782415 BUSINESS ADDRESS: STREET 1: 1865 WEST 2100 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 BUSINESS PHONE: 800-242-7272 MAIL ADDRESS: STREET 1: 1865 WEST 2100 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 FORMER COMPANY: FORMER CONFORMED NAME: Quest Solution, Inc. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: AMERIGO ENERGY, INC. DATE OF NAME CHANGE: 20081112 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC GAMING INVESTMENTS, INC. DATE OF NAME CHANGE: 20060501 10-K 1 form10-k.htm
0000278165 false FY P2Y 0 0 0 0 0 0.03 0.079 0.76 0.44 0000278165 2022-01-01 2022-12-31 0000278165 2022-06-30 0000278165 2023-03-10 0000278165 2021-01-01 2021-12-31 0000278165 2022-12-31 0000278165 2021-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2021-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-12-31 0000278165 us-gaap:TradeNamesMember 2022-12-31 0000278165 us-gaap:TradeNamesMember 2021-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2022-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2021-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-12-31 0000278165 us-gaap:CommonStockMember 2020-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000278165 us-gaap:RetainedEarningsMember 2020-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2020-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000278165 2020-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0000278165 us-gaap:CommonStockMember 2021-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000278165 us-gaap:RetainedEarningsMember 2021-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2021-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000278165 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000278165 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000278165 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0000278165 us-gaap:CommonStockMember 2022-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000278165 us-gaap:RetainedEarningsMember 2022-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2022-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember srt:MinimumMember 2022-01-01 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-12-31 0000278165 us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2022-01-01 2022-12-31 0000278165 us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2021-01-01 2021-12-31 0000278165 OMQS:EquityIncentivePlanMember OMQS:BoardOfDirectorsMember 2021-10-31 0000278165 OMQS:EquityIncentivePlanMember 2021-01-01 2021-12-31 0000278165 OMQS:BoardOfDirectorsMember OMQS:TwoThousandTwentyPlanMember 2020-09-30 0000278165 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-01-01 2022-12-31 0000278165 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:ComputerEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0000278165 us-gaap:ComputerEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:OfficeEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0000278165 us-gaap:OfficeEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:SoftwareDevelopmentMember 2022-01-01 2022-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0000278165 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0000278165 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000278165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000278165 us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 us-gaap:WarrantMember 2021-01-01 2021-12-31 0000278165 OMQS:DangotComputersLtdMember 2022-01-01 2022-12-31 0000278165 OMQS:WesternAllianceBankMember 2022-03-25 0000278165 OMQS:ActionCapitalMember 2022-03-25 0000278165 OMQS:ScanSourceIncMember 2022-03-25 2022-03-25 0000278165 OMQS:BlueStarMember 2022-12-31 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:DangotComputersLimitedMember 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:OmniqTechnologiesMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-07-08 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:HaimDangotMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:HaimDangotMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:HaimDangotMember 2021-05-03 0000278165 2021-10-02 0000278165 OMQS:HaimDangotMember 2021-10-02 0000278165 2021-05-02 2021-05-03 0000278165 2022-04-01 2022-04-01 0000278165 OMQS:DangotComputersLtdMember 2021-01-01 2021-12-31 0000278165 OMQS:DangotComputersLimitedMember 2022-01-01 2022-12-31 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:DangotComputersLimitedMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotComputersLimitedMember 2021-05-02 2021-05-03 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:CustomerMember 2022-01-01 2022-12-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneCustomerMember 2021-01-01 2021-12-31 0000278165 OMQS:ManufacturingAndLabEquipmentMember 2022-12-31 0000278165 OMQS:ManufacturingAndLabEquipmentMember 2021-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000278165 us-gaap:ComputerEquipmentMember 2022-12-31 0000278165 us-gaap:ComputerEquipmentMember 2021-12-31 0000278165 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000278165 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000278165 us-gaap:VehiclesMember 2022-12-31 0000278165 us-gaap:VehiclesMember 2021-12-31 0000278165 srt:MinimumMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:FiniteLivedIntangibleAssetsMember srt:MinimumMember 2022-01-01 2022-12-31 0000278165 us-gaap:FiniteLivedIntangibleAssetsMember srt:MaximumMember 2022-01-01 2022-12-31 0000278165 us-gaap:GoodwillMember 2022-12-31 0000278165 us-gaap:GoodwillMember 2021-12-31 0000278165 us-gaap:IntellectualPropertyMember 2022-12-31 0000278165 us-gaap:IntellectualPropertyMember 2021-12-31 0000278165 OMQS:BusinessFinanceAgreementMember OMQS:BridgeBankMember 2022-03-25 0000278165 OMQS:BusinessFinanceAgreementMember OMQS:BridgeBankMember 2022-03-23 2022-03-25 0000278165 OMQS:NotePayableMarinMember 2022-12-31 0000278165 OMQS:NotePayableMarinMember 2021-12-31 0000278165 OMQS:NotePayableThometMember 2022-12-31 0000278165 OMQS:NotePayableThometMember 2021-12-31 0000278165 OMQS:NotePayableMarinMember 2017-12-31 0000278165 OMQS:NotePayableMarinMember 2017-12-01 2017-12-31 0000278165 OMQS:NotePayableThometMember 2017-12-31 0000278165 OMQS:NotePayableThometMember 2017-12-01 2017-12-31 0000278165 OMQS:NotePayableSecuredSupplierMember 2022-12-31 0000278165 OMQS:NotePayableSecuredSupplierMember 2021-12-31 0000278165 OMQS:NotesPayableOtherMember 2022-12-31 0000278165 OMQS:NotesPayableOtherMember 2021-12-31 0000278165 OMQS:OtherNotePayableMember 2022-12-31 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-17 2016-07-18 0000278165 OMQS:LeumiBankMember 2021-07-29 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-07-28 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-11-28 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2021-11-28 0000278165 OMQS:LeumiBankMember 2021-11-27 2021-11-28 0000278165 2021-08-11 0000278165 2021-08-10 2021-08-11 0000278165 OMQS:LeumiBankMember 2022-03-27 0000278165 OMQS:LeumiBankMember OMQS:IsraeliPrimeRateMember 2022-03-27 0000278165 OMQS:LeumiBankMember 2022-03-26 2022-03-27 0000278165 OMQS:HapoalimBankMember 2022-09-13 0000278165 OMQS:HapoalimBankMember 2022-09-13 2022-09-13 0000278165 us-gaap:LineOfCreditMember 2021-12-31 0000278165 OMQS:AkronMember 2022-01-01 2022-12-31 0000278165 OMQS:AkronMember 2022-12-31 0000278165 OMQS:SaltLackCityMember 2022-01-01 2022-12-31 0000278165 OMQS:SaltLackCityMember 2022-12-31 0000278165 OMQS:YadHarutzimMember OMQS:DangotComputersLtdMember 2022-12-31 0000278165 OMQS:YadHarutzimMember 2022-12-31 0000278165 OMQS:RivalStreetMember 2022-12-31 0000278165 srt:DirectorMember 2022-01-01 2022-12-31 0000278165 OMQS:PreferredStockSeriesCMember 2022-12-31 0000278165 OMQS:PreferredStockSeriesCMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember OMQS:HoldersMember 2021-01-01 2021-12-31 0000278165 us-gaap:CommonStockMember OMQS:HoldersMember 2021-01-01 2021-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-10-01 2021-10-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-10-31 0000278165 us-gaap:CommonStockMember OMQS:EmployeesAndConsultantsMember 2022-01-01 2022-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-01 2020-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:CommonStockMember OMQS:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0000278165 us-gaap:CommonStockMember OMQS:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-31 0000278165 us-gaap:WarrantMember 2021-07-31 0000278165 srt:DirectorMember OMQS:SharePurchaseOptionPlanMember 2014-11-17 0000278165 srt:DirectorMember OMQS:SharePurchaseOptionPlanMember 2022-01-01 2022-12-31 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeOneMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeOneMember us-gaap:WarrantMember 2022-12-31 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeTwoMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2022-12-31 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2022-12-31 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeFourMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeFourMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeSixMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeSixMember us-gaap:WarrantMember 2022-12-31 0000278165 us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2022-12-31 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2021-12-31 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2022-12-31 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2021-12-31 0000278165 OMQS:SeptemberOneTwoThousandTwentyFiveMember 2022-12-31 0000278165 OMQS:SeptemberOneTwoThousandTwentyFiveMember 2021-12-31 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2022-12-31 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2021-12-31 0000278165 OMQS:JulySevenTwoThousandTwentySixMember 2022-12-31 0000278165 OMQS:JulySevenTwoThousandTwentySixMember 2021-12-31 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MarchTwentyFifthTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MarchTwentyFifthTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenOneMember 2022-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenOneMember 2021-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2022-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2022-01-01 2022-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2022-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2022-01-01 2022-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2022-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2022-01-01 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2022-01-01 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-12-31 0000278165 OMQS:ConsultingAgreementMember OMQS:MrCarlosJNissensonMember 2020-02-01 2020-02-28 0000278165 OMQS:ConsultingAgreementMember OMQS:MrCarlosJNissensonMember 2020-02-28 0000278165 OMQS:ConsultingAgreementMember OMQS:MrCarlosJNissensonMember 2020-02-28 0000278165 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember OMQS:CustomerOneMember 2022-01-01 2022-12-31 0000278165 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember OMQS:CustomerOneMember 2021-01-01 2021-12-31 0000278165 country:US 2022-01-01 2022-12-31 0000278165 country:US 2021-01-01 2021-12-31 0000278165 country:IL 2022-01-01 2022-12-31 0000278165 country:IL 2021-01-01 2021-12-31 0000278165 OMQS:RestOfTheWorldMember 2022-01-01 2022-12-31 0000278165 OMQS:RestOfTheWorldMember 2021-01-01 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS utr:D OMQS:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-09047

 

OMNIQ CORP.

(Exact name of Registrant as specified in its charter)

 

Delaware   20-3454263
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)

 

1865 West 2100 South, Salt Lake City, UT 84119

(Address of principal executive offices) (zip code)

 

(800) 242-7272

(Issuer’s telephone number, including area code)

 

Securities registered under Section 12(b) of the Exchange Act: None.

 

Securities registered under Section 12(g) of the Exchange Act:

 

Title of class   Trading symbol   Name of each exchange on which registered
Common Stock, $0.001 par value   OMQS   The Nasdaq Stock Market LLC

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates, computed by reference to the price at which the common equity was last sold or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter, June 30, 2022, was $ 31,794,449.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 7,882,628 shares of common stock were outstanding as of March 10, 2023.

 

 

 

   
 

 

TABLE OF CONTENTS

 

PART I
ITEM 1. BUSINESS 4
ITEM 1A. RISK FACTORS 8
ITEM 1B. UNRESOLVED STAFF COMMENTS 8
ITEM 2. PROPERTIES 8
ITEM 3. LEGAL PROCEEDINGS 8
ITEM 4. MINE SAFETY DISCLOSURES 8
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 9
ITEM 6. [RESERVED] 10
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 11
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 17
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENETARY DATA 17
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 18
ITEM 9A. CONTROLS AND PROCEDURES 18
ITEM 9B. OTHER INFORMATION 19
PART III  
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE 19
ITEM 11. EXECUTIVE COMPENSATION 20
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 24
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 25
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 25
PART IV  
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 26
ITEM 16. SUMMARY 26

 

2
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “may”, “could”, “would”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, “intend”, “foresee” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement the strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs and sources of liquidity. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We believe that these risks and uncertainties include, but are not limited to, those described in the “Risk Factors” section of this Annual Report on Form 10-K. These factors should not be construed as exhaustive and should be read with the other cautionary statements in this Annual Report on Form 10-K.

 

Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the expansion of product offerings geographically or through new marketing applications, the timing and cost of planned capital expenditures, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. In addition, even if our actual results are consistent with the forward-looking statements contained in this Annual Report on Form 10-K, those results may not be indicative of results or developments in subsequent periods. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

 

  ● Our ability to raise capital when needed and on acceptable terms and conditions;
     
   ● Our ability to manage credit and debt structures from vendors, debt holders and secured lenders.
     
  ● Our ability to manage the growth of our business through internal growth and acquisitions;
     
  ● Competitive pressures;
     
  ● General economic conditions, including the overall effect of the current banking crisis; and
     
  ● Our ability to attract and retain management, and to integrate and maintain technical information and management information systems.
     
  ● Compliance with laws and regulations, including those relating to environmental matters, corporate governance matters and tax matters, as well as any future changes to such laws and regulations; and
     
  ● Other factors discussed under Item 1A – Risk Factors or elsewhere in this Annual Report on Form 10-K.

 

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the Securities and Exchange Commission (“SEC”), we are under no obligation to publicly update or revise any forward-looking statements after we file this Annual Report on Form 10-K, whether as a result of any new information, future events or otherwise. Investors, potential investors and other readers are urged to consider the above-mentioned factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results or performance.

 

3
 

 

PART I

 

ITEM 1. BUSINESS

 

General

 

OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its wholly owned and majority owned subsidiaries, referred to herein as “we”, “us”, “our,” “OMNIQ,” or the “Company,” was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.

 

Our Company

 

From 2008 to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for us.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:

 

  ● Quest Solutions, Inc. (January 2014)
  ● Bar Code Specialties, Inc. (November 2014)
  ● HTS Image Processing, Inc. (October 2018)
  ● EyepaxIT Consulting LLC. (February 2020)
  ● Dangot Computers Ltd. (July 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. We provide printing solutions, credit card terminals, automatic kiosks and point of care units. We also offer technical service and support. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals. Since 2014, our annual consolidated revenues have grown to more than $100 million with clients in more than 40 countries. We currently address several billion-dollar markets with double-digit growth, including the Global Safe City market, forecasted to grow to $29.6 billion, and the Ticketless Safe Parking market, forecasted to grow to $5.2 billion by 2023.

 

4
 

 

Our Strategy

 

Our strategy is to focus on operational excellence and cost reduction, addressing the balance sheet debt and putting together a business plan that is based on revenue growth and technological leadership. We intend to continue to identify synergies within the Company to offer a more complete line of products, services and technological solutions to customers throughout the United States and Israel. Furthermore, the market in which OMNIQ operates is undergoing consolidation and OMNIQ has started identifying strategic companies in the data collection, big data analytics and mobile systems integration market, as well as other complementary technologies for potential future acquisition in order to become the leading specialty integrator within our served markets.

 

We are a provider of products and solutions to two main markets: supply chain management and smart/safe city. We have expanded our product solutions, which are based on artificial intelligence and machine learning algorithms, offering computer vision applications. Our product offerings have established us as an innovative and technological company, and we are able to offer our Fortune 1000 customers an end-to-end solution. We are a pioneer in providing cutting-edge technology solutions to the markets we serve.

 

As a world-wide systems integrator, we focus on design, delivery, deployment and support of fully integrated mobile and automatic identification data collection solutions. We use unique computer vision technology and additional identification technologies in its solutions. We also manufacture and distribute labels, tags, ribbons and RFID identification tags. We provide printing solutions, credit card terminals, automatic kiosks and point of care units. We also offer customers technical service and support. We take a consultative approach by offering end-to-end solutions that include software, algorithm, hardware, service contracts, communications and full lifecycle management services.

 

We simplify the integration process because of our experienced team of professionals. We deliver problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, some of which we developed, and some is sourced from third parties. We are a leading providing of bar-code labels and ribbons (media). We provide consultative services to companies to select, design and manufacture the right label for their product offering. Once a company purchases our product, sales generally recur on a regular basis.

 

Our ground-breaking AI-based vision solutions are currently in use for sensitive Homeland Security anti-terror projects and automated parking solutions. Inspired by time-critical “friend or foe” decision-making processes, our patented algorithms are based on a combination of cognitive science and machine-learning-based pattern-recognition technology which is arbitrated through a multi-layered decision-making process that offers both speed and accuracy.

 

Our experienced team of consulting and integration professionals guide companies through the entire development and deployment process, from selecting technology, to the successful company-wide rollout of a customized solution that fits a company’s unique requirements. After performing a thorough technical evaluation of the client’s current operations and specific operational problems, our team determines the optimal hardware and software solutions to optimize the client’s operational workflow. We deliver ongoing services provided throughout the deployment process and throughout the entire product life cycle. We also deliver full installation services for all mobile data-collection computers, automatic kiosks, points of care and printing equipment including full staging and kitting of the equipment.

 

We have been successful in delivering mission-critical mobile-computing and data-collection solutions to Fortune 1000 companies for over two decades. The requirements and needs of our customers continue to evolve as they require new mobile and wireless technologies and services to make their business more competitive and profitable. The result is a continuous flow of opportunities for us to assist customers to evaluate, choose, implement, and support the right mobile and data collection solutions. As we focus on what we do best, we believe that there is more than adequate market size, growth, and opportunity available to the Company to succeed.

 

Core to the solutions offered by the Company is a full suite of configurable packaged software solutions that were internally developed and provide customers with unique solutions with significant business Return on Investment (“ROI”), including:

 

Order Entry: Software designed to increase productivity in the field. Remote workers increasingly demand rapid access to real-time information and up-to-date data to facilitate and streamline their job functions in the field—our Order Entry Software is the answer.

 

5
 

 

Intelligent Order Entry: Adds intelligence to aging order entry system to maximize profits. The hand-held industry is a vital link in getting remote orders from the field to corporate. Our Intelligent Order Entry Software adds this capability to aging order entry systems.

 

iTrack: Track Device Deployment. iTrack, an Internet Tracking System, is a management tool that tracks the deployment of hardware devices in the field and their repair history.

 

Warehouse: Enhances efficiency in distribution and manufacturing environments. The warehouse is a collection of applications for portable devices that extend the power of the existing system out to the warehouse floor and dock doors.

 

Proof of Delivery: Enhances document delivery performance. We offer proof-of-delivery capabilities as part of its Mobility Suite that gives companies an edge over competitors by improving customer service.

 

WTMiP: Extends business beyond four walls. WTMiP provides the link between corporate and the mobile worker. WTMiP servers allow files and data to seamlessly synchronize between the corporate host and laptops, handheld devices, and Windows CE or Windows Mobile devices.

 

Easy Order: Easy order on-line purchasing portal. Our Easy Order Solution offers companies a customized portal that streamlines and simplifies ordering by providing clients with their own unique private on-line store.

 

QTSaaS (Quest Total Solutions as a Service): QTSaaS is a complete mobile services offering that includes hardware, software, services, and wireless data in a bundled subscription payment offering over a period of time. Our partnership with Hyperion Partners LLC and wireless carriers allows us to offer mobility solutions to our customers on platforms that extend the market into new mobile applications that previously were not being automated.

 

Media and Label Business: Repeatable easy order online purchasing portal. The largest segment of data collection opportunity for us is the barcode label market providing ongoing and repeatable purchasing business. We intend to continue in the label business in the United States of America to drive business growth and increased margins.

 

Our Target Markets

 

Two markets we serve are Smart/Safe City and Supply Chain Management. Our groundbreaking AI-based vision solutions are currently in use for sensitive Homeland Security anti-terror projects and discerning customers within the access control, airport, border crossing, municipality safety, and parking industries. We seek to utilize our expertise and end-to-end software solutions in markets which provide the greatest opportunity to increase margins.

 

Within the Supply Chain Management market, we believe we can further develop our existing customer base needing to replace their legacy systems with a new go-to-market strategy leveraging our field sales and system resources, telemarketing, customer portals, and vertical market and barcode label specialists. We believe the ideal candidates for our machine learning technology are our base of industry-leading customers for the barcode label and ribbon (media) products in the manufacturing, distribution, transportation and logistics, retail and healthcare sectors—which sectors are at the core of our business.

 

For over two decades, we have been successful in integrating mission critical mobile computing and data collection solutions for Fortune 1000 companies. The requirements and needs of our customers continue to evolve as they require new mobile and wireless technologies and services to make their business more competitive and profitable. The result is a continuous flow of opportunities to assist customers to evaluate, choose, implement, and support the right mobile and data collection solutions. As we focus on what we do best, we believe there is more than adequate market size, growth, and opportunity available for us to succeed.

 

6
 

 

We believe integrating our patented and proprietary AI technology into its existing Supply Chain offerings will allow for automated logistics monitoring and optimization, creating operational efficiencies at higher margins for us, and our Fortune 1000 clients.

 

Our Sales Strategy

 

Our direct sales teams are supported by systems engineers averaging over twenty (20) years of experience in the mobile industry. The sales organization’s growth in-reach mirrors the addition of new products and services. Sales team members are organized by industry areas of opportunity, areas of expertise, and territory. Our sales teams are organized to address national accounts offering a broad array of unique solutions for key lines of business applications, which provides opportunities for upsell and cross sell to our clients. For the barcode label (media) business, we utilize a specialty sales force, resellers, and distributors of our manufactured private label products. For the Israeli market we have direct sales teams that are organized by industry and product line. In Israel we also offer comprehensive technical service and support which increases customer confidence and supports the sales process.

 

Salespeople are supported internally by sales support personnel, who coordinate quotes and logistics, and by members of the systems engineering group and software teams.

 

The normal sales cycle is one (1) to six (6) months, and typically involves the development of a scope of work and preparation of a ROI analysis. We use Company developed analysis templates in order to reduce the sales cycle. The analyses and proposals include information on leasing and other financing options, which helps differentiate us from our competitors. The label business sales cycles are shorter, with purchases made more frequently on a transactional basis.

 

Competition

 

The mobile system integration market is characterized by a limited number of large competitors and numerous smaller niche players. We typically pursue larger accounts and national customers, competing most often with larger channel partners. For specific solutions, we also compete with niche players who are often focused on a single industry. Hardware sales are competitive because of online retailers. We believe our consultative, integrated solutions approach is a clear differentiator for most prospective customers.

 

Human Capital

 

OMNIQ’s operating philosophy is our growth and continued success are the result of management and employees working together in a spirit of cooperation and teamwork. Our core values emphasize an environment where safety, diversity, inclusion, talent development, training, and retention are top priorities. This has enabled us to meet various challenges over the years. The progress that has been achieved by us reflects this strong mutual commitment between the Company and its employees. We believe our employees are our greatest asset. We remain focused on furnishing friendly and safe working conditions, providing competitive pay, offering quality benefits, and producing revenue for the continued growth of the Company and the communities in which we operate. All of this with an emphasis on the welfare of our employees and their families. We realize our success is a direct result of the hard work and dedication of our employees. Each employee at OMNIQ is a contributing partner in our future growth and we strive to maintain a mutually beneficial workplace culture that also fosters the professional development of each employee.

 

As of December 31, 2022, we had approximately 216 employees. Of these employees, 189 are salaried (including commissioned employees) personnel and 27 are hourly personnel. Our employees perform the following functions: sales operations, parts operations, technical services, and office and administrative support. We believe we have good relations with our employees, and we have never experienced a work stoppage. Generally, the total number of employees does not significantly fluctuate throughout the year.

 

7
 

 

Concentrations

 

For the years ended December 31, 2022 and 2021, one customer accounted for 30% and 23%, respectively, of the Company’s consolidated revenues.

 

Accounts receivables are made up of trade receivables due from customers in the ordinary course of business. As of December 31, 2022, no customer accounted for more than 10% of the outstanding receivables, and one customer accounted for 17% of the balance of accounts receivable as of December 31, 2021.

 

As of December 31, 2022 and 2021 one vendor made up 48% and 65%, respectively, of our purchases.

 

Available Information

 

OMNIQ’s website, www.omniq.com, and the information contained on that site, or connected to that site, are not part of or incorporated by reference into this filing.

 

We file electronically with the SEC annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Copies of these reports, proxy and information statements and other information may be obtained by electronic request at the following e-mail address: publicinfo@sec.gov. We use the Investor section of our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor section of our website, in addition to following press releases, SEC filings, and public conference calls and webcasts.

 

ITEM 1A. RISK FACTORS

 

This section is not required for smaller reporting companies.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

This section is not required for smaller reporting companies.

 

ITEM 2. PROPERTIES

 

OMNIQ’s corporate offices are currently located at 1865 West 2100 South, Salt Lake City, UT 84119. Our executive management, sales, operations, accounting, and administrative functions are located at the corporate offices. The corporate office annual lease expense is $284 thousand. The space is under a five-year lease and expires June 2026.

 

We lease office space for our software developers in Akron, Ohio. The lease provides for monthly payments of $3,000. The space is under a five-year lease and expires May 2023.

 

We lease office and warehouse space for our satellite sales and technical support staff in Anaheim, California. The lease is month to month and the annual lease expense is $36 thousand.

 

We also lease office space for research and development employees located in Israel. The lease expense for the year ending December 31, 2022 was 260,353 NIS. The lease is currently at a rate of 23,383 NIS per month and the lease expires in August 2023.

 

Dangot’s corporate offices are currently located at Yad Harutzim 14 Tel-Aviv, Israel. The main corporate office, Yad Harutzim 14, serves as the company’s main building on the 2nd and 3rd floors, used by the management and most of the sales staff, technicians, etc. The corporate office annual lease expense is NIS 784,380. The space is under a five years and eleven months lease and expires November 2024.

 

We lease office space (Gamdan- 1st floor) for our finance and service department at Yad Harutzim 14 Tel-Aviv, Israel. The lease provides for monthly payments of NIS 22,134. The space is under a five-year lease and expires December 2023.

 

We lease office and warehouse space for our products and technical support staff at Rival Street, Tel-Aviv, Israel. The lease provides for monthly payments of NIS 41,200. The space is under a six and half year lease and expires June 2025.

 

ITEM 3. LEGAL PROCEEDINGS

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. The Company is defending the case. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

NONE.

 

8
 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

On October 8, 2021 the Company’s common stock became available on The Nasdaq Stock Market LLC under the symbol “OMQS”. Before then, shares of OMNIQ’s common stock were not traded on an established market. OMNIQ’s common stock was traded through broker/dealers and in private transactions, and quotations reported on the OTCQB under the symbol “OMQS”. OTCQB quotations reflected interdealer prices, without mark-up, mark-down or commission and may not represent actual transactions. No dividends have been declared or paid on OMNIQ’s common stock and none are likely to be declared or paid in the near future.

 

   Common Stock 
   High   Low 
         
Fiscal Year Ended December 31, 2021:           
Fiscal Quarter Ended March 31, 2021   $10.25   $4.16 
Fiscal Quarter Ended June 30, 2021   $12.00   $7.01 
Fiscal Quarter Ended September 30, 2021   $16.00   $7.10 
Fiscal Quarter Ended December 31, 2021   $10.88   $6.01 
           
Fiscal Year Ended December 31, 2022:           
Fiscal Quarter Ended March 31, 2022   $7.05   $4.35 
Fiscal Quarter Ended June 30, 2022   $7.32   $5.13 
Fiscal Quarter Ended September 30, 2022   $8.75   $5.27 
Fiscal Quarter Ended December 30, 2022   $6.38   $4.13 

 

Equity Compensation Plan Information

 

Plan category  Number of securities to be issued upon exercise of outstanding options, warrants and rights   Weighted-average exercise price of outstanding options, warrants and rights   Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a) 
   (a)   (b)   (c) 
Equity compensation plans approved by security holders   3,672,317   $5.94    646,856 

 

9
 

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. No shares were issued under the Plan in 2021. On February 25, 2022, the Company granted 792,500 stock options. These options were granted to employees as part of the Company’s Equity Incentive Plan. On October 23, 2022 19,000 stock options were granted to employees as part of the Company’s Equity Incentive Plan.

 

Dividends and other Distributions

 

OMNIQ has never declared or paid any cash dividends on its common stock. The Company currently plans to retain future earnings to finance growth and development of its business and does not anticipate paying any cash dividends in the foreseeable future. OMNIQ may incur indebtedness in the future which may prohibit or effectively restrict the payment of dividends, although the Company has no current plans to do so. Any future determination to pay cash dividends will be at the discretion of OMNIQ’s Board of Directors. The Company’s Series C Preferred Stock pays a 6% dividend, but the Company has been unable to make such dividend payments and so those dividends are accrued quarterly. Accrued but unpaid dividends do not bear interest.

 

At the time of acquisition of Dangot Computers Ltd certain dividend payables were owed to non-controlling interests. These liabilities were assumed by OMNIQ and during the year ended December 31, 2021 Dangot Computers Ltd paid $306 thousand to those non-controlling interests.

 

Recent Sales of Unregistered Securities

 

During 2022, the Company issued an aggregate of 7,025 shares of common stock to certain individuals as part of the Company’s Employee Stock Purchase Program valued at approximately $37 thousand.

 

For the year ended December 31, 2022, $147 thousand in stock options and stock warrants were exercised in exchange for 128,221 shares of OMNIQ common stock.

 

On June 15, 2022 our Board of Directors approved issuing 20,000 shares as part of a consulting agreement. The shares were valued at $109 thousand.

 

On June 15, 2022 our Board of Directors granted 30,000 warrants as part of a consulting agreement. The shares were valued at $176 thousand.

 

On June 15, 2022 our Board of Directors granted 30,000 stock options as part of a consulting agreement. The shares were valued at $173 thousand.

 

On August 8, 2022 our Board of Directors approved issuing 80,000 shares as compensation for executives valued at $670 thousand. Shared were issued on October 11, 2022.

 

On August 8, 2022 our Board of Directors approved issuing 40,000 warrants as part of a consulting agreement valued at $209 thousand.

 

On November 11, 2022 our Board of Directors approved issuing 20,000 shares as part of employment agreements valued at $101 thousand.

 

ITEM 6. [RESERVED]

 

Reserved.

 

10
 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion summarizes the financial position of OMNIQ, Corp. and its consolidated subsidiaries as of December 31, 2022, and its consolidated results of operations for the year ended December 31, 2022, and should be read in conjunction with our consolidated financial statements and the accompanying notes thereto included elsewhere in this Annual Report on Form 10-K. The following discussion contains, in addition to historical information, forward-looking statements that include risks and uncertainties (see discussion of “Forward-Looking Statements” included elsewhere in this Annual Report on Form 10-K). Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those factors set forth under Item 1A—Risk Factors of this Annual Report on Form 10-K.

 

The Company’s consolidated revenue for the year ended December 31, 2022 were $102.5 million, representing an increase of $24 million from the year ended December 31, 2021 of $78.3 million. Revenues in 2022 and 2021 are presented in accordance with Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606).

 

Net loss attributable to common stockholders’ of OmniQ Corp was $13.8 million in 2022, an increase of $400 thousand from the 2021 loss of $13.4 million. Basic loss per share attributable to common stockholders was $1.82 for the year 2022 compared to $2.20 per share for the year 2021.

 

On May 3, 2021, the Company and OmniQ Technologies Ltd., a wholly owned subsidiary of the Company (“OmniQ Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, OmniQ Technologies agreed to purchase 51%, or 5,100 shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to 23,740,500 NIS (New Israeli Shekel), which is equal to US $7.7 million (the “Closing Consideration”), based on the exchange rate at the date of acquisition of NIS to dollars.

 

The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued 220,103 shares of its common stock having a share value of $2,084 thousand and (b) cash in the amount of $5,058 thousand and $600 thousand payable to owner.

 

Haim Dangot also granted OmniQ Technologies an irrevocable option to purchase the remaining 4,900 shares, or 49%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of 489,500 NIS (US $150,522 per each 1% of Dangot’s remaining shares on a fully diluted basis) which is the same valuation per share as the purchase price for the 51%. Effective October 1, 2021 the Company exercised a portion of its option and purchased an additional 26% of Dangot bringing its ownership to 77%. The Company paid $4,012,000 to purchase the additional shares.

 

On April 1, 2022, the Company closed on its acquisition of Dangot and exercised the remaining portion of its option to purchase 23.0% of the capital stock, thereby making Dangot a fully owned subsidiary of the Company. The Company paid $3,518,000 to purchase the additional shares. The Company utilized its working capital and a combination of short and long term loans.

 

11
 

 

GOING CONCERN

 

The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:

 

● Balancing the need for operational cash with the need to add additional products.
● Timely and cost-effective development of products
● Working capital deficit of $38 million as of December 31, 2022
● Accumulated deficit of $84 million as of December 31, 2022
● Multiple years of losses from operations
● Multiple years of negative cash flows from operations
● Noncompliance with certain debt covenants

 

Management Evaluation

 

Management considers the condition outlined above as the most significant factors in raising substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.

 

Management’s Plans to Mitigate and Alleviate Conditions or Events

 

The following conditions, plans and actions are currently being implemented to address the Company’s conditions:

 

● Outstanding warrants exist from prior offerings that could be exercised for cash depending upon the performance of our stock.
● The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability, and cash flow and is expected to help the Company as a whole to generate positive cash flows from operations for the foreseeable future.
● The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group.
● The acquisition of Dangot has added capabilities to the Company which have already transformed into significant new orders in the Parking segment. Management expects the collaboration and cross sales to contribute to improved revenues and margins.
● Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations. Management has already cut staff by about 5% and will continue to do additional overhead cuts.
● March 25, 2022 management finalized an $8.5M line of credit from Western Alliance Bank. This line of credit replaced the high interest Action Capital line of Credit ($6M) and settle the ScanSource debt $2.5M.
● Blue Star - The Company’s total accounts payable due to Blue Star as of December 31, 2022 was approximately $36 million. Blue Star is an unsecured creditor, financing a substantial amount the Company’s supply chain demand. Management believes that Blue Star will continue supplying the Company with preferable credit terms. Blue Star has agreed to the annual interest rate of 5% on invoices that are past due. As an unsecured creditor of the Company, Blue Star has no incentive to force a liquidation. The Company has enjoyed a good mutual relationship for the past four years.

 

12
 

 

Overview – Results of Operations

 

The following table sets forth certain selected condensed statement of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

 

   Year ended December 31,   Variation 
In thousands  2022   2021   $   % 
Revenue  $102,545    78,251   $24,294    31.05%
Cost of Goods sold   80,441    61,582    18,859    30.62%
Gross Profit   22,104    16,669    5,435    32.60%
Operating Expenses   31,656    27,149    4,507    16.60%
Loss from operations   (9,552)   (10,480)   928    8.85%
Net loss   (13,614)   (13,144)   (470)   (3.58%)
Net Loss per common Share from continuing operations  $(1.82)  $(2.20)  $0.38    17.19%

 

Revenues

 

Revenue for the years ended December 31, 2022 and 2021 were generated from the sales of hardware, service contracts, software, labels and ribbons and related services provided by the Company to its customers. For the years ended December 31, 2022 and 2021, the Company recognized $102.5 million and $78.3 million in net revenues, respectively. This represents an increase of 31.05%. The increase was due to growth in the marketplace and the acquisition of Dangot.

 

Cost of Goods Sold

 

For the years ended December 31, 2022 and 2021, the Company recognized a total of $80.4 million and $61.6 million respectively, of cost of goods sold. Cost of goods sold was 78% of net revenues for 2022 and 79% of revenue for 2021. Our gross margin percentage has remained relatively stable in an industry that is experiencing gross margin pressure.

 

Operating Expenses

 

For the years ended December 31, 2022 and 2021, operating expenses were $31.7 million and $27.1 million, respectively. This represents an increase of $4.5 million, or 16.6%, which is due to a general increase in business operations, including the addition of Dangot in July 2021. The following explains in detail the change in operating expenses.

 

Research & Development – Research and development for the year ended December 31, 2022 and 2021 totaled $1.8 million per year.

 

Selling, General and Administrative – Selling, General and Administrative expenses were $27.7 million for the year ended December 31, 2022, compared to $21.9 million for the year ended December 31, 2021, representing an increase of $5.8 million, or 27%. The increase was due to additional share issuances to employees and directors as well as a large software implementation.

 

Depreciation – Depreciation for the year ended December 31, 2022 were $324 thousand compared to $251 thousand for the year ended December 31, 2021. This represents an increase of $73 thousand, or 29%, attributable to growth in fixed assets.

 

Intangible Amortization – Intangible amortization expenses for the year ended December 31, 2022 were $1.8 million, compared to $3.2 million for the year ended December 31, 2021. This represents a decrease of $1.4 million, or 43%, attributable to the acquisition of additional intangibles.

 

13
 

 

Other Income and Expenses

 

The Company incurred $3.5 million in interest expense for the year ended December 31, 2022, compared to $2.5 million for the year ended December 31, 2021. The interest expense is comprised of interest incurred on promissory notes payable, the company’s line of credit, and vendor payables.

 

Foreign Currency Transactions

 

The Company has multiple subsidiaries conducting operations in Israel, therefore there were transactions denominated in currency other than US dollars for both 2022 and 2021. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.

 

Provision for Income Taxes

 

For the year ended December 31, 2022, the Company has $35 thousand of current income tax provision (US State & Local and Foreign) and $30 thousand deferred income tax expense.

 

For the year ended December 31, 2021, the Company has $321 thousand of current income tax provision (US State & Local and Foreign) and $165 thousand deferred income tax benefit.

 

Net loss

 

The Company realized a net loss of $13.6 million for the year ended December 31, 2022, compared to a net loss from continuing operations of $13.1 million for the year ended December 31, 2021. The increased loss in 2022 is due primarily to an increase in stock compensation.

 

Liquidity and Capital Resources

 

As of December 31, 2022, the Company had cash in the amount of $1.3 million and a working capital deficit of $38 million, compared to cash in the amount of $7.1 million, and a working capital deficit of $22.9 million as of December 31, 2021. The Company had stockholders’ deficit attributable to OmniQ stockholders of $10.5 million and $98 thousand as of December 31, 2022 and 2021, respectively. This increase in our stockholders’ deficit was primarily attributable to net losses.

 

The Company’s accumulated deficit was $84.4 million and $70.6 million as of December 31, 2022 and 2021, respectively.

 

The Company’s operations provided net cash of $1.2 million and used $3.2 million the years ended December 31, 2022 and 2021, respectively. The increase of cash from operations of $4.4 million is primarily a result of reduction in accounts receivable.

 

The Company’s cash used in investing activities was $4,154 thousand for the year ended December 31, 2022 compared to cash provided by investing activities of $9,235 thousand for the year ended December 31, 2021.

 

The Company’s financing activities used $3.1 million of cash during the year ended December 31, 2022, and provided $14.5 million during the year ended December 31, 2021. During the year ended December 31, 2022, the Company made payments of $2.5 million on its notes payable, including its Supplier Secured Promissory note and related party notes payable, compared to the year ended December 31, 2021, when the Company made payments of $4.7 million on its notes payable, including its Supplier Secured Promissory note and related party notes payable. Additionally, the Company borrowed $4 million on the Company’s line of credit during the year ended December 31, 2022, compared to the year ended December 31, 2021, when $1 million was paid on the Company’s line of credit. The Company did not raise funds during the year ended December 31, 2022, compared to $13.3 million raised for the year ended December 31, 2021.

 

Off-Balance Sheet Arrangements

 

The Company currently does not have any off-balance sheet arrangements.

 

Critical Accounting Policies

 

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The application of many accounting principles requires us to make assumptions, estimates and/or judgments that affect the reported amounts of assets, liabilities, revenues and expenses in our consolidated financial statements. We base our estimates and judgments on historical experience and other assumptions that we believe are reasonable under the circumstances. These assumptions, estimates and/or judgments, however, are often subjective and they and our actual results may change based on changing circumstances or changes in our analyses. If actual amounts are ultimately different from our estimates, the revisions are included in our results of operations for the period in which the actual amounts first become known. We believe the following critical accounting policies could potentially produce materially different results if we were to change underlying assumptions, estimates and/or judgments. See also note 2 to our consolidated financial statements for a summary of our significant accounting policies.

 

14
 

 

Revenue Recognition.

 

When entering into contracts with our customers, we review the five steps outlined in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

We account for contracts with our customers when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance, and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether or not we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or other asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, and delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)
     
  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
     
  ii. The customer has legal title to the product,
     
  iii. We have transferred physical possession of the product to the customer,
     
  iv. The customer has the risk and rewards of ownership of the product, and
     
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties that only provide assurance the products and services will conform to their specifications. These assurance-type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and record revenue on a net basis at the point of sale.

 

15
 

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
     
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
     
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
     
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and record revenue on a net basis at the point of sale.

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing, and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage a services team that provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Definite-lived Intangible Assets Impairment Evaluation

 

The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded no impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.

 

When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.

 

If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.

 

Indefinite-lived Intangible Assets, Including Goodwill

 

Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, no impairment has been recognized.

 

16
 

 

Stock Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.

 

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.

 

Additional accounting policies can be found in Note 2 to our Audited Consolidated Financial Statements.

 

Recent Accounting Pronouncements

 

Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

This section is not required for smaller reporting companies.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements required by this Item are included as a separate section of this report commencing on page F-1.

 

17
 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

NONE

 

ITEM 9A. CONTROLS AND PROCEDURES

 

(a) Evaluation of Disclosure and Control Procedures

 

We maintain “disclosure controls and procedures”, as such terms are defined under Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosures. The Company acknowledges that any controls and procedures can provide only reasonable assurances of achieving the desired control objectives.

 

We have carried out an evaluation as required by Rule 13a-15(d) under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedure as of December 31, 2022. Based upon their evaluation, the Chief Executive Officer and Principal Accounting Officer concluded that, as of December 31, 2022, the Company’s disclosure controls and procedures were not effective. Although we have determined that the existing controls and procedures are not effective, the deficiencies identified have not been deemed material to our reporting disclosures.

 

(b) Management’s Report on Internal Controls over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting refers to the process designed by, or under the supervision of, our principal executive officer and principal financial officer, and effected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

Internal control over financial reporting cannot provide absolute assurance of achieving their objectives. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgement and breakdowns resulting from human failures. Due to their inherent limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. It is possible to design safeguards to reduce, but not eliminate, this risk. Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.

 

Management has used the framework set forth in the report entitled Internal Control—Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), known as COSO, to evaluate the effectiveness of our internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Based on such evaluation, our CEO concluded that, as of December 31, 2022, our internal controls over financial reporting were not effective.

 

As a result of our evaluation, we identified a material weakness in our controls related to segregation of duties and other immaterial weaknesses in several areas of data management and documentation.

 

18
 

 

Our management is composed of a small number of professionals resulting in a situation where limitations on segregation of duties exist. Accordingly, and as a result of the material weakness identified above, we have concluded that the control deficiencies result in a reasonable possibility that a material misstatement of the annual or interim financial statements may not be prevented on a timely basis by the Company’s internal controls. We continue to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by executives. In addition, we evaluate and assess our internal controls and procedures regarding our financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary on an on-going basis.

 

Commencing at the end of 2021, the Company engaged a professional consulting firm to help with implementing an internal process in accordance with section 404a of the Sarbanes-Oxley Act 2000 (SOX). The Company is in the process of implementing the SOX process and is currently performing the documentation phase. The controls in the main business processes that refer to the preparation of financial statement reporting of the main Company were documented, gaps were noted, and a remediation plan was prepared. The Company is in the process of implementing the remediation plan in order for these controls to be found effective in the test phase. The Company is working on completing the documentation phase in its other subsidiaries that recently switched to our ERP system.

 

While the material weakness set forth above were the result of the scale of the Company’s operations and is intrinsic to its small size, the Company believes the risk of material misstatements relative to financial reporting are minimal.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by its registered public accounting firm pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permits the Company to provide only management’s report in this annual report.

 

(c) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

NONE.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table presents information with respect to our officers and directors as of the date of this Report:

 

Name   Age   Positions

Shai Lustgarten

   52   CEO and Chairman
Neev Nissenson   44   Chief Financial Officer and Director
Andrew J. MacMillan   75   Director
Yaron Shalem   50   Director
Guy Elhanani   49   Director
Mina Teicher   76   Director

 

Background of our officers and directors

 

The following is a brief account of the education and business experience during at least the past five years of our officers and directors, indicating each person’s principal occupation during that period, and the name and principal business of the organization in which such occupation and employment were carried out.

 

Shai S. Lustgarten, was appointed the Company’s CEO in April 2017 and served as the Company’s interim CFO from December 2018 through September 4, 2019. Mr. Lustgarten had been the Chief Executive Officer of Teamtronics, Inc. beginning June 2016. Teamtronics manufactures rugged computers and electronic equipment mainly used in the Gas and oil industry. From 2014 to 2017, Mr. Lustgarten was the Chief Executive Officer at Micronet Limited Inc., a developer and manufacturer of mobile computing platforms for integration into fleet management and mobile workforce solutions listed on the Tel Aviv Stock Exchange. From 2013 to 2014, Mr. Lustgarten served as EVP Business Development and Head of the Aerospace and defense Division of Micronet EnertecTechnologies, a technology company listed on the NASDAQ Capital Market. From 2009 to 2013 Mr. Lustgarten was VP of Sales, Marketing and CMO of TAT Technologies, a world leading supplier of electronic systems to the commercial and defense markets, from. His prior experience also includes serving as CEO of T.C.E. Aviation Ltd. in Belgium and serving from 1993 to 1997 as the assistant to the Military Attaché at the Embassy of Israel in Washington, DC. He received his Bachelor of Science degree in Business Management & Computer Science from the University of Maryland.

 

19
 

 

Neev Nissenson became a director of the Company in April 2017 and was appointed as our CFO on September 5, 2019, effective October 10, 2019. He is an experienced entrepreneur and financial officer. In 2015, Mr. Nissenson founded Hotwine, Inc., a California based wine startup company. Since August 2016 and until October 10, 2019, Mr. Nissenson served as the Chief Financial Officer of Hypnocore, Ltd., an Israeli based startup company that develops mobile applications for sleep monitoring and therapy. From 2011 to 2015, Mr. Nissenson was the Chief Financial Officer of GMW, Inc., a high-end wine retailer from Napa, California. Before that, Mr. Nissenson served as the Vice President from 2006 to 2011 and the Chief Financial Officer from 2009 to 2011 at Phoenix International Ventures, Inc., an aerospace defense company. Mr. Nissenson was also a member of the Municipal Committee for Business from 2004 to 2007 and a member of Municipal Committee for Street Naming from 2005 to 2007 in the City of Herzliya, Israel. He is also an armored platoon commander in the Israeli Defense Forces (Reserve) Armored Corps with a rank of Captain. Mr. Nissenson graduated from Tel Aviv University in 2005 with a B.A. majoring in General History and Political Science. In 2007, he graduated from the Hebrew University with an Executive Master’s degree in Business Administration specializing in Integrative Management.

 

Andrew J. MacMillan became a director of the Company in April 2017. He is a corporate communications professional with 20 years of corporate communications experience in the global securities industry, plus 18 years of direct investment banking and related experience. He was a director of NTS, Inc. since December 20, 2012 and since December 27, 2012 served as the Chairman of its Nominating and Corporate Governance Committee until NTS’ sale to a private equity firm in June 2014. Since 2010, Mr. MacMillan has served as an independent management consultant providing marketing and communications advisory to clients. Prior to that from 2007 until 2010, Mr. MacMillan served as Director, Global Communications & Marketing of AXA Rosenberg, a leading equity asset management firm. Prior to that, Mr. MacMillan served in a variety of corporate communication roles including Senior Vice President of Corporate Communications & Government Affairs at Ameriprise Financial, Head of Corporate Communications (Americas) at Barclays Capital, Senior Vice President of Corporate Communications of The NASDAQ Stock Market and Director of Corporate Communications at Credit Suisse First Boston. Mr. MacMillan previously served as an investment banker, acquisition officer, and consultant directly involved with capital raising, acquisitions, and financial feasibility studies. Mr. MacMillan holds a BS in Industrial Engineering from the University of Iowa and a Masters in Business Administration from Harvard.

 

Yaron Shalem became a director of the Company in April 2017. He has extensive experience in financial and business management. Mr. Shalem has served as the Chief Financial Officer at Saga Monetary Technologies Limited (UK) since January 2018. Prior to that Mr. Shalem served as the Chief Financial Officer at Singulariteam VC from January 2014 till January 2018. He also worked as the Chief Financial Officer at Mobli Media Inc. from January 2014 to December 2016. Mr. Shalem’s experience also includes serving as the Chief Financial Officer of TAT Technologies Ltd., a NASDAQ listing company, from April 2008 to December 2013. Mr. Shalem is a CPA in Israel. He received his B.A. in Economy & Accounting from Tel Aviv University in 1999 and an MBA degree from Bar-Ilan University in 2004.

 

Mr. Elhanani is a qualified CFO with experience leading financial strategies to facilitate a company’s growth plans. Mr. Elhanani has been the CFO and a partner of Singulariteam VC, a venture capital firm, since 2017. Mr. Elhananai has been the CFO of Sirin Labs since 2017. Sirin Labs is a multinational, high-tech company specializing in secured mobile phones. From 2015 to 2017, Mr. Elhanani was the CFO of SalesTech, an online internet technology servicing company. Mr. Elhanani has also served as the CFO of other companies, including: Micronet Ltd. (2012-2015); InterLogic Ltd. (2007-2012); and Finotec Group Inc. (2006-2007). From 2003 to 2006, Mr. Elhanani was the corporate controller of On Track Innovations Ltd. From 1999 to 2003, Mr. Elhanani was a senior auditor at Kesselman and Kesselman (PWC Israel). Mr. Elhanani was a lecturer at IVC College in Israel from 2014 to 2018 and at Hebrew University in Jerusalem from 2001 to 2003. Mr. Elhanani has also served as a board member for various companies, including: General Robotics (2017-Present); Effective Space Solutions (2017-Present); Octopus Systems (2017-Present); and Infinity AR (2017-2019). Mr. Elhanani received a B.A. in Accounting and Economics, and a Master of Business Administration, specializing in finance, from Hebrew University.

 

Mina Teicher is the former Chief Scientist of the Israel government. She is a leading mathematician specializing in Algebraic Geometry and applications to computer vision, cryptography, cyber security, neuroscience, neuro-medical devices, and complex societal systems, such as financial markets and health systems. She earned a PhD in Mathematics from Tel Aviv University and a postdoctoral fellowship from the Institute for Advanced Study in Princeton. She published 140 scientific papers, wrote 5 books, mentored 80 students (Master, PhD, and postdocs) in Israel and the USA, organized 20 international conferences, and won prestigious invitations to deliver lectures, numerous awards, and highly competitive research grants (in Israel, Germany, Italy, the European Union, the USA and China).

 

ITEM 11. EXECUTIVE COMPENSATION

 

The table below shows the compensation for services in all capacities we paid during the year ended December 31, 2022 to the individuals serving as our principal executive officers during the last completed fiscal year and our other two most highly paid executive officers at the end of the last completed fiscal year (whom we refer to collectively as our “named executive officers”);

 

Name and Principal Position  Year    Salary ($)   Bonus ($)   Stock Awards   Option Awards   All Other Compensation   Total 
In thousands                            
Shai Lustgarten   2022    588    110    335    791    -   $1,824 
Chief Executive Officer   2021    583    -    -    -    432   $1,015 
                                    
Neev Nissenson   2022    166    30    168    51    -   $415 
Chief Financial Officer   2021    170    167    -    -    18   $355 

 

20
 

 

Bonuses

 

Any bonuses granted in the future will relate to meeting certain performance criteria that are directly related to areas within the named executive’s responsibilities with the Company. As we continue to grow, more defined bonus programs may be established to attract and retain our employees at all levels.

 

Employment Contracts

 

In February 2020, we entered into an employment agreement with Mr. Lustgarten, the Company’s Chief Executive Officer, (the “Lustgarten Agreement”) pursuant to which Mr. Lustgarten shall continue to serve as the Company’s Chief Executive Officer. The Lustgarten Agreement has a four (4) year term and automatically renews for additional one (1) year periods unless either party elects to terminate the Lustgarten Agreement. Pursuant to the Lustgarten Agreement, the Company shall pay Mr. Lustgarten an annual base salary of $560,000. Mr. Lustgarten shall also be eligible to receive i) equity awards pursuant to the Company’s 2018 Equity Incentive Plan and the 2020 Equity Incentive Plan and ii) certain milestone bonuses as set forth in the Lustgarten Agreement. In the event Mr. Lustgarten’s employment is terminated by Mr. Lustgarten for good reason, or terminated by the Company without cause, Mr. Lustgarten shall be entitled to the greater of (i) the unpaid base salary or (ii) one (1) year’s base salary.

 

At the sole discretion of our Board, all officers are entitled to merit-based cash and equity bonuses.

 

Director Compensation

 

Name  Year   Fees Earned or Paid in Cash ($)   Stock Awards   Option(1) Awards   Non-Equity Incentive Plan Compensation   Nonqualified Deferred Compensation   All Other Compensation   Total 
In thousands                                
Andrew MacMillan (1)   2022    24    -    46    -    -    -    70 
    2021    24    -    -    -    -    -    24 
Yaron Shalem (1)   2022    24    -    46    -    -    -    70 
    2021    24    -    -    -    -    -    24 
Guy Elhanani (1)   2022    24    -    46    -    -    -    70 
    2021    8    -    -    -    -    -    8 
Itzhak Almog (1)   2022    24    -    46    -    -    -    70 
    2021    8    -    -    -    -    -    8 

 

  1. The fair value of the options awarded to Mr. MacMillan, Mr. Shalem, Mr. Elhanani and Mr. Almog in 2022 was determined to be $46 thousand, respectively using the Black-Scholes Option Pricing Model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends

 

21
 

 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

 

The employment agreements for our named executive officers generally provide that in the event of termination of such executive’s employment for any reason, or if the executive resigns, the Company is required to pay certain separation benefits, including (i) unpaid annual salary earned through the termination date; (ii) unused vacation; (iii) accrued and unpaid expenses; and (iv) other vested and accrued benefits to which he is entitled under the Company’s employee benefit plan. In the event the executive voluntarily resigns for “good reason” (as defined in each executive’s respective Employment Agreement) or the Company terminates their employment for any reason other than for cause (as defined in each executive’s respective Employment Agreement), the Company will be required to pay certain termination benefits, including (i) a lump sum payment equal to the greater of (A) unpaid annual salary through the end of the Initial Term or Renewal Term (as those terms are defined in each executive’s respective Employment Agreement) or (B) two years of annual salary and (ii) COBRA reimbursement.

 

CORPORATE GOVERNANCE

 

Board Leadership Structure and Risk Oversight

 

Our Board currently consists of six members. Shai Lustgarten, Mr. Neev Nissenson, Mr. Andrew J. MacMillan and Mr. Yaron Shalem, Mr. Guy Elhanani and Ms. Mina Teicher.

 

One of the key functions of our Board is to provide oversight of our risk management process. Our Board administers this oversight function directly, with support from its three standing committees—the Audit Committee, the Compensation Committee, and the Corporate Governance/Nominating Committee.

 

Director Independence

 

Pursuant to Item 407(a)(1)(ii) of Regulation S-K promulgated under the Securities Act, we have adopted the definition of “independent director” as set forth in Rules 5000(a)(19) and 5605(a)(2) of the rules of the Nasdaq Stock Market. The Board determined that Mr. Andrew J. MacMillan, Mr. Yaron Shalem, Mr. Guy Elhanani and Ms. Mina Teicher qualify as “independent directors” pursuant to such rules.

 

Board Committees

 

We have three standing committees: the Audit Committee, the Compensation Committee, and the Corporate Governance/Nominating Committee. We believe that the members of the Audit Committee, Compensation Committee and Corporate Governance/Nominating Committee are deemed to be “independent” pursuant to the NASDAQ listing standards and applicable SEC rules. We believe that all members of our Board have been and remain qualified to serve on the committees of our Board and have the experience and knowledge to perform the duties required of the committees.

 

22
 

 

Audit Committee

 

The Audit Committee consists of Mr. Yaron Shalem, Mr. Andy MacMillan, and Ms. Mina Teicher whereby Mr. Shalem is the Chairperson. Our Board has determined that Mr. Shalem qualifies as an “audit committee financial expert,” as defined under the rules of the SEC.

 

The primary responsibility of the Audit Committee is to oversee our financial reporting process on behalf of the Board and report the results of their activities to the Board. The Audit Committee’s responsibilities include providing assistance to the Board in fulfilling the Board’s oversight responsibility relating to:

 

  ● the integrity of the Company’s financial statements and the related public reports,
     
  ● disclosures and regulatory filings in which they appear;
     
  ● the systems of internal control over financial reporting, operations, and legal/regulatory compliance;
     
  ● the performance, qualifications and independence of the Company’s independent accountants;
     
  ● the performance, qualifications and independence of the Company’s internal audit function, and
     
  ● compliance with the Company’s ethics policies and applicable legal and regulatory requirements.

 

Our Audit Committee charter is available on the “Investor Lounge” subpage of our website (www.omniq.com) under the link “Corporate Governance”.

 

Compensation Committee

 

The Compensation Committee consists of Mr. Andrew J. MacMillan, and Mr. Yaron Shalem. Mr. MacMillan serves as Chairperson.

 

The Compensation Committee’s responsibilities include, among others:

 

  ● approve annually the corporate goals and objectives applicable to the compensation of the Chief Executive Officer and/or President, evaluate at least annually the Chief Executive Officer’s and/or President’s performance in light of those goals and objectives, and determine and approve the Chief Executive Officer’s and/or President’s compensation level based on this evaluation;
     
  ● review matters relating to executive succession and management development;
     
  ● formulate, evaluate, and approve compensation for the Company’s officers;
     
  ● formulate, evaluate, and approve cash incentives and deferred compensation plans for executives;
     
  ● formulate, approve, and administer and, when appropriate, recommend to the Board for approval, incentive compensation plans and equity-based plans; and
     
  ● approve employment contracts, severance agreements, change in control provisions, and other compensatory arrangements with Company executives.

 

The Compensation Committee has the authority, in its sole discretion, to select, retain, and obtain the advice of a compensation consultant as necessary to assist with the execution of its duties and responsibilities.

 

Our Compensation Committee charter is available on the “About” subpage of our website (www.omniq.com) under the link “Corporate Governance”.

 

23
 

 

Corporate Governance/Nominating Committee

 

The Corporate Governance/Nominating Committee consists of Andrew J. MacMillan, and Yaron Shalem. Andrew J. MacMillan is the Chairman.

 

The Corporate Governance/Nominating Committee’s responsibilities include, among others:

 

  ● develop and oversee the Company’s corporate governance practices and procedures, including identifying best practices, reviewing, and recommending to the Board for approval any changes to the documents, policies, and procedures in the Company’s corporate governance framework;
     
   ● establish procedures for the director nomination and to determine the qualifications, qualities, skills, and other expertise required to be a director and to develop, and recommend to the Board for its approval, criteria to be considered in selecting nominees for director;
     
  ● identify and screen individuals qualified to become members of the Board, consistent with the above criteria, considering any director candidates recommended by the Company’s stockholders;
     
  ● oversee a process for an annual evaluation of the Company’s Chief Executive Officer and/or President; and
     
  ● develop and oversee a process for an annual evaluation of the Board and its committees, including a formal assessment of each individual director.

 

Our Corporate Governance/Nominating Committee charter is available on the “About” subpage of our website (www.omniq.com) under the link “Corporate Governance”.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table sets forth certain information regarding beneficial ownership of our Common Stock as of December 31, 2021: (i) by each of our directors; (ii) by each of our executive officers; (iii) by our executive officers and directors as a group, and (iv) by each person or entity known by us to beneficially own 5% or more of any class of our common stock. As of December 31, 2022, there were 7,714,780 shares of our common stock outstanding.

 

Name of Beneficial Owner  Amount of Beneficial Ownership   Percentage of Shares Outstanding 
Shai Lustgarten (Chairman and CEO) (1)   1,537,964    13.82%
Andrew MacMillan (2)   38,996    0.35%
Yaron Shalem (5)   61,525    0.55%
Neev Nissenson (CFO) (4)   182,289    1.64%
Itzhak Almog (6)   10,000    0.09%
Guy Elhanani (7)   10,000    0.09%
All Executive Officers and Directors as a group (6 individuals)   1,955,774    17.66%
           
Carlos Nissensohn (3)   1,019,667    9.16%

 

  1. Includes 500,000 shares issuable upon the exercise of options. Also includes (i) 1,004,631 shares and (ii) 33,333 shares issuable upon the exercise of warrants held by Walefar Investments Ltd., which is beneficially owned by Mr. Lustgarten.
     
  2. Includes 20,000 shares issuable upon the exercise of options. Also includes (i) 18,996 shares
     
  3. Includes 739,308 shares held by Campbeltown Consulting Ltd., which is beneficially owned by Mr. Carlos J. Nissensohn. Also includes (i) 57,026 shares. Also includes 223,333 shares underlying option and warrants
     
  4. Includes 125,000 shares issuable upon exercise of options. Also includes (i) 57,289 shares
     
  5. Includes 42,500 shares issuable upon exercise of options. Also includes (i) 19,025 shares
     
  6. Includes 10,000 shares issuable upon the exercise of options.
     
  7.

Includes 10,000 shares issuable upon the exercise of options.

 

 

24
 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

2020

 

In February 2020, OMNIQ entered into a consulting agreement with Mr. Carlos J. Nissensohn and/or an entity under his control, a consultant to the Company and principal stockholder, (the “Nissensohn Agreement”) pursuant to Mr. Carlos J. Nissensohn and/or an entity under his control will provide certain consulting services to the Company. The Nissensohn Agreement has a four (4) year term and automatically renews for additional one (1) year periods unless either party elects to terminate the Nissensohn Agreement. Pursuant to the Nissensohn Agreement, we will pay Mr. Nissensohn a monthly fee of $30,000. Mr. Nissensohn shall also be eligible to receive certain milestone bonuses as set forth in the Nissensohn Agreement. Mr. Nissensohn is a principal stockholder of the Company. Mr. Carlos J. Nissensohn is the father of Neev Nissenson, our CFO and board member.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Aggregate fees billed or incurred related to the following years for professional services rendered by Haynie & Company for 2022 and 2021 were $205 thousand and $182 thousand respectively.

 

25
 

 

In the above table, in accordance with the SEC’s definitions and rules, “audit fees” are fees for professional services for the audit of a company’s financial statements included in the annual report on Form 10-K, for the review of a company’s financial statements included in the quarterly reports on Form 10-Q, and for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements; “audit-related fees” are fees for assurance and related services that are reasonably related to the performance of the audit or review of a company’s financial statements; “tax fees” are fees for tax compliance, tax advice, and tax planning; and “all other fees” are fees for any services not included in the first three categories.

 

Our policy is to pre-approve all audit and permissible non-audit services performed by the independent accountants. These services may include audit services, audit-related services, tax services and other services. Under our Audit Committee’s policy, pre-approval is generally provided for particular services or categories of services, including planned services, project-based services and routine consultations. In addition, the Audit Committee may also pre-approve particular services on a case-by-case basis. Our Audit Committee approved all services that our independent accountants provided to us in the past two fiscal years.

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a)(1) The following documents are filed under pages F-1 through F-26 and are included as part of this Form 10-K:

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (HAYNIE) F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (BARZILY)  
CONSOLIDATED BALANCE SHEETS F-3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS F-4
CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT) F-5
CONSOLIDATED STATEMENTS OF CASH FLOWS F-6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS F-7

 

(a)(2) Financial statement schedules are omitted as they are not applicable.

 

(a)(3) Exhibits required by Item 601 of Regulation S-K are incorporated herein by reference and are listed on the attached Exhibit Index, which begins immediately following the financial statements of this Annual Report on Form 10-K.

 

ITEM 16. SUMMARY.

 

NONE.

 

26
 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: March 30, 2023

 

  OMNIQ CORP.  
     
  By: /s/ Shai Lustgarten
    Shai Lustgarten
    Chief Executive Officer and Chairman of the Board

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Shai Lustgarten   Chairman of the Board, Chief Executive Officer   March 30, 2023
Shai Lustgarten        
         
/s/ Neev Nissenson   Director, Chief Financial Officer   March 30, 2023
Neev Nissenson        
         
/s/ Yaron Shalem   Director   March 30, 2023
Yaron Shalem        
         
/s/ Andrew J. MacMillan   Director   March 30, 2023
Andrew J. MacMillan        
         
/s/ Mina Teicher   Director   March 30, 2023
Mina Teicher        
         
/s/ Guy Elhananai   Director   March 30, 2023
Guy Elhanani        

 

27
 

 

OMNIQ CORP.

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM PCAOB: 457 (HAYNIE) F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM PCAOB: 2015 (BARZILY) F-4
CONSOLIDATED BALANCE SHEETS F-5
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME F-6
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (DEFICIT) F-7
CONSOLIDATED STATEMENTS OF CASH FLOWS F-8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS F-9

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of OMNIQ Corp.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of OMNIQ Corp. (the Company) as of December 31, 2022 and 2021, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2022 and 2021 and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

We did not audit portions of the December 31, 2022 consolidated financial statements for Dangot Computers, Ltd., a wholly owned subsidiary. The portions not audited by us include assets of $27.5 million as of December 31, 2022, and total revenues of $45.5 million for the year ended December 31, 2022. Those portions of the December 31, 2022 consolidated financial statements were audited by other auditors whose report has been furnished to us, and our opinion, insofar as they relate to the amounts included for Dangot Computers, Ltd. is based solely on the reports of the other auditors.

 

Consideration of the Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has a deficit in stockholders’ equity, and has sustained recurring losses from operations. This raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans with regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

F-2

 

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Goodwill and Intangible Assets— Refer to Note 8 to the consolidated financial statements

 

The Company has goodwill of $16.5 million and other intangible assets of $7.5 million as of December 31, 2022. The Company evaluates its goodwill and intangible assets at least annually or more frequently when events or changes in circumstances indicate the carrying value may not be recoverable. For goodwill, the Company performed an impairment analysis by considering the value of its operating segment and comparing it to the carrying amount of its goodwill. In consideration of its intangible assets, the Company employed an income approach using a discounted cash flow using a forecast developed by management. These valuation methods require management to make significant estimates and assumptions related to projected cash flows. No impairment was recorded by the Company for the year ended December 31, 2022.

 

We identified potential impairment of these assets as a critical audit matter because of the significant estimates and assumptions made by management to estimate fair value, including the impact of forecasted growth, and the difference between the fair values and the carrying values as of December 31, 2022. This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialist, when performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions related to certain assumptions within the projected cash flows.

 

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, gaining an understanding of management’s process for developing the fair value estimate. We used professionals inside our firm with specialized skills and knowledge to assess the Company’s methodology. In evaluating the Company’s assumptions, we compared them to historical results, financial information subsequent to year end, and to customer orders to be filled. Finally, we considered the sensitivity of their cash flow model assumptions by assessing different scenarios.

 

/s/ Haynie & Company  
Salt Lake City, Utah  
March 30, 2023  
   
We have served as the Company’s auditor since 2019.  

 

F-3

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

OMNIQ CORP.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Dangot Computers Ltd. (the “Company”) as of December 31, 2022, the related consolidated statement of operation and comprehensive loss, chang in stockholders’ equity (defecit) and cash flow for the year then ended, and the related notes (collectively referred to as the “Financial Statement”). In our opinion, the financial statement present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operation and its cash flow for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the board of directors and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.

 

We have served as the Company’s auditor since 2020.  
   
BARZILY AND CO., CPA’s  
    
Jerusalem, Israel  
March 30,2023  

 

F-4

 

 

OMNIQ CORP.

CONSOLIDATED BALANCE SHEETS

As of December 31,

 

       
(In thousands, except share and per share data)    
   2022   2021 
ASSETS          
Current assets          
Cash and cash equivalents  $1,311   $7,085 
Accounts receivable, net   23,893    27,123 
Inventory   8,726    6,955 
Prepaid expenses   1,268    1,987 
Other current assets   473    9 
Total current assets   35,671    43,159 
           
Property and equipment, net of accumulated depreciation of $1,030 and $2,203 respectively   1,086    1,127 
Goodwill   16,542    16,453 
Trade name, net of accumulated amortization of $4,458 and $3,863, respectively   1,826    2,421 
Customer relationships, net of accumulated amortization of $10,762 and $9,660, respectively   4,967    6,069 
Other intangibles, net of accumulated amortization of $1,541 and $1,457, respectively   675    865 
           
Right of use lease asset   2,300    3,556 
Other assets   1,744    1,431 
Total assets  $64,811   $75,081 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities          
Accounts payable and accrued liabilities  $54,736   $45,553 
Line of credit   1,971    5,951 
Accrued payroll and sales tax   2,633    2,658 
Notes payable, related parties – current portion   293    390 
Notes payable – current portion   11,572    7,521 
Lease liability – current portion   942    1,341 
Other current liabilities   1,394    2,683 
Total current liabilities   73,541    66,097 
           
Long term liabilities          
Notes payable, related party, less current portion   -    293 
Accrued interest and accrued liabilities, related party   72    63 
Notes payable, less current portion   55    2,646 
Lease liability   1,404    2,266 
Other long-term liabilities   265    1,418 
Total liabilities   75,337    72,783 
           
Stockholders’ equity deficit          
Series A Preferred stock; $0.001 par value; 2,000,000 shares designated, 0 shares issued and outstanding   -    - 
Series B Preferred stock; $0.001 par value; 1 share designated, 0 shares issued and outstanding   -    - 
Series C Preferred stock; $0.001 par value; 3,000,000 shares designated, 544,500 shares issued and outstanding, respectively   1    1 
Common stock; $0.001 par value; 15,000,000 shares authorized; 7,714,780 and 7,459,534 shares issued and outstanding, respectively.   8    20 
Additional paid-in capital   73,714    70,606 
Accumulated deficit   (84,460)   (70,571)
           
Cumulative translation adjustment   211    (154)
Total OmniQ stockholders’ equity (deficit)   (10,526)   (98)
Non-controlling interest   -    2,396 
TOTAL EQUITY (DEFICIT)   (10,526)   2,298 
           
Total liabilities and equity (deficit)  $64,811   $75,081 

 

The accompanying notes are integral to these consolidated financial statements

 

F-5

 

 

OMNIQ CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

For the Years Ended December 31,

 

       
(In thousands, except share and per share data)  2022   2021 
Revenues          
Total revenues  $102,545   $78,251 
           
Cost of goods sold          
Cost of goods sold   80,441    61,582 
           
Gross profit   22,104    16,669 
           
Operating expenses          
Research & development   1,826    1,873 
Selling, general and administrative   27,707    21,865 
Depreciation   324    251 
Amortization   1,799    3,160 
Total operating expenses   31,656    27,149 
           
Loss from operations   (9,552)   (10,480)
           
Other income (expenses):          
Interest expense   (3,496)   (2,515)
Other (expenses) income   (601)   7 
Total other expenses   (4,097)   (2,508)
           
Net loss before income taxes   (13,649)   (12,988)
           
Provision for income taxes          
Current   35   (156)
Total provision for income taxes   35   (156)
           
Net loss  $(13,614)  $(13,144)
Net income attributable to non-controlling interest   67    218 
Net loss attributable to OmniQ Corp  $(13,681)  $(13,362)
           
Net loss  $(13,614)  $(13,144)
           
Foreign currency translation adjustment   365    71 
           
Comprehensive loss   (13,249)   (13,073)
           
Less comprehensive loss attributable to non-controlling interests   20    (59)
Comprehensive loss attributable to OmniQ Corp  $(13,229)  $(13,132)
Reconciliation of net loss to net loss attributable to common shareholders          
Net loss  $(13,614)  $(13,144)
Less: dividends attributable to non-common stockholders’ of OmniQ Corp   (206)   (77)
Net loss less non-common stockholder dividends   (13,820)   (13,221)
           
Non-common stockholder dividends attributable to non-controlling interest   -    218 
Net loss attributable to common stockholders’ of OmniQ Corp  $(13,820)  $(13,439)
Net loss per share - basic attributable to common stockholders’ of OmniQ Corp  $(1.82)  $(2.20)
           
Weighted average number of common shares outstanding - basic   7,576,434    6,082,763 

 

The accompanying notes are integral to these consolidated financial statements.

 

F-6

 

 

OMNIQ CORP.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (DEFICIT)

 

For the Years Ended December 31, 2022 and 2021

 

   Shares      Shares                   
   Series C       Additional       Non   Accumulated Other   Total Stockholders’ 
(In thousands)  Preferred Stock   Common Stock   Paid-in   Accumulated   Controlling   Comprehensive   Equity 
   Shares   Amount   Shares   Amount   Capital   Deficit   Interest   Income (Loss)   (Deficit) 
Balance, December 31, 2020   2,145   $2    4,685   $5   $51,842   $(56,726)  $-   $(166)  $(5,043)
Dividend on class C shares   -    -    -    -    -    (77)   -    -    (77)
Dividend declared to non-controlling interest   -    -    -    -    -    (398)   -    -    (398)
ESPP stock issuance   -    -    2    -    16    -    -    -    16 
Stock-based compensation – options, warrants, issuances   -    -    -    -    2,552    -    -    -    2,552 
Stock and warrant issued for services   -    -    25    -    188    -    -    -    188 
Stock and warrant issuances, net of issuance costs   -    -    2,143    15    13,282    -    -    -    13,297 
Exercise of stock options and warrants   -    -    279    -    438    -    -    -    438 
Stock and warrant issuance for acquisition   -    -    220    -    2,084    -    -    -    2,084 
Dangot acquisition   -    -    -    -    -    -    6,508    -    6,508 
Exercise to purchase additional Dangot shares   -    -    -    -    -    -    (4,012)   -    (4,012)
Post-acquisition adjustment   -    -    -    -    -    (1)   (377)   -    (378)
Cumulative translation adjustment   -    -    -    -    -    -    59    12    71 
Other   -    -    -    -    -    (7)   -    -    (7)
Conversion of equity   (1,400)   (1)   70    -    1    -    -    -    - 
Conversion of debt   (201)   -    35    -    203    -    -    -    203 
Net income (loss)   -    -    -    -    -    (13,362)   218    -    (13,144)
Balance, December 31, 2021   544   $1    7,459   $20   $70,606   $(70,571)  $2,396   $(154)  $2,298 
Dividends   -     -     -     -     -     (206)   -     -     (206)
ESPP stock issuance   -     -     7    -    37    -     -     -     37 
Stock-based compensation – options, warrants, issuances   -     -     100    -     3,173    -     -     -     3,173 
Stock issued for services   -     -     20    -     109    -     -     -     109 
Warrant issuances, net of issuance costs   -     -     -     -     298    -     -     -     298 
Exercise of stock options   -     -     128    -     147    -     -     -     147 
Non-controlling interests, distributions and other   -     -     -     -     (668)   -     (2,443)   -    (3,111)
Other   -     -     -     (12)   12    -    -    -    - 
Cumulative translation adjustment   -     -     -     -     -     (2)     (20)   365    343 
Net loss   -     -     -     -     -     (13,681)   67    -    (13,614)
Balance, December 31, 2022   544   $1    7,714   $8   $73,714   $(84,460)  $-   $211   $(10,526)

 

The accompanying notes to the financials should be read in conjunction with these financial statements.

 

F-7

 

 

OMNIQ CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31,

 

(In thousands)  2022   2021 
Cash flows from operations          
Net loss  $(13,614)  $(13,144)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Loss on disposal of PP&E   46    - 
Noncash interest expense   248    - 
Stock-based compensation   3,173    2,552 
Stock and warrant issued for services   109    188 
Depreciation and amortization   2,119    3,411 
Amortization of ROU asset   1,000    199 
Changes in operating assets and liabilities:          
Accounts receivable   1,472   (3,291)
Prepaid expenses   585    (295)
Inventory   (2,490)   (538)
Other assets   131    (117)
Accounts payable and accrued liabilities   10,830    8,352 
Accrued interest and accrued liabilities, related party   8    7 
Accrued payroll and sales taxes payable   268    (180)
Lease liability   (1,000)   (192)
Deferred tax assets, net   (263)   58 
Other liabilities   (1,419)   (185)
Net cash provided by (used in) operating activities   1,203    (3,175)
           
Cash flows from investing activities          
Payment for additional ownership in subsidiary   (3,518)   (4,012)
Payment for acquisition, net of cash acquired   -    (4,992)
Purchase of property and equipment   (451)   (299)
Proceeds from sale (purchase) of other assets   (185)   68 
Net cash used in investing activities   (4,154)   (9,235)
           
Cash flows from financing activities          
Proceeds from ESPP stock issuance   37    16 
Proceeds from exercise of options and warrants   147    438 
Dividends paid to non-controlling interest   (1,448)   (306)
Net proceeds from issuance of common stock   -    13,297 
Payments on notes payable   (2,525)   (4,612)
Proceeds from the issuance of notes payable   4,770    4,603 
Net activity on line of credit   (4,038)   1,037 
Net cash (used in) provided by financing activities   (3,057)   14,473 
           
Net change in cash and cash equivalents   (6,008)   2,063 
           
Effect of foreign exchange rates on cash and cash equivalents   234    (105)
           
Cash and cash equivalents at beginning of period   7,085    5,127 
           
Cash and cash equivalents at end of period  $1,311   $7,085 
           
Non-cash activities:          
Declared dividends payable  $33   $464 
Net assets acquired in business combination  $-   $7,390 
Stock compensation in exchange for debt  $298   $- 
Purchase of PP&E with financing  $-   $155 
Debt conversion  $-   $203 
Equity conversion  $-   $2 
Right of use asset acquired in exchange for lease liability  $-   $1,108 
Change in terms of accounts payable  $-   $47 
Supplemental disclosure of cash flow information:          
Cash paid for interest  $3,487   $1,547 
Cash paid for income taxes  $160   $151 

 

The accompanying notes are integral to these consolidated financial statements.

 

F-8

 

 

OMNIQ CORP.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

For the Years Ended December 31, 2022 and 2021

 

NOTE 1 – NATURE OF OPERATIONS

 

OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its majority and wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.

 

From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:

 

  ● Quest Solutions, Inc. (January 2014)
  ● Bar Code Specialties, Inc. (November 2014)
  ● ViascanQdata, Inc (October 2015 – later sold in September 2016)
  ● HTS Image Processing, Inc. (October 2018)
  ● EyepaxIT Consulting LLC. (February 2020)
  ● Dangot Computers Ltd. (July 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.

 

F-9

 

 

NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation and Basis of Presentation

 

Our consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers Ltd. collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these consolidated financial statements. Business combinations are included in the consolidated financial statements from their respective dates of acquisition.

 

Use of Estimates

 

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 

Cash and Cash Equivalents

 

Cash consists of petty cash, checking, savings, and money market accounts. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of December 31, 2022 and 2021.

 

The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.

 

F-10

 

 

Accounts Receivable

 

We manage credit risk associated with our accounts receivables at the customer level. Because the same customers typically generate the revenues that are accounted for under both Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606) and Accounting Standards Codification Topic 326, Credit Losses (Topic 326)., the discussions below on credit risk and our allowances for doubtful accounts address our total revenues from Topic 606 and Topic 326.

 

We believe concentration of credit risk, with respect to our receivables, is limited because our customer base is comprised of a number of geographically diverse customers. We manage credit risk through credit approvals, credit limits and other monitoring procedures.

 

Pursuant to Topic 326 for our accounts receivables, we maintain an allowance for doubtful accounts that reflects our estimate of our expected credit losses. Our allowance is estimated using a loss rate model based on delinquency. The estimated loss rate is based on our historical experience with specific customers, our understanding of our current economic circumstances, reasonable and supportable forecasts, and our own judgment as to the likelihood of ultimate payment based upon available data. We perform credit evaluations of customers and establish credit limits based on reviews of our customers’ current credit information and payment histories. We believe our credit risk is somewhat mitigated by our geographically diverse customer base and our credit evaluation procedures. The actual rate of future credit losses, however, may not be similar to past experience. Our estimate of doubtful accounts could change based on changing circumstances, including changes in the economy or in the particular circumstances of individual customers. Accordingly, we may be required to increase or decrease our allowance for doubtful accounts. Based on management’s evaluation, accounts receivable has a balance in the allowance for doubtful accounts of $455 thousand and $6 thousand for the years ended December 31, 2022 and 2021, respectively.

 

Inventory

 

Substantially all inventory consists of raw materials and finished goods and are valued at the lower of historic cost or net realizable value; where net realizable value is considered to be the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. Historic inventory costs are calculated on a first-in-first-out basis or specific cost.

 

Property and Equipment

 

Property and equipment are recorded at cost and depreciated using straight-line over the estimated useful lives. Ordinary repair and maintenance costs are included in sales, general and administrative (“SG&A”) expenses on our consolidated statements of operations. However, expenditures for additions or improvements that significantly extend the useful life of the asset are capitalized in the period incurred. At the time assets are sold or disposed of, the cost and accumulated depreciation are removed from their respective accounts and the related gains or losses are reflected in the statements of operations in gains from sales of property and equipment, net.

 

F-11

 

 

We periodically evaluate the appropriateness of remaining depreciable lives assigned to property and equipment. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or the remaining term of the lease, whichever is shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was $324 thousand and $251 thousand, respectively. Generally, we assign the following estimated useful lives to these categories:

 

Category   Estimated Useful Life

Furniture and fixtures

Computer equipment

Office equipment

Software

Leasehold improvements

  

5 to 7 years

3 to 5 years

3 to 10 years

3 years

15 years

Vehicles   5 years

 

Fair Value of Financial Instruments

 

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The FASB fair value measurement guidance established a fair value hierarchy that prioritizes the inputs used to measure fair value. The three broad levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly

 

Level 3 – Unobservable inputs for which little or no market data exists, therefore requiring a company to develop its own assumptions

 

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. We review the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.

 

The carrying amounts of certain financial instruments, such as cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.

 

F-12

 

 

Definite-lived Intangible Assets

 

The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded no impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.

 

When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.

 

If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.

 

Definite-lived intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from 3 to 11 years with a remaining weighted average lifespan of 7.5 years.

 

Indefinite-lived Intangible Assets, Including Goodwill

 

Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, no impairment has been recognized.

 

Accounts Payable

 

Accounts payable are made up of payables due to vendors in the ordinary course of business a December 31, 2022 and 2021. One vendor made up 48% and 65% of our purchases in 2022 and 2021, respectively.

 

Leases

 

We determine whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset, and we have the right to control the asset for a period of time in exchange for consideration. Lease arrangements can take several forms. Some arrangements are clearly within the scope of lease accounting, such as a real estate contract that provides an explicit contractual right to use a building for a specified period of time in exchange for consideration. However, the right to use an asset can also be conveyed through arrangements that are not leases in form, such as leases embedded within service and supply contracts. We analyze all arrangements with potential embedded leases to determine if an identified asset is present, if substantive substitution rights are present, and if the arrangement provides the customer control of the asset.

 

F-13

 

 

Our lease portfolio is substantially comprised of operating leases related to leases of real estate and improvements. From time to time, we may also lease various types of small equipment and vehicles.

 

Operating lease right-of-use (“ROU”) assets represent our right to use an individual asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide the lessor’s implicit rate, we use our incremental borrowing rate (“IBR”) at the commencement date in determining the present value of lease payments by utilizing a fully collateralized rate for a fully amortizing loan with the same term as the lease.

 

Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the term. Our leases can include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when such renewal options and/or termination options are reasonably certain of exercise.

 

A ROU asset is subject to the same impairment guidance as assets categorized as plant, property, and equipment. As such, any impairment loss on ROU assets is presented in the same manner as an impairment loss recognized on other long-lived assets.

 

A lease modification is a change to the terms and conditions of a contract that change the scope or consideration of a lease. For example, a change to the terms and conditions to the contract that adds or terminates the right to use one or more underlying assets, or extends or shortens the contractual lease term, is a modification. Depending on facts and circumstances, a lease modification may be accounted as either: (1) the original lease plus the lease of a separate asset(s) or (2) a modified lease. A lease will be remeasured if there are changes to the lease contract that do not give rise to a separate lease.

 

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 

Revenue Recognition

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

F-14

 

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)
     
  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

F-15

 

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
     
  ii. The customer has legal title to the product,
     
  iii. We have transferred physical possession of the product to the customer,
     
  iv. The customer has the risk and rewards of ownership of the product, and
     
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
     
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
     
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
     
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

F-16

 

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.

 

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.

 

F-17

 

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. No shares were issued in 2021 as part of the Plan.

 

In August 2020, the Board of Directors approved our 2020 Equity Incentive Plan and later amended it. In September 2020, our shareholders adopted and ratified the 2020 Equity Incentive Plan. The total number of shares of Common Stock authorized for issuance under the 2020 Plan is 1,000,000.

 

Equity instruments issued to parties other than employees for acquiring goods or services.

 

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

Warrants. The fair value of the warrants is estimated on the date of issuance using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the expected term of the warrants, expected stock price volatility, and expected dividends. These estimates involve inherent uncertainties and the application of management’s judgment. Expected volatilities used in the valuation model are based on the average volatility of the Company’s stock. The risk-free rate for the expected term of the option is based on the United States Treasury yield curve in effect at the time of grant.

 

Advertising

 

The Company expenses marketing and advertising costs as incurred. During 2022 and 2021, the Company spent $630 thousand and $213 thousand, respectively, on marketing, trade show and store front expense and advertising, net of co-operative rebates.

 

The Company received rebates on advertising from co-operative advertising agreements with several vendors and suppliers. These rebates have been recorded as a reduction to the related advertising and marketing expense.

 

Foreign Currency Translation

 

Our consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operations were maintained in the local currency and translated to the reporting currency as follows: assets and liabilities are converted using the balance sheet period-end date exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.

 

F-18

 

 

Income Taxes

 

We account for our income taxes in accordance with Income Taxes Topic of the FASB ASC 740, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 

Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for consolidated financial reporting purposes and such amounts recognized for tax purposes and are measured by applying enacted tax rates in effect in years in which the differences are expected to reverse.

 

We also follow the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Our income is subject to taxation in both the U.S. and a foreign jurisdiction, Israel. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company establishes reserves for income tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves for tax contingencies are established when we believe positions do not meet the more-likely-than-not recognition threshold. We adjust uncertain tax liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or lapse of a statute of limitations. The provision for income taxes includes the impact of uncertain tax liabilities and changes in liabilities that are considered appropriate.

 

Comprehensive Income (Loss)

 

Comprehensive income (loss) is defined as a change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Our other comprehensive income (loss) is composed of foreign currency translation adjustments.

 

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the years ended December 31, 2022 and December 31, 2021 were 7,576,434 and 6,082,763, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:

  2022   2021 
Options to purchase common stock  $2,190,583   $1,559,300 
Warrants to purchase common stock   1,481,734    1,378,929 
Potential shares excluded from diluted net loss per share  $3,672,317   $2,938,229 

 

F-19

 

 

Recent Accounting Pronouncements not yet adopted

 

Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.

 

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:

 

● Balancing the need for operational cash with the need to add additional products
● Timely and cost-effective development of products
● Working capital deficit of $38 million as of December 31, 2022
● Accumulated deficit of $84 million as of December 31, 2022
● Multiple years of losses from operations
●

Non compliance with certain debt covenants 

 

These facts and others have raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.

 

The following conditions, plans and actions are currently being implemented to address the Company’s conditions:

 

● Outstanding warrants exist from prior offerings that could be exercised for cash depending upon the performance of our stock.
● The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability, and cash flow and is expected to help the Company as a whole to generate positive cash flows from operations for the foreseeable future.
● The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group.
● The acquisition of Dangot has added capabilities to the Company which have already transformed into significant new orders in the Parking segment. Management expects the collaboration and cross sales to contribute to improved revenues and margins.
● Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations. Management has already cut staff by about 5% and will continue to do additional overhead cuts.
● On March 25, 2022 management finalized an $8.5M line of credit from Western Alliance Bank. This line of credit replaced the high interest Action Capital line of Credit ($6M) and settle the ScanSource debt $2.5M.
● Blue Star - The Company’s total accounts payable due to Blue Star as of December 31, 2022 was approximately $36 million. Blue Star is an unsecured creditor, financing a substantial amount the Company’s supply chain demand. Management believes that Blue Star will continue supplying the Company with preferable credit terms. Blue Star has agreed to the annual interest rate of 5% on invoices that are past due. As an unsecured creditor of the Company, Blue Star has no incentive to force a liquidation. The Company has enjoyed a good mutual relationship for the past four years.

 

F-20

 

 

NOTE 4 – BUSINESS ACQUISITIONS

 

Dangot Computers Ltd

 

On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase 51%, or 5,100 shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to 23,740,500 NIS (New Israeli Shekel), which is equal to US$7.6 million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.

 

The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued 220,103 shares of its common stock having a share value of $2,084 thousand and (b) cash in the amount of $5,058 thousand and $600 thousand payable to owner.

 

Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining 4,900 shares, or 49%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of 465,500 NIS, which is equal to US$143 thousand, per each 1% of Dangot’s remaining shares on a fully diluted basis which is the same valuation per share as the purchase price for the 51%. Effective October 1, 2021 the Company exercised a portion of its option and purchased an additional 26% of Dangot bringing its ownership to 77%. The Company paid $4,012,000 to purchase the additional shares.

 

On April 1, 2022, the Company closed on its acquisition of Dangot and exercised the remaining portion of its option to purchase 23.0% of the capital stock, thereby making Dangot a fully owned subsidiary of the Company. The Company paid $3,518,000 to purchase the additional shares. The Company utilized its working capital and a combination of short and long term loans.

 

The following table summarizes the consideration given and the purchase price allocation:

 

 

      
Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner   600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts receivable   13,470 
Inventory   4,616 
Other assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 

 

The proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2021 were $92.5 million in revenues and $10.8 million net loss.

 

Since the acquisition the amounts included in the consolidated statement of comprehensive income from Dangot Computers Ltd. for the year ended December 31, 2021, was $20.6 million in revenue and $566 thousand in net income.

 

F-21

 

 

NOTE 5 – ACCOUNTS RECEIVABLE

 

Accounts receivable consisted of the following as of December 31:

 

           
In thousands  2022   2021 
Trade accounts receivable  $24,348   $27,129 
Less allowance for doubtful accounts   (455)   (6)
Total accounts receivable (net)  $23,893   $27,123 

 

Accounts receivable as of December 31, 2022 and 2021 are made up of trade receivables due from customers in the ordinary course of business. No customer accounted for more than 10% of the balance of accounts receivable as of December 31, 2022, and one customer accounted for 17% of the accounts receivable balance as of December 31, 2021.

 

NOTE 6 – INVENTORY

 

Inventory consisted of the following as of December 31:

 

           
In thousands  2022   2021 
         
Raw materials  $649   $894 
Inventory in transit   2,004    - 
Finished goods (less allowance)   6,073    6,061 
Total inventories  $8,726   $6,955 

 

NOTE 7 – PROPERTY AND EQUIPMENT

 

The following is a summary of the components of property and equipment as of December 31,:

 

           
In thousands  2022   2021 
Manufacturing and lab equipment  $98   $499 
Leasehold improvements   521    609 
Software and computer equipment   987    1,650 
Furniture and equipment   236    254 
Vehicle   274    318 
Property and equipment, Gross        - 
Less: accumulated depreciation   (1,030)   (2,203)
Property and equipment, Net  $1,086   $1,127 

 

Depreciation expense for the year ended December 31, 2022 was approximately $324 thousand. Depreciation expense for the year ended December 31, 2021 was approximately $251 thousand.

 

NOTE 8 – GOODWILL AND INTANGIBLE ASSETS

 

We have made acquisitions in the past that resulted in the recognition of goodwill. Based on our analysis there have been no impairment charges recorded against goodwill in 2022 and 2021. Identifiable intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over the estimated useful lives ranging from 3 to 11 years. Amortization expense for the years ended December 31, 2022 and 2021 was $1,799 million and $3.2 million, respectively.

 

Goodwill and Intangible assets consisted of the following as of December 31:

SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS 

           
In thousands  2022   2021 
Goodwill  $16,542   $16,453 
Trade names   6,284    6,284 
Customer relationships   15,729    15,729 
Other intangibles   2,216    2,322 
Accumulated amortization   (16,761)   (14,980)
Intangibles, net  $24,010   $25,808 

 

The future amortization expense on the trade names, customer relationships, and other intangibles are as follows:

 

      
In thousands    
Years ending December 31,    
2023  $1,625 
2024   952 
2025   943 
2026   943 
2027   776 
Thereafter   2,229 
      
Total  $7,468 

 

F-22

 

 

Goodwill is not amortized but is evaluated for impairment annually or when indicators of a potential impairment are present. The impairment testing of goodwill is performed separately from our impairment testing of intangibles. The annual evaluation for impairment of goodwill and intangibles is based on valuation models that incorporate assumptions and internal projections of expected future cash flows and operating plans. None of the goodwill is deductible for income tax purposes.

 

Purchased intangible assets with finite useful lives are amortized over their respective estimated useful lives (using an accelerated method for customer relationships and trade names) to their estimated residual values, if any. The Company’s finite-lived intangible assets consist of customer relationships, contractor and resume databases, trade names, and internal use software and are being amortized over periods ranging from two to nine years. Purchased intangible assets are reviewed annually to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, recoverability is assessed by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the rate of amortization is accelerated, and the remaining carrying value is amortized over the new shorter useful life. No impairments were identified or changes to estimated useful lives have been recorded as of December 31, 2022 and 2021.

 

NOTE 9 – CREDIT FACILITIES AND LINE OF CREDIT

 

We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.

 

On March 25, 2022 we entered into a Business Finance Agreement (the “BFA”) with BridgeBank a division of Western Alliance Bank (“BridgeBank”) to establish the sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivables to BridgeBank. Pursuant to the BFA, the outstanding principal amount of advances made by BridgeBank at any time shall not exceed $8.5 million. BridgeBank reserves and withholds to 15% of the face amount of each account purchased in a reserve account.

 

The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the BFA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 1.5%, plus a monthly fee equal to 0.15% of the average outstanding balance. The BFA credit facility is collateralized with a senior security interest in certain assets of the Company. The BFA includes customary representations and warranties and default provisions for transactions of this type.

 

F-23

 

 

NOTE 10 – RELATED PARTY NOTES PAYABLE

 

Related party notes payable, consisted of the following as of December 31:

           
   2022   2021 
In thousands          
Note payable –Marin  $180   $420 
Note payable –Thomet   113    263 
           
Total notes payable   293    683 
Less current portion   293    390 
Long-term portion  $-   $293 

 

For the years ended December 31, 2022 and December 31, 2021, the Company recorded interest expense in connection with these notes in the amount of $8 thousand and $10 thousand, respectively.

 

Note Payable -Marin

 

In December 2017, we entered into a $660 thousand, 1.89% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in 60 monthly principal payments of $20 thousand beginning in October 2018. Accrued interest payable as of December 31, 2022, was $71 thousand. Accrued interest is payable at maturity.

 

Note Payable – Thomet

 

In December 2017, we entered into a $750 thousand, zero percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in 60 monthly principal payments of $13 thousand beginning in October 2018.

 

F-24

 

 

NOTE 11 – OTHER NOTES PAYABLE

 

Other notes payable consists of the following as of December 31,

           
In thousands  2022   2021 
Note Payable - Secured Supplier Note  $-   $2,243 
Notes Payable - other   11,627    7,924 
Total   11,627    10,167 
Less current portion   11,572    7,521 
Long Term Notes Payable  $55   $2,646 

 

Future maturities of notes payable are as follows for the years ending December 31, 2022:

 

In thousands

      
2023  $11,572 
2024   55 
Total  $11,627 

 

Secured Supplier Note Payable

 

On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $12.5 million (the “Secured Promissory Note”). The USD Note accrues interest at 18% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $250 thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016. This note was extended and amended multiple times and as of March 25, 2022, is paid in full.

 

Other Notes Payable

 

On July 29, 2021, the Company entered into a long-term loan from Leumi Bank totalling NIS 7 million, which at the time was approximately $2.16 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On November 28, 2021, the Company entered into another long-term loan from Leumi Bank totalling NIS 3.5 million, which at the time was approximately $1.1 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On August 11, 2021, the Company purchased vehicles using cash and financing of NIS 500 thousand, approximately $155 thousand, to be paid off in monthly interest and principal payments over 5 years. The loan accrues interest at 7.5% per annum and is secured by the vehicles. As of December 31, 2022, the remaining balance was NIS 342 thousand, approximately $97 thousand.

 

On March 27, 2022, the Company entered into another long-term loan from Leumi Bank totalling NIS 3.5 million, which at the time was approximately $1.1 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On September 13, 2022, the Company entered into a long-term loan from Hapoalim Bank totalling NIS 3 million, which at the time was approximately $0.9 million. The note accrues interest at 6.03% per annum and is payable in 36 instalments of principal and interest over 3 years. as of December 31, 2022, the outstanding balance was NIS 2.8 million, approximately $0.8 million.

 

During the year ended December 31, 2021, the Company entered into five lines of credit totalling NIS 17.5 million, as of December 31, 2021, the outstanding balance was NIS 13.6 million, approximately $4.4 million. These loans were replaced in 2022.

 

During the year ended December 31, 2022, the Company entered into five short term loans totalling NIS 26.8 million, approximately $7.6 million. The note accrues average interest at 6.3% per annum.

 

As of December 31, 2022, the Company was not in compliance with certain financial covenants related to the Bank Leumi and Bank Hapoalim debt. The Company’s failure to comply with these financial covenants could result in an event of default under its debt agreements. Therefore, we reclassified the total balance as current debt on the balance sheet. The Company is actively pursuing options to address its noncompliance. The lenders have not requested early repayment of the loan as of the date when these financial statements were available to be issued.

 

F-25

 

 

NOTE 12 – OTHER LIABILITIES

 

As of December 31, 2022 and 2021, other liabilities consisted of the following:

 

           
In thousands  2022   2021 
Other vendor payable  $801    801 
Dividend payable   153    1,418 
Others   705    1,882 
Total other liabilities   1,659    4,101 
Less current portion   (1,394)   (2,683)
Total long term other liabilities  $265   $1,418 

 

NOTE 13 – COMMITMENTS AND CONTINGENCIES

 

Profit Sharing Plan

 

We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the year ending December 31, 2022 and 2021, the company has elected to match, the total expense was $122 thousand and $108 thousand.

 

Operating Leases

 

As of December 31, 2022, we had 5 Operating leases as follows:

 

  ● Office space in Akron, Ohio, with monthly payments of $3 thousand and an incremental borrowing rate of 14.55%. As of December 31, 2022, we had 5 months remaining on the lease.
     
  ● Office space in Salt Lake City UT with monthly payments of $24 thousand. As of December 31, 2022, the Company had 44 months remaining on the lease.
     
  ● Dangot’s corporate offices are currently located at Yad harutzim 14 Tel-Aviv, Israel and serves as the company’s main operating location. As of December 31, 2022, we had 23 months remaining on the lease.
     
  ● The Company lease additional office space for our finance and service department at Yad harutzim 14 Tel-Aviv, Israel. As of December 31, 2022, the Company had 12 months remaining on the lease.
     
  ● The Company also lease office and warehouse space for our products and technical support staff in Rival Street, Tel-Aviv, Israel. As of December 31, 2022, the Company had 30 months remaining on the lease.

 

F-26

 

 

Other information related to our operating leases is as follows:

 

In thousands    
ROU asset - January 1, 2021  $76 
Amortization   (199)
Effective foreign exchange rates   

121

 
Increase   3558 
ROU asset - December 31, 2021   3,556 
Increase   - 
Effective foreign exchange rates   (256)
Amortization   (1,000)
ROU asset - December 31, 2022  $2,300 

 

In thousands    
Lease liability - January 1, 2021  $79 
Increase   3,558 
Effective foreign exchange rates   169 
      
Amortization   (199)
Lease liability - December 31, 2021   3,607 
Decrease   - 
Increase (Decrease)   - 
      
Effective foreign exchange rates   (261)
Amortization   (1,000)
Lease liability - December 31, 2022  $2,346 

 

As of December 31, 2022, our operating leases had a weighted average remaining lease term of 29 months and a weighted average discount rate of 5.7%.

 

The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2022:

      
In thousands    
Year  Minimum lease payments 
2023  $1,102 
2024   873 
2025   397 
2026   176 
2027   - 
Total   2,548 
Less interest   (202)
Present value of future minimum lease payments   2,346 
Less current obligations   (942)
Long term lease obligations  $1,404 

 

LITIGATION

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. The Company is defending the case. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020.

 

F-27

 

 

The company is not a party to any other pending material legal proceeding in which it is defending against any claims of material significance. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

 

NOTE 14 – STOCKHOLDERS’ EQUITY

 

PREFERRED STOCK

 

Series A

 

As of December 31, 2022 and 2021, there were 2,000,000 Series A preferred shares authorized and zero Series A preferred shares outstanding. The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 13 common shares.

 

Series B

 

As of December 31, 2022 and 2021, there was one (1) preferred share authorized and zero preferred shares outstanding.

 

Series C

 

As of December 31, 2022 and 2021, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 544,500 and 544,500 issued and outstanding, respectively. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum and have a liquidation preference of $1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of December 31, 2022 and 2021, the accrued dividends on the Series C Preferred Stock was $153 thousand and $126 thousand, respectively.

 

In 2021, certain holders of Series C Shares elected to convert $1.6 million or 1,600,530 Series C shares and $194 thousand in accrued dividends in exchange for 105,551 OMNIQ common stock shares.

 

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.

 

COMMON STOCK

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the December 2021, shareholders’ meeting. 841,500 shares were issued to employees and consultants in 2022, and no shares were issued under the Plan in 2021.

 

In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, one million (1,000,000) shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the September 2020, shareholders’ meeting. No shares were issued under the Plan in 2021, or 2022.

 

In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the years ending December 31, 2022 and 2021, employees purchased 7,025 ($37 thousand) shares and 2,186 ($16 thousand) shares of commons stock.

 

F-28

 

 

Warrants and Stock Options

 

In connection with the July 2021 Securities Purchase Agreement previously described, we issued warrants to purchase 171,429 shares of our common stock at an exercise price equal to $7.70 per Warrant Share, which warrants are exercisable for a period of five years from the issuance date. The warrants were valued at $1.3 million.

 

Options and warrants are valued at the grant date using the Black-Scholes valuation methodology. The Company determines the assumptions used in the valuation of warrants and option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options and warrants granted throughout the year.

 

The valuation assumptions used to determine the fair value of each option and warrant awarded in 2022: expected stock price volatility ranged from 104.33 to 126.44%; expected term in years 3.25; and risk-free interest rate ranged from 1.76% to 4.52%.

 

The valuation assumptions used to determine the fair value of each warrant awarded in 2021: expected stock price volatility 151.0% expected term in years 5; and risk-free interest rate 0.41%.

 

No additional options were issued in 2021.

 

No warrants were exercised during the year ended December 31, 2022.

 

For warrants exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $683 thousand.

 

The following table summarizes information about warrants granted during the years ended December 31:

   2022   2021 
   Number of
Warrants		   Weighted
Average
Exercise Price		   Number of
Warrants		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,378,929   $7.40    1,366,667   $7.19 
Warrants granted   112,805    6.59    171,429    7.70 
Warrants expired   10,000    8.00    40,000    10.00 
Warrants exercised   -    -    119,167    6.99 
                     
Balance, end of year   1,481,734    7.34    1,378,929    7.40 
                     
Exercisable warrants   1,424,234   $7.38    1,295,596   $6.38 

 

Outstanding warrants as of December 31, 2022 are as follows:

   Weighted Average       Weighted       Weighted 
Range of  Residual Life       Average       Average 
Exercise  Span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
5.91   4.33    40,000   $5.91    5,000   $5.91 
6.95   4.23    42,805    6.95    42,805    6.95 
7.00   2.62    847,500    7.00    855,000    7.00 
7.50   3.68    250,000    7.50    250,000    7.50 
7.70   3.52    171,429    7.70    171,429    7.70 
                          
10.00   0.39    100,000    10.00    100,000    10.00 
                          
5.91 to 10.00   2.41    1,481,734   $7.34    1,424,234   $7.38 

 

F-29

 

 

Warrants outstanding have the following expiry date and exercise prices as of the years ended December 31:

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 27, 2022   8.00    -    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    50,000 
October 06, 2024   7.00    847,500    847,500 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 7, 2026   7.70    171,429    171,429 
December 04, 2027   7.50    83,333    83,333 
March 25, 2027   6.95    42,805    - 
May 1, 2027   7.00    30,000    - 
May 1, 2027   5.91    40,000    - 
         1,481,734    1,378,929 


 

We have a stock option plan whereby the Board of Directors, may grant to directors, officers, employees, or consultants of the Company options to acquire common shares. The Board of Directors of the Company has the authority to determine the terms, limits, restrictions and conditions of the grant of options, to interpret the plan, and make all decisions relating thereto. The plan was adopted by the Company’s Board of Directors on November 17, 2014 in order to provide an inducement and serve as a long-term incentive program. The maximum number of common shares that may be reserved for issuance was set at 500,000.

 

The option exercise price is established by the Board of Directors and may not be lower than the market price of the common shares at the time of grant. The options may be exercised during the option period determined by the Board of Directors, which may vary, but will not exceed ten years from the date of the grant. There are 500,000 of the Company’s common shares which may be issued pursuant to the exercise of share options granted under the Plan.

 

For options exercised during the year ended December 31, 2022, the difference between the fair value of the Common Stock issued and the respective exercise price was $369 thousand. As of December 31, 2022, the intrinsic value for vested stock options was $477 thousand.

 

For options exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $1.5 million. As of December 31, 2021, the intrinsic value for vested stock options was $6.6 million.

 

Stock Options - The following table summarizes information about stock options granted during the years ended December 31,

 

   2022   2021 
   Number of
Stock
Options		   Weighted
Average
Exercise Price		   Number of
Stock
Options		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,559,300   $4.58    1,811,550   $4.32 
                     
Stock options granted   841,500    -    -    - 
Stock options expired   -    -    28,750    - 
Stock options cancelled, forfeited   9,000    -    -    - 
Stock options exercised   201,217    -    223,500    - 
                     
Balance, end of year   2,190,583    5.00    1,559,300    4.58 
                     
Exercisable stock options   1,420,312   $4.96    1,065,133   $4.56 

 

F-30

 

 

Stock options outstanding at the end of the year have the following expiry date and exercise prices as of December 31,

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 17, 2022   1.50    -    38,017 
February 17, 2022   1.80    -    76,033 
February 28, 2023   5.00    20,000    20,000 
March 05, 2023   2.40    242,000    247,000 
July 31, 2023   5.00    127,500    127,500 
October 31, 2023   4.40    10,000    54,000 
November 30, 2023   5.40    120,250    131,750 
November 20, 2024   10.00    125,000    125,000 
April 20, 2025   4.20    10,000    10,000 
March 1, 2027   5.14    648,500    - 
March 1, 2027   5.65    140,000    - 
May 1, 2027   5.90    30,000    - 
October 31, 2027   5.98    19,000    - 
September 30, 2030   4.40    318,333    350,000 
September 30, 2030   4.84    380,000    380,000 
                
         2,190,583    1,559,300 

 

F-31

 

 

We recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31,

 

           
   2022   2021 
In thousands        
Stock compensation  $1,321   $951 
Stock Option vesting   1,852    1,600 
Total  $3,173   $2,551 

 

NOTE 15 – RELATED PARTY TRANSACTIONS

 

In February 2020 we amended the consulting agreement with Mr. Carlos J. Nissensohn, a principal shareholder of the Company and a family member of a Director and Officer of the Company. The terms and condition of the contract are as follows:

 

  ● 48-month term with 90-day termination notice by the Company
     
  ● A monthly fee of $30 thousand.
     
  ● If we procure debt financing during the term of Mr. Nissensohn’s agreement, without any equity component, Mr. Nissensohn shall be entitled to 3% of the gross funds raised, however if we are required to pay a success fee to another external entity, then Mr. Nissensohn shall be entitled to only 2% of the gross funds raised.
     
  ● In addition to the above, in the event of an equity financing resulting in gross proceeds of at least $3 million to us within 24 months of the date the contract, Mr. Nissensohn shall further be entitled to certain warrants to be granted by us which upon their exercise pursuant to their terms, Mr. Nissensohn shall be entitled to receive OMNIQ shares which represent 3% of the OMNIQ issued share capital immediately prior to the consummation of such investment. The warrants will carry an exercise price per warrant/share representing 100% of the closing price per share as closed in the equity financing. This section and the issue of the warrant by OMNIQ are subject to the approval of the Board of Directors of OMNIQ. However, if the Board does not approve the issuance of warrants; then Mr. Nissensohn will be entitled to a fee with the equivalent value based on a Black Scholes valuation
     
  ● In addition to the above, Mr. Nissensohn will be entitled to a $80 thousand one-time payment which shall be paid on the 1st day that the OMNIQ shares become traded on the NASDAQ or NYSE Stock Market within 24 months of the date of the contract
     
  ● In addition to the aforementioned, in the event that we close any M&A transaction with a third party target, Mr. Nissensohn shall be entitled to a success fee in the amount equal to 5% of the total transaction price, in any combination of cash and shares that will be determined by OMNIQ

 

Additional related party transactions are discussed in Note 10.

 

NOTE 16 – CONCENTRATION AND GEOGRAPHIC DATA

 

For the years ended December 31, 2022 and 2021, one customer accounted for 30% and 23%, respectively, of the Company’s revenues.

 

Information about Geographic Areas

 

Revenues by geography are based on the billing addresses of our customers. The following tables set forth revenues by geographic area for the years ended December 31,

 

           
In thousands  2022   2021 
Revenues:          
United States  $51,023   $53,725 
Israel   42,217    21,848 
Rest of the world   9,305    2,678 
Total revenues  $102,545   $78,251 

 

The Company’s operations are subject to various political, economic, and other risks and uncertainties inherent in the countries in which the Company operates. Among other risks, the Company’s operations are subject to the risks of restrictions on transfer of funds; export duties, quotas and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; and political conditions and governmental regulations.

 

NOTE 17 – INCOME TAX

 

For the year ended December 31, 2022, the Company has $35 thousand of current income tax provision (US State & Local and Foreign) and $30 thousand deferred income tax expense.

 

The tax effect of temporary differences that give rise to deferred tax assets and deferred tax liabilities are as follows as of December 31,

 

           
In thousands        
Deferred tax assets  2022   2021 
Reserves and deferred revenue  $411   $182 
163(j) Limitation   2,260    1,682 
Foreign deferred tax assets   135    

165

 
Net operating loss   8,353    7,164 
Total gross deferred tax assets   11,158    9,193 
Less: Valuation Allowance   (10,890)   (8,720)
Net deferred tax assets   269    473 
           
Deferred tax liabilities          
Amortization of intangible assets and depreciation   (134)   (308)
Total deferred tax liabilities   (134)   (308)
           
Net deferred tax assets  $135   $

165

 

 

F-32

 

 

Components of net deferred tax assets, including a valuation allowance, are as follows as of December 31:

           
   2022   2021 
Deferred tax assets  $11,025   $8,885 
Valuation allowance   (10,890)   (8,720)
Total deferred tax assets  $135   $

165

 

 

The valuation allowance for deferred tax assets as of December 31, 2022 and 2021 was $10.9 million and $8.7 million, respectively. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Management has recorded a 100% Valuation Allowance, against its U.S. Net Deferred Tax Assets, since Management believes it is more likely than not that it will not be realized at the date of this statement. The Company will continue to monitor the potential utilization of this asset. Should factors and evidence change to aid in this assessment, a potential adjustment to the valuation allowance in future periods may occur. The Company records any penalties and interest as a component of operating expenses.

 

The reconciliation between statutory rate and effective rate is as follows as of December 31,:

 

           
   2022   2021 
Federal statutory tax rate   21.00%   21.0%
State taxes   (0.07)%   (0.03)%
Foreign income taxes   (4.45)%   

(6.38

)%
Change in valuation allowance   (16.13)%   (15.24)%
Return to provision adjustments   (.03)%   .079%
Other   (.76)%   (1.37)%
        
Effective tax rate   (.44)%   (1.23)%

 

The Company reported no uncertain tax liability as of December 31, 2022 and expects no significant change to the uncertain tax liability over the next twelve months. The Company’s 2015, 2016, 2017, 2018, 2019, 2020 and 2021 federal and state income tax returns are open for examination by the applicable governmental authorities.

 

As of December 31, 2022, the Company had a net operating loss (NOL) carryforward of approximately $39.7 million. A portion of the NOL carryforward begins to expire in 2027. Under Section 382 of the Internal Revenue Code of 1986, as amended (“IRC Section 382”), a corporation that undergoes an “ownership change” is subject to limitations on its use of pre-change NOL carryforwards to offset future taxable income. Within the meaning of IRC Section 382, an “ownership change” occurs when the aggregate stock ownership of certain stockholders (generally 5% shareholders, applying certain look-through rules and aggregation rules which combine unrelated shareholders that do not individually own 5% or more of the corporation’s stock into one or more “public groups” that may be treated as 5-percent shareholder) increases by more than 50 percentage points over such stockholders’ lowest percentage ownership during the testing period (generally three years). In general, the annual use limitation equals the aggregate value of common stock at the time of the ownership change multiplied by a specified tax-exempt interest rate. The Company has not completed a study as to whether there is a 382 limitation on its NOLs that will limit or possibly eliminate the use of its NOLs in the future. Company’s Management has recorded a 100% valuation allowance on the entire NOL as it believes that it is more likely than not that the deferred tax asset associated with the NOLs will not be realized regardless of whether or not an “ownership change” has occurred.

 

F-33

 

 

EXHIBIT INDEX—we will update the exhibit index

 

Exhibit No.   Description
     
(a)   Exhibits.
     
3.1   Form of Certificate of Amendment to the Certificate of Incorporation, as amended, dated November 18, 2019 incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on November 18, 2019.
     
3.2   Amendment to Certificate of Designation of Series C Preferred Stock on June 17, 2016, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 21, 2016.
     
3.3   Form of Certificate of Amendment to the Certificate of Incorporation, as amended, of OMNIQ Corp., dated September 30, 2020, incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on October 2, 2020.
     
4.1   $12,492,136.51 Secured Promissory Note, from Quest Solution, Inc., Bar Code Specialties, Inc., Quest Marketing, Inc., Quest Solution Canada Inc., Quest Exchange Ltd. and their subsidiaries and/or affiliates, jointly and severally, to ScanSource, Inc., incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 22, 2016.
     
4.2*   Description of Securities
     
4.3   $483,173.60 CAD Secured Promissory Note, from Quest Solution, Inc., Bar Code Specialties, Inc., Quest Marketing, Inc., Quest Solution Canada Inc., Quest Exchange Ltd. and their subsidiaries and/or affiliates, jointly and severally, to ScanSource, Inc., incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the SEC on July 22, 2016.
     
4.4   Form of Warrant, incorporated by referenced to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 9, 2019.
     
4.5   Form of Placement Agent Warrant, incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the SEC on April 9, 2019.
     
10.1   Employment Agreement by and between the Company and Shai Lustgarten dated February 17, 2017, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 6, 2017.
     
10.2   Modification Agreement by and between the Company and Shai Lustgarten dated February 17, 2017, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 6, 2017.
     
10.14   Consulting Agreement by and between the Company and Carlos J Nissensohn dated August 2, 2017 incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 4, 2017.
     
10.15   Consulting Agreement by and between the Company and YES-IF dated September 8, 2017, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 8, 2017.
     
10.17   Employment Agreement by and between the Company and Benjamin Kemper dated October 2, 2017, incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on October 5, 2017.
     
10.24   Employment Agreement by and between the Company and David Marin dated February 28, 2018. 2018 Equity Incentive Plan incorporated by reference to Exhibit 10.9 to the Company’s Current Report on Form 8-K filed with the SEC on March 12, 2018.

 

28
 

 

10.36   Neev Nissenson Employment Agreement, incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on September 9, 2019.
     
10.37   Asset Purchase Agreement, dated February 28, 2020, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 4, 2020.
     
10.38   Shai Lustgarten Employment Agreement, dated as of February 27, 2020, incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on March 4, 2020.
     
10.39   Consulting Agreement, dated as of February 27, 2020, incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on March 4, 2020.
     
10.40   Asset Purchase Agreement on February 28, 2020, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 4, 2020.
     
10.41   Employment Agreement with Shai Lustgarten on September, 2019, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 9, 2019.
     
10.42   Consulting Agreement with Carlos J. Nissensohn on September, 2019, incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 9, 2019.
     
10.43   2020 Equity Incentive Plan, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2020.
     
21.1*   Subsidiaries of the Registrant
     
23.1*   Consent of Independent Registered Public Accounting Firm
     
31.1*   Certification of our Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2*   Certification of our Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*   Certification of our Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

ITEM 16. NONE.

 

29

 

 EX-4.2 2 ex4-2.htm

 

Exhibit 4.2

 

Description of Securities

 

We are authorized to issue up to 15,000,000 shares of common stock, $0.001 per share. We have designated 2,000,000 shares of preferred stock as Series A Preferred Stock, one share of preferred stock as Series B Preferred Stock and 3,000,000 shares of preferred stock as Series C Preferred Stock.

 

As of March 10, 2023, we have 7,882,628 shares of common stock outstanding. The following description of our common stock is a summary and is subject to and is qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation which is incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-k for the year ended December 31, 2022.

 

Common Stock

 

The holders of common stock are entitled to one vote per share. Our Certificate of Incorporation does not expressly prohibit cumulative voting. The holders of our common stock are entitled to share ratably such dividends, if any, as may be declared by the Board of Directors out of legally available funds. Upon liquidation, dissolution or winding- up, the holders of our common stock are entitled to share ratably in all assets that are legally available for distribution. All outstanding shares of common stock are fully paid and non- assessable. The holders of our common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of holders of any series of preferred stock, which may be designated solely by action of the Board of Directors and issued in the future.

 

Our common stock is quoted under the symbol “OMQS”.

 

   

 EX-21.1 3 ex21-1.htm

 

Exhibit 21.1

 

Subsidiaries of the Registrant

 

Name   Jurisdiction of Organization
     
Quest Marketing, Inc.   Oregon
     
HTS Image Processing, Inc.   Delaware
     
OmniQ Vision Inc.   Delaware
     
HTS Image Ltd.   Israel
     
OmniQ Technologies Ltd   Israel
     
Dangot Computers, Ltd   Israel

 

   

 EX-23.1 4 ex23-1.htm

 

EXHIBIT 23.1

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

We consent to the incorporation by reference in the Registration Statement of OMNIQ Corp. and subsidiaries, formerly known as Quest Solution, Inc., on Form S-8 (File No. 333-213746) of our report dated March 30, 2022, with respect to our audit of the consolidated financial statements of OMNIQ Corp. as of December 31, 2022 and for the year then ended, which report is included in this Annual Report on Form 10-K.

 

/s/ Haynie & Company

Haynie & Company

 

Salt Lake City, Utah

March 30, 2023

 

   

 EX-31.1 5 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION BY CHIEF EXECUTIVE OFFICER

 

PURSUANT TO RULE 13A-14(a) under the Securities Exchange Act of 1934

 

I, Shai Lustgarten, certify that:

 

1. I have reviewed this annual report on Form 10-K of OMNIQ Corp. for the fiscal year ended December 31, 2022;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d – 15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 30, 2023

 

By: /s/ Shai Lustgarten  
  Shai Lustgarten  
  Chief Executive Officer, Chairman of the Board and Principal Executive Officer  

 

   

 EX-31.2 6 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATION BY CHIEF FINANCIAL OFFICER

 

PURSUANT TO RULE 13A-14(a) under the Securities Exchange Act of 1934)

 

I, Neev Nissenson, certify that:

 

1. I have reviewed this annual report on Form 10-K of OMNIQ Corp. for the fiscal year ended December 31, 2022;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d – 15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 30, 2023

 

By: /s/ Neev Nissenson  
  Neev Nissenson  
  Director, Chief Financial Officer and Principal Accounting Officer  

 

   

 EX-32.1 7 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of OMNIQ Corp. (the “Company”) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Shai Lustgarten, Chief Executive Officer and Chairman of the Board does certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 30, 2023

 

By: /s/ Shai Lustgarten  
  Shai Lustgarten  
  Chief Executive Officer, Chairman of the Board and Principal Executive Officer  

 

   

 EX-32.2 8 ex32-2.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of OMNIQ Corp. (the “Company”) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Neev Nissenson, Chief Executive Officer and Chairman of the Board does certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 30, 2023

 

By: /s/ Neev Nissenson  
  Neev Nissenson  
 

Director, Chief Financial Officer and Principal

Accounting Officer

  

 

   

 EX-101.SCH 9 omqs-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - BUSINESS ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - RELATED PARTY NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - OTHER NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - OTHER LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - BUSINESS ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - OTHER NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - OTHER LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - INCOME TAX (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - BUSINESS ACQUISITIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - OTHER NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF STOCK COMPENSATION EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF REVENUES (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - INCOME TAX (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 omqs-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 omqs-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 12 omqs-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Finite-Lived Intangible Assets by Major Class [Axis] Trade Names [Member] Customer Relationships [Member] Other Intangible Assets [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Noncontrolling Interest [Member] AOCI Attributable to Parent [Member] Asset Class [Axis] Indefinite-Lived Intangible Assets [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Accounts Payable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Vendor [Member] Plan Name [Axis] Equity Incentive Plan [Member] Title of Individual [Axis] Board of Directors [Member] 2020 Plan [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Computer Equipment [Member] Office Equipment [Member] Software Development [Member] Leasehold Improvements [Member] Vehicles [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Business Acquisition [Axis] Dangot Computers Ltd [Member] Western Alliance Bank [Member] Related Party Transaction [Axis] Action Capital [Member] Legal Entity [Axis] Scan Source Inc [Member] Blue Star [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Dangot Share Purchase Agreement [Member] Dangot Computers Ltd [Member] Omniq Technologies [Member] Haim Dangot [Member] Investment, Name [Axis] Accounts Receivable [Member] Customer [Member] One Customer [Member] Manufacturing and Lab Equipment [Member] Finite-Lived Intangible Assets [Member] Goodwill [Member] Intellectual Property [Member] Business Finance Agreement [Member] Lender Name [Axis] Bridge Bank [Member] Debt Instrument [Axis] Note Payable Marin [Member] Note Payable - Thomet [Member] Note Payable Secured Supplier [Member] Notes Payable Other [Member] Other Notes Payable[Member] Long-Term Debt, Type [Axis] Secured Promissory Note [Member] Leumi Bank [Member] Award Type [Axis] Israeli Prime Rate [Member] Hapoalim Bank [Member] Short-Term Debt, Type [Axis] Line of Credit [Member] Geographical [Axis] Akron [Member] Salt Lack City [Member] Yad Harutzim [Member] Rival Street [Member] Director [Member] Preferred Stock Series C [Member] Holders [Member] Employees And Consultants [Member] Employee Stock Purchase Plan [Member] Securities Purchase Agreement [Member] Share Purchase Option Plan [Member] Exercise Price Range [Axis] Exercise Price Range 1 [Member] Exercise Price Range 2 [Member] Exercise Price Range 3 [Member] Exercise Price Range 4 [Member] Exercise Price Range 5 [Member] Exercise Price Range 6 [Member] Award Date [Axis] February Twenty Seven Thousand Twenty Two [Member] May 18, 2023 [Member] October Fourteen Two Thousand Twenty Three [Member] October Six Two Thousand Twenty Four [Member] September 1, 2025 [Member] June 4, 2026 [Member] July 7, 2026 [Member] December 4, 2027 [Member] March Twenty Fifth Two Thousand Twenty Seven [Member] May First Two Thousand Twenty Seven [Member] May First Two Thousand Twenty Seven One[Member] February 17, 2022 [Member] February 17, 2022 [Member] February 28, 2023 [Member] March 05, 2023 [Member] July 31, 2023 [Member] October 31, 2023 [Member] November 30, 2023 [Member] November 20, 2024 [Member] April 20, 2025 [Member] March 1, 2027 [Member] March 1, 2027 [Member] October 31, 2027 [Member] September 30, 2030 [Member] September 30, 2030 [Member] Consulting Agreement [Member] Mr. Carlos J. Nissenson [Member] Revenue Benchmark [Member] Customer One [Member] UNITED STATES ISRAEL Rest Of The World [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement [Table] Statement [Line Items] ASSETS Current assets Cash and cash equivalents Accounts receivable, net Inventory Prepaid expenses Other current assets Total current assets Property and equipment, net of accumulated depreciation of $1,030 and $2,203 respectively Goodwill Trade name, net of accumulated amortization of $4,458 and $3,863, respectively Customer relationships, net of accumulated amortization of $10,762 and $9,660, respectively Other intangibles, net of accumulated amortization of $1,541 and $1,457, respectively Right of use lease asset Other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Current liabilities Accounts payable and accrued liabilities Line of credit Accrued payroll and sales tax Notes payable, related parties – current portion Notes payable – current portion Lease liability – current portion Other current liabilities Total current liabilities Long term liabilities Notes payable, related party, less current portion Accrued interest and accrued liabilities, related party Notes payable, less current portion Lease liability Other long-term liabilities Total liabilities Stockholders’ equity deficit Preferred Stock Value Common stock; $0.001 par value; 15,000,000 shares authorized; 7,714,780 and 7,459,534 shares issued and outstanding, respectively. Additional paid-in capital Accumulated deficit Cumulative translation adjustment Total OmniQ stockholders’ equity (deficit) Non-controlling interest TOTAL EQUITY (DEFICIT) Total liabilities and equity (deficit) Property and equipment, accumulated depreciation Other intangibles, accumulated amortization Preferred stock, par value Preferred stock, shares designated Preferred stock, shares outstanding Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares, issued Common stock, shares outstanding Income Statement [Abstract] Revenues Total revenues Cost of goods sold Cost of goods sold Gross profit Operating expenses Research & development Selling, general and administrative Depreciation Amortization Total operating expenses Loss from operations Other income (expenses): Interest expense Other (expenses) income Total other expenses Net loss before income taxes Provision for income taxes Current Total provision for income taxes Net loss Net income attributable to non-controlling interest Net loss attributable to OmniQ Corp Foreign currency translation adjustment Comprehensive loss Less comprehensive loss attributable to non-controlling interests Comprehensive loss attributable to OmniQ Corp Reconciliation of net loss to net loss attributable to common shareholders Less: dividends attributable to non-common stockholders’ of OmniQ Corp Net loss less non-common stockholder dividends Non-common stockholder dividends attributable to non-controlling interest Net loss attributable to common stockholders’ of OmniQ Corp Net loss per share - basic attributable to common stockholders’ of OmniQ Corp Weighted average number of common shares outstanding - basic Beginning balance, value Beginning balance, shares Dividends Dividend declared to non-controlling interest ESPP stock issuance ESPP Stock Issuance, shares Stock-based compensation – options, warrants, issuances Stock-based compensation - options, warrants, issuances, shares Stock issued for services Stock and warrant issued for services, shares Warrant issuances, net of issuance costs Stock and warrant issuances, net of issuance costs, shares Exercise of stock options Exercise of stock options and warrants, shares Stock and warrant issuance for acquisition Stock and warrant issuance for Acquisition, shares Dangot acquisition Exercise to purchase additional Dangot shares Post-acquisition adjustment Cumulative translation adjustment Other Conversion of equity Conversion of equity, shares Conversion of debt Conversion of debt, shares Net income (loss) Non-controlling interests, distributions and other Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operations Net loss Adjustments to reconcile net loss to net cash provided by operating activities: Loss on disposal of PP&E Noncash interest expense Stock-based compensation Stock and warrant issued for services Depreciation and amortization Amortization of ROU asset Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Inventory Other assets Accounts payable and accrued liabilities Accrued interest and accrued liabilities, related party Accrued payroll and sales taxes payable Lease liability Deferred tax assets, net Other liabilities Net cash provided by (used in) operating activities Cash flows from investing activities Payment for additional ownership in subsidiary Payment for acquisition, net of cash acquired Purchase of property and equipment Proceeds from sale (purchase) of other assets Net cash used in investing activities Cash flows from financing activities Proceeds from ESPP stock issuance Proceeds from exercise of options and warrants Dividends paid to non-controlling interest Net proceeds from issuance of common stock Payments on notes payable Proceeds from the issuance of notes payable Net activity on line of credit Net cash (used in) provided by financing activities Net change in cash and cash equivalents Effect of foreign exchange rates on cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Non-cash activities: Declared dividends payable Net assets acquired in business combination Stock compensation in exchange for debt Purchase of PP&E with financing Debt conversion Equity conversion Right of use asset acquired in exchange for lease liability Change in terms of accounts payable Supplemental disclosure of cash flow information: Cash paid for interest Cash paid for income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN Business Combination and Asset Acquisition [Abstract] BUSINESS ACQUISITIONS Receivables [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORY Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND INTANGIBLE ASSETS Debt Disclosure [Abstract] CREDIT FACILITIES AND LINE OF CREDIT Related Party Notes Payable RELATED PARTY NOTES PAYABLE OTHER NOTES PAYABLE Other Liabilities Disclosure [Abstract] OTHER LIABILITIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS’ EQUITY Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Concentration And Geographic Data CONCENTRATION AND GEOGRAPHIC DATA Income Tax Disclosure [Abstract] INCOME TAX Principles of Consolidation and Basis of Presentation Use of Estimates Cash and Cash Equivalents Accounts Receivable Inventory Property and Equipment Fair Value of Financial Instruments Definite-lived Intangible Assets Indefinite-lived Intangible Assets, Including Goodwill Accounts Payable Leases Purchase Accounting and Business Combinations Revenue Recognition Stock-Based Compensation Advertising Foreign Currency Translation Income Taxes Comprehensive Income (Loss) Net Loss Per Common Share Recent Accounting Pronouncements SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORY SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE SCHEDULE OF NOTES PAYABLE, RELATED PARTIES SCHEDULE OF OTHER NOTES PAYABLE SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE SCHEDULE OF OTHER LIABILITIES SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF OUTSTANDING WARRANTS SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES SCHEDULE OF STOCK OPTIONS GRANTED SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES SCHEDULE OF STOCK COMPENSATION EXPENSE SCHEDULE OF REVENUES SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful life Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential shares excluded from diluted net loss per share Schedule of Product Information [Table] Product Information [Line Items] Allowance for doubtful accounts Impairment indefinite-lived intangible assets Useful life Remaining weighted average lifespan Impairment indefinite-lived intangible assets Concentration risk percentage Shares of Common Stock authorized Shares issued Marketing and advertising costs Income tax Likelihood Weighted-average number of common shares outstanding Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Working capital deficit Accumulated deficit Business acquisition, description of acquired entity Line of credit Repayments of related party debt Accounts payable, related parties Debt instrument, interest rate, stated percentage Cash payments Accrued payable to owner Fair value of stock issued (220,103 shares) Debt assumed Total consideration Cash Accounts receivable Inventory Other assets Property and equipment Goodwill Trade name Customer relationship Other intangible assets Assets acquired Current liabilities assumed Non-controlling interest Net assets acquired Fair value of stock issued shares Purchase price percentage Issued shares Value issued Cash Payable to owner Remaining acquired percentage Percentage of remaining shares on fully diluted basis Purchase of additional option percent Ownership percent Payment to purchase additional shares Purchase of shares, percent Business acquisition, pro forma revenue Business acquisition, pro forma net income (loss) Revenues Net income Trade accounts receivable Less allowance for doubtful accounts Total accounts receivable (net) Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts, Notes, Loans and Financing Receivable [Line Items] Raw materials Inventory in transit Finished goods (less allowance) Total inventories Property and equipment, Gross Less: accumulated depreciation Property and equipment, Net Depreciation expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Intangibles gross Accumulated amortization Intangibles, net 2023 2024 2025 2026 2027 Thereafter Total Impairment charges Finite-lived intangible asset, useful life Amortization expense Estimated useful lives Line of Credit Facility [Table] Line of Credit Facility [Line Items] Line of credit facility maximum borrowing capacity Percentage of reserve account Line of credit, interest rate, description Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Total notes payable Less current portion Long-term portion Interest expense Notes payable related parties Annual interest rate note payable Debt instrument, frequency of periodic payment Principal payments Accrued interest payable Total Less current portion Long Term Notes Payable 2023 2024 Total Principal amount Debt interest rate Principal and accrued interest amount Loans payable Number of installements Debt instrument term Loans payable outstanding amount Short term loans Accrues average interest Other vendor payable Dividend payable Others Total other liabilities Less current portion Total long term other liabilities ROU asset, Beginning balance Amortization Effective foreign exchange rates Increase Increase ROU asset, Ending balance Lease liability, Beginning balance Decrease Effective foreign exchange rate Amortization Lease liability, Ending balance 2023 2024 2025 2026 2027 Total Less interest Present value of future minimum lease payments Less current obligations Long term lease obligations Product Liability Contingency [Table] Product Liability Contingency [Line Items] Total expense Monthly payments Weighted average discount rate Remaining lease month Weighted average remaining lease term Unpaid commission Number of warrants, Outstanding, Beginning of period Weighted Average Exercise Price balance, Outstanding, Beginning of period Number of warrants, Warrants granted Weighted Average Exercise Price, Warrants granted Number of warrants, Warrants expired Weighted Average Exercise Price, Warrants expired Number of warrants, Warrants exercised Weighted Average Exercise Price, Warrants exercised Number of warrants, Outstanding, End of period Weighted Average Exercise Price, Outstanding, End of period Number of warrants, Exercisable warrants Weighted Average Exercise Price, Exercisable warrants Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Range of Exercise Prices, upper range limit Weighted Average Residual Life Span (in years) Outstanding Warrants Weighted Average Exercise Price Exercisable Warrants Weighted Average Exercise Price Range of Exercise Prices, lower range limit Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Expiry Date Warrant Exercise Prices Warrant Outstanding Number of stock options, Outstanding, Beginning of period Weighted Average Exercise Price, Outstanding, Beginning of period Number of stock options, Stock options granted Weighted Average Exercise Price, Stock options granted Number of stock options, Stock options expired Weighted Average Exercise Price, Stock options expired Number of stock options, Stock options cancelled, forfeited Weighted Average Exercise Price, Stock options cancelled, forfeited Number of stock options, Stock options exercised Weighted Average Exercise Price, Stock options exercised Number of stock options, Outstanding, End of period Weighted Average Exercise Price, Outstanding, Ending of period Number of stock options, Exercisable stock options Weighted Average Exercise Price, Exercisable stock options Expiry Date Exercise Prices Stock option outstanding Stock compensation Stock Option vesting Total Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, shares authorized Preferred stock, voting rights Dividends payable, amount per share Liquidation preference Accrued dividends Stock issued during period, value, conversion of convertible securities Stock issued during period, shares, conversion of convertible securities Preferred stock conversion, description Shares issued Value issued Issued warrants shares Exercise price Warrants valued Expected volatility rate minimum Expected volatility rate maximum Expected term Risk- free interest rate Risk- free interest rate Stock price volatility Risk-free interest rate Stock issued during period, value, warrants exercised Reserved for issuance Options granted Stock issued during period, value, stock options exercised Intrinsic value for vested stock options Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Debt periodic payment Equity component description Gross proceeds Ownership percentage Warrant exercise price percentage Payment of financing and stock issuance costs Transaction price percentage Reserves and deferred revenue 163(j) Limitation Foreign deferred tax assets Net operating loss Total gross deferred tax assets Less: Valuation Allowance Net deferred tax assets Amortization of intangible assets and depreciation Total deferred tax liabilities Net deferred tax assets Deferred tax assets Valuation allowance Federal statutory tax rate State taxes Foreign income taxes Change in valuation allowance Return to provision adjustments Other Effective tax rate Current income tax provision Deferred income tax expense benefit Valuation allowance for deferred tax assets Net operating loss carryforward Schedule of Estimated Useful Lives of Property and Equipment. Intangible assets intangible assets indefinite lived policy. One Vendor [Member] Reverse Stock Split [Policy Text Block] Equity Incentive Plan [Member] Board Of Directors [Member] 2020 Plan [Member]. Net loss after noncommon stockholder dividends Net income after noncommon stockholder dividends attributable to noncontrolling interest Working capital deficit. Blue Star [Member] Western Alliance Bank [Member] Action Capital [Member] Scan Source Inc [Member] Dangot Computers Ltd [Member] Dangot Share Purchase Agreement [Member] Dangot Computers Ltd [Member] Omniq Technologies [Member] Accrued Payable to Owner. Haim Dangot [Member] Remaining acquired percentage Percentage of remaining shares on fully diluted basis. Purchase of additional option percent. Percentage of purchase of shares. Fair value of stock issued. Business combination recognized identifiable assets acquired and liabilities assumed goodwill. Business combination recognized identifiable assets acquired and liabilities assumed trade name. Business combination recognized identifiable assets acquired and liabilities assumed customer relationship. Customer One [Member] One Customer [Member] Dividend declared to non controlling interest. Customer [Member] Stock issued during period warrant issuances net of issuance costs. Stock issued during period value exercise of stock options and warrants. Stock issued during period value for dangot acquisition. Exercise to purchase additional dangot acquisition. Adjustments for post acquisition to additional paid in capital other Manufacturing and Lab Equipment [Member] Stock issued during period shares warrant issuances net of issuance costs, Stock issued during period shares exercise of stock options and warrants. Business Finance Agreement [Member] Bridge Bank [Member] Percentage of reserve account. Conversion of debt shares. Note Payable Marin [Member] Note Payable Thomet [Member] Schedule of Future Maturities Of Notes Payable Related Parties [Table Text Block] Increase in accounts payable and accrued liabilities, related party. Note Payable Secured Supplier [Member] Other Notes Payable[Member] Payment for additional ownership in subsidiary. Proceeds fom repayments of sale of other productive assets. Secured Promissory Note [Member] Leumi Bank [Member] Declared dividends payable. Net assets obtained net of cash including noncontrolling interest. Israeli Prime Rate [Member] Purchase of PPP with financing. Right of use lease asset on non cash information. Change in terms of accounts payable. Number of installments. Loans payable outstanding amount. Hapoalim Bank [Member] Akron [Member] Salt Lack City [Member] Yad Harutzim [Member] Rival Street [Member] Increase decrease in right of use asset. Operating lease asset of effective foreign exchange rate. Increase decrease in operating lease liability. Amortization of operating lease liability. Operating lease liability effective foreign exchange rate. Unpaid commission. Preferred Stock Series C [Member] Holders [Member] Employees And Consultants [Member] Consultants and Advisors [Member] Employee Stock Purchase Plan [Member] Securities Purchase Agreement [Member] Stock issued during period value warrants exercised. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. Schedule of Outstanding Warrants [Table Text Block] Exercise Price Range 1 [Member] Exercise Price Range 2 [Member] Exercise Price Range 3 [Member] Exercise Price Range 4 [Member] Exercise Price Range 5 [Member] Exercise Price Range 6 [Member] Trade And Other Accounts Payable [Policy Text Block] Schedule of warrants outstanding expiry date and exercise prices [Table Text Block] February Twenty Seven Thousand Twenty Two [Member] October Fourteen Two Thousand Twenty Three [Member] October Six Two Thousand Twenty Four [Member] June 4, 2026 [Member] July 7, 2026 [Member] December 4, 2027 [Member] March Twenty Fifth Two Thousand Twenty Seven [Member] May First Two Thousand Twenty Seven [Member] May First Two Thousand Twenty Seven One[Member] May 18, 2023 [Member] Share Purchase Option Plan [Member] Consulting Agreement [Member] Mr. Carlos J. Nissenson [Member] Equity component description. Warrant exercise price percentage. Total transaction price percentage. Geographic Data [Text Block] Deferred tax assets. Valuation allowance for deferred tax assets. February 17, 2022 [Member] February 28, 2023 [Member] March 05, 2023 [Member] July 31, 2023 [Member] October 31, 2023 [Member] November 30, 2023 [Member] November 20, 2024 [Member] April 20, 2025 [Member] Effective income tax rate reconciliation acquisition accounting adjustments percentage. September 30, 2030 [Member] September 30, 2030 [Member] August 2, 2021 [Member] February 17, 2022 [Member] March 1, 2027 [Member] March 1, 2027 [Member] October 31, 2027 [Member] Stock Option vesting. Related Party Notes Payable Disclosure [Text Block] September 1, 2025 [Member] 2023 [Member] Increase decreases in operating lease asset. Stock compensation exchange for debt. Dangot Computers Ltd [Member] [Default Label] February 17, 2022 [Member] [Default Label] March 1, 2027 [Member] [Default Label] September 30, 2030 [Member] [Default Label] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Goods and Services Sold Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Current Income Tax Expense (Benefit) Income Tax Expense (Benefit) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred Stock Dividends, Income Statement Impact NetLossAfterNoncommonStockholderDividends Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Dividends, Preferred Stock Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Gain (Loss) on Disposition of Property Plant Equipment Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty Increase (Decrease) in Operating Lease Liability Increase (Decrease) in Deferred Income Taxes Net Cash Provided by (Used in) Operating Activities PaymentForAdditionalOwnershipInSubsidiary Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Dividends Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Inventory, Policy [Policy Text Block] Intangible Assets, Net (Including Goodwill) Long-Term Line of Credit Business Combination, Consideration Transferred Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Cash [Default Label] Revenues [Default Label] Accounts Receivable, Allowance for Credit Loss Accounts Receivable, after Allowance for Credit Loss Finite-Lived Intangible Assets, Net Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Other Liabilities IncreaseDecreaseInRightOfUseAsset AmortizationOfOperatingLeaseLiability Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Share-Based Payment Arrangement, Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Net Deferred Tax Assets, Net Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent EX-101.PRE 13 omqs-20221231_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 10, 2023
Jun. 30, 2022
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2022      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2022      
Current Fiscal Year End Date --12-31      
Entity File Number 000-09047      
Entity Registrant Name OMNIQ CORP.      
Entity Central Index Key 0000278165      
Entity Tax Identification Number 20-3454263      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One 1865 West 2100 South      
Entity Address, City or Town Salt Lake City      
Entity Address, State or Province UT      
Entity Address, Postal Zip Code 84119      
City Area Code (800)      
Local Phone Number 242-7272      
Title of 12(b) Security Common Stock, $0.001 par value      
Trading Symbol OMQS      
Security Exchange Name NASDAQ      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 31,794,449
Entity Common Stock, Shares Outstanding     7,882,628  
ICFR Auditor Attestation Flag false      
Auditor Firm ID 2015 457    
Auditor Name BARZILY AND CO., CPA’s Haynie & Company    
Auditor Location Jerusalem, Israel Salt Lake City, Utah    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 1,311 $ 7,085
Accounts receivable, net 23,893 27,123
Inventory 8,726 6,955
Prepaid expenses 1,268 1,987
Other current assets 473 9
Total current assets 35,671 43,159
Property and equipment, net of accumulated depreciation of $1,030 and $2,203 respectively 1,086 1,127
Goodwill 16,542 16,453
Trade name, net of accumulated amortization of $4,458 and $3,863, respectively 1,826 2,421
Customer relationships, net of accumulated amortization of $10,762 and $9,660, respectively 4,967 6,069
Other intangibles, net of accumulated amortization of $1,541 and $1,457, respectively 675 865
Right of use lease asset 2,300 3,556
Other assets 1,744 1,431
Total assets 64,811 75,081
Current liabilities    
Accounts payable and accrued liabilities 54,736 45,553
Line of credit 1,971 5,951
Accrued payroll and sales tax 2,633 2,658
Notes payable, related parties – current portion 293 390
Notes payable – current portion 11,572 7,521
Lease liability – current portion 942 1,341
Other current liabilities 1,394 2,683
Total current liabilities 73,541 66,097
Long term liabilities    
Notes payable, related party, less current portion 293
Accrued interest and accrued liabilities, related party 72 63
Notes payable, less current portion 55 2,646
Lease liability 1,404 2,266
Other long-term liabilities 265 1,418
Total liabilities 75,337 72,783
Stockholders’ equity deficit    
Common stock; $0.001 par value; 15,000,000 shares authorized; 7,714,780 and 7,459,534 shares issued and outstanding, respectively. 8 20
Additional paid-in capital 73,714 70,606
Accumulated deficit (84,460) (70,571)
Cumulative translation adjustment 211 (154)
Total OmniQ stockholders’ equity (deficit) (10,526) (98)
Non-controlling interest 2,396
TOTAL EQUITY (DEFICIT) (10,526) 2,298
Total liabilities and equity (deficit) 64,811 75,081
Series A Preferred Stock [Member]    
Stockholders’ equity deficit    
Preferred Stock Value
Series B Preferred Stock [Member]    
Stockholders’ equity deficit    
Preferred Stock Value
Series C Preferred Stock [Member]    
Stockholders’ equity deficit    
Preferred Stock Value $ 1 $ 1
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Property and equipment, accumulated depreciation $ 1,030 $ 2,203
Other intangibles, accumulated amortization $ (16,761) $ (14,980)
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 15,000,000 15,000,000
Common stock, shares, issued 7,714,780 7,459,534
Common stock, shares outstanding 7,714,780 7,459,534
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 2,000,000 2,000,000
Preferred stock, shares outstanding 0 0
Preferred stock, shares issued 0 0
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 1 1
Preferred stock, shares outstanding 0 0
Preferred stock, shares issued 0 0
Series C Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 3,000,000 3,000,000
Preferred stock, shares outstanding 544,500 544,500
Preferred stock, shares issued 544,500 544,500
Trade Names [Member]    
Other intangibles, accumulated amortization $ 4,458 $ 3,863
Customer Relationships [Member]    
Other intangibles, accumulated amortization 10,762 9,660
Other Intangible Assets [Member]    
Other intangibles, accumulated amortization $ 1,541 $ 1,457
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues    
Total revenues $ 102,545 $ 78,251
Cost of goods sold    
Cost of goods sold 80,441 61,582
Gross profit 22,104 16,669
Operating expenses    
Research & development 1,826 1,873
Selling, general and administrative 27,707 21,865
Depreciation 324 251
Amortization 1,799 3,160
Total operating expenses 31,656 27,149
Loss from operations (9,552) (10,480)
Other income (expenses):    
Interest expense (3,496) (2,515)
Other (expenses) income (601) 7
Total other expenses (4,097) (2,508)
Net loss before income taxes (13,649) (12,988)
Provision for income taxes    
Current 35 (156)
Total provision for income taxes 35 (156)
Net loss (13,614) (13,144)
Net income attributable to non-controlling interest 67 218
Net loss attributable to OmniQ Corp (13,681) (13,362)
Foreign currency translation adjustment 365 71
Comprehensive loss (13,249) (13,073)
Less comprehensive loss attributable to non-controlling interests 20 (59)
Comprehensive loss attributable to OmniQ Corp (13,229) (13,132)
Reconciliation of net loss to net loss attributable to common shareholders    
Less: dividends attributable to non-common stockholders’ of OmniQ Corp (206) (77)
Net loss less non-common stockholder dividends (13,820) (13,221)
Non-common stockholder dividends attributable to non-controlling interest 218
Net loss attributable to common stockholders’ of OmniQ Corp $ (13,820) $ (13,439)
Net loss per share - basic attributable to common stockholders’ of OmniQ Corp $ (1.82) $ (2.20)
Weighted average number of common shares outstanding - basic 7,576,434 6,082,763
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 2 $ 5 $ 51,842 $ (56,726) $ (166) $ (5,043)
Beginning balance, shares at Dec. 31, 2020 2,145 4,685          
Dividends (77) (77)
Dividend declared to non-controlling interest (398) (398)
ESPP stock issuance 16 16
ESPP Stock Issuance, shares   2          
Stock-based compensation – options, warrants, issuances 2,552 2,552
Stock-based compensation - options, warrants, issuances, shares            
Stock issued for services 188 188
Stock and warrant issued for services, shares   25          
Warrant issuances, net of issuance costs $ 15 13,282 13,297
Stock and warrant issuances, net of issuance costs, shares   2,143,000          
Exercise of stock options 438 438
Exercise of stock options and warrants, shares   279,000          
Stock and warrant issuance for acquisition 2,084 2,084
Stock and warrant issuance for Acquisition, shares   220          
Dangot acquisition 6,508 6,508
Exercise to purchase additional Dangot shares (4,012) (4,012)
Post-acquisition adjustment (1) (377) (378)
Cumulative translation adjustment 59 12 71
Other (7) (7)
Conversion of equity $ (1) 1
Conversion of equity, shares (1,400) 70          
Conversion of debt 203 203
Conversion of debt, shares (201) 35,000          
Net income (loss) (13,362) 218 (13,144)
Ending balance, value at Dec. 31, 2021 $ 1 $ 20 70,606 (70,571) 2,396 (154) 2,298
Ending balance, shares at Dec. 31, 2021 544,000 7,459,000          
Dividends (206) (206)
ESPP stock issuance 37 37
ESPP Stock Issuance, shares   7,000          
Stock-based compensation – options, warrants, issuances 3,173 3,173
Stock-based compensation - options, warrants, issuances, shares   100          
Stock issued for services 109 109
Stock and warrant issued for services, shares   20          
Warrant issuances, net of issuance costs 298 298
Exercise of stock options 147 147
Exercise of stock options and warrants, shares   128,000          
Cumulative translation adjustment (2) (20) 365 343
Other (12) 12
Conversion of debt
Conversion of debt, shares          
Net income (loss) (13,681) 67 (13,614)
Non-controlling interests, distributions and other (668) (2,443) (3,111)
Ending balance, value at Dec. 31, 2022 $ 1 $ 8 $ 73,714 $ (84,460) $ 211 $ (10,526)
Ending balance, shares at Dec. 31, 2022 544 7,714          
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operations    
Net loss $ (13,614) $ (13,144)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Loss on disposal of PP&E 46
Noncash interest expense 248
Stock-based compensation 3,173 2,552
Stock and warrant issued for services 109 188
Depreciation and amortization 2,119 3,411
Amortization of ROU asset 1,000 199
Changes in operating assets and liabilities:    
Accounts receivable 1,472 (3,291)
Prepaid expenses 585 (295)
Inventory (2,490) (538)
Other assets 131 (117)
Accounts payable and accrued liabilities 10,830 8,352
Accrued interest and accrued liabilities, related party 8 7
Accrued payroll and sales taxes payable 268 (180)
Lease liability (1,000) (192)
Deferred tax assets, net (263) 58
Other liabilities (1,419) (185)
Net cash provided by (used in) operating activities 1,203 (3,175)
Cash flows from investing activities    
Payment for additional ownership in subsidiary (3,518) (4,012)
Payment for acquisition, net of cash acquired (4,992)
Purchase of property and equipment (451) (299)
Proceeds from sale (purchase) of other assets (185) 68
Net cash used in investing activities (4,154) (9,235)
Cash flows from financing activities    
Proceeds from ESPP stock issuance 37 16
Proceeds from exercise of options and warrants 147 438
Dividends paid to non-controlling interest (1,448) (306)
Net proceeds from issuance of common stock 13,297
Payments on notes payable (2,525) (4,612)
Proceeds from the issuance of notes payable 4,770 4,603
Net activity on line of credit (4,038) 1,037
Net cash (used in) provided by financing activities (3,057) 14,473
Net change in cash and cash equivalents (6,008) 2,063
Effect of foreign exchange rates on cash and cash equivalents 234 (105)
Cash and cash equivalents at beginning of period 7,085 5,127
Cash and cash equivalents at end of period 1,311 7,085
Non-cash activities:    
Declared dividends payable 33 464
Net assets acquired in business combination 7,390
Stock compensation in exchange for debt 298
Purchase of PP&E with financing 155
Debt conversion 203
Equity conversion 2
Right of use asset acquired in exchange for lease liability 1,108
Change in terms of accounts payable 47
Supplemental disclosure of cash flow information:    
Cash paid for interest 3,487 1,547
Cash paid for income taxes $ 160 $ 151
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
NATURE OF OPERATIONS
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF OPERATIONS

NOTE 1 – NATURE OF OPERATIONS

 

OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its majority and wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.

 

From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:

 

  ● Quest Solutions, Inc. (January 2014)
  ● Bar Code Specialties, Inc. (November 2014)
  ● ViascanQdata, Inc (October 2015 – later sold in September 2016)
  ● HTS Image Processing, Inc. (October 2018)
  ● EyepaxIT Consulting LLC. (February 2020)
  ● Dangot Computers Ltd. (July 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.

 

 
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation and Basis of Presentation

 

Our consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers Ltd. collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these consolidated financial statements. Business combinations are included in the consolidated financial statements from their respective dates of acquisition.

 

Use of Estimates

 

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 

Cash and Cash Equivalents

 

Cash consists of petty cash, checking, savings, and money market accounts. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of December 31, 2022 and 2021.

 

The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.

 

 

Accounts Receivable

 

We manage credit risk associated with our accounts receivables at the customer level. Because the same customers typically generate the revenues that are accounted for under both Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606) and Accounting Standards Codification Topic 326, Credit Losses (Topic 326)., the discussions below on credit risk and our allowances for doubtful accounts address our total revenues from Topic 606 and Topic 326.

 

We believe concentration of credit risk, with respect to our receivables, is limited because our customer base is comprised of a number of geographically diverse customers. We manage credit risk through credit approvals, credit limits and other monitoring procedures.

 

Pursuant to Topic 326 for our accounts receivables, we maintain an allowance for doubtful accounts that reflects our estimate of our expected credit losses. Our allowance is estimated using a loss rate model based on delinquency. The estimated loss rate is based on our historical experience with specific customers, our understanding of our current economic circumstances, reasonable and supportable forecasts, and our own judgment as to the likelihood of ultimate payment based upon available data. We perform credit evaluations of customers and establish credit limits based on reviews of our customers’ current credit information and payment histories. We believe our credit risk is somewhat mitigated by our geographically diverse customer base and our credit evaluation procedures. The actual rate of future credit losses, however, may not be similar to past experience. Our estimate of doubtful accounts could change based on changing circumstances, including changes in the economy or in the particular circumstances of individual customers. Accordingly, we may be required to increase or decrease our allowance for doubtful accounts. Based on management’s evaluation, accounts receivable has a balance in the allowance for doubtful accounts of $455 thousand and $6 thousand for the years ended December 31, 2022 and 2021, respectively.

 

Inventory

 

Substantially all inventory consists of raw materials and finished goods and are valued at the lower of historic cost or net realizable value; where net realizable value is considered to be the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. Historic inventory costs are calculated on a first-in-first-out basis or specific cost.

 

Property and Equipment

 

Property and equipment are recorded at cost and depreciated using straight-line over the estimated useful lives. Ordinary repair and maintenance costs are included in sales, general and administrative (“SG&A”) expenses on our consolidated statements of operations. However, expenditures for additions or improvements that significantly extend the useful life of the asset are capitalized in the period incurred. At the time assets are sold or disposed of, the cost and accumulated depreciation are removed from their respective accounts and the related gains or losses are reflected in the statements of operations in gains from sales of property and equipment, net.

 

 

We periodically evaluate the appropriateness of remaining depreciable lives assigned to property and equipment. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or the remaining term of the lease, whichever is shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was $324 thousand and $251 thousand, respectively. Generally, we assign the following estimated useful lives to these categories:

 

Category   Estimated Useful Life

Furniture and fixtures

Computer equipment

Office equipment

Software

Leasehold improvements

  

5 to 7 years

3 to 5 years

3 to 10 years

3 years

15 years

Vehicles   5 years

 

Fair Value of Financial Instruments

 

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The FASB fair value measurement guidance established a fair value hierarchy that prioritizes the inputs used to measure fair value. The three broad levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly

 

Level 3 – Unobservable inputs for which little or no market data exists, therefore requiring a company to develop its own assumptions

 

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. We review the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.

 

The carrying amounts of certain financial instruments, such as cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.

 

 

Definite-lived Intangible Assets

 

The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded no impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.

 

When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.

 

If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.

 

Definite-lived intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from 3 to 11 years with a remaining weighted average lifespan of 7.5 years.

 

Indefinite-lived Intangible Assets, Including Goodwill

 

Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, no impairment has been recognized.

 

Accounts Payable

 

Accounts payable are made up of payables due to vendors in the ordinary course of business a December 31, 2022 and 2021. One vendor made up 48% and 65% of our purchases in 2022 and 2021, respectively.

 

Leases

 

We determine whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset, and we have the right to control the asset for a period of time in exchange for consideration. Lease arrangements can take several forms. Some arrangements are clearly within the scope of lease accounting, such as a real estate contract that provides an explicit contractual right to use a building for a specified period of time in exchange for consideration. However, the right to use an asset can also be conveyed through arrangements that are not leases in form, such as leases embedded within service and supply contracts. We analyze all arrangements with potential embedded leases to determine if an identified asset is present, if substantive substitution rights are present, and if the arrangement provides the customer control of the asset.

 

 

Our lease portfolio is substantially comprised of operating leases related to leases of real estate and improvements. From time to time, we may also lease various types of small equipment and vehicles.

 

Operating lease right-of-use (“ROU”) assets represent our right to use an individual asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide the lessor’s implicit rate, we use our incremental borrowing rate (“IBR”) at the commencement date in determining the present value of lease payments by utilizing a fully collateralized rate for a fully amortizing loan with the same term as the lease.

 

Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the term. Our leases can include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when such renewal options and/or termination options are reasonably certain of exercise.

 

A ROU asset is subject to the same impairment guidance as assets categorized as plant, property, and equipment. As such, any impairment loss on ROU assets is presented in the same manner as an impairment loss recognized on other long-lived assets.

 

A lease modification is a change to the terms and conditions of a contract that change the scope or consideration of a lease. For example, a change to the terms and conditions to the contract that adds or terminates the right to use one or more underlying assets, or extends or shortens the contractual lease term, is a modification. Depending on facts and circumstances, a lease modification may be accounted as either: (1) the original lease plus the lease of a separate asset(s) or (2) a modified lease. A lease will be remeasured if there are changes to the lease contract that do not give rise to a separate lease.

 

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 

Revenue Recognition

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)
     
  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
     
  ii. The customer has legal title to the product,
     
  iii. We have transferred physical possession of the product to the customer,
     
  iv. The customer has the risk and rewards of ownership of the product, and
     
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
     
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
     
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
     
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.

 

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.

 

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. No shares were issued in 2021 as part of the Plan.

 

In August 2020, the Board of Directors approved our 2020 Equity Incentive Plan and later amended it. In September 2020, our shareholders adopted and ratified the 2020 Equity Incentive Plan. The total number of shares of Common Stock authorized for issuance under the 2020 Plan is 1,000,000.

 

Equity instruments issued to parties other than employees for acquiring goods or services.

 

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

Warrants. The fair value of the warrants is estimated on the date of issuance using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the expected term of the warrants, expected stock price volatility, and expected dividends. These estimates involve inherent uncertainties and the application of management’s judgment. Expected volatilities used in the valuation model are based on the average volatility of the Company’s stock. The risk-free rate for the expected term of the option is based on the United States Treasury yield curve in effect at the time of grant.

 

Advertising

 

The Company expenses marketing and advertising costs as incurred. During 2022 and 2021, the Company spent $630 thousand and $213 thousand, respectively, on marketing, trade show and store front expense and advertising, net of co-operative rebates.

 

The Company received rebates on advertising from co-operative advertising agreements with several vendors and suppliers. These rebates have been recorded as a reduction to the related advertising and marketing expense.

 

Foreign Currency Translation

 

Our consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operations were maintained in the local currency and translated to the reporting currency as follows: assets and liabilities are converted using the balance sheet period-end date exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.

 

 

Income Taxes

 

We account for our income taxes in accordance with Income Taxes Topic of the FASB ASC 740, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 

Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for consolidated financial reporting purposes and such amounts recognized for tax purposes and are measured by applying enacted tax rates in effect in years in which the differences are expected to reverse.

 

We also follow the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Our income is subject to taxation in both the U.S. and a foreign jurisdiction, Israel. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company establishes reserves for income tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves for tax contingencies are established when we believe positions do not meet the more-likely-than-not recognition threshold. We adjust uncertain tax liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or lapse of a statute of limitations. The provision for income taxes includes the impact of uncertain tax liabilities and changes in liabilities that are considered appropriate.

 

Comprehensive Income (Loss)

 

Comprehensive income (loss) is defined as a change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Our other comprehensive income (loss) is composed of foreign currency translation adjustments.

 

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the years ended December 31, 2022 and December 31, 2021 were 7,576,434 and 6,082,763, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:

  2022   2021 
Options to purchase common stock  $2,190,583   $1,559,300 
Warrants to purchase common stock   1,481,734    1,378,929 
Potential shares excluded from diluted net loss per share  $3,672,317   $2,938,229 

 

 

Recent Accounting Pronouncements not yet adopted

 

Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.

 
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:

 

● Balancing the need for operational cash with the need to add additional products
● Timely and cost-effective development of products
● Working capital deficit of $38 million as of December 31, 2022
● Accumulated deficit of $84 million as of December 31, 2022
● Multiple years of losses from operations
●

Non compliance with certain debt covenants 

 

These facts and others have raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.

 

The following conditions, plans and actions are currently being implemented to address the Company’s conditions:

 

● Outstanding warrants exist from prior offerings that could be exercised for cash depending upon the performance of our stock.
● The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability, and cash flow and is expected to help the Company as a whole to generate positive cash flows from operations for the foreseeable future.
● The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group.
● The acquisition of Dangot has added capabilities to the Company which have already transformed into significant new orders in the Parking segment. Management expects the collaboration and cross sales to contribute to improved revenues and margins.
● Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations. Management has already cut staff by about 5% and will continue to do additional overhead cuts.
● On March 25, 2022 management finalized an $8.5M line of credit from Western Alliance Bank. This line of credit replaced the high interest Action Capital line of Credit ($6M) and settle the ScanSource debt $2.5M.
● Blue Star - The Company’s total accounts payable due to Blue Star as of December 31, 2022 was approximately $36 million. Blue Star is an unsecured creditor, financing a substantial amount the Company’s supply chain demand. Management believes that Blue Star will continue supplying the Company with preferable credit terms. Blue Star has agreed to the annual interest rate of 5% on invoices that are past due. As an unsecured creditor of the Company, Blue Star has no incentive to force a liquidation. The Company has enjoyed a good mutual relationship for the past four years.

 

 
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITIONS
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
BUSINESS ACQUISITIONS

NOTE 4 – BUSINESS ACQUISITIONS

 

Dangot Computers Ltd

 

On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase 51%, or 5,100 shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to 23,740,500 NIS (New Israeli Shekel), which is equal to US$7.6 million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.

 

The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued 220,103 shares of its common stock having a share value of $2,084 thousand and (b) cash in the amount of $5,058 thousand and $600 thousand payable to owner.

 

Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining 4,900 shares, or 49%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of 465,500 NIS, which is equal to US$143 thousand, per each 1% of Dangot’s remaining shares on a fully diluted basis which is the same valuation per share as the purchase price for the 51%. Effective October 1, 2021 the Company exercised a portion of its option and purchased an additional 26% of Dangot bringing its ownership to 77%. The Company paid $4,012,000 to purchase the additional shares.

 

On April 1, 2022, the Company closed on its acquisition of Dangot and exercised the remaining portion of its option to purchase 23.0% of the capital stock, thereby making Dangot a fully owned subsidiary of the Company. The Company paid $3,518,000 to purchase the additional shares. The Company utilized its working capital and a combination of short and long term loans.

 

The following table summarizes the consideration given and the purchase price allocation:

 

 

      
Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner   600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts receivable   13,470 
Inventory   4,616 
Other assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 

 

The proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2021 were $92.5 million in revenues and $10.8 million net loss.

 

Since the acquisition the amounts included in the consolidated statement of comprehensive income from Dangot Computers Ltd. for the year ended December 31, 2021, was $20.6 million in revenue and $566 thousand in net income.

 

 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE
 12 Months Ended
Dec. 31, 2022
Receivables [Abstract]  
ACCOUNTS RECEIVABLE

NOTE 5 – ACCOUNTS RECEIVABLE

 

Accounts receivable consisted of the following as of December 31:

 

           
In thousands  2022   2021 
Trade accounts receivable  $24,348   $27,129 
Less allowance for doubtful accounts   (455)   (6)
Total accounts receivable (net)  $23,893   $27,123 

 

Accounts receivable as of December 31, 2022 and 2021 are made up of trade receivables due from customers in the ordinary course of business. No customer accounted for more than 10% of the balance of accounts receivable as of December 31, 2022, and one customer accounted for 17% of the accounts receivable balance as of December 31, 2021.

 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 6 – INVENTORY

 

Inventory consisted of the following as of December 31:

 

           
In thousands  2022   2021 
         
Raw materials  $649   $894 
Inventory in transit   2,004    - 
Finished goods (less allowance)   6,073    6,061 
Total inventories  $8,726   $6,955 

 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 7 – PROPERTY AND EQUIPMENT

 

The following is a summary of the components of property and equipment as of December 31,:

 

           
In thousands  2022   2021 
Manufacturing and lab equipment  $98   $499 
Leasehold improvements   521    609 
Software and computer equipment   987    1,650 
Furniture and equipment   236    254 
Vehicle   274    318 
Property and equipment, Gross        - 
Less: accumulated depreciation   (1,030)   (2,203)
Property and equipment, Net  $1,086   $1,127 

 

Depreciation expense for the year ended December 31, 2022 was approximately $324 thousand. Depreciation expense for the year ended December 31, 2021 was approximately $251 thousand.

 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS

NOTE 8 – GOODWILL AND INTANGIBLE ASSETS

 

We have made acquisitions in the past that resulted in the recognition of goodwill. Based on our analysis there have been no impairment charges recorded against goodwill in 2022 and 2021. Identifiable intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over the estimated useful lives ranging from 3 to 11 years. Amortization expense for the years ended December 31, 2022 and 2021 was $1,799 million and $3.2 million, respectively.

 

Goodwill and Intangible assets consisted of the following as of December 31:

SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS 

           
In thousands  2022   2021 
Goodwill  $16,542   $16,453 
Trade names   6,284    6,284 
Customer relationships   15,729    15,729 
Other intangibles   2,216    2,322 
Accumulated amortization   (16,761)   (14,980)
Intangibles, net  $24,010   $25,808 

 

The future amortization expense on the trade names, customer relationships, and other intangibles are as follows:

 

      
In thousands    
Years ending December 31,    
2023  $1,625 
2024   952 
2025   943 
2026   943 
2027   776 
Thereafter   2,229 
      
Total  $7,468 

 

 

Goodwill is not amortized but is evaluated for impairment annually or when indicators of a potential impairment are present. The impairment testing of goodwill is performed separately from our impairment testing of intangibles. The annual evaluation for impairment of goodwill and intangibles is based on valuation models that incorporate assumptions and internal projections of expected future cash flows and operating plans. None of the goodwill is deductible for income tax purposes.

 

Purchased intangible assets with finite useful lives are amortized over their respective estimated useful lives (using an accelerated method for customer relationships and trade names) to their estimated residual values, if any. The Company’s finite-lived intangible assets consist of customer relationships, contractor and resume databases, trade names, and internal use software and are being amortized over periods ranging from two to nine years. Purchased intangible assets are reviewed annually to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, recoverability is assessed by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the rate of amortization is accelerated, and the remaining carrying value is amortized over the new shorter useful life. No impairments were identified or changes to estimated useful lives have been recorded as of December 31, 2022 and 2021.

 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
CREDIT FACILITIES AND LINE OF CREDIT
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
CREDIT FACILITIES AND LINE OF CREDIT

NOTE 9 – CREDIT FACILITIES AND LINE OF CREDIT

 

We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.

 

On March 25, 2022 we entered into a Business Finance Agreement (the “BFA”) with BridgeBank a division of Western Alliance Bank (“BridgeBank”) to establish the sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivables to BridgeBank. Pursuant to the BFA, the outstanding principal amount of advances made by BridgeBank at any time shall not exceed $8.5 million. BridgeBank reserves and withholds to 15% of the face amount of each account purchased in a reserve account.

 

The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the BFA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 1.5%, plus a monthly fee equal to 0.15% of the average outstanding balance. The BFA credit facility is collateralized with a senior security interest in certain assets of the Company. The BFA includes customary representations and warranties and default provisions for transactions of this type.

 

 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY NOTES PAYABLE
 12 Months Ended
Dec. 31, 2022
Related Party Notes Payable  
RELATED PARTY NOTES PAYABLE

NOTE 10 – RELATED PARTY NOTES PAYABLE

 

Related party notes payable, consisted of the following as of December 31:

           
   2022   2021 
In thousands          
Note payable –Marin  $180   $420 
Note payable –Thomet   113    263 
           
Total notes payable   293    683 
Less current portion   293    390 
Long-term portion  $-   $293 

 

For the years ended December 31, 2022 and December 31, 2021, the Company recorded interest expense in connection with these notes in the amount of $8 thousand and $10 thousand, respectively.

 

Note Payable -Marin

 

In December 2017, we entered into a $660 thousand, 1.89% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in 60 monthly principal payments of $20 thousand beginning in October 2018. Accrued interest payable as of December 31, 2022, was $71 thousand. Accrued interest is payable at maturity.

 

Note Payable – Thomet

 

In December 2017, we entered into a $750 thousand, zero percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in 60 monthly principal payments of $13 thousand beginning in October 2018.

 

 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER NOTES PAYABLE
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
OTHER NOTES PAYABLE

NOTE 11 – OTHER NOTES PAYABLE

 

Other notes payable consists of the following as of December 31,

           
In thousands  2022   2021 
Note Payable - Secured Supplier Note  $-   $2,243 
Notes Payable - other   11,627    7,924 
Total   11,627    10,167 
Less current portion   11,572    7,521 
Long Term Notes Payable  $55   $2,646 

 

Future maturities of notes payable are as follows for the years ending December 31, 2022:

 

In thousands

      
2023  $11,572 
2024   55 
Total  $11,627 

 

Secured Supplier Note Payable

 

On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $12.5 million (the “Secured Promissory Note”). The USD Note accrues interest at 18% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $250 thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016. This note was extended and amended multiple times and as of March 25, 2022, is paid in full.

 

Other Notes Payable

 

On July 29, 2021, the Company entered into a long-term loan from Leumi Bank totalling NIS 7 million, which at the time was approximately $2.16 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On November 28, 2021, the Company entered into another long-term loan from Leumi Bank totalling NIS 3.5 million, which at the time was approximately $1.1 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On August 11, 2021, the Company purchased vehicles using cash and financing of NIS 500 thousand, approximately $155 thousand, to be paid off in monthly interest and principal payments over 5 years. The loan accrues interest at 7.5% per annum and is secured by the vehicles. As of December 31, 2022, the remaining balance was NIS 342 thousand, approximately $97 thousand.

 

On March 27, 2022, the Company entered into another long-term loan from Leumi Bank totalling NIS 3.5 million, which at the time was approximately $1.1 million. The note accrues interest at the Israeli Prime Rate plus 4.5% which currently equals 8.25% per annum and is payable in 8 instalments of principal and interest over 4 years. The note is secured by shares of Dangot Computers, Ltd.

 

On September 13, 2022, the Company entered into a long-term loan from Hapoalim Bank totalling NIS 3 million, which at the time was approximately $0.9 million. The note accrues interest at 6.03% per annum and is payable in 36 instalments of principal and interest over 3 years. as of December 31, 2022, the outstanding balance was NIS 2.8 million, approximately $0.8 million.

 

During the year ended December 31, 2021, the Company entered into five lines of credit totalling NIS 17.5 million, as of December 31, 2021, the outstanding balance was NIS 13.6 million, approximately $4.4 million. These loans were replaced in 2022.

 

During the year ended December 31, 2022, the Company entered into five short term loans totalling NIS 26.8 million, approximately $7.6 million. The note accrues average interest at 6.3% per annum.

 

As of December 31, 2022, the Company was not in compliance with certain financial covenants related to the Bank Leumi and Bank Hapoalim debt. The Company’s failure to comply with these financial covenants could result in an event of default under its debt agreements. Therefore, we reclassified the total balance as current debt on the balance sheet. The Company is actively pursuing options to address its noncompliance. The lenders have not requested early repayment of the loan as of the date when these financial statements were available to be issued.

 

 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER LIABILITIES
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
OTHER LIABILITIES

NOTE 12 – OTHER LIABILITIES

 

As of December 31, 2022 and 2021, other liabilities consisted of the following:

 

           
In thousands  2022   2021 
Other vendor payable  $801    801 
Dividend payable   153    1,418 
Others   705    1,882 
Total other liabilities   1,659    4,101 
Less current portion   (1,394)   (2,683)
Total long term other liabilities  $265   $1,418 

 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 13 – COMMITMENTS AND CONTINGENCIES

 

Profit Sharing Plan

 

We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the year ending December 31, 2022 and 2021, the company has elected to match, the total expense was $122 thousand and $108 thousand.

 

Operating Leases

 

As of December 31, 2022, we had 5 Operating leases as follows:

 

  ● Office space in Akron, Ohio, with monthly payments of $3 thousand and an incremental borrowing rate of 14.55%. As of December 31, 2022, we had 5 months remaining on the lease.
     
  ● Office space in Salt Lake City UT with monthly payments of $24 thousand. As of December 31, 2022, the Company had 44 months remaining on the lease.
     
  ● Dangot’s corporate offices are currently located at Yad harutzim 14 Tel-Aviv, Israel and serves as the company’s main operating location. As of December 31, 2022, we had 23 months remaining on the lease.
     
  ● The Company lease additional office space for our finance and service department at Yad harutzim 14 Tel-Aviv, Israel. As of December 31, 2022, the Company had 12 months remaining on the lease.
     
  ● The Company also lease office and warehouse space for our products and technical support staff in Rival Street, Tel-Aviv, Israel. As of December 31, 2022, the Company had 30 months remaining on the lease.

 

 

Other information related to our operating leases is as follows:

 

In thousands    
ROU asset - January 1, 2021  $76 
Amortization   (199)
Effective foreign exchange rates   

121

 
Increase   3558 
ROU asset - December 31, 2021   3,556 
Increase   - 
Effective foreign exchange rates   (256)
Amortization   (1,000)
ROU asset - December 31, 2022  $2,300 

 

In thousands    
Lease liability - January 1, 2021  $79 
Increase   3,558 
Effective foreign exchange rates   169 
      
Amortization   (199)
Lease liability - December 31, 2021   3,607 
Decrease   - 
Increase (Decrease)   - 
      
Effective foreign exchange rates   (261)
Amortization   (1,000)
Lease liability - December 31, 2022  $2,346 

 

As of December 31, 2022, our operating leases had a weighted average remaining lease term of 29 months and a weighted average discount rate of 5.7%.

 

The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2022:

      
In thousands    
Year  Minimum lease payments 
2023  $1,102 
2024   873 
2025   397 
2026   176 
2027   - 
Total   2,548 
Less interest   (202)
Present value of future minimum lease payments   2,346 
Less current obligations   (942)
Long term lease obligations  $1,404 

 

LITIGATION

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. The Company is defending the case. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020.

 

 

The company is not a party to any other pending material legal proceeding in which it is defending against any claims of material significance. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 14 – STOCKHOLDERS’ EQUITY

 

PREFERRED STOCK

 

Series A

 

As of December 31, 2022 and 2021, there were 2,000,000 Series A preferred shares authorized and zero Series A preferred shares outstanding. The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 13 common shares.

 

Series B

 

As of December 31, 2022 and 2021, there was one (1) preferred share authorized and zero preferred shares outstanding.

 

Series C

 

As of December 31, 2022 and 2021, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 544,500 and 544,500 issued and outstanding, respectively. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum and have a liquidation preference of $1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of December 31, 2022 and 2021, the accrued dividends on the Series C Preferred Stock was $153 thousand and $126 thousand, respectively.

 

In 2021, certain holders of Series C Shares elected to convert $1.6 million or 1,600,530 Series C shares and $194 thousand in accrued dividends in exchange for 105,551 OMNIQ common stock shares.

 

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.

 

COMMON STOCK

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the December 2021, shareholders’ meeting. 841,500 shares were issued to employees and consultants in 2022, and no shares were issued under the Plan in 2021.

 

In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, one million (1,000,000) shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the September 2020, shareholders’ meeting. No shares were issued under the Plan in 2021, or 2022.

 

In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the years ending December 31, 2022 and 2021, employees purchased 7,025 ($37 thousand) shares and 2,186 ($16 thousand) shares of commons stock.

 

 

Warrants and Stock Options

 

In connection with the July 2021 Securities Purchase Agreement previously described, we issued warrants to purchase 171,429 shares of our common stock at an exercise price equal to $7.70 per Warrant Share, which warrants are exercisable for a period of five years from the issuance date. The warrants were valued at $1.3 million.

 

Options and warrants are valued at the grant date using the Black-Scholes valuation methodology. The Company determines the assumptions used in the valuation of warrants and option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options and warrants granted throughout the year.

 

The valuation assumptions used to determine the fair value of each option and warrant awarded in 2022: expected stock price volatility ranged from 104.33 to 126.44%; expected term in years 3.25; and risk-free interest rate ranged from 1.76% to 4.52%.

 

The valuation assumptions used to determine the fair value of each warrant awarded in 2021: expected stock price volatility 151.0% expected term in years 5; and risk-free interest rate 0.41%.

 

No additional options were issued in 2021.

 

No warrants were exercised during the year ended December 31, 2022.

 

For warrants exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $683 thousand.

 

The following table summarizes information about warrants granted during the years ended December 31:

   2022   2021 
   Number of
Warrants		   Weighted
Average
Exercise Price		   Number of
Warrants		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,378,929   $7.40    1,366,667   $7.19 
Warrants granted   112,805    6.59    171,429    7.70 
Warrants expired   10,000    8.00    40,000    10.00 
Warrants exercised   -    -    119,167    6.99 
                     
Balance, end of year   1,481,734    7.34    1,378,929    7.40 
                     
Exercisable warrants   1,424,234   $7.38    1,295,596   $6.38 

 

Outstanding warrants as of December 31, 2022 are as follows:

   Weighted Average       Weighted       Weighted 
Range of  Residual Life       Average       Average 
Exercise  Span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
5.91   4.33    40,000   $5.91    5,000   $5.91 
6.95   4.23    42,805    6.95    42,805    6.95 
7.00   2.62    847,500    7.00    855,000    7.00 
7.50   3.68    250,000    7.50    250,000    7.50 
7.70   3.52    171,429    7.70    171,429    7.70 
                          
10.00   0.39    100,000    10.00    100,000    10.00 
                          
5.91 to 10.00   2.41    1,481,734   $7.34    1,424,234   $7.38 

 

 

Warrants outstanding have the following expiry date and exercise prices as of the years ended December 31:

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 27, 2022   8.00    -    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    50,000 
October 06, 2024   7.00    847,500    847,500 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 7, 2026   7.70    171,429    171,429 
December 04, 2027   7.50    83,333    83,333 
March 25, 2027   6.95    42,805    - 
May 1, 2027   7.00    30,000    - 
May 1, 2027   5.91    40,000    - 
         1,481,734    1,378,929 


 

We have a stock option plan whereby the Board of Directors, may grant to directors, officers, employees, or consultants of the Company options to acquire common shares. The Board of Directors of the Company has the authority to determine the terms, limits, restrictions and conditions of the grant of options, to interpret the plan, and make all decisions relating thereto. The plan was adopted by the Company’s Board of Directors on November 17, 2014 in order to provide an inducement and serve as a long-term incentive program. The maximum number of common shares that may be reserved for issuance was set at 500,000.

 

The option exercise price is established by the Board of Directors and may not be lower than the market price of the common shares at the time of grant. The options may be exercised during the option period determined by the Board of Directors, which may vary, but will not exceed ten years from the date of the grant. There are 500,000 of the Company’s common shares which may be issued pursuant to the exercise of share options granted under the Plan.

 

For options exercised during the year ended December 31, 2022, the difference between the fair value of the Common Stock issued and the respective exercise price was $369 thousand. As of December 31, 2022, the intrinsic value for vested stock options was $477 thousand.

 

For options exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $1.5 million. As of December 31, 2021, the intrinsic value for vested stock options was $6.6 million.

 

Stock Options - The following table summarizes information about stock options granted during the years ended December 31,

 

   2022   2021 
   Number of
Stock
Options		   Weighted
Average
Exercise Price		   Number of
Stock
Options		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,559,300   $4.58    1,811,550   $4.32 
                     
Stock options granted   841,500    -    -    - 
Stock options expired   -    -    28,750    - 
Stock options cancelled, forfeited   9,000    -    -    - 
Stock options exercised   201,217    -    223,500    - 
                     
Balance, end of year   2,190,583    5.00    1,559,300    4.58 
                     
Exercisable stock options   1,420,312   $4.96    1,065,133   $4.56 

 

 

Stock options outstanding at the end of the year have the following expiry date and exercise prices as of December 31,

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 17, 2022   1.50    -    38,017 
February 17, 2022   1.80    -    76,033 
February 28, 2023   5.00    20,000    20,000 
March 05, 2023   2.40    242,000    247,000 
July 31, 2023   5.00    127,500    127,500 
October 31, 2023   4.40    10,000    54,000 
November 30, 2023   5.40    120,250    131,750 
November 20, 2024   10.00    125,000    125,000 
April 20, 2025   4.20    10,000    10,000 
March 1, 2027   5.14    648,500    - 
March 1, 2027   5.65    140,000    - 
May 1, 2027   5.90    30,000    - 
October 31, 2027   5.98    19,000    - 
September 30, 2030   4.40    318,333    350,000 
September 30, 2030   4.84    380,000    380,000 
                
         2,190,583    1,559,300 

 

 

We recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31,

 

           
   2022   2021 
In thousands        
Stock compensation  $1,321   $951 
Stock Option vesting   1,852    1,600 
Total  $3,173   $2,551 

 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 15 – RELATED PARTY TRANSACTIONS

 

In February 2020 we amended the consulting agreement with Mr. Carlos J. Nissensohn, a principal shareholder of the Company and a family member of a Director and Officer of the Company. The terms and condition of the contract are as follows:

 

  ● 48-month term with 90-day termination notice by the Company
     
  ● A monthly fee of $30 thousand.
     
  ● If we procure debt financing during the term of Mr. Nissensohn’s agreement, without any equity component, Mr. Nissensohn shall be entitled to 3% of the gross funds raised, however if we are required to pay a success fee to another external entity, then Mr. Nissensohn shall be entitled to only 2% of the gross funds raised.
     
  ● In addition to the above, in the event of an equity financing resulting in gross proceeds of at least $3 million to us within 24 months of the date the contract, Mr. Nissensohn shall further be entitled to certain warrants to be granted by us which upon their exercise pursuant to their terms, Mr. Nissensohn shall be entitled to receive OMNIQ shares which represent 3% of the OMNIQ issued share capital immediately prior to the consummation of such investment. The warrants will carry an exercise price per warrant/share representing 100% of the closing price per share as closed in the equity financing. This section and the issue of the warrant by OMNIQ are subject to the approval of the Board of Directors of OMNIQ. However, if the Board does not approve the issuance of warrants; then Mr. Nissensohn will be entitled to a fee with the equivalent value based on a Black Scholes valuation
     
  ● In addition to the above, Mr. Nissensohn will be entitled to a $80 thousand one-time payment which shall be paid on the 1st day that the OMNIQ shares become traded on the NASDAQ or NYSE Stock Market within 24 months of the date of the contract
     
  ● In addition to the aforementioned, in the event that we close any M&A transaction with a third party target, Mr. Nissensohn shall be entitled to a success fee in the amount equal to 5% of the total transaction price, in any combination of cash and shares that will be determined by OMNIQ

 

Additional related party transactions are discussed in Note 10.

 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATION AND GEOGRAPHIC DATA
 12 Months Ended
Dec. 31, 2022
Concentration And Geographic Data  
CONCENTRATION AND GEOGRAPHIC DATA

NOTE 16 – CONCENTRATION AND GEOGRAPHIC DATA

 

For the years ended December 31, 2022 and 2021, one customer accounted for 30% and 23%, respectively, of the Company’s revenues.

 

Information about Geographic Areas

 

Revenues by geography are based on the billing addresses of our customers. The following tables set forth revenues by geographic area for the years ended December 31,

 

           
In thousands  2022   2021 
Revenues:          
United States  $51,023   $53,725 
Israel   42,217    21,848 
Rest of the world   9,305    2,678 
Total revenues  $102,545   $78,251 

 

The Company’s operations are subject to various political, economic, and other risks and uncertainties inherent in the countries in which the Company operates. Among other risks, the Company’s operations are subject to the risks of restrictions on transfer of funds; export duties, quotas and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; and political conditions and governmental regulations.

 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX

NOTE 17 – INCOME TAX

 

For the year ended December 31, 2022, the Company has $35 thousand of current income tax provision (US State & Local and Foreign) and $30 thousand deferred income tax expense.

 

The tax effect of temporary differences that give rise to deferred tax assets and deferred tax liabilities are as follows as of December 31,

 

           
In thousands        
Deferred tax assets  2022   2021 
Reserves and deferred revenue  $411   $182 
163(j) Limitation   2,260    1,682 
Foreign deferred tax assets   135    

165

 
Net operating loss   8,353    7,164 
Total gross deferred tax assets   11,158    9,193 
Less: Valuation Allowance   (10,890)   (8,720)
Net deferred tax assets   269    473 
           
Deferred tax liabilities          
Amortization of intangible assets and depreciation   (134)   (308)
Total deferred tax liabilities   (134)   (308)
           
Net deferred tax assets  $135   $

165

 

 

 

Components of net deferred tax assets, including a valuation allowance, are as follows as of December 31:

           
   2022   2021 
Deferred tax assets  $11,025   $8,885 
Valuation allowance   (10,890)   (8,720)
Total deferred tax assets  $135   $

165

 

 

The valuation allowance for deferred tax assets as of December 31, 2022 and 2021 was $10.9 million and $8.7 million, respectively. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Management has recorded a 100% Valuation Allowance, against its U.S. Net Deferred Tax Assets, since Management believes it is more likely than not that it will not be realized at the date of this statement. The Company will continue to monitor the potential utilization of this asset. Should factors and evidence change to aid in this assessment, a potential adjustment to the valuation allowance in future periods may occur. The Company records any penalties and interest as a component of operating expenses.

 

The reconciliation between statutory rate and effective rate is as follows as of December 31,:

 

           
   2022   2021 
Federal statutory tax rate   21.00%   21.0%
State taxes   (0.07)%   (0.03)%
Foreign income taxes   (4.45)%   

(6.38

)%
Change in valuation allowance   (16.13)%   (15.24)%
Return to provision adjustments   (.03)%   .079%
Other   (.76)%   (1.37)%
        
Effective tax rate   (.44)%   (1.23)%

 

The Company reported no uncertain tax liability as of December 31, 2022 and expects no significant change to the uncertain tax liability over the next twelve months. The Company’s 2015, 2016, 2017, 2018, 2019, 2020 and 2021 federal and state income tax returns are open for examination by the applicable governmental authorities.

 

As of December 31, 2022, the Company had a net operating loss (NOL) carryforward of approximately $39.7 million. A portion of the NOL carryforward begins to expire in 2027. Under Section 382 of the Internal Revenue Code of 1986, as amended (“IRC Section 382”), a corporation that undergoes an “ownership change” is subject to limitations on its use of pre-change NOL carryforwards to offset future taxable income. Within the meaning of IRC Section 382, an “ownership change” occurs when the aggregate stock ownership of certain stockholders (generally 5% shareholders, applying certain look-through rules and aggregation rules which combine unrelated shareholders that do not individually own 5% or more of the corporation’s stock into one or more “public groups” that may be treated as 5-percent shareholder) increases by more than 50 percentage points over such stockholders’ lowest percentage ownership during the testing period (generally three years). In general, the annual use limitation equals the aggregate value of common stock at the time of the ownership change multiplied by a specified tax-exempt interest rate. The Company has not completed a study as to whether there is a 382 limitation on its NOLs that will limit or possibly eliminate the use of its NOLs in the future. Company’s Management has recorded a 100% valuation allowance on the entire NOL as it believes that it is more likely than not that the deferred tax asset associated with the NOLs will not be realized regardless of whether or not an “ownership change” has occurred.
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation

 

Our consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers Ltd. collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these consolidated financial statements. Business combinations are included in the consolidated financial statements from their respective dates of acquisition.

 
Use of Estimates

Use of Estimates

 

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

Cash consists of petty cash, checking, savings, and money market accounts. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of December 31, 2022 and 2021.

 

The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.

 

 
Accounts Receivable

Accounts Receivable

 

We manage credit risk associated with our accounts receivables at the customer level. Because the same customers typically generate the revenues that are accounted for under both Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606) and Accounting Standards Codification Topic 326, Credit Losses (Topic 326)., the discussions below on credit risk and our allowances for doubtful accounts address our total revenues from Topic 606 and Topic 326.

 

We believe concentration of credit risk, with respect to our receivables, is limited because our customer base is comprised of a number of geographically diverse customers. We manage credit risk through credit approvals, credit limits and other monitoring procedures.

 

Pursuant to Topic 326 for our accounts receivables, we maintain an allowance for doubtful accounts that reflects our estimate of our expected credit losses. Our allowance is estimated using a loss rate model based on delinquency. The estimated loss rate is based on our historical experience with specific customers, our understanding of our current economic circumstances, reasonable and supportable forecasts, and our own judgment as to the likelihood of ultimate payment based upon available data. We perform credit evaluations of customers and establish credit limits based on reviews of our customers’ current credit information and payment histories. We believe our credit risk is somewhat mitigated by our geographically diverse customer base and our credit evaluation procedures. The actual rate of future credit losses, however, may not be similar to past experience. Our estimate of doubtful accounts could change based on changing circumstances, including changes in the economy or in the particular circumstances of individual customers. Accordingly, we may be required to increase or decrease our allowance for doubtful accounts. Based on management’s evaluation, accounts receivable has a balance in the allowance for doubtful accounts of $455 thousand and $6 thousand for the years ended December 31, 2022 and 2021, respectively.

 
Inventory

Inventory

 

Substantially all inventory consists of raw materials and finished goods and are valued at the lower of historic cost or net realizable value; where net realizable value is considered to be the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. Historic inventory costs are calculated on a first-in-first-out basis or specific cost.

 
Property and Equipment

Property and Equipment

 

Property and equipment are recorded at cost and depreciated using straight-line over the estimated useful lives. Ordinary repair and maintenance costs are included in sales, general and administrative (“SG&A”) expenses on our consolidated statements of operations. However, expenditures for additions or improvements that significantly extend the useful life of the asset are capitalized in the period incurred. At the time assets are sold or disposed of, the cost and accumulated depreciation are removed from their respective accounts and the related gains or losses are reflected in the statements of operations in gains from sales of property and equipment, net.

 

 

We periodically evaluate the appropriateness of remaining depreciable lives assigned to property and equipment. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or the remaining term of the lease, whichever is shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was $324 thousand and $251 thousand, respectively. Generally, we assign the following estimated useful lives to these categories:

 

Category   Estimated Useful Life

Furniture and fixtures

Computer equipment

Office equipment

Software

Leasehold improvements

  

5 to 7 years

3 to 5 years

3 to 10 years

3 years

15 years

Vehicles   5 years

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The FASB fair value measurement guidance established a fair value hierarchy that prioritizes the inputs used to measure fair value. The three broad levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly

 

Level 3 – Unobservable inputs for which little or no market data exists, therefore requiring a company to develop its own assumptions

 

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. We review the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.

 

The carrying amounts of certain financial instruments, such as cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.

 

 
Definite-lived Intangible Assets

Definite-lived Intangible Assets

 

The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded no impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.

 

When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.

 

If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.

 

Definite-lived intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from 3 to 11 years with a remaining weighted average lifespan of 7.5 years.

 
Indefinite-lived Intangible Assets, Including Goodwill

Indefinite-lived Intangible Assets, Including Goodwill

 

Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, no impairment has been recognized.

 
Accounts Payable

Accounts Payable

 

Accounts payable are made up of payables due to vendors in the ordinary course of business a December 31, 2022 and 2021. One vendor made up 48% and 65% of our purchases in 2022 and 2021, respectively.

 
Leases

Leases

 

We determine whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset, and we have the right to control the asset for a period of time in exchange for consideration. Lease arrangements can take several forms. Some arrangements are clearly within the scope of lease accounting, such as a real estate contract that provides an explicit contractual right to use a building for a specified period of time in exchange for consideration. However, the right to use an asset can also be conveyed through arrangements that are not leases in form, such as leases embedded within service and supply contracts. We analyze all arrangements with potential embedded leases to determine if an identified asset is present, if substantive substitution rights are present, and if the arrangement provides the customer control of the asset.

 

 

Our lease portfolio is substantially comprised of operating leases related to leases of real estate and improvements. From time to time, we may also lease various types of small equipment and vehicles.

 

Operating lease right-of-use (“ROU”) assets represent our right to use an individual asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide the lessor’s implicit rate, we use our incremental borrowing rate (“IBR”) at the commencement date in determining the present value of lease payments by utilizing a fully collateralized rate for a fully amortizing loan with the same term as the lease.

 

Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the term. Our leases can include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when such renewal options and/or termination options are reasonably certain of exercise.

 

A ROU asset is subject to the same impairment guidance as assets categorized as plant, property, and equipment. As such, any impairment loss on ROU assets is presented in the same manner as an impairment loss recognized on other long-lived assets.

 

A lease modification is a change to the terms and conditions of a contract that change the scope or consideration of a lease. For example, a change to the terms and conditions to the contract that adds or terminates the right to use one or more underlying assets, or extends or shortens the contractual lease term, is a modification. Depending on facts and circumstances, a lease modification may be accounted as either: (1) the original lease plus the lease of a separate asset(s) or (2) a modified lease. A lease will be remeasured if there are changes to the lease contract that do not give rise to a separate lease.

 
Purchase Accounting and Business Combinations

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 
Revenue Recognition

Revenue Recognition

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)
     
  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
     
  ii. The customer has legal title to the product,
     
  iii. We have transferred physical possession of the product to the customer,
     
  iv. The customer has the risk and rewards of ownership of the product, and
     
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
     
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
     
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
     
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 
Stock-Based Compensation

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.

 

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.

 

 

In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, 1,118,856 shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. No shares were issued in 2021 as part of the Plan.

 

In August 2020, the Board of Directors approved our 2020 Equity Incentive Plan and later amended it. In September 2020, our shareholders adopted and ratified the 2020 Equity Incentive Plan. The total number of shares of Common Stock authorized for issuance under the 2020 Plan is 1,000,000.

 

Equity instruments issued to parties other than employees for acquiring goods or services.

 

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

Warrants. The fair value of the warrants is estimated on the date of issuance using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the expected term of the warrants, expected stock price volatility, and expected dividends. These estimates involve inherent uncertainties and the application of management’s judgment. Expected volatilities used in the valuation model are based on the average volatility of the Company’s stock. The risk-free rate for the expected term of the option is based on the United States Treasury yield curve in effect at the time of grant.

 
Advertising

Advertising

 

The Company expenses marketing and advertising costs as incurred. During 2022 and 2021, the Company spent $630 thousand and $213 thousand, respectively, on marketing, trade show and store front expense and advertising, net of co-operative rebates.

 

The Company received rebates on advertising from co-operative advertising agreements with several vendors and suppliers. These rebates have been recorded as a reduction to the related advertising and marketing expense.

 
Foreign Currency Translation

Foreign Currency Translation

 

Our consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operations were maintained in the local currency and translated to the reporting currency as follows: assets and liabilities are converted using the balance sheet period-end date exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.

 

 
Income Taxes

Income Taxes

 

We account for our income taxes in accordance with Income Taxes Topic of the FASB ASC 740, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

 

Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for consolidated financial reporting purposes and such amounts recognized for tax purposes and are measured by applying enacted tax rates in effect in years in which the differences are expected to reverse.

 

We also follow the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Our income is subject to taxation in both the U.S. and a foreign jurisdiction, Israel. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company establishes reserves for income tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves for tax contingencies are established when we believe positions do not meet the more-likely-than-not recognition threshold. We adjust uncertain tax liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or lapse of a statute of limitations. The provision for income taxes includes the impact of uncertain tax liabilities and changes in liabilities that are considered appropriate.

 
Comprehensive Income (Loss)

Comprehensive Income (Loss)

 

Comprehensive income (loss) is defined as a change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Our other comprehensive income (loss) is composed of foreign currency translation adjustments.

 
Net Loss Per Common Share

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the years ended December 31, 2022 and December 31, 2021 were 7,576,434 and 6,082,763, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:

  2022   2021 
Options to purchase common stock  $2,190,583   $1,559,300 
Warrants to purchase common stock   1,481,734    1,378,929 
Potential shares excluded from diluted net loss per share  $3,672,317   $2,938,229 

 

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements not yet adopted

 

Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.

 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT

 

Category   Estimated Useful Life

Furniture and fixtures

Computer equipment

Office equipment

Software

Leasehold improvements

  

5 to 7 years

3 to 5 years

3 to 10 years

3 years

15 years

Vehicles   5 years
SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE

The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:

  2022   2021 
Options to purchase common stock  $2,190,583   $1,559,300 
Warrants to purchase common stock   1,481,734    1,378,929 
Potential shares excluded from diluted net loss per share  $3,672,317   $2,938,229 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITIONS (Tables)
 12 Months Ended
Dec. 31, 2022
Dangot Computers Ltd [Member]  
Business Acquisition [Line Items]  
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED

The following table summarizes the consideration given and the purchase price allocation:

 

 

      
Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner   600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts receivable   13,470 
Inventory   4,616 
Other assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE (Tables)
 12 Months Ended
Dec. 31, 2022
Receivables [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Accounts receivable consisted of the following as of December 31:

 

           
In thousands  2022   2021 
Trade accounts receivable  $24,348   $27,129 
Less allowance for doubtful accounts   (455)   (6)
Total accounts receivable (net)  $23,893   $27,123 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

Inventory consisted of the following as of December 31:

 

           
In thousands  2022   2021 
         
Raw materials  $649   $894 
Inventory in transit   2,004    - 
Finished goods (less allowance)   6,073    6,061 
Total inventories  $8,726   $6,955 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

The following is a summary of the components of property and equipment as of December 31,:

 

           
In thousands  2022   2021 
Manufacturing and lab equipment  $98   $499 
Leasehold improvements   521    609 
Software and computer equipment   987    1,650 
Furniture and equipment   236    254 
Vehicle   274    318 
Property and equipment, Gross        - 
Less: accumulated depreciation   (1,030)   (2,203)
Property and equipment, Net  $1,086   $1,127 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS

Goodwill and Intangible assets consisted of the following as of December 31:

SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS 

           
In thousands  2022   2021 
Goodwill  $16,542   $16,453 
Trade names   6,284    6,284 
Customer relationships   15,729    15,729 
Other intangibles   2,216    2,322 
Accumulated amortization   (16,761)   (14,980)
Intangibles, net  $24,010   $25,808 
SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE

The future amortization expense on the trade names, customer relationships, and other intangibles are as follows:

 

      
In thousands    
Years ending December 31,    
2023  $1,625 
2024   952 
2025   943 
2026   943 
2027   776 
Thereafter   2,229 
      
Total  $7,468 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY NOTES PAYABLE (Tables)
 12 Months Ended
Dec. 31, 2022
Related Party Notes Payable  
SCHEDULE OF NOTES PAYABLE, RELATED PARTIES

Related party notes payable, consisted of the following as of December 31:

           
   2022   2021 
In thousands          
Note payable –Marin  $180   $420 
Note payable –Thomet   113    263 
           
Total notes payable   293    683 
Less current portion   293    390 
Long-term portion  $-   $293 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER NOTES PAYABLE (Tables)
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
SCHEDULE OF OTHER NOTES PAYABLE

Other notes payable consists of the following as of December 31,

           
In thousands  2022   2021 
Note Payable - Secured Supplier Note  $-   $2,243 
Notes Payable - other   11,627    7,924 
Total   11,627    10,167 
Less current portion   11,572    7,521 
Long Term Notes Payable  $55   $2,646 
SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE

Future maturities of notes payable are as follows for the years ending December 31, 2022:

 

In thousands

      
2023  $11,572 
2024   55 
Total  $11,627 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF OTHER LIABILITIES

As of December 31, 2022 and 2021, other liabilities consisted of the following:

 

           
In thousands  2022   2021 
Other vendor payable  $801    801 
Dividend payable   153    1,418 
Others   705    1,882 
Total other liabilities   1,659    4,101 
Less current portion   (1,394)   (2,683)
Total long term other liabilities  $265   $1,418 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE

Other information related to our operating leases is as follows:

 

In thousands    
ROU asset - January 1, 2021  $76 
Amortization   (199)
Effective foreign exchange rates   

121

 
Increase   3558 
ROU asset - December 31, 2021   3,556 
Increase   - 
Effective foreign exchange rates   (256)
Amortization   (1,000)
ROU asset - December 31, 2022  $2,300 

 

In thousands    
Lease liability - January 1, 2021  $79 
Increase   3,558 
Effective foreign exchange rates   169 
      
Amortization   (199)
Lease liability - December 31, 2021   3,607 
Decrease   - 
Increase (Decrease)   - 
      
Effective foreign exchange rates   (261)
Amortization   (1,000)
Lease liability - December 31, 2022  $2,346 
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2022:

      
In thousands    
Year  Minimum lease payments 
2023  $1,102 
2024   873 
2025   397 
2026   176 
2027   - 
Total   2,548 
Less interest   (202)
Present value of future minimum lease payments   2,346 
Less current obligations   (942)
Long term lease obligations  $1,404 
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
SCHEDULE OF WARRANTS ACTIVITY

The following table summarizes information about warrants granted during the years ended December 31:

   2022   2021 
   Number of
Warrants		   Weighted
Average
Exercise Price		   Number of
Warrants		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,378,929   $7.40    1,366,667   $7.19 
Warrants granted   112,805    6.59    171,429    7.70 
Warrants expired   10,000    8.00    40,000    10.00 
Warrants exercised   -    -    119,167    6.99 
                     
Balance, end of year   1,481,734    7.34    1,378,929    7.40 
                     
Exercisable warrants   1,424,234   $7.38    1,295,596   $6.38 
SCHEDULE OF OUTSTANDING WARRANTS

Outstanding warrants as of December 31, 2022 are as follows:

   Weighted Average       Weighted       Weighted 
Range of  Residual Life       Average       Average 
Exercise  Span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
5.91   4.33    40,000   $5.91    5,000   $5.91 
6.95   4.23    42,805    6.95    42,805    6.95 
7.00   2.62    847,500    7.00    855,000    7.00 
7.50   3.68    250,000    7.50    250,000    7.50 
7.70   3.52    171,429    7.70    171,429    7.70 
                          
10.00   0.39    100,000    10.00    100,000    10.00 
                          
5.91 to 10.00   2.41    1,481,734   $7.34    1,424,234   $7.38 
SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES

Warrants outstanding have the following expiry date and exercise prices as of the years ended December 31:

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 27, 2022   8.00    -    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    50,000 
October 06, 2024   7.00    847,500    847,500 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 7, 2026   7.70    171,429    171,429 
December 04, 2027   7.50    83,333    83,333 
March 25, 2027   6.95    42,805    - 
May 1, 2027   7.00    30,000    - 
May 1, 2027   5.91    40,000    - 
         1,481,734    1,378,929 
SCHEDULE OF STOCK OPTIONS GRANTED

 

   2022   2021 
   Number of
Stock
Options		   Weighted
Average
Exercise Price		   Number of
Stock
Options		   Weighted
Average
Exercise Price		 
                 
Balance, beginning of year   1,559,300   $4.58    1,811,550   $4.32 
                     
Stock options granted   841,500    -    -    - 
Stock options expired   -    -    28,750    - 
Stock options cancelled, forfeited   9,000    -    -    - 
Stock options exercised   201,217    -    223,500    - 
                     
Balance, end of year   2,190,583    5.00    1,559,300    4.58 
                     
Exercisable stock options   1,420,312   $4.96    1,065,133   $4.56 
SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES

Stock options outstanding at the end of the year have the following expiry date and exercise prices as of December 31,

 

   Exercise         
Expiry Date  Prices   2022   2021 
             
February 17, 2022   1.50    -    38,017 
February 17, 2022   1.80    -    76,033 
February 28, 2023   5.00    20,000    20,000 
March 05, 2023   2.40    242,000    247,000 
July 31, 2023   5.00    127,500    127,500 
October 31, 2023   4.40    10,000    54,000 
November 30, 2023   5.40    120,250    131,750 
November 20, 2024   10.00    125,000    125,000 
April 20, 2025   4.20    10,000    10,000 
March 1, 2027   5.14    648,500    - 
March 1, 2027   5.65    140,000    - 
May 1, 2027   5.90    30,000    - 
October 31, 2027   5.98    19,000    - 
September 30, 2030   4.40    318,333    350,000 
September 30, 2030   4.84    380,000    380,000 
                
         2,190,583    1,559,300 
SCHEDULE OF STOCK COMPENSATION EXPENSE

We recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31,

 

           
   2022   2021 
In thousands        
Stock compensation  $1,321   $951 
Stock Option vesting   1,852    1,600 
Total  $3,173   $2,551 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATION AND GEOGRAPHIC DATA (Tables)
 12 Months Ended
Dec. 31, 2022
Concentration And Geographic Data  
SCHEDULE OF REVENUES

Revenues by geography are based on the billing addresses of our customers. The following tables set forth revenues by geographic area for the years ended December 31,

 

           
In thousands  2022   2021 
Revenues:          
United States  $51,023   $53,725 
Israel   42,217    21,848 
Rest of the world   9,305    2,678 
Total revenues  $102,545   $78,251 
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The tax effect of temporary differences that give rise to deferred tax assets and deferred tax liabilities are as follows as of December 31,

 

           
In thousands        
Deferred tax assets  2022   2021 
Reserves and deferred revenue  $411   $182 
163(j) Limitation   2,260    1,682 
Foreign deferred tax assets   135    

165

 
Net operating loss   8,353    7,164 
Total gross deferred tax assets   11,158    9,193 
Less: Valuation Allowance   (10,890)   (8,720)
Net deferred tax assets   269    473 
           
Deferred tax liabilities          
Amortization of intangible assets and depreciation   (134)   (308)
Total deferred tax liabilities   (134)   (308)
           
Net deferred tax assets  $135   $

165

 
SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES

Components of net deferred tax assets, including a valuation allowance, are as follows as of December 31:

           
   2022   2021 
Deferred tax assets  $11,025   $8,885 
Valuation allowance   (10,890)   (8,720)
Total deferred tax assets  $135   $

165

 
SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE

The reconciliation between statutory rate and effective rate is as follows as of December 31,:

 

           
   2022   2021 
Federal statutory tax rate   21.00%   21.0%
State taxes   (0.07)%   (0.03)%
Foreign income taxes   (4.45)%   

(6.38

)%
Change in valuation allowance   (16.13)%   (15.24)%
Return to provision adjustments   (.03)%   .079%
Other   (.76)%   (1.37)%
        
Effective tax rate   (.44)%   (1.23)%
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)
 12 Months Ended
Dec. 31, 2022
Furniture and Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 5 years
Furniture and Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 7 years
Computer Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 3 years
Computer Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 5 years
Office Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 3 years
Office Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 10 years
Software Development [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 3 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 15 years
Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 5 years
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 3,672,317 2,938,229
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 2,190,583 1,559,300
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 1,481,734 1,378,929
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Oct. 31, 2021
Sep. 30, 2020
Product Information [Line Items]        
Allowance for doubtful accounts $ 455,000 $ 6,000    
Depreciation 324,000 251,000    
Impairment indefinite-lived intangible assets $ 0 $ 0    
Common stock, par value $ 0.001 $ 0.001    
Marketing and advertising costs $ 630,000 $ 213,000    
Income tax Likelihood greater than 50% likelihood      
Weighted-average number of common shares outstanding 7,576,434 6,082,763    
Equity Incentive Plan [Member]        
Product Information [Line Items]        
Shares issued   0    
Equity Incentive Plan [Member] | Board of Directors [Member]        
Product Information [Line Items]        
Shares of Common Stock authorized     1,118,856  
Common stock, par value     $ 0.001  
2020 Plan [Member] | Board of Directors [Member]        
Product Information [Line Items]        
Shares of Common Stock authorized       1,000,000
Accounts Payable [Member] | Customer Concentration Risk [Member] | One Vendor [Member]        
Product Information [Line Items]        
Concentration risk percentage 48.00% 65.00%    
Indefinite-Lived Intangible Assets [Member]        
Product Information [Line Items]        
Remaining weighted average lifespan 7 years 6 months      
Impairment indefinite-lived intangible assets $ 0 $ 0    
Indefinite-Lived Intangible Assets [Member] | Minimum [Member]        
Product Information [Line Items]        
Useful life 3 years      
Indefinite-Lived Intangible Assets [Member] | Maximum [Member]        
Product Information [Line Items]        
Useful life 11 years      
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 25, 2022
Dec. 31, 2022
Dec. 31, 2021
Aug. 11, 2021
Restructuring Cost and Reserve [Line Items]        
Working capital deficit   $ 38,000    
Accumulated deficit   84,460 $ 70,571  
Debt instrument, interest rate, stated percentage       7.50%
Scan Source Inc [Member]        
Restructuring Cost and Reserve [Line Items]        
Repayments of related party debt $ 2,500      
Blue Star [Member]        
Restructuring Cost and Reserve [Line Items]        
Accounts payable, related parties   $ 36,000    
Debt instrument, interest rate, stated percentage   5.00%    
Action Capital [Member]        
Restructuring Cost and Reserve [Line Items]        
Line of credit 6,000      
Western Alliance Bank [Member]        
Restructuring Cost and Reserve [Line Items]        
Line of credit $ 8,500      
Dangot Computers Ltd [Member]        
Restructuring Cost and Reserve [Line Items]        
Business acquisition, description of acquired entity   The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group.    
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jul. 08, 2021
May 03, 2021
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Cash payments     $ 4,992
Dangot Share Purchase Agreement [Member]        
Business Acquisition [Line Items]        
Accrued payable to owner $ 600      
Dangot Share Purchase Agreement [Member] | Dangot Computers Ltd [Member]        
Business Acquisition [Line Items]        
Cash payments   $ 5,058    
Accrued payable to owner   600    
Fair value of stock issued (220,103 shares)   2,084    
Debt assumed   5,310    
Total consideration   13,052    
Cash   666    
Accounts receivable   13,470    
Inventory   4,616    
Other assets   5,392    
Property and equipment   638    
Goodwill   1,758    
Trade name   1,893    
Customer relationship   3,139    
Other intangible assets   899    
Assets acquired   32,471    
Current liabilities assumed   (12,911)    
Non-controlling interest   (6,508)    
Net assets acquired   $ 13,052    
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)
May 03, 2021
shares
Dangot Computers Ltd [Member]  
Business Acquisition [Line Items]  
Fair value of stock issued shares 220,103
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITIONS (Details Narrative)
 12 Months Ended
Apr. 01, 2022
USD ($)
Jul. 08, 2021
USD ($)
shares
May 03, 2021
USD ($)
shares
May 03, 2021
ILS (₪)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 02, 2021
Business Acquisition [Line Items]              
Purchase of additional option percent             26.00%
Payment to purchase additional shares $ 3,518,000   $ 4,012,000        
Purchase of shares, percent             23.00%
Business acquisition, pro forma revenue           $ 92,500,000  
Business acquisition, pro forma net income (loss)           10,800,000  
Net income         $ (13,681,000) (13,362,000)  
Haim Dangot [Member]              
Business Acquisition [Line Items]              
Ownership percent             77.00%
Dangot Computers Ltd [Member]              
Business Acquisition [Line Items]              
Revenues           20,600,000  
Net income           $ 566,000  
Dangot Share Purchase Agreement [Member]              
Business Acquisition [Line Items]              
Issued shares | shares   220,103          
Value issued   $ 2,084,000          
Cash   5,058,000          
Payable to owner   $ 600,000          
Remaining acquired percentage     49.00% 49.00%      
Dangot Share Purchase Agreement [Member] | Omniq Technologies [Member]              
Business Acquisition [Line Items]              
Issued shares | shares     5,100 5,100      
Value issued     $ 7,600,000 ₪ 23,740,500      
Dangot Share Purchase Agreement [Member] | Haim Dangot [Member]              
Business Acquisition [Line Items]              
Issued shares | shares     4,900 4,900      
Value issued     $ 143,000 ₪ 465,500      
Dangot Share Purchase Agreement [Member] | Dangot Computers Ltd [Member]              
Business Acquisition [Line Items]              
Purchase price percentage     51.00% 51.00%      
Payable to owner     $ 600,000        
Dangot Share Purchase Agreement [Member] | Haim Dangot [Member]              
Business Acquisition [Line Items]              
Purchase price percentage     51.00% 51.00%      
Percentage of remaining shares on fully diluted basis     1.00% 1.00%      
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Receivables [Abstract]    
Trade accounts receivable $ 24,348 $ 27,129
Less allowance for doubtful accounts (455) (6)
Total accounts receivable (net) $ 23,893 $ 27,123
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE (Details Narrative) - Accounts Receivable [Member] - Customer Concentration Risk [Member]
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Customer [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Concentration risk percentage 10.00%  
One Customer [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Concentration risk percentage   17.00%
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INVENTORY (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials $ 649 $ 894
Inventory in transit 2,004
Finished goods (less allowance) 6,073 6,061
Total inventories $ 8,726 $ 6,955
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross  
Less: accumulated depreciation $ (1,030) (2,203)
Property and equipment, Net 1,086 1,127
Manufacturing and Lab Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross 98 499
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross 521 609
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross 987 1,650
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross 236 254
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, Gross $ 274 $ 318
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 324 $ 251
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Accumulated amortization $ (16,761) $ (14,980)
Intangibles, net 24,010 25,808
Goodwill [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangibles gross 16,542 16,453
Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangibles gross 6,284 6,284
Accumulated amortization 4,458 3,863
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangibles gross 15,729 15,729
Accumulated amortization 10,762 9,660
Intellectual Property [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangibles gross $ 2,216 $ 2,322
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 1,625
2024 952
2025 943
2026 943
2027 776
Thereafter 2,229
Total $ 7,468
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLE ASSETS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Impairment charges $ 0 $ 0
Amortization expense 1,799,000 3,160,000
Estimated useful lives $ 0 $ 0
Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 3 years  
Minimum [Member] | Finite-Lived Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 2 years  
Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 11 years  
Maximum [Member] | Finite-Lived Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible asset, useful life 9 years  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.1
CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) - Business Finance Agreement [Member] - Bridge Bank [Member]
$ in Millions
Mar. 25, 2022
USD ($)
Line of Credit Facility [Line Items]  
Line of credit facility maximum borrowing capacity $ 8.5
Percentage of reserve account 15.00%
Line of credit, interest rate, description The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the BFA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 1.5%, plus a monthly fee equal to 0.15% of the average outstanding balance.
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2017
Short-Term Debt [Line Items]      
Total notes payable $ 293 $ 683  
Less current portion 293 390  
Long-term portion 293  
Note Payable Marin [Member]      
Short-Term Debt [Line Items]      
Total notes payable 180 420 $ 660
Note Payable - Thomet [Member]      
Short-Term Debt [Line Items]      
Total notes payable $ 113 $ 263 $ 750
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY NOTES PAYABLE (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2022
Dec. 31, 2021
Aug. 11, 2021
Short-Term Debt [Line Items]        
Interest expense   $ 8 $ 10  
Notes payable related parties   293 683  
Annual interest rate note payable       7.50%
Note Payable Marin [Member]        
Short-Term Debt [Line Items]        
Notes payable related parties $ 660 180 420  
Annual interest rate note payable 1.89%      
Debt instrument, frequency of periodic payment 60 monthly      
Principal payments $ 20      
Accrued interest payable   71    
Note Payable - Thomet [Member]        
Short-Term Debt [Line Items]        
Notes payable related parties $ 750 $ 113 $ 263  
Annual interest rate note payable 0.00%      
Debt instrument, frequency of periodic payment 60 monthly      
Principal payments $ 13      
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OTHER NOTES PAYABLE (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Short-Term Debt [Line Items]    
Total $ 11,627 $ 10,167
Less current portion 11,572 7,521
Long Term Notes Payable 55 2,646
Note Payable Secured Supplier [Member]    
Short-Term Debt [Line Items]    
Total 2,243
Notes Payable Other [Member]    
Short-Term Debt [Line Items]    
Total $ 11,627 $ 7,924
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Short-Term Debt [Line Items]    
Total $ 11,627 $ 10,167
Other Notes Payable[Member]    
Short-Term Debt [Line Items]    
2023 11,572  
2024 55  
Total $ 11,627  
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER NOTES PAYABLE (Details Narrative)
₪ in Thousands, $ in Thousands
Sep. 13, 2022
USD ($)
Integer
Mar. 27, 2022
USD ($)
Integer
Nov. 28, 2021
USD ($)
Integer
Aug. 11, 2021
USD ($)
Jul. 29, 2021
USD ($)
Integer
Jul. 18, 2016
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
ILS (₪)
Sep. 13, 2022
ILS (₪)
Integer
Mar. 27, 2022
ILS (₪)
Integer
Dec. 31, 2021
USD ($)
Dec. 31, 2021
ILS (₪)
Nov. 28, 2021
ILS (₪)
Integer
Aug. 11, 2021
ILS (₪)
Jul. 29, 2021
ILS (₪)
Integer
Short-Term Debt [Line Items]                              
Debt interest rate       7.50%                   7.50%  
Loans payable       $ 155     $ 97 ₪ 342           ₪ 500  
Debt instrument term       5 years                      
Loans payable outstanding amount             800 2,800       ₪ 13,600      
Short term loans             $ 7,600 ₪ 26,800              
Accrues average interest             6.30% 6.30%              
Line of Credit [Member]                              
Short-Term Debt [Line Items]                              
Loans payable | ₪                       ₪ 17,500      
Loans payable outstanding amount                     $ 4,400        
Leumi Bank [Member]                              
Short-Term Debt [Line Items]                              
Debt interest rate   8.25% 8.25%   8.25%         8.25%     8.25%   8.25%
Loans payable   $ 1,100 $ 1,100   $ 2,160         ₪ 3,500     ₪ 3,500   ₪ 7,000
Number of installements | Integer   8 8   8         8     8   8
Debt instrument term   4 years 4 years   4 years                    
Leumi Bank [Member] | Israeli Prime Rate [Member]                              
Short-Term Debt [Line Items]                              
Debt interest rate   4.50% 4.50%   4.50%         4.50%     4.50%   4.50%
Hapoalim Bank [Member]                              
Short-Term Debt [Line Items]                              
Debt interest rate 6.03%               6.03%            
Loans payable $ 900               ₪ 3,000            
Number of installements | Integer 36               36            
Debt instrument term 3 years                            
Secured Promissory Note [Member]                              
Short-Term Debt [Line Items]                              
Principal amount           $ 12,500                  
Debt interest rate           18.00%                  
Principal and accrued interest amount           $ 250                  
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OTHER LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]    
Other vendor payable $ 801 $ 801
Dividend payable 153 1,418
Others 705 1,882
Total other liabilities 1,659 4,101
Less current portion (1,394) (2,683)
Total long term other liabilities $ 265 $ 1,418
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
ROU asset, Beginning balance $ 3,556 $ 76
Amortization (1,000) (199)
Effective foreign exchange rates (256) 121
Increase   3,558
Increase  
ROU asset, Ending balance 2,300 3,556
Lease liability, Beginning balance 3,607 79
Decrease 3,558
Effective foreign exchange rate (261) 169
Amortization (1,000) (199)
Lease liability, Ending balance $ 2,346 $ 3,607
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]      
2023 $ 1,102    
2024 873    
2025 397    
2026 176    
2027    
Total 2,548    
Less interest (202)    
Present value of future minimum lease payments 2,346 $ 3,607 $ 79
Less current obligations (942) (1,341)  
Long term lease obligations $ 1,404 $ 2,266  
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product Liability Contingency [Line Items]    
Total expense $ 122 $ 108
Weighted average discount rate 5.70%  
Weighted average remaining lease term 29 months  
Unpaid commission $ 60  
Akron [Member]    
Product Liability Contingency [Line Items]    
Monthly payments $ 3  
Weighted average discount rate 14.55%  
Remaining lease month 5 months  
Salt Lack City [Member]    
Product Liability Contingency [Line Items]    
Monthly payments $ 24  
Remaining lease month 44 months  
Yad Harutzim [Member]    
Product Liability Contingency [Line Items]    
Remaining lease month 12 months  
Yad Harutzim [Member] | Dangot Computers Ltd [Member]    
Product Liability Contingency [Line Items]    
Remaining lease month 23 months  
Rival Street [Member]    
Product Liability Contingency [Line Items]    
Remaining lease month 30 months  
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Number of warrants, Outstanding, Beginning of period 1,378,929 1,366,667
Weighted Average Exercise Price balance, Outstanding, Beginning of period $ 7.40 $ 7.19
Number of warrants, Warrants granted 112,805 171,429
Weighted Average Exercise Price, Warrants granted $ 6.59 $ 7.70
Number of warrants, Warrants expired 10,000 40,000
Weighted Average Exercise Price, Warrants expired $ 8.00 $ 10.00
Number of warrants, Warrants exercised 119,167
Weighted Average Exercise Price, Warrants exercised $ 6.99
Number of warrants, Outstanding, End of period 1,481,734 1,378,929
Weighted Average Exercise Price, Outstanding, End of period $ 7.34 $ 7.40
Number of warrants, Exercisable warrants 1,424,234 1,295,596
Weighted Average Exercise Price, Exercisable warrants $ 7.38 $ 6.38
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OUTSTANDING WARRANTS (Details) - Warrant [Member]
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 10.00
Weighted Average Residual Life Span (in years) 2 years 4 months 28 days
Outstanding Warrants | shares 1,481,734
Weighted Average Exercise Price $ 7.34
Exercisable Warrants | shares 1,424,234
Weighted Average Exercise Price $ 7.38
Range of Exercise Prices, lower range limit 5.91
Exercise Price Range 1 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 5.91
Weighted Average Residual Life Span (in years) 4 years 3 months 29 days
Outstanding Warrants | shares 40,000
Weighted Average Exercise Price $ 5.91
Exercisable Warrants | shares 5,000
Weighted Average Exercise Price $ 5.91
Exercise Price Range 2 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 6.95
Weighted Average Residual Life Span (in years) 4 years 2 months 23 days
Outstanding Warrants | shares 42,805
Weighted Average Exercise Price $ 6.95
Exercisable Warrants | shares 42,805
Weighted Average Exercise Price $ 6.95
Exercise Price Range 3 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 7.00
Weighted Average Residual Life Span (in years) 2 years 7 months 13 days
Outstanding Warrants | shares 847,500
Weighted Average Exercise Price $ 7.00
Exercisable Warrants | shares 855,000
Weighted Average Exercise Price $ 7.00
Exercise Price Range 4 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 7.50
Weighted Average Residual Life Span (in years) 3 years 8 months 4 days
Outstanding Warrants | shares 250,000
Weighted Average Exercise Price $ 7.50
Exercisable Warrants | shares 250,000
Weighted Average Exercise Price $ 7.50
Exercise Price Range 5 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 7.70
Weighted Average Residual Life Span (in years) 3 years 6 months 7 days
Outstanding Warrants | shares 171,429
Weighted Average Exercise Price $ 7.70
Exercisable Warrants | shares 171,429
Weighted Average Exercise Price $ 7.70
Exercise Price Range 6 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, upper range limit $ 10.00
Weighted Average Residual Life Span (in years) 4 months 20 days
Outstanding Warrants | shares 100,000
Weighted Average Exercise Price $ 10.00
Exercisable Warrants | shares 100,000
Weighted Average Exercise Price $ 10.00
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Warrant Outstanding 1,481,734 1,378,929
February Twenty Seven Thousand Twenty Two [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Feb. 27, 2022  
Warrant Exercise Prices $ 8.00  
Warrant Outstanding 10,000
May 18, 2023 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date May 18, 2023  
Warrant Exercise Prices $ 10.00  
Warrant Outstanding 50,000 50,000
October Fourteen Two Thousand Twenty Three [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Oct. 14, 2023  
Warrant Exercise Prices $ 10.00  
Warrant Outstanding 50,000 50,000
October Six Two Thousand Twenty Four [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Oct. 06, 2024  
Warrant Exercise Prices $ 7.00  
Warrant Outstanding 847,500 847,500
September 1, 2025 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Sep. 01, 2025  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,334 83,334
June 4, 2026 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Jun. 04, 2026  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,333 83,333
July 7, 2026 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Jul. 07, 2026  
Warrant Exercise Prices $ 7.70  
Warrant Outstanding 171,429 171,429
December 4, 2027 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Dec. 04, 2027  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,333 83,333
March Twenty Fifth Two Thousand Twenty Seven [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date Mar. 25, 2027  
Warrant Exercise Prices $ 6.95  
Warrant Outstanding 42,805
May First Two Thousand Twenty Seven [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date May 01, 2027  
Warrant Exercise Prices $ 7.00  
Warrant Outstanding 30,000
May First Two Thousand Twenty Seven One[Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expiry Date May 01, 2027  
Warrant Exercise Prices $ 5.91  
Warrant Outstanding 40,000
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK OPTIONS GRANTED (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Number of stock options, Outstanding, Beginning of period 1,559,300 1,811,550
Weighted Average Exercise Price, Outstanding, Beginning of period $ 4.58 $ 4.32
Number of stock options, Stock options granted 841,500
Weighted Average Exercise Price, Stock options granted
Number of stock options, Stock options expired 28,750
Weighted Average Exercise Price, Stock options expired
Number of stock options, Stock options cancelled, forfeited 9,000
Weighted Average Exercise Price, Stock options cancelled, forfeited
Number of stock options, Stock options exercised 201,217 223,500
Weighted Average Exercise Price, Stock options exercised
Number of stock options, Outstanding, End of period 2,190,583 1,559,300
Weighted Average Exercise Price, Outstanding, Ending of period $ 5.00 $ 4.58
Number of stock options, Exercisable stock options 1,420,312 1,065,133
Weighted Average Exercise Price, Exercisable stock options $ 4.96 $ 4.56
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Exercise Prices $ 5.00 $ 4.58 $ 4.32
Stock option outstanding 2,190,583 1,559,300 1,811,550
February 17, 2022 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Feb. 17, 2022    
Exercise Prices $ 1.50    
Stock option outstanding 38,017  
February 17, 2022 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Feb. 17, 2022    
Exercise Prices $ 1.80    
Stock option outstanding 76,033  
February 28, 2023 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Feb. 28, 2023    
Exercise Prices $ 5.00    
Stock option outstanding 20,000 20,000  
March 05, 2023 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Mar. 05, 2023    
Exercise Prices $ 2.40    
Stock option outstanding 242,000 247,000  
July 31, 2023 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Jul. 31, 2023    
Exercise Prices $ 5.00    
Stock option outstanding 127,500 127,500  
October 31, 2023 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Oct. 31, 2023    
Exercise Prices $ 4.40    
Stock option outstanding 10,000 54,000  
November 30, 2023 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Nov. 30, 2023    
Exercise Prices $ 5.40    
Stock option outstanding 120,250 131,750  
November 20, 2024 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Nov. 20, 2024    
Exercise Prices $ 10.00    
Stock option outstanding 125,000 125,000  
April 20, 2025 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Apr. 20, 2025    
Exercise Prices $ 4.20    
Stock option outstanding 10,000 10,000  
March 1, 2027 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Mar. 01, 2027    
Exercise Prices $ 5.14    
Stock option outstanding 648,500  
March 1, 2027 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Mar. 01, 2027    
Exercise Prices $ 5.65    
Stock option outstanding 140,000  
May First Two Thousand Twenty Seven [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date May 01, 2027    
Exercise Prices $ 5.90    
Stock option outstanding 30,000  
October 31, 2027 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Oct. 31, 2027    
Exercise Prices $ 5.98    
Stock option outstanding 19,000  
September 30, 2030 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Sep. 30, 2030    
Exercise Prices $ 4.40    
Stock option outstanding 318,333 350,000  
September 30, 2030 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Expiry Date Sep. 30, 2030    
Exercise Prices $ 4.84    
Stock option outstanding 380,000 380,000  
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK COMPENSATION EXPENSE (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Stock compensation $ 1,321 $ 951
Stock Option vesting 1,852 1,600
Total $ 3,173 $ 2,551
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Oct. 31, 2021
Aug. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Aug. 31, 2021
Jul. 31, 2021
Nov. 17, 2014
Class of Stock [Line Items]              
Stock issued during period, value, conversion of convertible securities            
Common stock, par value     $ 0.001 $ 0.001      
Value issued     $ 37 $ 16      
Expected volatility rate minimum     104.33%        
Expected volatility rate maximum     126.44%        
Expected term     3 years 3 months 5 years      
Risk- free interest rate     1.76%        
Risk- free interest rate     4.52%        
Stock price volatility       151.00%      
Risk-free interest rate       0.41%      
Stock issued during period, value, warrants exercised       $ 683      
Options granted     841,500      
Stock issued during period, value, stock options exercised     $ 369 $ 1,500      
Intrinsic value for vested stock options     $ 477 $ 6,600      
Securities Purchase Agreement [Member]              
Class of Stock [Line Items]              
Issued warrants shares           171,429  
Exercise price           $ 7.70  
Equity Incentive Plan [Member]              
Class of Stock [Line Items]              
Shares issued       0      
Common Stock [Member]              
Class of Stock [Line Items]              
Stock issued during period, value, conversion of convertible securities            
Stock issued during period, shares, conversion of convertible securities       70      
Shares issued     7,000 2      
Value issued          
Common Stock [Member] | Equity Incentive Plan [Member]              
Class of Stock [Line Items]              
Shares issued 1,118,856 1,000,000 0 0      
Common stock, par value $ 0.001       $ 0.001    
Common Stock [Member] | Employee Stock Purchase Plan [Member]              
Class of Stock [Line Items]              
Shares issued     7,025 2,186      
Value issued     $ 37 $ 16      
Warrant [Member]              
Class of Stock [Line Items]              
Warrants valued           $ 1,300  
Director [Member]              
Class of Stock [Line Items]              
Preferred stock, voting rights     The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 13 common shares.        
Director [Member] | Share Purchase Option Plan [Member]              
Class of Stock [Line Items]              
Reserved for issuance             500,000
Options granted     500,000        
Holders [Member] | Common Stock [Member]              
Class of Stock [Line Items]              
Stock issued during period, shares, conversion of convertible securities       105,551      
Employees And Consultants [Member] | Common Stock [Member]              
Class of Stock [Line Items]              
Shares issued     841,500        
Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock, shares authorized     2,000,000 2,000,000      
Preferred stock, shares outstanding     0 0      
Preferred stock, shares issued     0 0      
Series B Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock, shares authorized     1 1      
Preferred stock, shares outstanding     0 0      
Preferred stock, shares issued     0 0      
Series C Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock, shares authorized     3,000,000 3,000,000      
Preferred stock, shares outstanding     544,500 544,500      
Preferred stock, shares issued     544,500 544,500      
Dividends payable, amount per share     $ 0.06        
Liquidation preference     $ 1        
Accrued dividends     $ 153 $ 126      
Preferred stock conversion, description     The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.        
Series C Preferred Stock [Member] | Holders [Member]              
Class of Stock [Line Items]              
Accrued dividends       194      
Stock issued during period, value, conversion of convertible securities       $ 1,600      
Stock issued during period, shares, conversion of convertible securities       1,600,530      
Preferred Stock Series C [Member]              
Class of Stock [Line Items]              
Preferred stock, shares outstanding     544,500 544,500      
Preferred stock, shares issued     544,500 544,500      
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 1 Months Ended
Apr. 01, 2022
May 03, 2021
Feb. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Payment of financing and stock issuance costs $ 3,518,000 $ 4,012,000  
Consulting Agreement [Member] | Mr. Carlos J. Nissenson [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Ownership percentage     3.00%
Consulting Agreement [Member] | Mr. Carlos J. Nissenson [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Debt periodic payment     $ 30,000
Equity component description     If we procure debt financing during the term of Mr. Nissensohn’s agreement, without any equity component, Mr. Nissensohn shall be entitled to 3% of the gross funds raised, however if we are required to pay a success fee to another external entity, then Mr. Nissensohn shall be entitled to only 2% of the gross funds raised.
Gross proceeds     $ 3,000,000
Warrant exercise price percentage     100.00%
Payment of financing and stock issuance costs     $ 80,000
Transaction price percentage     5.00%
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF REVENUES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Total revenues $ 102,545 $ 78,251
UNITED STATES    
Total revenues 51,023 53,725
ISRAEL    
Total revenues 42,217 21,848
Rest Of The World [Member]    
Total revenues $ 9,305 $ 2,678
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]    
Product Information [Line Items]    
Concentration risk percentage 30.00% 23.00%
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Reserves and deferred revenue $ 411 $ 182
163(j) Limitation 2,260 1,682
Foreign deferred tax assets 135 165
Net operating loss 8,353 7,164
Total gross deferred tax assets 11,158 9,193
Less: Valuation Allowance (10,890) (8,720)
Net deferred tax assets 269 473
Amortization of intangible assets and depreciation (134) (308)
Total deferred tax liabilities (134) (308)
Net deferred tax assets $ 135 $ 165
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Deferred tax assets $ 11,025 $ 8,885
Valuation allowance (10,890) (8,720)
Net deferred tax assets $ 135 $ 165
XML 88 R75.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Federal statutory tax rate 21.00% 21.00%
State taxes (0.07%) (0.03%)
Foreign income taxes (4.45%) (6.38%)
Change in valuation allowance (16.13%) (15.24%)
Return to provision adjustments 0.03% 0.079%
Other 0.76% (1.37%)
Effective tax rate 0.44% (1.23%)
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Current income tax provision $ 35  
Deferred income tax expense benefit 30  
Valuation allowance for deferred tax assets 10,900 $ 8,700
Net operating loss carryforward $ 39,700  
XML 90 form10-k_htm.xml IDEA: XBRL DOCUMENT 0000278165 2022-01-01 2022-12-31 0000278165 2022-06-30 0000278165 2023-03-10 0000278165 2021-01-01 2021-12-31 0000278165 2022-12-31 0000278165 2021-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2021-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2022-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-12-31 0000278165 us-gaap:TradeNamesMember 2022-12-31 0000278165 us-gaap:TradeNamesMember 2021-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2022-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2021-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000278165 us-gaap:CommonStockMember 2020-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000278165 us-gaap:RetainedEarningsMember 2020-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2020-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000278165 2020-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0000278165 us-gaap:CommonStockMember 2021-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000278165 us-gaap:RetainedEarningsMember 2021-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2021-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000278165 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000278165 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0000278165 us-gaap:CommonStockMember 2022-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000278165 us-gaap:RetainedEarningsMember 2022-12-31 0000278165 us-gaap:NoncontrollingInterestMember 2022-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000278165 srt:MinimumMember us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0000278165 us-gaap:IndefinitelivedIntangibleAssetsMember 2021-12-31 0000278165 OMQS:OneVendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000278165 OMQS:OneVendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000278165 OMQS:BoardOfDirectorsMember OMQS:EquityIncentivePlanMember 2021-10-31 0000278165 OMQS:EquityIncentivePlanMember 2021-01-01 2021-12-31 0000278165 OMQS:BoardOfDirectorsMember OMQS:TwoThousandTwentyPlanMember 2020-09-30 0000278165 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0000278165 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0000278165 srt:MinimumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0000278165 us-gaap:SoftwareDevelopmentMember 2022-01-01 2022-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0000278165 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0000278165 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000278165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000278165 us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 us-gaap:WarrantMember 2021-01-01 2021-12-31 0000278165 OMQS:DangotComputersLtdMember 2022-01-01 2022-12-31 0000278165 OMQS:WesternAllianceBankMember 2022-03-25 0000278165 OMQS:ActionCapitalMember 2022-03-25 0000278165 OMQS:ScanSourceIncMember 2022-03-25 2022-03-25 0000278165 OMQS:BlueStarMember 2022-12-31 0000278165 OMQS:DangotComputersLimitedMember OMQS:DangotSharePurchaseAgreementMember 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:OmniqTechnologiesMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-07-08 0000278165 OMQS:DangotSharePurchaseAgreementMember OMQS:HaimDangotMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharePurchaseAgreementMember 2021-05-03 0000278165 OMQS:HaimDangotMember OMQS:DangotSharePurchaseAgreementMember 2021-05-02 2021-05-03 0000278165 OMQS:HaimDangotMember OMQS:DangotSharePurchaseAgreementMember 2021-05-03 0000278165 2021-10-02 0000278165 OMQS:HaimDangotMember 2021-10-02 0000278165 2021-05-02 2021-05-03 0000278165 2022-04-01 2022-04-01 0000278165 OMQS:DangotComputersLtdMember 2021-01-01 2021-12-31 0000278165 OMQS:DangotComputersLimitedMember 2022-01-01 2022-12-31 0000278165 OMQS:DangotComputersLimitedMember OMQS:DangotSharePurchaseAgreementMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotComputersLimitedMember 2021-05-02 2021-05-03 0000278165 OMQS:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000278165 OMQS:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000278165 OMQS:ManufacturingAndLabEquipmentMember 2022-12-31 0000278165 OMQS:ManufacturingAndLabEquipmentMember 2021-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000278165 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000278165 us-gaap:ComputerEquipmentMember 2022-12-31 0000278165 us-gaap:ComputerEquipmentMember 2021-12-31 0000278165 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000278165 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000278165 us-gaap:VehiclesMember 2022-12-31 0000278165 us-gaap:VehiclesMember 2021-12-31 0000278165 srt:MinimumMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember 2022-01-01 2022-12-31 0000278165 srt:MinimumMember us-gaap:FiniteLivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 srt:MaximumMember us-gaap:FiniteLivedIntangibleAssetsMember 2022-01-01 2022-12-31 0000278165 us-gaap:GoodwillMember 2022-12-31 0000278165 us-gaap:GoodwillMember 2021-12-31 0000278165 us-gaap:IntellectualPropertyMember 2022-12-31 0000278165 us-gaap:IntellectualPropertyMember 2021-12-31 0000278165 OMQS:BridgeBankMember OMQS:BusinessFinanceAgreementMember 2022-03-25 0000278165 OMQS:BridgeBankMember OMQS:BusinessFinanceAgreementMember 2022-03-23 2022-03-25 0000278165 OMQS:NotePayableMarinMember 2022-12-31 0000278165 OMQS:NotePayableMarinMember 2021-12-31 0000278165 OMQS:NotePayableThometMember 2022-12-31 0000278165 OMQS:NotePayableThometMember 2021-12-31 0000278165 OMQS:NotePayableMarinMember 2017-12-31 0000278165 OMQS:NotePayableMarinMember 2017-12-01 2017-12-31 0000278165 OMQS:NotePayableThometMember 2017-12-31 0000278165 OMQS:NotePayableThometMember 2017-12-01 2017-12-31 0000278165 OMQS:NotePayableSecuredSupplierMember 2022-12-31 0000278165 OMQS:NotePayableSecuredSupplierMember 2021-12-31 0000278165 OMQS:NotesPayableOtherMember 2022-12-31 0000278165 OMQS:NotesPayableOtherMember 2021-12-31 0000278165 OMQS:OtherNotePayableMember 2022-12-31 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-17 2016-07-18 0000278165 OMQS:LeumiBankMember 2021-07-29 0000278165 OMQS:IsraeliPrimeRateMember OMQS:LeumiBankMember 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-07-28 2021-07-29 0000278165 OMQS:LeumiBankMember 2021-11-28 0000278165 OMQS:IsraeliPrimeRateMember OMQS:LeumiBankMember 2021-11-28 0000278165 OMQS:LeumiBankMember 2021-11-27 2021-11-28 0000278165 2021-08-11 0000278165 2021-08-10 2021-08-11 0000278165 OMQS:LeumiBankMember 2022-03-27 0000278165 OMQS:IsraeliPrimeRateMember OMQS:LeumiBankMember 2022-03-27 0000278165 OMQS:LeumiBankMember 2022-03-26 2022-03-27 0000278165 OMQS:HapoalimBankMember 2022-09-13 0000278165 OMQS:HapoalimBankMember 2022-09-13 2022-09-13 0000278165 us-gaap:LineOfCreditMember 2021-12-31 0000278165 OMQS:AkronMember 2022-01-01 2022-12-31 0000278165 OMQS:AkronMember 2022-12-31 0000278165 OMQS:SaltLackCityMember 2022-01-01 2022-12-31 0000278165 OMQS:SaltLackCityMember 2022-12-31 0000278165 OMQS:YadHarutzimMember OMQS:DangotComputersLtdMember 2022-12-31 0000278165 OMQS:YadHarutzimMember 2022-12-31 0000278165 OMQS:RivalStreetMember 2022-12-31 0000278165 srt:DirectorMember 2022-01-01 2022-12-31 0000278165 OMQS:PreferredStockSeriesCMember 2022-12-31 0000278165 OMQS:PreferredStockSeriesCMember 2021-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0000278165 OMQS:HoldersMember us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0000278165 OMQS:HoldersMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-10-01 2021-10-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-10-31 0000278165 OMQS:EmployeesAndConsultantsMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-01 2020-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 OMQS:EmployeeStockPurchasePlanMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000278165 OMQS:EmployeeStockPurchasePlanMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-31 0000278165 us-gaap:WarrantMember 2021-07-31 0000278165 srt:DirectorMember OMQS:SharePurchaseOptionPlanMember 2014-11-17 0000278165 srt:DirectorMember OMQS:SharePurchaseOptionPlanMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeOneMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeOneMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeFourMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeFourMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:ExercisePriceRangeSixMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 OMQS:ExercisePriceRangeSixMember us-gaap:WarrantMember 2022-12-31 0000278165 us-gaap:WarrantMember 2022-01-01 2022-12-31 0000278165 us-gaap:WarrantMember 2022-12-31 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2022-12-31 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2021-12-31 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2022-12-31 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2021-12-31 0000278165 OMQS:SeptemberOneTwoThousandTwentyFiveMember 2022-12-31 0000278165 OMQS:SeptemberOneTwoThousandTwentyFiveMember 2021-12-31 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2022-12-31 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2021-12-31 0000278165 OMQS:JulySevenTwoThousandTwentySixMember 2022-12-31 0000278165 OMQS:JulySevenTwoThousandTwentySixMember 2021-12-31 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MarchTwentyFifthTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MarchTwentyFifthTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenOneMember 2022-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenOneMember 2021-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2022-12-31 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2022-12-31 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2022-01-01 2022-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2022-12-31 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2022-01-01 2022-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2022-12-31 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2022-01-01 2022-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2022-12-31 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2022-01-01 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2022-12-31 0000278165 OMQS:MarchFirstTwoThousandTwentySevenOneMember 2021-12-31 0000278165 OMQS:MayFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2022-01-01 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2022-12-31 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentySevenMember 2021-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2022-01-01 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2022-01-01 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2022-12-31 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-12-31 0000278165 OMQS:MrCarlosJNissensonMember OMQS:ConsultingAgreementMember 2020-02-01 2020-02-28 0000278165 OMQS:MrCarlosJNissensonMember OMQS:ConsultingAgreementMember 2020-02-28 0000278165 OMQS:MrCarlosJNissensonMember OMQS:ConsultingAgreementMember 2020-02-28 0000278165 OMQS:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000278165 OMQS:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000278165 country:US 2022-01-01 2022-12-31 0000278165 country:US 2021-01-01 2021-12-31 0000278165 country:IL 2022-01-01 2022-12-31 0000278165 country:IL 2021-01-01 2021-12-31 0000278165 OMQS:RestOfTheWorldMember 2022-01-01 2022-12-31 0000278165 OMQS:RestOfTheWorldMember 2021-01-01 2021-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:ILS utr:D OMQS:Integer 0000278165 false FY P2Y 0 0 0 0 0 0.0003 0.00079 0.0076 0.0044 10-K true 2022-12-31 --12-31 2022 false 000-09047 OMNIQ CORP. DE 20-3454263 1865 West 2100 South Salt Lake City UT 84119 (800) 242-7272 Common Stock, $0.001 par value OMQS NASDAQ No No No No Yes Yes Non-accelerated Filer true false false false 31794449 7882628 457 2015 Haynie & Company Salt Lake City, Utah BARZILY AND CO., CPA’s Jerusalem, Israel 1311000 7085000 23893000 27123000 8726000 6955000 1268000 1987000 473000 9000 35671000 43159000 1030000 2203000 1086000 1127000 16542000 16453000 4458000 3863000 1826000 2421000 10762000 9660000 4967000 6069000 1541000 1457000 675000 865000 2300000 3556000 1744000 1431000 64811000 75081000 54736000 45553000 1971000 5951000 2633000 2658000 293000 390000 11572000 7521000 942000 1341000 1394000 2683000 73541000 66097000 293000 72000 63000 55000 2646000 1404000 2266000 265000 1418000 75337000 72783000 0.001 0.001 2000000 2000000 0 0 0 0 0.001 0.001 1 1 0 0 0 0 0.001 0.001 3000000 3000000 544500 544500 544500 544500 1000 1000 0.001 0.001 15000000 15000000 7714780 7714780 7459534 7459534 8000 20000 73714000 70606000 -84460000 -70571000 211000 -154000 -10526000 -98000 2396000 -10526000 2298000 64811000 75081000 102545000 78251000 80441000 61582000 22104000 16669000 1826000 1873000 27707000 21865000 324000 251000 1799000 3160000 31656000 27149000 -9552000 -10480000 3496000 2515000 -601000 7000 -4097000 -2508000 -13649000 -12988000 -35000 156000 -35000 156000 -13614000 -13144000 67000 218000 -13681000 -13362000 -13614000 -13144000 365000 71000 -13249000 -13073000 -20000 59000 -13229000 -13132000 -13614000 -13144000 206000 77000 -13820000 -13221000 218000 -13820000 -13439000 -1.82 -2.20 7576434 6082763 2145 2000 4685 5000 51842000 -56726000 -166000 -5043000 77000 77000 -398000 -398000 2 16000 16000 2552000 2552000 25 188000 188000 2143000 15000 13282000 13297000 279000 438000 438000 220 2084000 2084000 6508000 6508000 -4012000 -4012000 -1000 -377000 -378000 59000 12000 71000 -7000 -7000 -1400 -1000 70 1000 -201 35000 203000 203000 -13362000 218000 -13144000 544000 1000 7459000 20000 70606000 -70571000 2396000 -154000 2298000 206000 206000 7000 37000 37000 100 3173000 3173000 20 109000 109000 298000 298000 128000 147000 147000 668000 2443000 3111000 -12000 12000 -2000 -20000 365000 343000 -13681000 67000 -13614000 -13681000 67000 -13614000 544 1000 7714 8000 73714000 -84460000 211000 -10526000 -13614000 -13144000 -46000 248000 3173000 2552000 109000 188000 2119000 3411000 1000000 199000 -1472000 3291000 -585000 295000 2490000 538000 -131000 117000 10830000 8352000 8000 7000 268000 -180000 -1000000 -192000 263000 -58000 -1419000 -185000 1203000 -3175000 3518000 4012000 4992000 451000 299000 -185000 68000 -4154000 -9235000 37000 16000 147000 438000 1448000 306000 13297000 2525000 4612000 4770000 4603000 -4038000 1037000 -3057000 14473000 -6008000 2063000 234000 -105000 7085000 5127000 1311000 7085000 33000 464000 7390000 298000 155000 203000 2000 1108000 47000 3487000 1547000 160000 151000 <p id="xdx_800_eus-gaap--NatureOfOperations_zPqSsPWozjZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_822_zOFT8Ag30xZg">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its majority and wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quest Solutions, Inc. (January 2014)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bar Code Specialties, Inc. (November 2014)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ViascanQdata, Inc (October 2015 – later sold in September 2016)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HTS Image Processing, Inc. (October 2018)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EyepaxIT Consulting LLC. (February 2020)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dangot Computers Ltd. (July 2021)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic &amp; parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zwUNuadJ7Inl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 –<span id="xdx_82E_zA2Rl81IDA97">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zHOGyj7SrBH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zCoGa2CfiLG8">Principles of Consolidation and Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers Ltd. collectively referred to herein as “we” or “us” or “our” or the “Company.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant intercompany accounts and transactions have been eliminated in these consolidated financial statements. Business combinations are included in the consolidated financial statements from their respective dates of acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zxMJeJDwoZQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zIQb3BNbBeE6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgVdgzyog4Ph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zvTFTCauhPH8">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash consists of petty cash, checking, savings, and money market accounts. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zcP79lN0LkZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpk09pL7Mvs7">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We manage credit risk associated with our accounts receivables at the customer level. Because the same customers typically generate the revenues that are accounted for under both <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606) </i>and <i>Accounting Standards Codification Topic 326, Credit Losses (Topic 326</i>)., the discussions below on credit risk and our allowances for doubtful accounts address our total revenues from Topic 606 and Topic 326.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe concentration of credit risk, with respect to our receivables, is limited because our customer base is comprised of a number of geographically diverse customers. We manage credit risk through credit approvals, credit limits and other monitoring procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Topic 326 for our accounts receivables, we maintain an allowance for doubtful accounts that reflects our estimate of our expected credit losses. Our allowance is estimated using a loss rate model based on delinquency. The estimated loss rate is based on our historical experience with specific customers, our understanding of our current economic circumstances, reasonable and supportable forecasts, and our own judgment as to the likelihood of ultimate payment based upon available data. We perform credit evaluations of customers and establish credit limits based on reviews of our customers’ current credit information and payment histories. We believe our credit risk is somewhat mitigated by our geographically diverse customer base and our credit evaluation procedures. The actual rate of future credit losses, however, may not be similar to past experience. Our estimate of doubtful accounts could change based on changing circumstances, including changes in the economy or in the particular circumstances of individual customers. Accordingly, we may be required to increase or decrease our allowance for doubtful accounts. Based on management’s evaluation, accounts receivable has a balance in the allowance for doubtful accounts of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zFgo7J6gR919" title="Allowance for doubtful accounts">455</span> thousand and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20211231_z8NWliCnTmzd" title="Allowance for doubtful accounts">6</span> thousand for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_ze8QF1hN1Lua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zlq3zO9yoqa2">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all inventory consists of raw materials and finished goods and are valued at the lower of historic cost or net realizable value; where net realizable value is considered to be the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. Historic inventory costs are calculated on a first-in-first-out basis or specific cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znPvHKsi8lPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zIica8ct8abb">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost and depreciated using straight-line over the estimated useful lives. Ordinary repair and maintenance costs are included in sales, general and administrative (“SG&amp;A”) expenses on our consolidated statements of operations. However, expenditures for additions or improvements that significantly extend the useful life of the asset are capitalized in the period incurred. At the time assets are sold or disposed of, the cost and accumulated depreciation are removed from their respective accounts and the related gains or losses are reflected in the statements of operations in gains from sales of property and equipment, net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We periodically evaluate the appropriateness of remaining depreciable lives assigned to property and equipment. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or the remaining term of the lease, whichever is shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zZlRs3TeEZU6" title="Depreciation">324</span> thousand and $<span id="xdx_900_eus-gaap--Depreciation_pn3n3_c20210101__20211231_zFbtuYoGBSK6" title="Depreciation">251</span> thousand, respectively. Generally, we assign the following estimated useful lives to these categories:</span></p> <p id="xdx_89B_ecustom--ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock_zLP0jpzHTEN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zYU1EoV27hfc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; width: 93%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Category</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zoiMUsQIYhI1" title="Estimated useful life">5</span> to <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zRILTWFt4PN5" title="Estimated useful life">7</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zUo52FbjpyUi" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBhxB0QiL644" title="Estimated useful life">5</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zhuEA9Hk425i" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1XE828GiZkf" title="Estimated useful life">10</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zHUahYFsXIzk" title="Estimated useful life">3</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBWHyJibGpXb" title="Estimated useful life">15</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zPrya1ye8PJl" title="Estimated useful life">5</span> years</span></td></tr> </table> <p id="xdx_8AC_zOFqFJvsclAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zQzcZiEiCaQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zEQMGsibcNF7">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The FASB fair value measurement guidance established a fair value hierarchy that prioritizes the inputs used to measure fair value. The three broad levels of the fair value hierarchy are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs for which little or no market data exists, therefore requiring a company to develop its own assumptions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. We review the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of certain financial instruments, such as cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_ecustom--IntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_z2TjhtTVGdO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zWLjQZqg5Euh">Definite-lived Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded <span id="xdx_902_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_do_c20221231_zYkwLtl1Uxn6" title="Impairment indefinite-lived intangible assets"><span id="xdx_906_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_do_c20211231_zKojNjyUfuBe" title="Impairment indefinite-lived intangible assets">no</span></span> impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite-lived intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_zbWj9LCZMKB9" title="Useful life">3</span> to <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_ztFjz6W0OOyb" title="Useful life">11</span> years with a remaining weighted average lifespan of <span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zpbqmsTFjiBk" title="Remaining weighted average lifespan">7.5</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zW3EV7Ud45N" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zCpesh8Mplu4">Indefinite-lived Intangible Assets, Including Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, <span id="xdx_905_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_do_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z5oItAlGmlg4" title="Impairment indefinite-lived intangible assets"><span id="xdx_902_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_do_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPE1pNA6Lp5c" title="Impairment indefinite-lived intangible assets">no</span></span> impairment has been recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--TradeAndOtherAccountsPayablePolicyTextBlock_z1UtUajfwPJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zg2ARyrRVZ5b">Accounts Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable are made up of payables due to vendors in the ordinary course of business a December 31, 2022 and 2021. One vendor made up <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zw599h9fFt01" title="Concentration risk percentage">48</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zjcy4xHQxjzc" title="Concentration risk percentage">65</span>% of our purchases in 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--LesseeLeasesPolicyTextBlock_zgTwUZeceUoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zkKDKmoelFt9">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We determine whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset, and we have the right to control the asset for a period of time in exchange for consideration. Lease arrangements can take several forms. Some arrangements are clearly within the scope of lease accounting, such as a real estate contract that provides an explicit contractual right to use a building for a specified period of time in exchange for consideration. However, the right to use an asset can also be conveyed through arrangements that are not leases in form, such as leases embedded within service and supply contracts. We analyze all arrangements with potential embedded leases to determine if an identified asset is present, if substantive substitution rights are present, and if the arrangement provides the customer control of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our lease portfolio is substantially comprised of operating leases related to leases of real estate and improvements. From time to time, we may also lease various types of small equipment and vehicles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use (“ROU”) assets represent our right to use an individual asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide the lessor’s implicit rate, we use our incremental borrowing rate (“IBR”) at the commencement date in determining the present value of lease payments by utilizing a fully collateralized rate for a fully amortizing loan with the same term as the lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the term. Our leases can include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when such renewal options and/or termination options are reasonably certain of exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A ROU asset is subject to the same impairment guidance as assets categorized as plant, property, and equipment. As such, any impairment loss on ROU assets is presented in the same manner as an impairment loss recognized on other long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification is a change to the terms and conditions of a contract that change the scope or consideration of a lease. For example, a change to the terms and conditions to the contract that adds or terminates the right to use one or more underlying assets, or extends or shortens the contractual lease term, is a modification. Depending on facts and circumstances, a lease modification may be accounted as either: (1) the original lease plus the lease of a separate asset(s) or (2) a modified lease. A lease will be remeasured if there are changes to the lease contract that do not give rise to a separate lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zZ1RzStSqBqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zZ8teeGMhjtf">Purchase Accounting and Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zahXMNY5Vtqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zI1sVNTUZtg5">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When entering into contracts with our customers, we review follow the five steps outline in <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606)</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with our customer.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to the performance obligations. And</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate the satisfaction of the performance obligations,</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A good or another asset from another party that we then transfer to our customer. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a right to payment for the product or service,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has legal title to the product,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have transferred physical possession of the product to the customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has the risk and rewards of ownership of the product, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has accepted the product. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Hardware. </i>Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Software. </i>Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the software provides its original intended functionality to the customer without the updates, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer would ascribe a higher value to the upgrades versus the up-front deliverable, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer chooses to not delay or always install upgrades. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Services. </i>We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Freight Costs. </i>We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ReverseStockSplitPolicyTextBlock_zejVMY8eaEf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zF6IEvLR64M6">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zznGOsTdPXra" title="Common stock shares">1,118,856</span> shares of the Company’s common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zoXkTxTEJCke" title="Common stock, par value">0.001</span> (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_do_c20210101__20211231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zhljWOkJLhXb" title="Shares issued">No</span> shares were issued in 2021 as part of the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the Board of Directors approved our 2020 Equity Incentive Plan and later amended it. In September 2020, our shareholders adopted and ratified the 2020 Equity Incentive Plan. The total number of shares of Common Stock authorized for issuance under the 2020 Plan is <span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20200930__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyPlanMember_zPjvvWAszXel" title="Shares of Common Stock authorized">1,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity instruments issued to parties other than employees for acquiring goods or services.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants. </i>The fair value of the warrants is estimated on the date of issuance using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the expected term of the warrants, expected stock price volatility, and expected dividends. These estimates involve inherent uncertainties and the application of management’s judgment. Expected volatilities used in the valuation model are based on the average volatility of the Company’s stock. The risk-free rate for the expected term of the option is based on the United States Treasury yield curve in effect at the time of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--AdvertisingCostsPolicyTextBlock_zUk1J8ZhXmuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zTjHoB4SXJi">Advertising</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses marketing and advertising costs as incurred. During 2022 and 2021, the Company spent $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231_z4mDt64dhTg" title="Marketing and advertising costs">630</span> thousand and $<span id="xdx_903_eus-gaap--AdvertisingExpense_pn3n3_c20210101__20211231_zQZmvCVm0aVd" title="Marketing and advertising costs">213</span> thousand, respectively, on marketing, trade show and store front expense and advertising, net of co-operative rebates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received rebates on advertising from co-operative advertising agreements with several vendors and suppliers. These rebates have been recorded as a reduction to the related advertising and marketing expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zmnvZOQr1rL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zpcs5QEKBGI4">Foreign Currency Translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operations were maintained in the local currency and translated to the reporting currency as follows: assets and liabilities are converted using the balance sheet period-end date exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zXLIh8WgfIl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z5OlyV1WoUuj">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our income taxes in accordance with Income Taxes Topic of the FASB ASC 740, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for consolidated financial reporting purposes and such amounts recognized for tax purposes and are measured by applying enacted tax rates in effect in years in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also follow the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220101__20221231_zmoiaew79pS1" title="Income tax Likelihood">greater than 50% likelihood</span> of being realized upon ultimate settlement with the relevant tax authority.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our income is subject to taxation in both the U.S. and a foreign jurisdiction, Israel. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company establishes reserves for income tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves for tax contingencies are established when we believe positions do not meet the more-likely-than-not recognition threshold. We adjust uncertain tax liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or lapse of a statute of limitations. The provision for income taxes includes the impact of uncertain tax liabilities and changes in liabilities that are considered appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z3goIVMRWXTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zIEEax49RHXd">Comprehensive Income (Loss)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive income (loss) is defined as a change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Our other comprehensive income (loss) is composed of foreign currency translation adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zNOd2lNt41zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zOQSRfezDBj5">Net Loss Per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the years ended December 31, 2022 and December 31, 2021 were <span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_z5Jgf1rxSB1j" title="Weighted-average number of common shares outstanding">7,576,434</span> and <span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zw7nRAQu7kke" title="Weighted-average number of common shares outstanding">6,082,763</span>, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_899_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3bRbg9UbMTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z7gzE22c4Csg" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic"/><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20220101__20221231_z6HJxRYUfNOb" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20210101__20211231_zVhj0Zo1YUC1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zzDujNeWifT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,190,583</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,559,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCBYWg3YkeN" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,481,734</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,378,929</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_z04x4G5n6yug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,672,317</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,938,229</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zIe7yYGV6Upa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zjS6p6r3MoQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_862_zof2VBhrOvJc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent Accounting Pronouncements </b></span><b>not yet adopted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zHOGyj7SrBH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zCoGa2CfiLG8">Principles of Consolidation and Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., HTS Image Processing, Inc., OmniQ Vision Inc., HTS Image Ltd., OmniQ Technologies Ltd., and Dangot Computers Ltd. collectively referred to herein as “we” or “us” or “our” or the “Company.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant intercompany accounts and transactions have been eliminated in these consolidated financial statements. Business combinations are included in the consolidated financial statements from their respective dates of acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zxMJeJDwoZQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zIQb3BNbBeE6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgVdgzyog4Ph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zvTFTCauhPH8">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash consists of petty cash, checking, savings, and money market accounts. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zcP79lN0LkZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpk09pL7Mvs7">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We manage credit risk associated with our accounts receivables at the customer level. Because the same customers typically generate the revenues that are accounted for under both <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606) </i>and <i>Accounting Standards Codification Topic 326, Credit Losses (Topic 326</i>)., the discussions below on credit risk and our allowances for doubtful accounts address our total revenues from Topic 606 and Topic 326.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe concentration of credit risk, with respect to our receivables, is limited because our customer base is comprised of a number of geographically diverse customers. We manage credit risk through credit approvals, credit limits and other monitoring procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Topic 326 for our accounts receivables, we maintain an allowance for doubtful accounts that reflects our estimate of our expected credit losses. Our allowance is estimated using a loss rate model based on delinquency. The estimated loss rate is based on our historical experience with specific customers, our understanding of our current economic circumstances, reasonable and supportable forecasts, and our own judgment as to the likelihood of ultimate payment based upon available data. We perform credit evaluations of customers and establish credit limits based on reviews of our customers’ current credit information and payment histories. We believe our credit risk is somewhat mitigated by our geographically diverse customer base and our credit evaluation procedures. The actual rate of future credit losses, however, may not be similar to past experience. Our estimate of doubtful accounts could change based on changing circumstances, including changes in the economy or in the particular circumstances of individual customers. Accordingly, we may be required to increase or decrease our allowance for doubtful accounts. Based on management’s evaluation, accounts receivable has a balance in the allowance for doubtful accounts of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zFgo7J6gR919" title="Allowance for doubtful accounts">455</span> thousand and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20211231_z8NWliCnTmzd" title="Allowance for doubtful accounts">6</span> thousand for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 455000 6000 <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_ze8QF1hN1Lua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zlq3zO9yoqa2">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all inventory consists of raw materials and finished goods and are valued at the lower of historic cost or net realizable value; where net realizable value is considered to be the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. Historic inventory costs are calculated on a first-in-first-out basis or specific cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znPvHKsi8lPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zIica8ct8abb">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost and depreciated using straight-line over the estimated useful lives. Ordinary repair and maintenance costs are included in sales, general and administrative (“SG&amp;A”) expenses on our consolidated statements of operations. However, expenditures for additions or improvements that significantly extend the useful life of the asset are capitalized in the period incurred. At the time assets are sold or disposed of, the cost and accumulated depreciation are removed from their respective accounts and the related gains or losses are reflected in the statements of operations in gains from sales of property and equipment, net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We periodically evaluate the appropriateness of remaining depreciable lives assigned to property and equipment. Leasehold improvements are amortized using the straight-line method over their estimated useful lives or the remaining term of the lease, whichever is shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zZlRs3TeEZU6" title="Depreciation">324</span> thousand and $<span id="xdx_900_eus-gaap--Depreciation_pn3n3_c20210101__20211231_zFbtuYoGBSK6" title="Depreciation">251</span> thousand, respectively. Generally, we assign the following estimated useful lives to these categories:</span></p> <p id="xdx_89B_ecustom--ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock_zLP0jpzHTEN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zYU1EoV27hfc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; width: 93%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Category</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zoiMUsQIYhI1" title="Estimated useful life">5</span> to <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zRILTWFt4PN5" title="Estimated useful life">7</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zUo52FbjpyUi" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBhxB0QiL644" title="Estimated useful life">5</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zhuEA9Hk425i" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1XE828GiZkf" title="Estimated useful life">10</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zHUahYFsXIzk" title="Estimated useful life">3</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBWHyJibGpXb" title="Estimated useful life">15</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zPrya1ye8PJl" title="Estimated useful life">5</span> years</span></td></tr> </table> <p id="xdx_8AC_zOFqFJvsclAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 324000 251000 <p id="xdx_89B_ecustom--ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock_zLP0jpzHTEN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zYU1EoV27hfc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; width: 93%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Category</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zoiMUsQIYhI1" title="Estimated useful life">5</span> to <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zRILTWFt4PN5" title="Estimated useful life">7</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zUo52FbjpyUi" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBhxB0QiL644" title="Estimated useful life">5</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zhuEA9Hk425i" title="Estimated useful life">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1XE828GiZkf" title="Estimated useful life">10</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zHUahYFsXIzk" title="Estimated useful life">3</span> years</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBWHyJibGpXb" title="Estimated useful life">15</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zPrya1ye8PJl" title="Estimated useful life">5</span> years</span></td></tr> </table> P5Y P7Y P3Y P5Y P3Y P10Y P3Y P15Y P5Y <p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zQzcZiEiCaQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zEQMGsibcNF7">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The FASB fair value measurement guidance established a fair value hierarchy that prioritizes the inputs used to measure fair value. The three broad levels of the fair value hierarchy are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs for which little or no market data exists, therefore requiring a company to develop its own assumptions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. We review the fair value hierarchy classification on a quarterly basis. Changes in the observable inputs may result in a reclassification of assets and liabilities within the three levels of the hierarchy outlined above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of certain financial instruments, such as cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_ecustom--IntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_z2TjhtTVGdO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zWLjQZqg5Euh">Definite-lived Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically evaluates the carrying value of definite-lived intangibles when events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important which could trigger an impairment review include, but are not limited to, significant under-performance relative to historical or projected future operating results, significant changes in the manner of its use of acquired assets or its overall business strategy, and significant industry or economic trends. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded <span id="xdx_902_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_do_c20221231_zYkwLtl1Uxn6" title="Impairment indefinite-lived intangible assets"><span id="xdx_906_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_do_c20211231_zKojNjyUfuBe" title="Impairment indefinite-lived intangible assets">no</span></span> impairment loss for definite-lived intangible assets during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When the Company determines that the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators, the Company determines the recoverability by comparing the carrying amount of the asset to net future undiscounted cash flows that the asset is expected to generate and recognizes an impairment charge equal to the amount by which the carrying amount exceeds the fair market value of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company’s revenues or other estimated operating results are not achieved at or above our forecasted level, and the Company is unable to recover such costs through price increases, the carrying value of certain of the Company’s intangible assets may prove to be unrecoverable and we may incur impairment charges of definitive-live intangible assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite-lived intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over useful lives ranging from <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_zbWj9LCZMKB9" title="Useful life">3</span> to <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_ztFjz6W0OOyb" title="Useful life">11</span> years with a remaining weighted average lifespan of <span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zpbqmsTFjiBk" title="Remaining weighted average lifespan">7.5</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 P3Y P11Y P7Y6M <p id="xdx_84E_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_zW3EV7Ud45N" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zCpesh8Mplu4">Indefinite-lived Intangible Assets, Including Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite-lived intangible assets, including goodwill, are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company is permitted the option to first assess qualitative factors to determine whether the existence of events and circumstances indicates that it is more likely than not that the fair value of the Company’s reporting unit is less than its corresponding carrying value. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its corresponding carrying value then the Company is not required to take further action. However, if the Company concludes otherwise, then the Company must calculate the fair value of the reporting unit and compare it with its carrying amount, including Indefinite-lived intangible assets and recognize impairment equal to the difference between the carrying amount of the reporting unit and its fair value, considering the related income tax effect from any tax-deductible goodwill. The estimated fair value of the reporting unit exceeded the carrying value as of December 31, 2022 and 2021, and, therefore, <span id="xdx_905_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_do_c20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_z5oItAlGmlg4" title="Impairment indefinite-lived intangible assets"><span id="xdx_902_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_do_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_zPE1pNA6Lp5c" title="Impairment indefinite-lived intangible assets">no</span></span> impairment has been recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_840_ecustom--TradeAndOtherAccountsPayablePolicyTextBlock_z1UtUajfwPJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zg2ARyrRVZ5b">Accounts Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable are made up of payables due to vendors in the ordinary course of business a December 31, 2022 and 2021. One vendor made up <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zw599h9fFt01" title="Concentration risk percentage">48</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zjcy4xHQxjzc" title="Concentration risk percentage">65</span>% of our purchases in 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.48 0.65 <p id="xdx_847_eus-gaap--LesseeLeasesPolicyTextBlock_zgTwUZeceUoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zkKDKmoelFt9">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We determine whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset, and we have the right to control the asset for a period of time in exchange for consideration. Lease arrangements can take several forms. Some arrangements are clearly within the scope of lease accounting, such as a real estate contract that provides an explicit contractual right to use a building for a specified period of time in exchange for consideration. However, the right to use an asset can also be conveyed through arrangements that are not leases in form, such as leases embedded within service and supply contracts. We analyze all arrangements with potential embedded leases to determine if an identified asset is present, if substantive substitution rights are present, and if the arrangement provides the customer control of the asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our lease portfolio is substantially comprised of operating leases related to leases of real estate and improvements. From time to time, we may also lease various types of small equipment and vehicles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use (“ROU”) assets represent our right to use an individual asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide the lessor’s implicit rate, we use our incremental borrowing rate (“IBR”) at the commencement date in determining the present value of lease payments by utilizing a fully collateralized rate for a fully amortizing loan with the same term as the lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. For leases with terms greater than 12 months, we record the related asset and obligation at the present value of lease payments over the term. Our leases can include rental escalation clauses, renewal options and/or termination options that are factored into our determination of lease payments when such renewal options and/or termination options are reasonably certain of exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A ROU asset is subject to the same impairment guidance as assets categorized as plant, property, and equipment. As such, any impairment loss on ROU assets is presented in the same manner as an impairment loss recognized on other long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification is a change to the terms and conditions of a contract that change the scope or consideration of a lease. For example, a change to the terms and conditions to the contract that adds or terminates the right to use one or more underlying assets, or extends or shortens the contractual lease term, is a modification. Depending on facts and circumstances, a lease modification may be accounted as either: (1) the original lease plus the lease of a separate asset(s) or (2) a modified lease. A lease will be remeasured if there are changes to the lease contract that do not give rise to a separate lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zZ1RzStSqBqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zZ8teeGMhjtf">Purchase Accounting and Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zahXMNY5Vtqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zI1sVNTUZtg5">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When entering into contracts with our customers, we review follow the five steps outline in <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606)</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with our customer.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to the performance obligations. And</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluate the satisfaction of the performance obligations,</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A good or another asset from another party that we then transfer to our customer. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a right to payment for the product or service,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has legal title to the product,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have transferred physical possession of the product to the customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has the risk and rewards of ownership of the product, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer has accepted the product. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Hardware. </i>Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Software. </i>Sales of software licenses are generally considered a single performance obligation. When we are considered the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the software provides its original intended functionality to the customer without the updates, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer would ascribe a higher value to the upgrades versus the up-front deliverable, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the customer chooses to not delay or always install upgrades. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition for Services. </i>We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Freight Costs. </i>We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ReverseStockSplitPolicyTextBlock_zejVMY8eaEf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zF6IEvLR64M6">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company estimates the expected volatility and expected option life assumption consistent with ASC Topic 718, Compensation – Stock Compensation. The expected volatility of the Company’s common stock at the date of grant is estimated based on a historic volatility rate and the expected option life is calculated based on historical stock option experience as the best estimate of future exercise patterns. The dividend yield assumption is based on historical and anticipated dividend payouts. The risk-free interest rate assumption is based on observed interest rates consistent with the expected life of each stock option grant. The Company uses historical data to estimate pre-vesting option forfeitures and records stock-based compensation expense only for those awards that are expected to vest. Compensation expense is recorded for all stock options expected to vest based on the amortization of the fair value at the date of grant on a straight-line basis primarily over the vesting period of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zznGOsTdPXra" title="Common stock shares">1,118,856</span> shares of the Company’s common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zoXkTxTEJCke" title="Common stock, par value">0.001</span> (the “Shares”), were set aside and reserved for issuance. The Plan was approved by our stockholders at the December 2021, shareholders’ meeting. <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_do_c20210101__20211231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zhljWOkJLhXb" title="Shares issued">No</span> shares were issued in 2021 as part of the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the Board of Directors approved our 2020 Equity Incentive Plan and later amended it. In September 2020, our shareholders adopted and ratified the 2020 Equity Incentive Plan. The total number of shares of Common Stock authorized for issuance under the 2020 Plan is <span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20200930__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyPlanMember_zPjvvWAszXel" title="Shares of Common Stock authorized">1,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity instruments issued to parties other than employees for acquiring goods or services.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants. </i>The fair value of the warrants is estimated on the date of issuance using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the expected term of the warrants, expected stock price volatility, and expected dividends. These estimates involve inherent uncertainties and the application of management’s judgment. Expected volatilities used in the valuation model are based on the average volatility of the Company’s stock. The risk-free rate for the expected term of the option is based on the United States Treasury yield curve in effect at the time of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1118856 0.001 0 1000000 <p id="xdx_849_eus-gaap--AdvertisingCostsPolicyTextBlock_zUk1J8ZhXmuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zTjHoB4SXJi">Advertising</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses marketing and advertising costs as incurred. During 2022 and 2021, the Company spent $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231_z4mDt64dhTg" title="Marketing and advertising costs">630</span> thousand and $<span id="xdx_903_eus-gaap--AdvertisingExpense_pn3n3_c20210101__20211231_zQZmvCVm0aVd" title="Marketing and advertising costs">213</span> thousand, respectively, on marketing, trade show and store front expense and advertising, net of co-operative rebates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received rebates on advertising from co-operative advertising agreements with several vendors and suppliers. These rebates have been recorded as a reduction to the related advertising and marketing expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 630000 213000 <p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zmnvZOQr1rL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zpcs5QEKBGI4">Foreign Currency Translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operations were maintained in the local currency and translated to the reporting currency as follows: assets and liabilities are converted using the balance sheet period-end date exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the consolidated statement of operations and comprehensive loss and were included in the amount of loss from comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zXLIh8WgfIl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z5OlyV1WoUuj">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our income taxes in accordance with Income Taxes Topic of the FASB ASC 740, which requires recognition of deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense is based on reported earnings before income taxes. Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for consolidated financial reporting purposes and such amounts recognized for tax purposes and are measured by applying enacted tax rates in effect in years in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also follow the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220101__20221231_zmoiaew79pS1" title="Income tax Likelihood">greater than 50% likelihood</span> of being realized upon ultimate settlement with the relevant tax authority.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our income is subject to taxation in both the U.S. and a foreign jurisdiction, Israel. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company establishes reserves for income tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves for tax contingencies are established when we believe positions do not meet the more-likely-than-not recognition threshold. We adjust uncertain tax liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or lapse of a statute of limitations. The provision for income taxes includes the impact of uncertain tax liabilities and changes in liabilities that are considered appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% likelihood <p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z3goIVMRWXTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zIEEax49RHXd">Comprehensive Income (Loss)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive income (loss) is defined as a change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Our other comprehensive income (loss) is composed of foreign currency translation adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zNOd2lNt41zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zOQSRfezDBj5">Net Loss Per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the years ended December 31, 2022 and December 31, 2021 were <span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_z5Jgf1rxSB1j" title="Weighted-average number of common shares outstanding">7,576,434</span> and <span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20211231_zw7nRAQu7kke" title="Weighted-average number of common shares outstanding">6,082,763</span>, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_899_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3bRbg9UbMTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z7gzE22c4Csg" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic"/><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20220101__20221231_z6HJxRYUfNOb" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20210101__20211231_zVhj0Zo1YUC1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zzDujNeWifT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,190,583</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,559,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCBYWg3YkeN" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,481,734</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,378,929</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_z04x4G5n6yug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,672,317</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,938,229</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zIe7yYGV6Upa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7576434 6082763 <p id="xdx_899_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3bRbg9UbMTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the potentially dilutive securities as of December 31, 2022 and 2021, excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z7gzE22c4Csg" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic"/><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20220101__20221231_z6HJxRYUfNOb" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_491_20210101__20211231_zVhj0Zo1YUC1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zzDujNeWifT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,190,583</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,559,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zCBYWg3YkeN" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,481,734</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,378,929</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_z04x4G5n6yug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,672,317</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,938,229</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2190583000 1559300000 1481734000 1378929000 3672317000 2938229000 <p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zjS6p6r3MoQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_862_zof2VBhrOvJc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent Accounting Pronouncements </b></span><b>not yet adopted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Management has evaluated all recent accounting pronouncements issued by the Financial Accounting Standards Board (FASB) and determined that none of the pronouncements will have a material impact on the financial statements of the Company. The Company will continue to monitor the issuance of any new accounting pronouncements and assess their potential impact on the financial statements in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80B_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zB9JvQ02TZg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_824_zjspxydw9uAb">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. The following are the principal conditions or events which potentially raise substantial doubt about the company’s ability to continue as a going concern:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balancing the need for operational cash with the need to add additional products</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timely and cost-effective development of products</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working capital deficit of $<span id="xdx_903_ecustom--WorkingCapitalDeficit_iI_pn6n6_c20221231_zdql5JZ4GoG8" title="Working capital deficit">38</span> million as of December 31, 2022</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit of $<span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn6n6_di_c20221231_zEEdNyHpYOH1" title="Accumulated deficit">84</span> million as of December 31, 2022</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple years of losses from operations</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt">●</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><p style="margin: 0">Non compliance with certain debt covenants<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></p> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These facts and others have raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following conditions, plans and actions are currently being implemented to address the Company’s conditions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; width: 0.5in; text-align: left">●</td> <td style="text-align: justify">Outstanding warrants exist from prior offerings that could be exercised for cash depending upon the performance of our stock.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify">The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability, and cash flow and is expected to help the Company as a whole to generate positive cash flows from operations for the foreseeable future.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify"><span id="xdx_90A_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLtdMember_zr0i1vsI0X7d" title="Business acquisition, description of acquired entity">The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group.</span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify">The acquisition of Dangot has added capabilities to the Company which have already transformed into significant new orders in the Parking segment. Management expects the collaboration and cross sales to contribute to improved revenues and margins.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify">Management is evaluating operating expenses and is developing a plan to reduce expenditures without negatively impacting current operations. Management has already cut staff by about 5% and will continue to do additional overhead cuts.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify">On March 25, 2022 management finalized an $<span id="xdx_902_eus-gaap--LineOfCredit_iI_pn5n6_c20220325__srt--TitleOfIndividualAxis__custom--WesternAllianceBankMember_zXRteVSqSRt1" title="Line of credit">8.5</span>M line of credit from Western Alliance Bank. This line of credit replaced the high interest Action Capital line of Credit ($<span id="xdx_90F_eus-gaap--LineOfCredit_iI_pn6n6_c20220325__us-gaap--RelatedPartyTransactionAxis__custom--ActionCapitalMember_znG2qngYHRI2" title="Line of credit">6</span>M) and settle the ScanSource debt $<span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_pn5n6_c20220325__20220325__dei--LegalEntityAxis__custom--ScanSourceIncMember_zMWH3X9E3Tw8" title="Repayments of related party debt">2.5</span>M.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">●</td> <td style="text-align: justify">Blue Star - The Company’s total accounts payable due to Blue Star as of December 31, 2022 was approximately $<span id="xdx_90F_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_iI_pn6n6_c20221231__dei--LegalEntityAxis__custom--BlueStarMember_zSkqSxCP4Zb" title="Accounts payable, related parties">36</span> million. Blue Star is an unsecured creditor, financing a substantial amount the Company’s supply chain demand. Management believes that Blue Star will continue supplying the Company with preferable credit terms. Blue Star has agreed to the annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__dei--LegalEntityAxis__custom--BlueStarMember_zDoNZ4YBwBfh" title="Debt instrument, interest rate, stated percentage">5</span>% on invoices that are past due. As an unsecured creditor of the Company, Blue Star has no incentive to force a liquidation. The Company has enjoyed a good mutual relationship for the past four years.</td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 38000000 -84000000 The Company received financing for the acquisition of the last 23% of shares of Dangot on March 30, 2022 (The company owns 100% of Dangot). The Company also expects that Dangot’s cashflow will be able to service the debts associated with its acquisition without the need for cash from the rest of the group. 8500000 6000000 2500000 36000000 0.05 <p id="xdx_804_eus-gaap--BusinessCombinationDisclosureTextBlock_zoIT5zK1Veal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zCOcvyB4tyy1">NOTE 4 – <span id="xdx_82A_zhx8zL3wPJZh">BUSINESS ACQUISITIONS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dangot Computers Ltd</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zQ3FaPAjUts6" title="Business acquisition percentage">51</span>%, or <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zlSVHUZGxIz" title="Shares issued">5,100</span> shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uIsraelinewsheqel_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zy2PKw7vM21i" title="Stock issued during period, value, new issues">23,740,500</span> NIS (New Israeli Shekel), which is equal to US$<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_uUSD_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zEXALi9nbzFa" title="Value issued">7.6</span> million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember_zd06kC1Cl9r8" title="Shares issued">220,103</span> shares of its common stock having a share value of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember_z1R13RZKYwM9" title="Value issued">2,084</span> thousand and (b) cash in the amount of $<span id="xdx_90D_eus-gaap--Cash_iI_pn3n3_c20210708__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember_z9EB3l9VXpy6" title="Cash">5,058</span> thousand and $<span id="xdx_904_ecustom--AccruedPayableToOwner_pn3n3_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember_zj00uaMl55X7" title="Payable to owner">600</span> thousand payable to owner.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--HaimDangotMember_zTmjXBi6lQK2" title="Issued shares">4,900</span> shares, or <span id="xdx_90B_ecustom--RemainingAcquiredPercentage_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember_zZK3sw3mgRs6" title="Remaining acquired percentage">49</span>%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uIsraelinewsheqel_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--HaimDangotMember_z2St4k40cQ3l" title="Value issued">465,500</span> NIS, which is equal to US$<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_uUSD_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__dei--LegalEntityAxis__custom--HaimDangotMember_z2DTGsBAFlbf" title="Value issued">143</span> thousand, per each <span id="xdx_907_ecustom--PercentageOfRemainingSharesOnFullyDilutedBasis_pid_dp_uPure_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HaimDangotMember_zpLLG0ILeG5l" title="Percentage of remaining shares on fully diluted basis">1</span>% of Dangot’s remaining shares on a fully diluted basis which is the same valuation per share as the purchase price for the <span id="xdx_905_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HaimDangotMember_zOKIPcqH9DYc" title="Purchase price percentage">51</span>%. Effective October 1, 2021 the Company exercised a portion of its option and purchased an additional <span id="xdx_904_ecustom--PurchaseOfAdditionalOptionPercent_iI_pid_dp_uPure_c20211002_zebGGJgz6Z3c" title="Purchase of additional option percent">26</span>% of Dangot bringing its ownership to <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211002__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HaimDangotMember_zACoXPeXngM" title="Ownership percent">77</span>%. The Company paid $<span id="xdx_905_eus-gaap--PaymentOfFinancingAndStockIssuanceCosts_c20210502__20210503_zktm1xuiZEbh" title="Payment to purchase additional shares">4,012,000</span> to purchase the additional shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">On April 1, 2022, the Company closed on its acquisition of Dangot and exercised the remaining portion of its option to purchase <span id="xdx_90A_ecustom--PercentageOfPurchaseOfShares_iI_dp_uPure_c20211002_zB2loIuyojy7" title="Purchase of shares, percent">23.0</span>% of the capital stock, thereby making Dangot a fully owned subsidiary of the Company. The Company paid $<span id="xdx_90E_eus-gaap--PaymentOfFinancingAndStockIssuanceCosts_c20220401__20220401_zTKisEZQUXN6" title="Payment to purchase additional shares">3,518,000</span> to purchase the additional shares. The Company utilized its working capital and a combination of short and long term loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z0fvG1qdpByh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the consideration given and the purchase price allocation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z3PNkCrxleH3" style="display: none">SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_496_20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z59VjfsektVc" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Purchase Price Consideration (in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total Consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left; padding-left: 0pt">Cash payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z5zEwhEZW74c" style="width: 18%; text-align: right" title="Cash payments">5,058</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Accrued payable to owner</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--AccruedPayableToOwner_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zLN9ZzuKrJlb" style="text-align: right" title="Accrued payable to owner">600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Fair value of stock issued (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgRkFJUiBWQUxVRVMgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z1hj1fTTg8N9" title="Fair value of stock issued shares">220,103</span> shares)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BusinessCombinationConsiderationFairValue_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zKYRKgWJnNI8" style="text-align: right" title="Fair value of stock issued (220,103 shares)">2,084</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Debt assumed</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--NoncashOrPartNoncashAcquisitionDebtAssumed1_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zAy4VT7XRGOc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Debt assumed">5,310</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zb8HOTfOuypl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total consideration">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_maBCRIAzwMR_zDyWfOt2WX16" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Cash</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">666</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_maBCRIAzwMR_zikfNQp0nHAk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,470</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pn3n3_maBCRIAzwMR_zALyyG5k15Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,616</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_maBCRIAzwMR_zo0sR9gzXfU7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,392</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maBCRIAzwMR_zoUj9PdZ9nl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">638</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_maBCRIAzwMR_zRIff8N3oylf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_maBCRIAzwMR_zq4ofF5JDRIb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Trade name</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,893</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship_iI_pn3n3_maBCRIAzwMR_zuk4PEG8cQr4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Customer relationship</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,139</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3_maBCRIAzwMR_zeoIrnqFErBf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Other intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">899</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtBCRIAzwMR_maBCRIAzxoV_zncq82QhUyud" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Assets acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">32,471</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pn3n3_di_msBCRIAzxoV_zMam7Ac1JSGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Current liabilities assumed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,911</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pn3n3_di_msBCRIAzxoV_z5vP6qVSuPWa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,508</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iTI_pn3n3_mtBCRIAzxoV_zLPojsgkgtT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zQAM4xGNdtu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2021 were $<span id="xdx_90A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn5n6_c20210101__20211231_zxb6y3QmJiF6" title="Business acquisition, pro forma revenue">92.5</span> million in revenues and $<span id="xdx_90E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn5n6_c20210101__20211231_zGPTGMlkX9V" title="Business acquisition, pro forma net income (loss)">10.8</span> million net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the acquisition the amounts included in the consolidated statement of comprehensive income from Dangot Computers Ltd. for the year ended December 31, 2021, was $<span id="xdx_903_eus-gaap--Revenues_pn5n6_c20210101__20211231__dei--LegalEntityAxis__custom--DangotComputersLtdMember_zUQNYMJrMYW8" title="Revenues">20.6</span> million in revenue and $<span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_c20210101__20211231__dei--LegalEntityAxis__custom--DangotComputersLtdMember_zrUciuYLBR91" title="Net income">566</span> thousand in net income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> 0.51 5100 23740500 7600000 220103 2084000 5058000 600000 4900 0.49 465500 143000 0.01 0.51 0.26 0.77 4012000 0.230 3518000 <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z0fvG1qdpByh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the consideration given and the purchase price allocation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z3PNkCrxleH3" style="display: none">SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_496_20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z59VjfsektVc" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Purchase Price Consideration (in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total Consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left; padding-left: 0pt">Cash payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z5zEwhEZW74c" style="width: 18%; text-align: right" title="Cash payments">5,058</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Accrued payable to owner</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--AccruedPayableToOwner_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zLN9ZzuKrJlb" style="text-align: right" title="Accrued payable to owner">600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Fair value of stock issued (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgRkFJUiBWQUxVRVMgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_z1hj1fTTg8N9" title="Fair value of stock issued shares">220,103</span> shares)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BusinessCombinationConsiderationFairValue_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zKYRKgWJnNI8" style="text-align: right" title="Fair value of stock issued (220,103 shares)">2,084</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Debt assumed</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--NoncashOrPartNoncashAcquisitionDebtAssumed1_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zAy4VT7XRGOc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Debt assumed">5,310</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_pn3n3_c20210502__20210503__us-gaap--TypeOfArrangementAxis__custom--DangotSharePurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLimitedMember_zb8HOTfOuypl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total consideration">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_maBCRIAzwMR_zDyWfOt2WX16" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Cash</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">666</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_maBCRIAzwMR_zikfNQp0nHAk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,470</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pn3n3_maBCRIAzwMR_zALyyG5k15Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,616</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_maBCRIAzwMR_zo0sR9gzXfU7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,392</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_maBCRIAzwMR_zoUj9PdZ9nl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">638</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_maBCRIAzwMR_zRIff8N3oylf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_maBCRIAzwMR_zq4ofF5JDRIb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Trade name</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,893</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship_iI_pn3n3_maBCRIAzwMR_zuk4PEG8cQr4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Customer relationship</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,139</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3_maBCRIAzwMR_zeoIrnqFErBf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Other intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">899</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_pn3n3_mtBCRIAzwMR_maBCRIAzxoV_zncq82QhUyud" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Assets acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">32,471</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pn3n3_di_msBCRIAzxoV_zMam7Ac1JSGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Current liabilities assumed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,911</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pn3n3_di_msBCRIAzxoV_z5vP6qVSuPWa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,508</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iTI_pn3n3_mtBCRIAzxoV_zLPojsgkgtT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5058000 600000 220103 2084000 5310000 13052000 666000 13470000 4616000 5392000 638000 1758000 1893000 3139000 899000 32471000 12911000 6508000 13052000 92500000 10800000 20600000 566000 <p id="xdx_803_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zJIFRkcO15Y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_822_zugSW8d7LHr2">ACCOUNTS RECEIVABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zAH9MI6SV4D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zxoS3JTv2XBl" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zXNEAVhvqnu4" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20211231_zzjZvSqKKQIi" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableGross_iI_pn3n3_maARNzOea_zUBtcsEa6Ny8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Trade accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">24,348</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">27,129</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pn3n3_di_msARNzOea_z3RDEbEhIqf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(455</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNet_iTI_pn3n3_mtARNzOea_zoklwHxMDOUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total accounts receivable (net)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,893</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,123</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z6yrJb0zcWY6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable as of December 31, 2022 and 2021 are made up of trade receivables due from customers in the ordinary course of business. No customer accounted for more than <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zswGkvNzYfX1" title="Concentration risk percentage">10</span>% of the balance of accounts receivable as of December 31, 2022, and one customer accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zH9WxU8v9Zxc" title="Concentration risk percentage">17</span>% of the accounts receivable balance as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zAH9MI6SV4D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zxoS3JTv2XBl" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zXNEAVhvqnu4" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20211231_zzjZvSqKKQIi" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableGross_iI_pn3n3_maARNzOea_zUBtcsEa6Ny8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Trade accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">24,348</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">27,129</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iNI_pn3n3_di_msARNzOea_z3RDEbEhIqf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(455</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNet_iTI_pn3n3_mtARNzOea_zoklwHxMDOUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total accounts receivable (net)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,893</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,123</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 24348000 27129000 455000 6000 23893000 27123000 0.10 0.17 <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zZxjeXh5EL87" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_827_zeeGWya4LWt2">INVENTORY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zhW47bfE5SZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zX6tDLpxbJTa" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_z0QtuVQvQ2gg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20211231_zvTXufmfKHj8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINzykx_zWMDslvXuc8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">649</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">894</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherInventoryInTransit_iI_maINzykx_zQqhEtBFVUP4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Inventory in transit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_maINzykx_zCxwxTOBzu1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Finished goods (less allowance)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,073</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,061</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_mtINzykx_znVWcxbhhQob" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,955</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_z2Mhw6hXW7z6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zhW47bfE5SZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zX6tDLpxbJTa" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_z0QtuVQvQ2gg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20211231_zvTXufmfKHj8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINzykx_zWMDslvXuc8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">649</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">894</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherInventoryInTransit_iI_maINzykx_zQqhEtBFVUP4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Inventory in transit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_maINzykx_zCxwxTOBzu1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Finished goods (less allowance)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,073</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,061</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_mtINzykx_znVWcxbhhQob" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,726</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,955</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 649000 894000 2004000 6073000 6061000 8726000 6955000 <p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ziAIlq2jZvmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_824_zZNdpTDxYVEb">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zZYKd4TD5zSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of the components of property and equipment as of December 31,:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zKm6lxh2rjP9" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zCSCkrqxvTX9" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_zSnNwh9jzts9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><i>In thousands</i></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingAndLabEquipmentMember_zmGwOKqIjETg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Manufacturing and lab equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">98</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">499</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zfquELw9DTxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">609</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zTFOeXblHKe5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Software and computer equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,650</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAfyNbLLShle" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Furniture and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zdan0wTLkIli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">318</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_z1L1ELJBcHt3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, Gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zpVOd4Me42He" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,203</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_z7R1EE8H7bp2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, Net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,086</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,127</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zk7cGKreAQg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the year ended December 31, 2022 was approximately $<span id="xdx_907_eus-gaap--Depreciation_pn3n3_c20220101__20221231_z6O8llUgic74" title="Depreciation expense">324</span> thousand. Depreciation expense for the year ended December 31, 2021 was approximately $<span id="xdx_909_eus-gaap--Depreciation_pn3n3_c20210101__20211231_zt3Wcumqy93b" title="Depreciation expense">251</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zZYKd4TD5zSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of the components of property and equipment as of December 31,:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zKm6lxh2rjP9" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zCSCkrqxvTX9" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_zSnNwh9jzts9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><i>In thousands</i></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingAndLabEquipmentMember_zmGwOKqIjETg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Manufacturing and lab equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">98</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">499</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zfquELw9DTxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">609</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zTFOeXblHKe5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Software and computer equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,650</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAfyNbLLShle" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Furniture and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zdan0wTLkIli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">318</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_z1L1ELJBcHt3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, Gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zpVOd4Me42He" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,203</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_z7R1EE8H7bp2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, Net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,086</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,127</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 98000 499000 521000 609000 987000 1650000 236000 254000 274000 318000 1030000 2203000 1086000 1127000 324000 251000 <p id="xdx_803_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zT8DafXTmvLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82A_zuUvqXrNT5L7">GOODWILL AND INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have made acquisitions in the past that resulted in the recognition of goodwill. Based on our analysis there have been <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_do_c20210101__20211231_zgkv6NVocsX7" title="Impairment charges"><span id="xdx_904_eus-gaap--GoodwillImpairmentLoss_do_c20220101__20221231_zAKH5Jpl8Ef8" title="Impairment charges">no</span></span> impairment charges recorded against goodwill in 2022 and 2021. Identifiable intangible assets are stated at cost, net of accumulated amortization. The assets are being amortized on the straight-line method over the estimated useful lives ranging from <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zGJ2BkL0Imi8" title="Estimated useful lives">3</span> to <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zPdzmmIdQnKc" title="Estimated useful lives">11</span> years. Amortization expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231_zkkzwKPXQcGb" title="Amortization expense">1,799</span> million and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20210101__20211231_zPD100voi3ek" title="Amortization expense">3.2</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_znijVgdL1Nbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill and Intangible assets consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zbZ4YBLQAlne">SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zbmn1WNIf8ed" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_z1kF9bfLBd21" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zqqOv20xFKB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; padding-left: 0pt">Goodwill</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">16,542</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">16,453</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zJb2SjwV1iAi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Trade names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,284</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,284</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zZPYFE1TcyBi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,729</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zRXIOsLoHgc3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Other intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,322</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zP9yQJ84QwW9" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Intangibles gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,322</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_zGWqm3Bpssj3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,761</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_zHWJdzhOxlkg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Intangibles, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,010</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,808</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z7Vrg5jAZrHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z9iiXXlVnMjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future amortization expense on the trade names, customer relationships, and other intangibles are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zTaKOkjycCQl" style="display: none">SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20221231_znL7esyxkfB6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Years ending December 31,</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzBz0_zw46oVEKA5t" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,625</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzBz0_zZ3zrBI3cUMk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">952</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzBz0_zLXUxnr1DJwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">943</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzBz0_zvcvCgMouZYh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">943</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzBz0_zZUMUcIxr1e1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzBz0_zDE1DyCWROH8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,229</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzBz0_z0T8ZPXgl2Ij" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zPaGmEF1l555" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is not amortized but is evaluated for impairment annually or when indicators of a potential impairment are present. The impairment testing of goodwill is performed separately from our impairment testing of intangibles. The annual evaluation for impairment of goodwill and intangibles is based on valuation models that incorporate assumptions and internal projections of expected future cash flows and operating plans. None of the goodwill is deductible for income tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased intangible assets with finite useful lives are amortized over their respective estimated useful lives (using an accelerated method for customer relationships and trade names) to their estimated residual values, if any. The Company’s finite-lived intangible assets consist of customer relationships, contractor and resume databases, trade names, and internal use software and are being amortized over periods ranging from <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtYxL_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_zJwBbr14UBw8" title="Finite-lived intangible asset, useful life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1170">two</span></span> to <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dc_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_zFMrXVYV6Ya1" title="Finite-lived intangible asset, useful life">nine years</span>. Purchased intangible assets are reviewed annually to determine if facts and circumstances indicate that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, recoverability is assessed by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the rate of amortization is accelerated, and the remaining carrying value is amortized over the new shorter useful life. <span id="xdx_901_eus-gaap--AssetImpairmentCharges_do_c20220101__20221231_zZ3AqDau8qq5" title="Estimated useful lives"><span id="xdx_90E_eus-gaap--AssetImpairmentCharges_do_c20210101__20211231_z4DC27oULAY5" title="Estimated useful lives">No</span></span> impairments were identified or changes to estimated useful lives have been recorded as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 P3Y P11Y 1799000 3200000 <p id="xdx_89D_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_znijVgdL1Nbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill and Intangible assets consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zbZ4YBLQAlne">SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zbmn1WNIf8ed" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_z1kF9bfLBd21" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zqqOv20xFKB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; padding-left: 0pt">Goodwill</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">16,542</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">16,453</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zJb2SjwV1iAi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Trade names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,284</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,284</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zZPYFE1TcyBi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,729</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zRXIOsLoHgc3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Other intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,322</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zP9yQJ84QwW9" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Intangibles gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,322</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_zGWqm3Bpssj3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,761</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_zHWJdzhOxlkg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Intangibles, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,010</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,808</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 16542000 16453000 6284000 6284000 15729000 15729000 2216000 2322000 2216000 2322000 -16761000 -14980000 24010000 25808000 <p id="xdx_891_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z9iiXXlVnMjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future amortization expense on the trade names, customer relationships, and other intangibles are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zTaKOkjycCQl" style="display: none">SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20221231_znL7esyxkfB6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Years ending December 31,</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzBz0_zw46oVEKA5t" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,625</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzBz0_zZ3zrBI3cUMk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">952</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzBz0_zLXUxnr1DJwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">943</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzBz0_zvcvCgMouZYh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">943</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzBz0_zZUMUcIxr1e1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzBz0_zDE1DyCWROH8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,229</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzBz0_z0T8ZPXgl2Ij" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1625000 952000 943000 943000 776000 2229000 7468000 P9Y 0 0 <p id="xdx_800_eus-gaap--ShortTermDebtTextBlock_zgQH8maYyUA8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82F_zJgL9LTNEGy7">CREDIT FACILITIES AND LINE OF CREDIT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022 we entered into a Business Finance Agreement (the “BFA”) with BridgeBank a division of Western Alliance Bank (“BridgeBank”) to establish the sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivables to BridgeBank. Pursuant to the BFA, the outstanding principal amount of advances made by BridgeBank at any time shall not exceed $<span id="xdx_900_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20220325__us-gaap--TypeOfArrangementAxis__custom--BusinessFinanceAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--BridgeBankMember_za3KXdugKSa5" title="Line of credit facility maximum borrowing capacity">8.5</span> million. BridgeBank reserves and withholds to <span id="xdx_907_ecustom--PercentageOfReserveAccount_pid_dp_uPure_c20220323__20220325__us-gaap--TypeOfArrangementAxis__custom--BusinessFinanceAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--BridgeBankMember_znPqVtCS3oLj" title="Percentage of reserve account">15</span>% of the face amount of each account purchased in a reserve account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--LineOfCreditFacilityInterestRateDescription_pid_c20220323__20220325__us-gaap--TypeOfArrangementAxis__custom--BusinessFinanceAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--BridgeBankMember_zaQc9GGo35d5" title="Line of credit, interest rate, description">The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the BFA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 1.5%, plus a monthly fee equal to 0.15% of the average outstanding balance.</span> The BFA credit facility is collateralized with a senior security interest in certain assets of the Company. The BFA includes customary representations and warranties and default provisions for transactions of this type.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> 8500000 0.15 The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the BFA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 1.5%, plus a monthly fee equal to 0.15% of the average outstanding balance. <p id="xdx_804_ecustom--RelatedPartyNotesPayableDisclosureTextBlock_zOxe30HBDNr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_82E_zrbt3eveh1p7">RELATED PARTY NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_ziSRhuumw0ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party notes payable, consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zeI8YlL8E49b" style="display: none">SCHEDULE OF NOTES PAYABLE, RELATED PARTIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zYz4HWP2ye99" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20211231_zIMwFuwTLbk9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left; padding-left: 0pt">In thousands</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zd5ZbFfFTYTi" style="vertical-align: bottom; background-color: White"> <td style="width: 62%; text-align: left; padding-left: 0pt">Note payable –Marin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">180</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">420</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zLcPmC6pUZRe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Note payable –Thomet</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">263</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_maNPRPNzTVx_zeVEQwdhixQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Total notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iI_pn3n3_maNPRPNzTVx_zLlJUgr8Cxk4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 10pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iTI_pn3n3_mtNPRPNzTVx_z3L0swR5xvff" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">293</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_z9ObN0UzdhEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and December 31, 2021, the Company recorded interest expense in connection with these notes in the amount of $<span id="xdx_908_eus-gaap--InterestExpenseDebt_pn3n3_c20220101__20221231_zjhfRuZHn6uf" title="Interest expense">8</span> thousand and $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_pn3n3_c20210101__20211231_zUUagiypw0Wb" title="Interest expense">10</span> thousand, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note Payable -Marin</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2017, we entered into a $<span id="xdx_907_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zE1eE1vdQwf2" title="Notes payable related parties">660</span> thousand, <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zIy7EHO13cU5" title="Annual interest rate note payable">1.89</span>% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in <span id="xdx_902_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20171201__20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zMpIBLqgf7Nd" title="Debt instrument, frequency of periodic payment">60 monthly</span> principal payments of $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20171201__20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zu3MnCVzL3Vj" title="Principal payments">20</span> thousand beginning in October 2018. Accrued interest payable as of December 31, 2022, was $<span id="xdx_90E_eus-gaap--InterestPayableCurrent_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zRMOqN6Lgz9e" title="Accrued interest payable">71</span> thousand. Accrued interest is payable at maturity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note Payable – Thomet</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2017, we entered into a $<span id="xdx_901_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_z0PTIQXFsxoe" title="Notes payable related parties">750</span> thousand, <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dpxH_uPure_c20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_z8wQ7MQu9P6e" title="Annual interest rate note payable::XDX::0">zero</span> percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in <span id="xdx_906_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20171201__20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zvyPvJmy3JWb" title="Debt instrument, frequency of periodic payment">60 monthly</span> principal payments of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20171201__20171231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zqqH2bwAjf1e" title="Principal payments">13</span> thousand beginning in October 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_ziSRhuumw0ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party notes payable, consisted of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zeI8YlL8E49b" style="display: none">SCHEDULE OF NOTES PAYABLE, RELATED PARTIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zYz4HWP2ye99" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20211231_zIMwFuwTLbk9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left; padding-left: 0pt">In thousands</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zd5ZbFfFTYTi" style="vertical-align: bottom; background-color: White"> <td style="width: 62%; text-align: left; padding-left: 0pt">Note payable –Marin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">180</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">420</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zLcPmC6pUZRe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Note payable –Thomet</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">263</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_maNPRPNzTVx_zeVEQwdhixQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Total notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">683</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iI_pn3n3_maNPRPNzTVx_zLlJUgr8Cxk4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 10pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iTI_pn3n3_mtNPRPNzTVx_z3L0swR5xvff" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1202">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">293</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 180000 420000 113000 263000 293000 683000 293000 390000 293000 8000 10000 660000 0.0189 60 monthly 20000 71000 750000 60 monthly 13000 <p id="xdx_80F_eus-gaap--DebtDisclosureTextBlock_z8HzqWQqUXIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_826_zGmVeDW3yEh9">OTHER NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zJxhdkca39za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other notes payable consists of the following as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span id="xdx_8B3_zAadj1RrQDpc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER NOTES PAYABLE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zLtEdmEUlCNk" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20211231_zmxEoebl1D8g" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherNotesPayable_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableSecuredSupplierMember_zbAcFlcDLSm1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Note Payable - Secured Supplier Note</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,243</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherNotesPayable_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableOtherMember_zU9GvjFQnS65" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Notes Payable - other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,627</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,924</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherNotesPayable_iI_pn3n3_z2RkvbgSVhid" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,627</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,167</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherNotesPayableCurrent_iI_pn3n3_z2Qt4JlKCNZa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,521</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_z7MsZK4gAKm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long Term Notes Payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,646</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zDeB2RszI9b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z2YRxAK6BMe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future maturities of notes payable are as follows for the years ending December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zDAMHW6qL3W6" style="display: none">SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In thousands </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231__us-gaap--DebtInstrumentAxis__custom--OtherNotePayableMember_z40QS8ApFeD6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maONPznUk_z5t0soiMuMP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">11,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maONPznUk_zPp1j7FNXT" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherNotesPayable_iTI_pn3n3_mtONPznUk_z0Y9pY6aU7R1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,627</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_z3Yeh5nM71T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Secured Supplier Note Payable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zSnpw0fLGaQ6" title="Principal amount">12.5</span> million (the “Secured Promissory Note”). The USD Note accrues interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zuei451PKmX4" title="Accrued interest">18</span>% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20160717__20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zi40hPtbJLVi" title="Principal and accrued interest amount">250</span> thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016. This note was extended and amended multiple times and as of March 25, 2022, is paid in full.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Notes Payable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 29, 2021, the Company entered into a long-term loan from Leumi Bank totalling NIS <span id="xdx_90F_eus-gaap--LoansPayable_iI_pn6n6_uIsraelinewsheqel_c20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zuGgqjYnKN89" title="Loans payable">7</span> million, which at the time was approximately $<span id="xdx_903_eus-gaap--LoansPayable_iI_pn4n6_c20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zP63wnt3Ol79" title="Loans payable">2.16</span> million. The note accrues interest at the Israeli Prime Rate plus <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember__us-gaap--AwardTypeAxis__custom--IsraeliPrimeRateMember_zpkDjiYltZO8" title="Debt interest rate">4.5</span>% which currently equals <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zyRwel4iEVdc" title="Debt interest rate">8.25</span>% per annum and is payable in <span id="xdx_902_ecustom--NumberOfInstallments_iI_pid_uInteger_c20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zozmtwFDnbD3" title="Number of installments">8</span> instalments of principal and interest over <span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dc_c20210728__20210729__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zYpfXQXBADtj" title="Debt instrument term">4 years</span>. The note is secured by shares of Dangot Computers, Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 28, 2021, the Company entered into another long-term loan from Leumi Bank totalling NIS <span id="xdx_900_eus-gaap--LoansPayable_iI_pn5n6_uIsraelinewsheqel_c20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zLOcftgnot6b" title="Loans payable">3.5</span> million, which at the time was approximately $<span id="xdx_902_eus-gaap--LoansPayable_iI_pn5n6_c20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_znUSMR2dSDCa" title="Loans payable">1.1</span> million. The note accrues interest at the Israeli Prime Rate plus <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember__us-gaap--AwardTypeAxis__custom--IsraeliPrimeRateMember_zpoq0OvR9c25" title="Debt interest rate">4.5</span>% which currently equals <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_znkuzWV9li2k" title="Debt interest rate">8.25</span>% per annum and is payable in <span id="xdx_90A_ecustom--NumberOfInstallments_iI_pid_uInteger_c20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_z5qx9QoMx60i" title="Number of installments">8</span> instalments of principal and interest over <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dc_c20211127__20211128__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zwd7SANaHHf7" title="Debt instrument term">4 years</span>. The note is secured by shares of Dangot Computers, Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 11, 2021, the Company purchased vehicles using cash and financing of NIS <span id="xdx_906_eus-gaap--LoansPayable_iI_pn3n3_uIsraelinewsheqel_c20210811_zXPGKXFe04k" title="Loans payable">500</span> thousand, approximately $<span id="xdx_90F_eus-gaap--LoansPayable_iI_pn3n3_c20210811_z5SRQrXxgVRf" title="Loans payable">155</span> thousand, to be paid off in monthly interest and principal payments over <span id="xdx_904_eus-gaap--DebtInstrumentTerm_dc_c20210810__20210811_zZ9slI5vPUii" title="Debt instrument term">5 years</span>. The loan accrues interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210811_zhqioqemk802" title="Debt interest per annum">7.5</span>% per annum and is secured by the vehicles. As of December 31, 2022, the remaining balance was NIS <span id="xdx_90C_eus-gaap--LoansPayable_iI_pn3n3_uIsraelinewsheqel_c20221231_zoXZVZVjb4l" title="Loans payable">342</span> thousand, approximately $<span id="xdx_90E_eus-gaap--LoansPayable_iI_pn3n3_c20221231_zGwpOlOsYAKd" title="Loans payable">97</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2022, the Company entered into another long-term loan from Leumi Bank totalling NIS <span id="xdx_901_eus-gaap--LoansPayable_iI_pn5n6_uIsraelinewsheqel_c20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zg3RpmM77Orh" title="Loans payable">3.5</span> million, which at the time was approximately $<span id="xdx_90D_eus-gaap--LoansPayable_iI_pn5n6_c20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zZX5vD4AHVcl" title="Loans payble">1.1</span> million. The note accrues interest at the Israeli Prime Rate plus <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember__us-gaap--AwardTypeAxis__custom--IsraeliPrimeRateMember_zfVJ0MgTsQk7" title="Debt interest rate">4.5</span>% which currently equals <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zKl9GW3V2sYf" title="Debt interest rate">8.25</span>% per annum and is payable in <span id="xdx_90A_ecustom--NumberOfInstallments_iI_pid_uInteger_c20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zNEVxPMkroMi" title="Number of installements">8</span> instalments of principal and interest over <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dc_c20220326__20220327__us-gaap--DebtInstrumentAxis__custom--LeumiBankMember_zpxkN5rxIUK8" title="Debt instrument term">4 years</span>. The note is secured by shares of Dangot Computers, Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 13, 2022, the Company entered into a long-term loan from Hapoalim Bank totalling NIS <span id="xdx_90B_eus-gaap--LoansPayable_iI_pn6n6_uIsraelinewsheqel_c20220913__us-gaap--DebtInstrumentAxis__custom--HapoalimBankMember_zUS5CcKoD73f" title="Loans payable">3</span> million, which at the time was approximately $<span id="xdx_902_eus-gaap--LoansPayable_iI_pn5n6_c20220913__us-gaap--DebtInstrumentAxis__custom--HapoalimBankMember_zxe7opbWG0y4" title="Loans payble">0.9</span> million. The note accrues interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220913__us-gaap--DebtInstrumentAxis__custom--HapoalimBankMember_zE6opKklWGfl" title="Debt interest rate">6.03</span>% per annum and is payable in <span id="xdx_906_ecustom--NumberOfInstallments_iI_pid_uInteger_c20220913__us-gaap--DebtInstrumentAxis__custom--HapoalimBankMember_zNluAlBTrHd2" title="Number of installements">36</span> instalments of principal and interest over <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dc_c20220913__20220913__us-gaap--DebtInstrumentAxis__custom--HapoalimBankMember_zOIJfQ0fkl92" title="Debt instrument term">3 years</span>. as of December 31, 2022, the outstanding balance was NIS<span id="xdx_909_ecustom--LoansPayableOutstandingAmount_iI_pn5n6_uIsraelinewsheqel_c20221231_zyXgGFXkXn44" title="Loans payable outstanding amount"> 2.8</span> million, approximately $<span id="xdx_902_ecustom--LoansPayableOutstandingAmount_iI_pn5n6_c20221231_zoey658fN8Gb" title="Loans payable outstanding amount">0.8</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company entered into five lines of credit totalling NIS <span id="xdx_901_eus-gaap--LoansPayable_iI_pn5n6_uIsraelinewsheqel_c20211231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LineOfCreditMember_zQRn2Z6VVjbj" title="Loans payable">17.5</span> million, as of December 31, 2021, the outstanding balance was NIS <span id="xdx_90C_ecustom--LoansPayableOutstandingAmount_iI_pn5n6_uIsraelinewsheqel_c20211231_zbdCZPqv4nLe" title="Loans payable outstanding amount">13.6</span> million, approximately $<span id="xdx_900_ecustom--LoansPayableOutstandingAmount_iI_pn5n6_c20211231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LineOfCreditMember_zKQ6fNzGq7k9" title="Loans payable outstanding amount">4.4</span> million. These loans were replaced in 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company entered into five short term loans totalling NIS <span id="xdx_90F_eus-gaap--OtherShortTermBorrowings_iI_pn5n6_uIsraelinewsheqel_c20221231_zB34dyNOzTii" title="Short term loans">26.8</span> million, approximately $<span id="xdx_906_eus-gaap--OtherShortTermBorrowings_iI_pn5n6_c20221231_zkOX0vLn7fAc" title="Short term loans">7.6</span> million. The note accrues average interest at <span id="xdx_902_eus-gaap--ShortTermDebtWeightedAverageInterestRate_iI_pid_dp_c20221231_z2chGDFfqzA3" title="Accrues average interest">6.3</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022, the Company was not in compliance with certain financial covenants related to the Bank Leumi and Bank Hapoalim debt. The Company’s failure to comply with these financial covenants could result in an event of default under its debt agreements. Therefore, we reclassified the total balance as current debt on the balance sheet. The Company is actively pursuing options to address its noncompliance. The lenders have not requested early repayment of the loan as of the date when these financial statements were available to be issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zJxhdkca39za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other notes payable consists of the following as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span id="xdx_8B3_zAadj1RrQDpc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OTHER NOTES PAYABLE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20221231_zLtEdmEUlCNk" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20211231_zmxEoebl1D8g" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherNotesPayable_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotePayableSecuredSupplierMember_zbAcFlcDLSm1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Note Payable - Secured Supplier Note</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">2,243</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherNotesPayable_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableOtherMember_zU9GvjFQnS65" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Notes Payable - other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,627</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,924</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherNotesPayable_iI_pn3n3_z2RkvbgSVhid" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,627</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,167</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherNotesPayableCurrent_iI_pn3n3_z2Qt4JlKCNZa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,572</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,521</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_z7MsZK4gAKm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long Term Notes Payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,646</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2243000 11627000 7924000 11627000 10167000 11572000 7521000 55000 2646000 <p id="xdx_89D_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z2YRxAK6BMe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future maturities of notes payable are as follows for the years ending December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zDAMHW6qL3W6" style="display: none">SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In thousands </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231__us-gaap--DebtInstrumentAxis__custom--OtherNotePayableMember_z40QS8ApFeD6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maONPznUk_z5t0soiMuMP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">11,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maONPznUk_zPp1j7FNXT" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherNotesPayable_iTI_pn3n3_mtONPznUk_z0Y9pY6aU7R1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,627</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 11572000 55000 11627000 12500000 0.18 250000 7000000 2160000 0.045 0.0825 8 P4Y 3500000 1100000 0.045 0.0825 8 P4Y 500000 155000 P5Y 0.075 342000 97000 3500000 1100000 0.045 0.0825 8 P4Y 3000000 900000 0.0603 36 P3Y 2800000 800000 17500000 13600000 4400000 26800000 7600000 0.063 <p id="xdx_80B_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zjkWwecEDQGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_827_zZGEDzOi4i78">OTHER LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--OtherLiabilitiesTableTextBlock_z8jKa2b2kUN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, other liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z74dt8CPRyb7" style="display: none">SCHEDULE OF OTHER LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_znQazAyywcRa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211231_zBO9NQ12kL1l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pn3n3_maOLzPr5_zgXQp2tF0Mrc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Other vendor payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pn3n3_maOLzPr5_z5r878axMaTk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,418</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherSundryLiabilities_iI_pn3n3_maOLzPr5_za0AYNQNMz24" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">705</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,882</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilities_iTI_pn3n3_mtOLzPr5_mtTOL_zBy5ZvegyDui" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Total other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,659</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,101</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_msTOL_zlytAe8AhS7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,394</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,683</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_maTOL_zXThPoMQ5Gra" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total long term other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">265</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,418</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zZtBazvRh3Bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--OtherLiabilitiesTableTextBlock_z8jKa2b2kUN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, other liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z74dt8CPRyb7" style="display: none">SCHEDULE OF OTHER LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_znQazAyywcRa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211231_zBO9NQ12kL1l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-style: italic">In thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pn3n3_maOLzPr5_zgXQp2tF0Mrc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Other vendor payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pn3n3_maOLzPr5_z5r878axMaTk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,418</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherSundryLiabilities_iI_pn3n3_maOLzPr5_za0AYNQNMz24" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">705</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,882</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilities_iTI_pn3n3_mtOLzPr5_mtTOL_zBy5ZvegyDui" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Total other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,659</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,101</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_msTOL_zlytAe8AhS7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,394</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,683</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_maTOL_zXThPoMQ5Gra" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total long term other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">265</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,418</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 801000 801000 153000 1418000 705000 1882000 1659000 4101000 1394000 2683000 265000 1418000 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zSQoL8Zp3ZMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_826_zF17g1ebKUeh">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Profit Sharing Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the year ending December 31, 2022 and 2021, the company has elected to match, the total expense was $<span id="xdx_908_eus-gaap--LitigationSettlementExpense_pn3n3_c20220101__20221231_zgZtBEINSlMi" title="Total expense">122</span> thousand and $<span id="xdx_90D_eus-gaap--LitigationSettlementExpense_pn3n3_c20210101__20211231_z5QuSPJC3wjf" title="Total expense">108</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Leases</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, we had 5 Operating leases as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office space in Akron, Ohio, with monthly payments of $<span id="xdx_90F_eus-gaap--PaymentsForRent_pn3n3_c20220101__20221231__srt--StatementGeographicalAxis__custom--AkronMember_zOxHX8h1sFOf" title="Monthly payments">3</span> thousand and an incremental borrowing rate of <span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231__srt--StatementGeographicalAxis__custom--AkronMember_zJYoKeFxKQTf" title="Incremental borrowing rate">14.55</span>%. As of December 31, 2022, we had <span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20221231__srt--StatementGeographicalAxis__custom--AkronMember_zar9negG1nU9" title="Remaining lease month">5</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office space in Salt Lake City UT with monthly payments of $<span id="xdx_90D_eus-gaap--PaymentsForRent_pn3n3_c20220101__20221231__srt--StatementGeographicalAxis__custom--SaltLackCityMember_zx8GmWbDXmD9" title="Monthly payments">24</span> thousand. As of December 31, 2022, the Company had <span id="xdx_904_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20221231__srt--StatementGeographicalAxis__custom--SaltLackCityMember_zJGUlyq0VVpe" title="Remaining lease month">44 </span>months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dangot’s corporate offices are currently located at Yad harutzim 14 Tel-Aviv, Israel and serves as the company’s main operating location. As of December 31, 2022, we had <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20221231__srt--StatementGeographicalAxis__custom--YadHarutzimMember__dei--LegalEntityAxis__custom--DangotComputersLtdMember_zsRKQcN8Fbj1" title="Remaining lease month">23</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company lease additional office space for our finance and service department at Yad harutzim 14 Tel-Aviv, Israel. As of December 31, 2022, the Company had <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20221231__srt--StatementGeographicalAxis__custom--YadHarutzimMember_zov5URaTEmgi" title="Remaining lease month">12</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also lease office and warehouse space for our products and technical support staff in Rival Street, Tel-Aviv, Israel. As of December 31, 2022, the Company had <span id="xdx_901_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20221231__srt--StatementGeographicalAxis__custom--RivalStreetMember_zciIqtOuM8c" title="Remaining lease month">30</span> months remaining on the lease.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_zbYceqEMfbL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other information related to our operating leases is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_z2nXBu4hEQob" style="display: none">SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 0pt">ROU asset - January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pn3n3_c20210101__20211231_zUJtPPt8IGvd" style="width: 15%; text-align: right" title="ROU asset, Beginning balance">76</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pn3n3_di_c20210101__20211231_zxBWes5xZZgk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(199</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Effective foreign exchange rates</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Amortization"><p id="xdx_98A_ecustom--OperatingLeaseAssetOfEffectiveForeignExchangeRate_pn3n3_c20210101__20211231_z3TKrLLhyRhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Effective foreign exchange rates">121</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Increase</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--IncreaseDecreasesInOperatingLeaseAsset_pn3n3_c20210101__20211231_zV4c1ymF2Yre" style="border-bottom: Black 1.5pt solid; text-align: right" title="Increase">3558</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0pt">ROU asset - December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pn3n3_c20220101__20221231_zdPwPYFJvHG1" style="font-weight: bold; text-align: right" title="ROU asset, Beginning balance">3,556</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Increase</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--IncreaseDecreaseInRightOfUseAsset_pn3n3_c20220101__20221231_zvGxpffHtUEc" style="text-align: right" title="Increase"><span style="-sec-ix-hidden: xdx2ixbrl1390">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseAssetOfEffectiveForeignExchangeRate_pn3n3_c20220101__20221231_zqktJ9gM4mBk" style="text-align: right" title="Effective foreign exchange rates">(256</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pn3n3_di_c20220101__20221231_z3xCsMzemKf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(1,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">ROU asset - December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pn3n3_c20220101__20221231_zdIz51zEkbS3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="ROU asset, Ending balance">2,300</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 0pt">Lease liability - January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iS_pn3n3_c20210101__20211231_zg4ILaJ4H8h1" style="width: 15%; text-align: right" title="Lease liability, Beginning balance">79</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Increase</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20210101__20211231_zIVOCjNapWeg" style="text-align: right" title="Increase">3,558</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--OperatingLeaseLiabilityEffectiveForeignExchangeRate_pn3n3_c20210101__20211231_zzlxAvJS0n6a" style="text-align: right" title="Effective foreign exchange rates">169</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AmortizationOfOperatingLeaseLiability_iN_pn3n3_di_c20210101__20211231_znfv7Iz274kl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(199</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 0pt">Lease liability - December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iS_pn3n3_c20220101__20221231_zZDcFWUPNzNf" style="text-align: right" title="Lease liability, Beginning balance">3,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Decrease</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20220101__20221231_zKASZGkt8By5" style="text-align: right" title="Decrease"><span style="-sec-ix-hidden: xdx2ixbrl1408">-</span></td><td style="text-align: left"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Increase (Decrease)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20220101__20221231_zZDINQ8hyKnl" style="text-align: right" title="Decrease"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseLiabilityEffectiveForeignExchangeRate_pn3n3_c20220101__20221231_zhYDBlNPBXo7" style="text-align: right" title="Effective foreign exchange rate">(261</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AmortizationOfOperatingLeaseLiability_iN_pn3n3_di_c20220101__20221231_zlwntSXeRJGf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(1,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; font-weight: bold; padding-left: 0pt">Lease liability - December 31, 2022</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iE_pn3n3_c20220101__20221231_zVCYft8rGGr1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Lease liability, Ending balance">2,346</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zV6MG2AmMbUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, our operating leases had a weighted average remaining lease term of <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20221231_zuzRyQQeCJy9" title="Weighted average remaining lease term">29</span> months and a weighted average discount rate of <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zpfEWZHSsAjl" title="Weighted average discount rate">5.7</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zGAjvOWSRqCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zuiqHvKuZ4t9" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20221231_zo6ljiR4A0Ak" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Minimum lease payments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzG5M_zRAMTC37j0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,102</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzG5M_zmF3ygmvJjfa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">873</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzG5M_zyCy9yudkmE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">397</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzG5M_zg3Gp8LEXdu4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">176</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzG5M_zIwT9FlYEhra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">2027</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG5M_zSaroEMoQp7g" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">2,548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zxU8DISigNzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(202</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrGg2SEmFdKa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,346</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zCtG4dCumGxc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current obligations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(942</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zDGhLAjaEn17" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long term lease obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zQqyHMPGjKZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LITIGATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was named a defendant in a case involving a former employee who claims he is owed approximately $<span id="xdx_901_ecustom--UnpaidCommission_iI_pn3n3_c20221231_zbRq5aGkiGw5" title="Unpaid commission">60</span> thousand in unpaid commissions. The Company is defending the case. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company is not a party to any other pending material legal proceeding in which it is defending against any claims of material significance. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 122000 108000 3000 0.1455 P5M 24000 P44M P23M P12M P30M <p id="xdx_89F_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_zbYceqEMfbL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other information related to our operating leases is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_z2nXBu4hEQob" style="display: none">SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 0pt">ROU asset - January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pn3n3_c20210101__20211231_zUJtPPt8IGvd" style="width: 15%; text-align: right" title="ROU asset, Beginning balance">76</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pn3n3_di_c20210101__20211231_zxBWes5xZZgk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(199</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Effective foreign exchange rates</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Amortization"><p id="xdx_98A_ecustom--OperatingLeaseAssetOfEffectiveForeignExchangeRate_pn3n3_c20210101__20211231_z3TKrLLhyRhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Effective foreign exchange rates">121</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Increase</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--IncreaseDecreasesInOperatingLeaseAsset_pn3n3_c20210101__20211231_zV4c1ymF2Yre" style="border-bottom: Black 1.5pt solid; text-align: right" title="Increase">3558</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-left: 0pt">ROU asset - December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseRightOfUseAsset_iS_pn3n3_c20220101__20221231_zdPwPYFJvHG1" style="font-weight: bold; text-align: right" title="ROU asset, Beginning balance">3,556</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Increase</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--IncreaseDecreaseInRightOfUseAsset_pn3n3_c20220101__20221231_zvGxpffHtUEc" style="text-align: right" title="Increase"><span style="-sec-ix-hidden: xdx2ixbrl1390">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseAssetOfEffectiveForeignExchangeRate_pn3n3_c20220101__20221231_zqktJ9gM4mBk" style="text-align: right" title="Effective foreign exchange rates">(256</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_pn3n3_di_c20220101__20221231_z3xCsMzemKf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(1,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">ROU asset - December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iE_pn3n3_c20220101__20221231_zdIz51zEkbS3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="ROU asset, Ending balance">2,300</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 0pt">Lease liability - January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iS_pn3n3_c20210101__20211231_zg4ILaJ4H8h1" style="width: 15%; text-align: right" title="Lease liability, Beginning balance">79</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">Increase</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20210101__20211231_zIVOCjNapWeg" style="text-align: right" title="Increase">3,558</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--OperatingLeaseLiabilityEffectiveForeignExchangeRate_pn3n3_c20210101__20211231_zzlxAvJS0n6a" style="text-align: right" title="Effective foreign exchange rates">169</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AmortizationOfOperatingLeaseLiability_iN_pn3n3_di_c20210101__20211231_znfv7Iz274kl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(199</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 0pt">Lease liability - December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iS_pn3n3_c20220101__20221231_zZDcFWUPNzNf" style="text-align: right" title="Lease liability, Beginning balance">3,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Decrease</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20220101__20221231_zKASZGkt8By5" style="text-align: right" title="Decrease"><span style="-sec-ix-hidden: xdx2ixbrl1408">-</span></td><td style="text-align: left"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Increase (Decrease)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--IncreaseDecreasesInOperatingLeaseLiability_pn3n3_c20220101__20221231_zZDINQ8hyKnl" style="text-align: right" title="Decrease"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Effective foreign exchange rates</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseLiabilityEffectiveForeignExchangeRate_pn3n3_c20220101__20221231_zhYDBlNPBXo7" style="text-align: right" title="Effective foreign exchange rate">(261</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 0pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AmortizationOfOperatingLeaseLiability_iN_pn3n3_di_c20220101__20221231_zlwntSXeRJGf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization">(1,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; font-weight: bold; padding-left: 0pt">Lease liability - December 31, 2022</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iE_pn3n3_c20220101__20221231_zVCYft8rGGr1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Lease liability, Ending balance">2,346</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 76000 199000 121000 3558000 3556000 -256000 1000000 2300000 79000 3558000 169000 199000 3607000 -261000 1000000 2346000 P29M 0.057 <p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zGAjvOWSRqCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zuiqHvKuZ4t9" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20221231_zo6ljiR4A0Ak" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Minimum lease payments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzG5M_zRAMTC37j0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left; padding-left: 0pt">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,102</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzG5M_zmF3ygmvJjfa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">873</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzG5M_zyCy9yudkmE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">397</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzG5M_zg3Gp8LEXdu4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">176</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_maLOLLPzG5M_zIwT9FlYEhra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">2027</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG5M_zSaroEMoQp7g" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">2,548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zxU8DISigNzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(202</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrGg2SEmFdKa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,346</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zCtG4dCumGxc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Less current obligations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(942</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zDGhLAjaEn17" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Long term lease obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1102000 873000 397000 176000 2548000 202000 2346000 942000 1404000 60000 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zAFoFQ38P33i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_824_zIfhqhJ7cZpb">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PREFERRED STOCK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series A</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zOUoFwitU1K6" title="Preferred stock, shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_znkLobbUoU9b" title="Preferred stock, shares authorized">2,000,000</span></span> Series A preferred shares authorized and <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dcxL_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zCtwBdkGUMbc" title="Preferred stock, shares outstanding::XDX::0"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dcxL_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zd65Wxt7Zn6d" title="Preferred stock, shares outstanding::XDX::0"><span style="-sec-ix-hidden: xdx2ixbrl1452"><span style="-sec-ix-hidden: xdx2ixbrl1454">zero</span></span></span></span> Series A preferred shares outstanding. <span id="xdx_90F_eus-gaap--PreferredStockVotingRights_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember_zaQXLa0zLo32" title="Preferred stock, voting rights">The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 13 common shares.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, there was one (<span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zyFP9jsrpt85" title="Preferred stock, shares authorized"><span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zvbhV1nFnOo4" title="Preferred stock, shares authorized">1</span></span>) preferred share authorized and <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dcxL_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLTNi5PL8SWc" title="Preferred stock, shares outstanding::XDX::0"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dcxL_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9hubbNXFUZ" title="Preferred stock, shares outstanding::XDX::0"><span style="-sec-ix-hidden: xdx2ixbrl1462"><span style="-sec-ix-hidden: xdx2ixbrl1464">zero</span></span></span></span> preferred shares outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series C</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, there were <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zK4Eu0Rn9PW9" title="Preferred stock, shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zoRp4uSgev4g" title="Preferred stock, shares authorized">3,000,000</span></span> Series C Preferred Shares (“Series C”) authorized with <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_znk9IDvZXQM4" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_zQvEWfOVaFYc" title="Preferred stock, shares outstanding">544,500</span></span> and <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_zrIVwqQesC43" title="Preferred stock, shares outstanding"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_z1qjFkbgoj79" title="Preferred stock, shares issued">544,500</span></span> issued and outstanding, respectively. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $<span id="xdx_902_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z8ialRQggGr1" title="Dividends payable, amount per share">0.06</span> per share per annum and have a liquidation preference of $<span id="xdx_905_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z73oa06tI5b2" title="Liquidation preference">1</span> per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of December 31, 2022 and 2021, the accrued dividends on the Series C Preferred Stock was $<span id="xdx_90A_eus-gaap--Dividends_pn3n3_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zxqCnMNFP8nb" title="Accrued dividends">153</span> thousand and $<span id="xdx_909_eus-gaap--Dividends_pn3n3_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zesECI3fpEdg" title="Accrued dividends">126</span> thousand, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021, certain holders of Series C Shares elected to convert $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn5n6_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zrxPT7C5vY6b" title="Stock issued during period, value, conversion of convertible securities">1.6</span> million or <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zIEacn8bCuBb" title="Stock issued during period, shares, conversion of convertible securities">1,600,530</span> Series C shares and $<span id="xdx_905_eus-gaap--Dividends_pn3n3_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zmzmPzNl3OHb" title="Accrued dividends">194</span> thousand in accrued dividends in exchange for <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zflJwcRpSwW" title="Stock issued during period, shares, conversion of convertible securities">105,551</span> OMNIQ common stock shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PreferredStockConversionBasis_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z971bR2Qf6Kb" title="Preferred stock conversion, description">The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON STOCK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211001__20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhQsLFROjkyj" title="Shares issued">1,118,856</span> shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211031__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRbBpWoWwhSg" title="Common stock, par value">0.001</span> (the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the December 2021, shareholders’ meeting. <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zJKwHul9LwBa" title="Shares issued">841,500</span> shares were issued to employees and consultants in 2022, and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_do_c20210101__20211231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmyKrg1afWE" title="Shares issued">no</span> shares were issued under the Plan in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain in the employ of and attract new employees, directors, officers, consultants, advisors and employees to the Company. Pursuant to the Plan, one million (<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200801__20200831__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzvr5D1JoUh3">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210831__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDne3ZqBwko1">0.001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the “Shares”), were set aside and reserved for issuance. The Plan approved by our stockholders at the September 2020, shareholders’ meeting. <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_do_c20210101__20211231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1EVtUENxofi"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_do_c20220101__20221231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zelmDfNBhWTd">No</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were issued under the Plan in 2021, or 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the years ending December 31, 2022 and 2021, employees purchased <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_zhnZ9AQ3AVvl" title="Shares issued">7,025</span> ($<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_zqDI9dxsBQL2" title="Value issued">37</span> thousand) shares and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_zCdECRahNGwe" title="Shares issued">2,186</span> ($<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_pn3n3_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_zrKDaVRTmphi" title="Value issued">16</span> thousand) shares of commons stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and Stock Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the July 2021 Securities Purchase Agreement previously described, we issued warrants to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210731__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpnJ8dfGScHl" title="Issued warrants shares">171,429</span> shares of our common stock at an exercise price equal to $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210731__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlMdo7eRvW74" title="Exercise price">7.70</span> per Warrant Share, which warrants are exercisable for a period of five years from the issuance date. The warrants were valued at $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20210731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc6mq98z5SB2" title="Warrants valued">1.3</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options and warrants are valued at the grant date using the Black-Scholes valuation methodology. The Company determines the assumptions used in the valuation of warrants and option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options and warrants granted throughout the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation assumptions used to determine the fair value of each option and warrant awarded in 2022: expected stock price volatility ranged from <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231_zDZ781mLNjg5" title="Expected volatility rate minimum">104.33</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231_zqVmXAdM82lb" title="Expected volatility rate maximum">126.44</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; expected term in years <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zPCK2p6uboIi" title="Expected term">3.25</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">; and risk-free interest rate ranged from <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231_zYUcVWdwVjRl" title="Risk- free interest rate">1.76</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231_zni6a6mMA8zi" title="Risk- free interest rate">4.52</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation assumptions used to determine the fair value of each warrant awarded in 2021: expected stock price volatility <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20211231_zusDLDtEPno9" title="Stock price volatility">151.0</span>% expected term in years <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zI0ElNUuzki3" title="Expected term">5</span>; and risk-free interest rate <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20211231_zLgZGIJnodH3" title="Risk-free interest rate">0.41</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No additional options were issued in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No warrants were exercised during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For warrants exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_c20210101__20211231_zAYulRvwxwB2" title="Stock issued during period, value, warrants exercised">683</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ziiEEiuGl8j4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants granted during the years ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zaByoYYYuqtj" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 0pt">Balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_z4M2qp3hrJua" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,378,929</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_z69ysbhi3Gn8" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zOe88tCJuIa9" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,366,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zV8Igh6Binu3" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.19</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_z22iqJHlwmU6" style="text-align: right" title="Number of warrants, Warrants granted">112,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zIw8Fk3kuco9" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">6.59</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_z2MxffuY7Wwi" style="text-align: right" title="Number of warrants, Warrants granted">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z2I21AAKxTT3" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Warrants expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20220101__20221231_zVyw8dHrYCUk" style="text-align: right" title="Number of warrants, Warrants expired">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zvF04T8dorOg" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20210101__20211231_zBJMdTEItr4i" style="text-align: right" title="Number of warrants, Warrants expired">40,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z6GjktB8xfYb" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">10.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20220101__20221231_zEEE8MQorjGi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zR0S6vCDi8Og" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1568">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20210101__20211231_zy7BrlchU4Dc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">119,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z1gntDDlvCAb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">6.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zsdEbQcopTA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zqN9EsPINxId" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210101__20211231_zM50panljPEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,378,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zfLlkGXFDDp6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Exercisable warrants</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20220101__20221231_z3AdnSW1jKCd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,424,234</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_z2mkhAOWRwt5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20210101__20211231_zd6YPJFLmlTj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,295,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zikLSbO51aEc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">6.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zsI38TRNso5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfOutstandingWarrantsTableTextBlock_zM4QlEruNmM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding warrants as of December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zdg3R2YCVaVd" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Range of</td><td> </td> <td colspan="2" style="text-align: center">Residual Life</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Exercise</td><td> </td> <td colspan="2" style="text-align: center">Span</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zPDXVjHVpxef" style="width: 15%; text-align: right" title="Range of Exercise Prices">5.91</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z978v3DZiqRc" title="Weighted Average Residual Life Span (in years)">4.33</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGH7MiPJ6N14" style="width: 13%; text-align: right" title="Outstanding Warrants">40,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr379dbVhbVh" style="width: 13%; text-align: right" title="Weighted Average Exercise Price">5.91</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHGvSziop3s4" style="width: 13%; text-align: right" title="Exercisable Warrants">5,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc6VupIqyqYj" style="width: 13%; text-align: right" title="Weighted Average Exercise Price">5.91</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z6RjcUaGiZPg" style="text-align: right" title="Range of Exercise Prices">6.95</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zDqctJpWsguk" title="Weighted Average Residual Life Span (in years)">4.23</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAu8ZwP50odd" style="text-align: right" title="Outstanding Warrants">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIgP96dB3Zl7" style="text-align: right" title="Weighted Average Exercise Price">6.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8jSKIKMBiW2" style="text-align: right" title="Exercisable Warrants">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zotkKMiODcz6" style="text-align: right" title="Weighted Average Exercise Price">6.95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zChCrQggzZXi" style="text-align: right" title="Range of Exercise Prices">7.00</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zFRCP0mbXiCk" title="Weighted Average Residual Life Span (in years)">2.62</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0ydmucSGRA5" style="text-align: right" title="Outstanding Warrants">847,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcsqzdzLUjUf" style="text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx8x8lqk4k3b" style="text-align: right" title="Exercisable Warrants">855,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrba0YbpTF75" style="text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zrsKVU8x4q27" style="text-align: right" title="Range of Exercise Prices">7.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zCm73WyF0Oc1" title="Weighted Average Residual Life Span (in years)">3.68</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsDZmGGioA72" style="text-align: right" title="Outstanding Warrants">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuf2HVnc1GF2" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znZ2iHV6HKR6" style="text-align: right" title="Exercisable Warrants">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpvwtn3Iz3k7" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z79GNOrb8Fye" style="text-align: right" title="Range of Exercise Prices">7.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zJ3R3VnMR37h" title="Weighted Average Residual Life Span (in years)">3.52</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdhZqoXFMG6g" style="text-align: right" title="Outstanding Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlS3TpW8MDm6" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGRWXEPPt0ed" style="text-align: right" title="Exercisable Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoYZN49jNxJb" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQTk5B2OJmjg" style="text-align: right; padding-bottom: 1.5pt" title="Range of Exercise Prices">10.00</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zX3sXujvlUYk" title="Weighted Average Residual Life Span (in years)">0.39</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyi0EuSzRcc9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Outstanding Warrants">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvZXqUDL5NYc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxFlyzsJbdNg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Warrants">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi8jjv13KJM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right; padding-bottom: 2.5pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziA4cDDRMcM8" title="Range of Exercise Prices, lower range limit">5.91</span> to <span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGFdQVe8dSD3" title="Range of Exercise Prices, upper range limit">10.00</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNyOFckj58S3" title="Weighted Average Residual Life Span (in years)">2.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHAyks31v9Xc" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding Warrants">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zb7uE4Nz1GQc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMgV2yN0hZof" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable Warrants">1,424,234</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCJDqXMIkjvg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zGkuOV025gBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock_zOx8A3IrGKJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding have the following expiry date and exercise prices as of the years ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zCtvt4eSYk78" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: center; padding-left: 0pt"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zMd710DEMjMb" title="Expiry Date">February 27, 2022</span></td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zojNDtS4xxwf" style="width: 11%; text-align: right" title="Warrant Exercise Prices">8.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zynN5qg9Oeq" style="width: 11%; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zxrBTm7Kak8d" style="width: 11%; text-align: right" title="Warrant Outstanding">10,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zkaMntoScZrl" title="Expiry Date">May 18, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zV6A2N6TIPrb" style="text-align: right" title="Warrant Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zrJS7eqvbpvh" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zjlYJ4lFPKMa" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zmYuluupizRj" title="Expiry Date">October 14, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zfBfslnQfHDe" style="text-align: right" title="Warrant Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_ztj4h50PPK89" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zVJFo2oWyxFf" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zyERURIXzm24" title="Expiry Date">October 06, 2024</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zTvyf68jqVCk" style="text-align: right" title="Warrant Exercise Prices">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zN9lfJuF6GV2" style="text-align: right" title="Warrant Outstanding">847,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zwy6LWjZl5T6" style="text-align: right" title="Warrant Outstanding">847,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_z8coU4pKhPb8" title="Expiry Date">September 01, 2025</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zzYawnM0Q0a7" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zRUqzja1Q1J9" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zIbMVQqk3mwb" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zyWofMiDDyt7" title="Expiry Date">June 04, 2026</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_z6UH06LdxCF5" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zCMjR7mNt9ob" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zHPbYIwhvJcb" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zBwIIv0jgoK9" title="Expiry Date">July 7, 2026</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zHYd8lkYZyV3" style="text-align: right" title="Warrant Exercise Prices">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zqq3mfSbLWBj" style="text-align: right" title="Warrant Outstanding">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zkQlwU3UjYX2" style="text-align: right" title="Warrant Outstanding">171,429</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zpijZCtXXCma" title="Expiry Date">December 04, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zOInMT8lD3Cd" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zwSn77KR7kai" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zNYr8z0dBaq" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zvPwxEEo80qe" title="Expiry Date">March 25, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zE6W4RRz0VA3" style="text-align: right" title="Warrant Exercise Prices">6.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zACUVGyWbEN9" style="text-align: right" title="Warrant Outstanding">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_ztDWY4KNpBh9" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zDoaViWiub1b" title="Expiry Date">May 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zYlM2w8tNZCg" style="text-align: right" title="Warrant Exercise Prices">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zzQ4Er3sNzLa" style="text-align: right" title="Warrant Outstanding">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zx9IC1wflklg" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zpbWTlnp9yfi" title="Expiry Date">May 1, 2027</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zzerMzVkXEY4" style="padding-bottom: 1.5pt; text-align: right" title="Warrant Exercise Prices">5.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zd7IwQyJyP2e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_znFkP8sUfFTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231_zf3th6il2Pqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231_zCjHzwohv848" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,378,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p> <p id="xdx_8AC_zuefelYnxAj2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a stock option plan whereby the Board of Directors, may grant to directors, officers, employees, or consultants of the Company options to acquire common shares. The Board of Directors of the Company has the authority to determine the terms, limits, restrictions and conditions of the grant of options, to interpret the plan, and make all decisions relating thereto. The plan was adopted by the Company’s Board of Directors on November 17, 2014 in order to provide an inducement and serve as a long-term incentive program. The maximum number of common shares that may be reserved for issuance was set at <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20141117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseOptionPlanMember_zE7RnePMwpt9" title="Reserved for issuance">500,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The option exercise price is established by the Board of Directors and may not be lower than the market price of the common shares at the time of grant. The options may be exercised during the option period determined by the Board of Directors, which may vary, but will not exceed ten years from the date of the grant. There are <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseOptionPlanMember_zenJJOKo9fIg" title="Options granted">500,000</span> of the Company’s common shares which may be issued pursuant to the exercise of share options granted under the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For options exercised during the year ended December 31, 2022, the difference between the fair value of the Common Stock issued and the respective exercise price was $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_c20220101__20221231_z8NDysdvpVse" title="Stock issued during period, value, stock options exercised">369</span> thousand. As of December 31, 2022, the intrinsic value for vested stock options was $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20221231_zQc10IQKlch1" title="Intrinsic value for vested stock options">477</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For options exercised during the year ended December 31, 2021, the difference between the fair value of the Common Stock issued and the respective exercise price was $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn5n6_c20210101__20211231_zeDP5P7eT4qb" title="Stock issued during period, value, stock options exercised">1.5</span> million. As of December 31, 2021, the intrinsic value for vested stock options was $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn5n6_c20211231_zw3X4Tl6lEPb" title="Intrinsic value for vested stock options">6.6 </span>million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock Options</span> - The following table summarizes information about stock options granted during the years ended December 31,</span></p> <p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zih4aLQYMUYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zxUNuG2WTVCj" style="display: none">SCHEDULE OF STOCK OPTIONS GRANTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Stock <br/> Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Stock <br/> Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 0pt">Balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zkUQ2EEeGKoj" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,559,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zQfZ461Uipv5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_znXccocgpoGe" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,811,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zps5VT84CLne" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.32</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Stock options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zuoizq7YSwpa" style="text-align: right" title="Number of stock options, Stock options granted">841,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zv6HlRFGGOMe" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_z1u0Hqymcvtk" style="text-align: right" title="Number of stock options, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zdxVpvAsx8Je" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Stock options expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20220101__20221231_z1azZDeKJLS1" style="text-align: right" title="Number of stock options, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zPzdvDGafYze" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20210101__20211231_zFIo0h4yA826" style="text-align: right" title="Number of stock options, Stock options expired">28,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zEHxca733G78" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1808">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Stock options cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231_z1t3UNmfMH38" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zOEmb556UiIf" style="text-align: right" title="Weighted Average Exercise Price, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20210101__20211231_zi6gWL6Yn9J5" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zBVWo03vPbE6" style="text-align: right" title="Weighted Average Exercise Price, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Stock options exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231_zfhLU1Ek0s78" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">201,217</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zEhW36KXp3T6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20210101__20211231_zRRzULgZmVO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">223,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zjaccS5rb1ih" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_ziJdUfQxB5j4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">2,190,583</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zSX8H1dTvzn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending of period">5.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231_zgGqkngjuyS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zcCUZwqOn2if" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending of period">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Exercisable stock options</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231_zgm6S3UhGaFe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,420,312</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zw9OPZAZHVs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.96</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231_zDYEFgr5QeTb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,065,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zV1QGIrMjuhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zfzh4ub8qHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zVjysL7Zs2s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options outstanding at the end of the year have the following expiry date and exercise prices as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zKfxQEO8ZPkg" style="display: none">SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES</span><span/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: center; padding-left: 0pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zk38n88wKgy1" title="Expiry Date">February 17, 2022</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_z3XTyWRtDzb8" style="width: 14%; text-align: right" title="Exercise Prices">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zAvMxC5pnWoj" style="width: 14%; text-align: right" title="Stock option outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zbN6z6eUvcy6" style="width: 14%; text-align: right" title="Stock option outstanding">38,017</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zWCCIKAEfwR4" title="Expiry Date">February 17, 2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zLpx5NHM4Tm6" style="text-align: right" title="Exercise Prices">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zuzsnBp6TAj" style="text-align: right" title="Stock option outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1856">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zxpN8QZkNMs5" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zQ5n5nAiP3ie" title="Expiry Date">February 28, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zWXbqxzqmG89" style="text-align: right" title="Exercise Prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zeK2tQOy3D8b" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zIHz2i6yNkXk" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zXtnNOwblkg6" title="Expiry Date">March 05, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z2tF31lBZrni" style="text-align: right" title="Exercise Prices">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z1uyt7uicUW" style="text-align: right" title="Stock option outstanding">242,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z5OfTvR9pcz5" style="text-align: right" title="Stock option outstanding">247,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zsIc0GRyMA3a" title="Expiry Date">July 31, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zMzoLhKl1Bm2" style="text-align: right" title="Exercise Prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z6Whbiaiz80a" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zCt0VUgdl8xc" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_z1roUZHRukQl" title="Expiry Date">October 31, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zG8EEKkcIL96" style="text-align: right" title="Exercise Prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zZuJc8muNH33" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zdJf32IFqxGj" style="text-align: right" title="Stock option outstanding">54,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zju1oHY9Hyz4" title="Expiry Date">November 30, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_z5gOAMwYNkq7" style="text-align: right" title="Exercise Prices">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_z9PlkA9N2wS2" style="text-align: right" title="Stock option outstanding">120,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zvSKGWrTILvk" style="text-align: right" title="Stock option outstanding">131,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zI4mi5Mj5xc1" title="Expiry Date">November 20, 2024</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zRe5vim3IrYb" style="text-align: right" title="Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zNXSajvF2nki" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zlP1qxM8FIge" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_z9Tjs9B8Ju4f" title="Expiry Date">April 20, 2025</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zutIlx2dWmmf" style="text-align: right" title="Exercise Prices">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zPwJtdcf7dU8" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zgxRmIzG3U05" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zfC4hfrenLC3" title="Expiry Date">March 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zdA5xxdeFon6" style="text-align: right" title="Exercise Prices">5.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zWujfDhVkay6" style="text-align: right" title="Stock option outstanding">648,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zcwiaux3E9z9" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zs9kezIF8vUc" title="Expiry Date">March 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zgmnJa3vy3Xh" style="text-align: right" title="Exercise Prices">5.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_z4cRDHRTNb6a" style="text-align: right" title="Stock option outstanding">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zDJs1NmDDVs8" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zXsacFzNbwkd" title="Expiry Date">May 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_z4IdNzT7fHD5" style="text-align: right" title="Exercise Prices">5.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zEWado5Jzv44" style="text-align: right" title="Stock option outstanding">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zILQZ7VcP9fl" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zrOmdzIhuCxd" title="Expiry Date">October 31, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zYbWUOzmdoM9" style="text-align: right" title="Exercise Prices">5.98</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_z1LZ68tNdkm8" style="text-align: right" title="Stock option outstanding">19,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zBqtHgvco0ik" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zo5Oh75hvbY1" title="Expiry Date">September 30, 2030</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_z51t8acj7hT7" style="text-align: right" title="Exercise Prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zq1BqgvbWUrl" style="text-align: right" title="Stock option outstanding">318,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zRdUDnPIDDZc" style="text-align: right" title="Stock option outstanding">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zGqF7NXvSl8i" title="Expiry Date">September 30, 2030</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zXKQt2rHktug" style="text-align: right" title="Exercise Prices">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zxL9yupIOj9h" style="text-align: right" title="Stock option outstanding">380,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_z8pqtH4nWLVb" style="text-align: right" title="Stock option outstanding">380,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231_zwiYcZTjOvw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option outstanding">2,190,583</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231_zriD5w5ylEN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option outstanding">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zOojeUVQRQ15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_892_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zAtD7CsdkJxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zTYuUV0t5hu8" style="display: none">SCHEDULE OF STOCK COMPENSATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220101__20221231_z3mpWAzC3wQf" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_z7XnUuJeXX7l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--StockOptionPlanExpense_pn3n3_maASBCEzshK_zRq51zc6NWqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Stock compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,321</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">951</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--StockOptionVesting_pn3n3_maASBCEzshK_z80Vx5aKPJq1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Stock Option vesting</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,852</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_iT_pn3n3_mtASBCEzshK_zrDWF5uTqDWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,173</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,551</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zrYpeasJAaG6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2000000 2000000 The board of directors had previously set the voting rights for the preferred stock at 1 share of preferred to 13 common shares. 1 1 3000000 3000000 544500 544500 544500 544500 0.06 1 153000 126000 1600000 1600530 194000 105551 The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days. 1118856 0.001 841500 0 1000000 0.001 0 0 7025 37000 2186 16000 171429 7.70 1300000 1.0433 1.2644 P3Y3M 0.0176 0.0452 1.510 P5Y 0.0041 683000 <p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ziiEEiuGl8j4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants granted during the years ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zaByoYYYuqtj" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 0pt">Balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_z4M2qp3hrJua" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,378,929</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_z69ysbhi3Gn8" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zOe88tCJuIa9" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,366,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zV8Igh6Binu3" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.19</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_z22iqJHlwmU6" style="text-align: right" title="Number of warrants, Warrants granted">112,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zIw8Fk3kuco9" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">6.59</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_z2MxffuY7Wwi" style="text-align: right" title="Number of warrants, Warrants granted">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z2I21AAKxTT3" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Warrants expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20220101__20221231_zVyw8dHrYCUk" style="text-align: right" title="Number of warrants, Warrants expired">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zvF04T8dorOg" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pid_c20210101__20211231_zBJMdTEItr4i" style="text-align: right" title="Number of warrants, Warrants expired">40,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z6GjktB8xfYb" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">10.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20220101__20221231_zEEE8MQorjGi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zR0S6vCDi8Og" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1568">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20210101__20211231_zy7BrlchU4Dc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">119,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z1gntDDlvCAb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">6.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zsdEbQcopTA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zqN9EsPINxId" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210101__20211231_zM50panljPEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,378,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zfLlkGXFDDp6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.40</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Exercisable warrants</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20220101__20221231_z3AdnSW1jKCd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,424,234</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_z2mkhAOWRwt5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20210101__20211231_zd6YPJFLmlTj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,295,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zikLSbO51aEc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">6.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1378929 7.40 1366667 7.19 112805 6.59 171429 7.70 10000 8.00 40000 10.00 119167 6.99 1481734 7.34 1378929 7.40 1424234 7.38 1295596 6.38 <p id="xdx_898_ecustom--ScheduleOfOutstandingWarrantsTableTextBlock_zM4QlEruNmM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding warrants as of December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zdg3R2YCVaVd" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Range of</td><td> </td> <td colspan="2" style="text-align: center">Residual Life</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Exercise</td><td> </td> <td colspan="2" style="text-align: center">Span</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zPDXVjHVpxef" style="width: 15%; text-align: right" title="Range of Exercise Prices">5.91</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z978v3DZiqRc" title="Weighted Average Residual Life Span (in years)">4.33</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGH7MiPJ6N14" style="width: 13%; text-align: right" title="Outstanding Warrants">40,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zr379dbVhbVh" style="width: 13%; text-align: right" title="Weighted Average Exercise Price">5.91</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHGvSziop3s4" style="width: 13%; text-align: right" title="Exercisable Warrants">5,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zc6VupIqyqYj" style="width: 13%; text-align: right" title="Weighted Average Exercise Price">5.91</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z6RjcUaGiZPg" style="text-align: right" title="Range of Exercise Prices">6.95</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zDqctJpWsguk" title="Weighted Average Residual Life Span (in years)">4.23</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAu8ZwP50odd" style="text-align: right" title="Outstanding Warrants">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIgP96dB3Zl7" style="text-align: right" title="Weighted Average Exercise Price">6.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8jSKIKMBiW2" style="text-align: right" title="Exercisable Warrants">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zotkKMiODcz6" style="text-align: right" title="Weighted Average Exercise Price">6.95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zChCrQggzZXi" style="text-align: right" title="Range of Exercise Prices">7.00</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zFRCP0mbXiCk" title="Weighted Average Residual Life Span (in years)">2.62</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0ydmucSGRA5" style="text-align: right" title="Outstanding Warrants">847,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcsqzdzLUjUf" style="text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx8x8lqk4k3b" style="text-align: right" title="Exercisable Warrants">855,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrba0YbpTF75" style="text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zrsKVU8x4q27" style="text-align: right" title="Range of Exercise Prices">7.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zCm73WyF0Oc1" title="Weighted Average Residual Life Span (in years)">3.68</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsDZmGGioA72" style="text-align: right" title="Outstanding Warrants">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuf2HVnc1GF2" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znZ2iHV6HKR6" style="text-align: right" title="Exercisable Warrants">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpvwtn3Iz3k7" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z79GNOrb8Fye" style="text-align: right" title="Range of Exercise Prices">7.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zJ3R3VnMR37h" title="Weighted Average Residual Life Span (in years)">3.52</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdhZqoXFMG6g" style="text-align: right" title="Outstanding Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlS3TpW8MDm6" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGRWXEPPt0ed" style="text-align: right" title="Exercisable Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoYZN49jNxJb" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQTk5B2OJmjg" style="text-align: right; padding-bottom: 1.5pt" title="Range of Exercise Prices">10.00</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zX3sXujvlUYk" title="Weighted Average Residual Life Span (in years)">0.39</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyi0EuSzRcc9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Outstanding Warrants">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvZXqUDL5NYc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxFlyzsJbdNg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Warrants">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi8jjv13KJM" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right; padding-bottom: 2.5pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziA4cDDRMcM8" title="Range of Exercise Prices, lower range limit">5.91</span> to <span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGFdQVe8dSD3" title="Range of Exercise Prices, upper range limit">10.00</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNyOFckj58S3" title="Weighted Average Residual Life Span (in years)">2.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHAyks31v9Xc" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding Warrants">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zb7uE4Nz1GQc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMgV2yN0hZof" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable Warrants">1,424,234</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCJDqXMIkjvg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5.91 P4Y3M29D 40000 5.91 5000 5.91 6.95 P4Y2M23D 42805 6.95 42805 6.95 7.00 P2Y7M13D 847500 7.00 855000 7.00 7.50 P3Y8M4D 250000 7.50 250000 7.50 7.70 P3Y6M7D 171429 7.70 171429 7.70 10.00 P0Y4M20D 100000 10.00 100000 10.00 5.91 10.00 P2Y4M28D 1481734 7.34 1424234 7.38 <p id="xdx_89C_ecustom--ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock_zOx8A3IrGKJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding have the following expiry date and exercise prices as of the years ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zCtvt4eSYk78" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: center; padding-left: 0pt"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zMd710DEMjMb" title="Expiry Date">February 27, 2022</span></td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zojNDtS4xxwf" style="width: 11%; text-align: right" title="Warrant Exercise Prices">8.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zynN5qg9Oeq" style="width: 11%; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zxrBTm7Kak8d" style="width: 11%; text-align: right" title="Warrant Outstanding">10,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zkaMntoScZrl" title="Expiry Date">May 18, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zV6A2N6TIPrb" style="text-align: right" title="Warrant Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zrJS7eqvbpvh" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zjlYJ4lFPKMa" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zmYuluupizRj" title="Expiry Date">October 14, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zfBfslnQfHDe" style="text-align: right" title="Warrant Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_ztj4h50PPK89" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zVJFo2oWyxFf" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zyERURIXzm24" title="Expiry Date">October 06, 2024</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zTvyf68jqVCk" style="text-align: right" title="Warrant Exercise Prices">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zN9lfJuF6GV2" style="text-align: right" title="Warrant Outstanding">847,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zwy6LWjZl5T6" style="text-align: right" title="Warrant Outstanding">847,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_z8coU4pKhPb8" title="Expiry Date">September 01, 2025</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zzYawnM0Q0a7" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zRUqzja1Q1J9" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThousandTwentyFiveMember_zIbMVQqk3mwb" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zyWofMiDDyt7" title="Expiry Date">June 04, 2026</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_z6UH06LdxCF5" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zCMjR7mNt9ob" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zHPbYIwhvJcb" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zBwIIv0jgoK9" title="Expiry Date">July 7, 2026</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zHYd8lkYZyV3" style="text-align: right" title="Warrant Exercise Prices">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zqq3mfSbLWBj" style="text-align: right" title="Warrant Outstanding">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JulySevenTwoThousandTwentySixMember_zkQlwU3UjYX2" style="text-align: right" title="Warrant Outstanding">171,429</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zpijZCtXXCma" title="Expiry Date">December 04, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zOInMT8lD3Cd" style="text-align: right" title="Warrant Exercise Prices">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zwSn77KR7kai" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zNYr8z0dBaq" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zvPwxEEo80qe" title="Expiry Date">March 25, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zE6W4RRz0VA3" style="text-align: right" title="Warrant Exercise Prices">6.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_zACUVGyWbEN9" style="text-align: right" title="Warrant Outstanding">42,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchTwentyFifthTwoThousandTwentySevenMember_ztDWY4KNpBh9" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zDoaViWiub1b" title="Expiry Date">May 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zYlM2w8tNZCg" style="text-align: right" title="Warrant Exercise Prices">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zzQ4Er3sNzLa" style="text-align: right" title="Warrant Outstanding">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zx9IC1wflklg" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zpbWTlnp9yfi" title="Expiry Date">May 1, 2027</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zzerMzVkXEY4" style="padding-bottom: 1.5pt; text-align: right" title="Warrant Exercise Prices">5.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_zd7IwQyJyP2e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenOneMember_znFkP8sUfFTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231_zf3th6il2Pqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,481,734</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20211231_zCjHzwohv848" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,378,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p> 2022-02-27 8.00 10000 2023-05-18 10.00 50000 50000 2023-10-14 10.00 50000 50000 2024-10-06 7.00 847500 847500 2025-09-01 7.50 83334 83334 2026-06-04 7.50 83333 83333 2026-07-07 7.70 171429 171429 2027-12-04 7.50 83333 83333 2027-03-25 6.95 42805 2027-05-01 7.00 30000 2027-05-01 5.91 40000 1481734 1378929 500000 500000 369000 477000 1500000 6600000 <p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zih4aLQYMUYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zxUNuG2WTVCj" style="display: none">SCHEDULE OF STOCK OPTIONS GRANTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Stock <br/> Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of<br/> Stock <br/> Options</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 0pt">Balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zkUQ2EEeGKoj" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,559,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zQfZ461Uipv5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_znXccocgpoGe" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,811,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zps5VT84CLne" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.32</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Stock options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_zuoizq7YSwpa" style="text-align: right" title="Number of stock options, Stock options granted">841,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zv6HlRFGGOMe" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_z1u0Hqymcvtk" style="text-align: right" title="Number of stock options, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zdxVpvAsx8Je" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Stock options expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20220101__20221231_z1azZDeKJLS1" style="text-align: right" title="Number of stock options, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zPzdvDGafYze" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_pid_c20210101__20211231_zFIo0h4yA826" style="text-align: right" title="Number of stock options, Stock options expired">28,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zEHxca733G78" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1808">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Stock options cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231_z1t3UNmfMH38" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zOEmb556UiIf" style="text-align: right" title="Weighted Average Exercise Price, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20210101__20211231_zi6gWL6Yn9J5" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zBVWo03vPbE6" style="text-align: right" title="Weighted Average Exercise Price, Stock options cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Stock options exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231_zfhLU1Ek0s78" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">201,217</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zEhW36KXp3T6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20210101__20211231_zRRzULgZmVO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">223,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zjaccS5rb1ih" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_ziJdUfQxB5j4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">2,190,583</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zSX8H1dTvzn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending of period">5.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231_zgGqkngjuyS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zcCUZwqOn2if" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending of period">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Exercisable stock options</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231_zgm6S3UhGaFe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,420,312</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zw9OPZAZHVs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.96</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231_zDYEFgr5QeTb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,065,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231_zV1QGIrMjuhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1559300 4.58 1811550 4.32 841500 28750 9000 201217 223500 2190583 5.00 1559300 4.58 1420312 4.96 1065133 4.56 <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zVjysL7Zs2s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options outstanding at the end of the year have the following expiry date and exercise prices as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zKfxQEO8ZPkg" style="display: none">SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES</span><span/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: center; padding-left: 0pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zk38n88wKgy1" title="Expiry Date">February 17, 2022</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_z3XTyWRtDzb8" style="width: 14%; text-align: right" title="Exercise Prices">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zAvMxC5pnWoj" style="width: 14%; text-align: right" title="Stock option outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zbN6z6eUvcy6" style="width: 14%; text-align: right" title="Stock option outstanding">38,017</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zWCCIKAEfwR4" title="Expiry Date">February 17, 2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zLpx5NHM4Tm6" style="text-align: right" title="Exercise Prices">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zuzsnBp6TAj" style="text-align: right" title="Stock option outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1856">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zxpN8QZkNMs5" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zQ5n5nAiP3ie" title="Expiry Date">February 28, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zWXbqxzqmG89" style="text-align: right" title="Exercise Prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zeK2tQOy3D8b" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zIHz2i6yNkXk" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zXtnNOwblkg6" title="Expiry Date">March 05, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z2tF31lBZrni" style="text-align: right" title="Exercise Prices">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z1uyt7uicUW" style="text-align: right" title="Stock option outstanding">242,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_z5OfTvR9pcz5" style="text-align: right" title="Stock option outstanding">247,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zsIc0GRyMA3a" title="Expiry Date">July 31, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zMzoLhKl1Bm2" style="text-align: right" title="Exercise Prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z6Whbiaiz80a" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_zCt0VUgdl8xc" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_z1roUZHRukQl" title="Expiry Date">October 31, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zG8EEKkcIL96" style="text-align: right" title="Exercise Prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zZuJc8muNH33" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zdJf32IFqxGj" style="text-align: right" title="Stock option outstanding">54,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zju1oHY9Hyz4" title="Expiry Date">November 30, 2023</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_z5gOAMwYNkq7" style="text-align: right" title="Exercise Prices">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_z9PlkA9N2wS2" style="text-align: right" title="Stock option outstanding">120,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zvSKGWrTILvk" style="text-align: right" title="Stock option outstanding">131,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zI4mi5Mj5xc1" title="Expiry Date">November 20, 2024</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zRe5vim3IrYb" style="text-align: right" title="Exercise Prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zNXSajvF2nki" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zlP1qxM8FIge" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_z9Tjs9B8Ju4f" title="Expiry Date">April 20, 2025</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zutIlx2dWmmf" style="text-align: right" title="Exercise Prices">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zPwJtdcf7dU8" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zgxRmIzG3U05" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zfC4hfrenLC3" title="Expiry Date">March 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zdA5xxdeFon6" style="text-align: right" title="Exercise Prices">5.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zWujfDhVkay6" style="text-align: right" title="Stock option outstanding">648,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenMember_zcwiaux3E9z9" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zs9kezIF8vUc" title="Expiry Date">March 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zgmnJa3vy3Xh" style="text-align: right" title="Exercise Prices">5.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_z4cRDHRTNb6a" style="text-align: right" title="Stock option outstanding">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MarchFirstTwoThousandTwentySevenOneMember_zDJs1NmDDVs8" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zXsacFzNbwkd" title="Expiry Date">May 1, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_z4IdNzT7fHD5" style="text-align: right" title="Exercise Prices">5.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zEWado5Jzv44" style="text-align: right" title="Stock option outstanding">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--MayFirstTwoThousandTwentySevenMember_zILQZ7VcP9fl" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zrOmdzIhuCxd" title="Expiry Date">October 31, 2027</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zYbWUOzmdoM9" style="text-align: right" title="Exercise Prices">5.98</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_z1LZ68tNdkm8" style="text-align: right" title="Stock option outstanding">19,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentySevenMember_zBqtHgvco0ik" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zo5Oh75hvbY1" title="Expiry Date">September 30, 2030</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_z51t8acj7hT7" style="text-align: right" title="Exercise Prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zq1BqgvbWUrl" style="text-align: right" title="Stock option outstanding">318,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zRdUDnPIDDZc" style="text-align: right" title="Stock option outstanding">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-left: 0pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zGqF7NXvSl8i" title="Expiry Date">September 30, 2030</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zXKQt2rHktug" style="text-align: right" title="Exercise Prices">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zxL9yupIOj9h" style="text-align: right" title="Stock option outstanding">380,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_z8pqtH4nWLVb" style="text-align: right" title="Stock option outstanding">380,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231_zwiYcZTjOvw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option outstanding">2,190,583</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20211231_zriD5w5ylEN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option outstanding">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2022-02-17 1.50 38017 2022-02-17 1.80 76033 2023-02-28 5.00 20000 20000 2023-03-05 2.40 242000 247000 2023-07-31 5.00 127500 127500 2023-10-31 4.40 10000 54000 2023-11-30 5.40 120250 131750 2024-11-20 10.00 125000 125000 2025-04-20 4.20 10000 10000 2027-03-01 5.14 648500 2027-03-01 5.65 140000 2027-05-01 5.90 30000 2027-10-31 5.98 19000 2030-09-30 4.40 318333 350000 2030-09-30 4.84 380000 380000 2190583 1559300 <p id="xdx_892_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zAtD7CsdkJxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recorded stock compensation expense relating to the vesting of stock options and warrants as follows for the years ended December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zTYuUV0t5hu8" style="display: none">SCHEDULE OF STOCK COMPENSATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220101__20221231_z3mpWAzC3wQf" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_z7XnUuJeXX7l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--StockOptionPlanExpense_pn3n3_maASBCEzshK_zRq51zc6NWqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Stock compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,321</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">951</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--StockOptionVesting_pn3n3_maASBCEzshK_z80Vx5aKPJq1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Stock Option vesting</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,852</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_iT_pn3n3_mtASBCEzshK_zrDWF5uTqDWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,173</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,551</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1321000 951000 1852000 1600000 3173000 2551000 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zr7BjNkRM7me" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 – <span id="xdx_828_zIoR5A4H31Pb">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2020 we amended the consulting agreement with Mr. Carlos J. Nissensohn, a principal shareholder of the Company and a family member of a Director and Officer of the Company. The terms and condition of the contract are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48-month term with 90-day termination notice by the Company</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A monthly fee of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_z7a9aTuxbsmd" title="Debt periodic payment">30</span> thousand.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--EquityComponentDescription_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_z7kQzo5ZNVIj" title="Equity component description">If we procure debt financing during the term of Mr. Nissensohn’s agreement, without any equity component, Mr. Nissensohn shall be entitled to 3% of the gross funds raised, however if we are required to pay a success fee to another external entity, then Mr. Nissensohn shall be entitled to only 2% of the gross funds raised.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the above, in the event of an equity financing resulting in gross proceeds of at least $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn6n6_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_zFFoddVJZj29" title="Gross proceeds">3</span> million to us within 24 months of the date the contract, Mr. Nissensohn shall further be entitled to certain warrants to be granted by us which upon their exercise pursuant to their terms, Mr. Nissensohn shall be entitled to receive OMNIQ shares which represent <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MrCarlosJNissensonMember_zfGMlVAqQesg" title="Ownership percentage">3%</span> of the OMNIQ issued share capital immediately prior to the consummation of such investment. The warrants will carry an exercise price per warrant/share representing <span id="xdx_90E_ecustom--WarrantExercisePricePercentage_iI_pid_dp_uPure_c20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_zFZ6QVkdw7Hg" title="Warrant exercise price percentage">100%</span> of the closing price per share as closed in the equity financing. This section and the issue of the warrant by OMNIQ are subject to the approval of the Board of Directors of OMNIQ. However, if the Board does not approve the issuance of warrants; then Mr. Nissensohn will be entitled to a fee with the equivalent value based on a Black Scholes valuation</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the above, Mr. Nissensohn will be entitled to a $<span id="xdx_902_eus-gaap--PaymentOfFinancingAndStockIssuanceCosts_pn3n3_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_zOgjMlK3aGb8" title="Payment of financing and stock issuance costs">80</span> thousand one-time payment which shall be paid on the 1<sup>st </sup>day that the OMNIQ shares become traded on the NASDAQ or NYSE Stock Market within 24 months of the date of the contract</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the aforementioned, in the event that we close any M&amp;A transaction with a third party target, Mr. Nissensohn shall be entitled to a success fee in the amount equal to <span id="xdx_909_ecustom--TotalTransactionPricePercentage_pid_dp_uPure_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrCarlosJNissensonMember_zL49oSry7WP2" title="Transaction price percentage">5%</span> of the total transaction price, in any combination of cash and shares that will be determined by OMNIQ</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional related party transactions are discussed in Note 10.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 30000 If we procure debt financing during the term of Mr. Nissensohn’s agreement, without any equity component, Mr. Nissensohn shall be entitled to 3% of the gross funds raised, however if we are required to pay a success fee to another external entity, then Mr. Nissensohn shall be entitled to only 2% of the gross funds raised. 3000000 0.03 1 80000 0.05 <p id="xdx_802_ecustom--GeographicDataTextBlock_z2VdsNPM1tzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 – <span id="xdx_82D_z2orsoFK8rvh">CONCENTRATION AND GEOGRAPHIC DATA</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, one customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zjp7Py0XnP0j" title="Concentration risk percentage">30%</span> and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7aVo8azaZW" title="Concentration risk percentage">23%</span>, respectively, of the Company’s revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information about Geographic Areas</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zTKVob26ycAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues by geography are based on the billing addresses of our customers. The following tables set forth revenues by geographic area for the years ended December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span id="xdx_8BF_zIMBVUdauMF4" style="display: none">SCHEDULE OF REVENUES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20220101__20221231_z6ZcXUhy4ME" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zOejMkMyZsT" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><i>In thousands</i></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Revenues:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_z3CcrVn22cV2" style="vertical-align: bottom; background-color: White"> <td style="width: 62%; text-align: left; padding-left: 0pt">United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">51,023</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">53,725</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--IL_zM1mQGDmjaxk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Israel</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,848</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--RestOfTheWorldMember_zSP1EVyGk4W9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Rest of the world</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,305</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,678</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_z93byddXRMh2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">102,545</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,251</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zDLZPhjZFlVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operations are subject to various political, economic, and other risks and uncertainties inherent in the countries in which the Company operates. Among other risks, the Company’s operations are subject to the risks of restrictions on transfer of funds; export duties, quotas and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; and political conditions and governmental regulations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.30 0.23 <p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zTKVob26ycAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues by geography are based on the billing addresses of our customers. The following tables set forth revenues by geographic area for the years ended December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span id="xdx_8BF_zIMBVUdauMF4" style="display: none">SCHEDULE OF REVENUES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20220101__20221231_z6ZcXUhy4ME" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zOejMkMyZsT" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><i>In thousands</i></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Revenues:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_z3CcrVn22cV2" style="vertical-align: bottom; background-color: White"> <td style="width: 62%; text-align: left; padding-left: 0pt">United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">51,023</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">53,725</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--IL_zM1mQGDmjaxk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0pt">Israel</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,848</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--RestOfTheWorldMember_zSP1EVyGk4W9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Rest of the world</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,305</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,678</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_z93byddXRMh2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">102,545</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,251</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 51023000 53725000 42217000 21848000 9305000 2678000 102545000 78251000 <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_z7VARumR0Dij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 – <span id="xdx_823_zDFSu33yp6Hg">INCOME TAX</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company has $<span id="xdx_90A_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_pn3n3_c20220101__20221231_zWWhnDZVix3a" title="Current income tax provision">35</span> thousand of current income tax provision (US State &amp; Local and Foreign) and $<span id="xdx_906_eus-gaap--DeferredIncomeTaxExpenseBenefit_pn3n3_c20220101__20221231_zswaoLIVwDN8" title="Deferred income tax expense benefit">30</span> thousand deferred income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zcc8mRvNsvZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effect of temporary differences that give rise to deferred tax assets and deferred tax liabilities are as follows as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zUD7AaQa6aAk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20221231_zQ0mdgRQK4yi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20211231_zjW8dwrAQnLb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzSnJ_zYMeYlJIpHR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Reserves and deferred revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">411</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">182</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pn3n3_maDTAGzSnJ_zavY6GBPpOq5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">163(j) Limitation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,260</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,682</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pn3n3_maDTAGzSnJ_zp8zMkGyX8Zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Foreign deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzSnJ_zpEbA0c2a5J3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,353</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,164</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzSnJ_maDTANzWq8_zU0rd5oBs344" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Total gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzWq8_zfxE3eFZz0S3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Less: Valuation Allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,720</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzWq8_maDTALNzBeD_zborK33L9fS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Net deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pn3n3_di_maDTLz7d1_zfxM8Ahe56D5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Amortization of intangible assets and depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLz7d1_msDTALNzBeD_zINIeRT3gZA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzBeD_zMfN6DOPZUp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zcv1WRGKQpK7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89E_eus-gaap--SummaryOfValuationAllowanceTextBlock_zVA15Fab58I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of net deferred tax assets, including a valuation allowance, are as follows as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BA_zg7yDtoTq8Ka" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20221231_zGnwZzhHV9Qa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20211231_zqtyCjUZ3NLj" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxAssetGross_iI_pn3n3_maDTALNz9fX_zVfhw0BV36Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Deferred tax assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">11,025</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">8,885</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz9fX_z0EduW2TAp88" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,720</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz9fX_zFcgzesmjFE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zrbABYCCeYJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation allowance for deferred tax assets as of December 31, 2022 and 2021 was $<span id="xdx_909_ecustom--DeferredTaxAssetsValuationAllowancesCurrent_iI_pn5n6_c20221231_z6ckcYsXnIg9" title="Valuation allowance for deferred tax assets">10.9</span> million and $<span id="xdx_900_ecustom--DeferredTaxAssetsValuationAllowancesCurrent_iI_pn5n6_c20211231_zLZLZQDg34L4" title="Valuation allowance for deferred tax assets">8.7</span> million, respectively. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Management has recorded a 100% Valuation Allowance, against its U.S. Net Deferred Tax Assets, since Management believes it is more likely than not that it will not be realized at the date of this statement. The Company will continue to monitor the potential utilization of this asset. Should factors and evidence change to aid in this assessment, a potential adjustment to the valuation allowance in future periods may occur. The Company records any penalties and interest as a component of operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z0i12NEch0Wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation between statutory rate and effective rate is as follows as of December 31,:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_za1VTQktqt55" style="display: none">SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_zLpnKdNmMFu" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210101__20211231_zl8yQuWFKHE4" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zwzIp6CMe1nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: justify; padding-left: 0pt">Federal statutory tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zy902Vges8xf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0pt">State taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.07</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zilHsgewSsv" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt">Foreign income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4.45</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(6.38</p></td><td style="text-align: left">)%</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zLwXxFbhwBa4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16.13</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(15.24</td><td style="text-align: left">)%</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_zY2MDesyq1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt">Return to provision adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">(.03</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2083">.079</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp_uPure_zOfUC8YbI4gf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">(.76</span></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.37</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zwN0ReOzSezj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt">Effective tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">(.44</span></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.23</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr> </table> <p id="xdx_8A3_zEezzvIRPCr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reported no uncertain tax liability as of December 31, 2022 and expects no significant change to the uncertain tax liability over the next twelve months. The Company’s 2015, 2016, 2017, 2018, 2019, 2020 and 2021 federal and state income tax returns are open for examination by the applicable governmental authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had a net operating loss (NOL) carryforward of approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20221231_zHtMuj7tTy4b" title="Net operating loss carryforward">39.7</span> million. A portion of the NOL carryforward begins to expire in 2027. Under Section 382 of the Internal Revenue Code of 1986, as amended (“IRC Section 382”), a corporation that undergoes an “ownership change” is subject to limitations on its use of pre-change NOL carryforwards to offset future taxable income. Within the meaning of IRC Section 382, an “ownership change” occurs when the aggregate stock ownership of certain stockholders (generally 5% shareholders, applying certain look-through rules and aggregation rules which combine unrelated shareholders that do not individually own 5% or more of the corporation’s stock into one or more “public groups” that may be treated as 5-percent shareholder) increases by more than 50 percentage points over such stockholders’ lowest percentage ownership during the testing period (generally three years).</span> In general, the annual use limitation equals the aggregate value of common stock at the time of the ownership change multiplied by a specified tax-exempt interest rate. The Company has not completed a study as to whether there is a 382 limitation on its NOLs that will limit or possibly eliminate the use of its NOLs in the future. Company’s Management has recorded a 100% valuation allowance on the entire NOL as it believes that it is more likely than not that the deferred tax asset associated with the NOLs will not be realized regardless of whether or not an “ownership change” has occurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 35000 30000 <p id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zcc8mRvNsvZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effect of temporary differences that give rise to deferred tax assets and deferred tax liabilities are as follows as of December 31,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zUD7AaQa6aAk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20221231_zQ0mdgRQK4yi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20211231_zjW8dwrAQnLb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic">In thousands</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzSnJ_zYMeYlJIpHR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Reserves and deferred revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">411</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">182</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pn3n3_maDTAGzSnJ_zavY6GBPpOq5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt">163(j) Limitation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,260</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,682</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pn3n3_maDTAGzSnJ_zp8zMkGyX8Zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Foreign deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzSnJ_zpEbA0c2a5J3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,353</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,164</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzSnJ_maDTANzWq8_zU0rd5oBs344" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Total gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzWq8_zfxE3eFZz0S3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Less: Valuation Allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,720</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzWq8_maDTALNzBeD_zborK33L9fS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Net deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pn3n3_di_maDTLz7d1_zfxM8Ahe56D5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Amortization of intangible assets and depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLz7d1_msDTALNzBeD_zINIeRT3gZA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzBeD_zMfN6DOPZUp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0pt">Net deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 411000 182000 2260000 1682000 135000 165000 8353000 7164000 11158000 9193000 10890000 8720000 269000 473000 134000 308000 134000 308000 135000 165000 <p id="xdx_89E_eus-gaap--SummaryOfValuationAllowanceTextBlock_zVA15Fab58I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of net deferred tax assets, including a valuation allowance, are as follows as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BA_zg7yDtoTq8Ka" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20221231_zGnwZzhHV9Qa" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20211231_zqtyCjUZ3NLj" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxAssetGross_iI_pn3n3_maDTALNz9fX_zVfhw0BV36Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; padding-left: 0pt">Deferred tax assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">11,025</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">8,885</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz9fX_z0EduW2TAp88" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,720</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz9fX_zFcgzesmjFE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">135</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">165</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 11025000 8885000 10890000 8720000 135000 165000 10900000 8700000 <p id="xdx_896_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z0i12NEch0Wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation between statutory rate and effective rate is as follows as of December 31,:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_za1VTQktqt55" style="display: none">SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_zLpnKdNmMFu" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210101__20211231_zl8yQuWFKHE4" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zwzIp6CMe1nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: justify; padding-left: 0pt">Federal statutory tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zy902Vges8xf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0pt">State taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.07</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_zilHsgewSsv" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt">Foreign income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4.45</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(6.38</p></td><td style="text-align: left">)%</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zLwXxFbhwBa4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16.13</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(15.24</td><td style="text-align: left">)%</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_zY2MDesyq1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt">Return to provision adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">(.03</span></td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2083">.079</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp_uPure_zOfUC8YbI4gf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">(.76</span></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.37</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zwN0ReOzSezj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt">Effective tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">(.44</span></td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.23</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr> </table> 0.2100 0.210 -0.0007 -0.0003 -0.0445 -0.0638 -0.1613 -0.1524 -0.0137 -0.0123 39700000 EXCEL 91 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�X*%5MU5 MG]:S:5JUY(=Y-=CNB=CD3 +%5+OVSBX&#HAJ6%0;Q;>V02.N=+O;9:;G*PIC MH.]3SM5A8P+4$SO\"U!+ P04 " "UGGY6J<$7-I\" "4!0 &0 'AL M+W=O.'^Y^_E_.=Z.UTL\F0[3P MF@MIQEYF;3'T?9-DF#-SK J4=+)4.F>6EGKEFT(C2RNG7/AA$/3]G''IQ:-J M[T['(U5:P27>:3!EGC/]-D&AUF.OXVTWYGR56;?AQZ."K? >[6-QIVGE-Y24 MYR@-5Q(T+L?>66P(,4EZP4=J[6E[B)I^=X MB1*F&F%=VW9##Y+26)5OG$E!SF7]9:^;_[#C, @^< @W#F&EN[ZH4CEEEL4C MK=:@G371W*0*M?(F<5RZI-Q;3:><_&Q\=?,TNWFXG?^"KP]L(= )$XQ.89NIPUA$(8'>-TF MRF[%ZWX4I7Q!:95^@RDWB5"FU B_SQ;&:GH6?_:%7 .C_4!7*D-3L 3''M6" M0?V"7OSE4Z MJ47-F3#P&?K1*8V#TZCUG@E.KIJ1! MA.P@B^-:ZX)+34TYAI13QOM)S-,"< M*"83/()^.SCINK'?:3THRP1!:AQ'=\V@?1+VW77MTUX/]B7"WZF4'/6JZ@<& M$E5*6Q=-L]NTG+.ZTM[-ZWYUS?2*2P,"E^0:')_T/-!U#Z@75A55W2V4I2JN MIAFU3=3.@,Z72MGMPEW0-.+X'U!+ P04 " "UGGY61,/J20L# "#!@ M&0 'AL+W=O1J32RW >5(DKC M>!"5C,MP-O%K"SV;J-H*+G&AP=1ER?3W2Q1J,PV3<+?PP->%=0O1;%*Q-3ZB M?:X6FJRH1)./+GO/W#I\X;LS>')R2I5)?G'&;3\/8$4*! MF74(C(87O$(A'!#1^+K%#-N4+G!_OD._\=I)RY(9O%+B'Y[;8AH.0\AQQ6IA M']3F/6[U]!U>IH3Q7]@TOCW*F-7&JG(;3';)93.R;]LZ[ 4,XU<"TFU ZGDW MB3S+:V;9;*+5!K3S)C0W\5)]-)'CTAW*H]6TRRG.SA8/'Q?SAZ=_X>+^&N9_ M/]\N[N;W3W#RQ)8"S>DDLI3$N4;9%O"R 4Q? 4Q2N%/2%@;F,L?\9X"(V+44 MTQW%R_0HXC5F9]!-.I#&:7H$K]M*[GJ\[FN2-5UI;;]W8"&8M,!D#O.O-:_H MKEGX[V)IK*;+\OF0]@:Y=QC9/:"QJ5B&TY!>B$']@N'L[1_)(/[S".]>R[MW M#'WV>/5^?OW\80X?;^#PL1UB?!3S,..G H.5$O1>N5P#-\!V;Q;4"FR!D*FR M4I+*9=Q*M2VHKR2VE61^DTX/RR5J=X)C^+V&X%92"E4; C/^R-TG">Z8K%=T M++5VI%PFP99[V=[ :$B?WF@4?$!ZIH42.?"2N+U@Z9GVTP0&\2AX5"N[81H] MB%-26Z+W VDT/(>D,^C'P4VM):>,^(NRM#N M-\+/F'!,X&0GO=(WC!8'"Q$ M!_[2RAAX1\2,&5,CRNJR%LQB3OV#RIYQYCO42=*)NS&,NG+: P2^ M]^@$D_MPX,&2]#^=V;_ U!+ M P04 " "UGGY6[_#?KI8# !>" &0 'AL+W=OO.'*K52-YXPO&D"P@02"MI02B0-J]:!\&^X"M MVC-T9BC9_?4]8X-+N@15VI?QF9-@ONH+=A:YRC?MH\2)JY#4J:E\A5+CA(7/7M MH7\]:IOSU8&/.>[4D0PFDJ40G\TD3ONV9QS" A-M$!A]ON(-%H4!(C>^[#'M MQJ11/)8/Z+=5[!3+DBF\$<6G/-59W^[:D.**;0O]*'8?][GX4BAZ[VB$.P5@LKOVE#EY9AI-NA)L0-I3A.: M$:I0*VUR+N>F*',M:3+H;3]_'H;@+#^7RRF,.[ M!5L6J"YZKB9C1L5-]L"C&CAX!=@/X%YPG2F8\!33EP N>=FX&AQ<'05G$<>8 M7$++=R#P@N ,7JL)O57AM5X+78ATEQ<%,)Y"S#7CZYR"A:%2J!6,P\][;\62"R8N1E4EF\4^&VG$USM/]:,?)>0-_&132?P(QI; M06#%1^MK*=3+W6&2;,LM85,66"FDSO^M[, [\JP3^7!!4NA<=3VX.(9R@-,E M_!:"T/%\SPAMI^MUX0Q-V@U-VC]-D]MX&B\FO][%'RBLX=,<6F1HK;;:=-:+_. S/34*0?"*.OI[ 9W] M5?ACU9RJ=\5_BL4,M-J33[TDVO^(_P4+K3^0207(4\/N(UX[%E&S98CH1$'; M3$*X:@=&:,-5V#)"=! ZT.E$%F6$7M25)GUB$O%O(30SI.XX872: >[1G4]Y M65&ULA51M3^) $/[> M7S&IQMPE:M^00X0F(!A-4 G@7?RXM -MKMWM[2ZB__YFV]+#!+D/E-F=F6>? M9R8SO:V0OU6"J.$]S[CJVXG61==Q5)1@SM2E*)"39R5DSC0=Y=I1A406ETEY MYOBNVW9REG([[)5W4QGVQ$9G*<>I!+7)'N&^[ MAA!F&&F#P.CO#6\QRPP0T?A38]K-DR9QW]ZAWY7:2$[VZV X&<.W!5MFJ+[W'$TOF7@GJE&'%:K_!:KGPZ/@.E$PYC'& MGP$\)5NS)C&&*9,Z@]X$AH5 MV1]&\"&Y%5CK,)@9G*XJ6(1]FR9#H7Q#.SP[\=KNS1&JK89JZQAZ.+^]'X]> MJ!_/=Y\;= [[W7L8SP\Q/XI]F'E=&ZLH:\/+VA15;F4PYG(+7<>G;\MV#48M$Y+35/"\ OQU8"Z%9]ED-^-J@Q9%.=M+H6E3E&9"JQFE"2#_ M2I#>^F >:)9]^!=02P,$% @ M9Y^5KSV/ <= P 40< !D !X;"]W M;W)K&ULE57;;MI $'WW5XSONKD/R]YU=&QLDYCB5H/(T9?)UB(G8]5S?W6_,XLU6FPVOW\W8!N>HE]E4TLJK4*(X M1:YBP4'BNN<._.MAR]A;@Z\Q[M3!'$PF*R%^F<4DZKEU0P@3#+5!8#0\XPTF MB0$B&K]+3+<*:1P/YWOT6YL[Y;)B"F]$\BV.]+;G7KD0X9KEB9Z)W1V6^5B" MH4B4_<*NL&VV70ASI45:.A.#-.;%R%[*.APX7-7?< A*A\#R+@)9EB.F6;\K MQ0ZDL28T,[&I6F\B%W,CREQ+.HW)3_>?%G?C&3P^+<9SF Z^#X;W8_BP8*L$ MU<>NIRF"L?/"$FU8H 5OH/D!/ BNMPK&/,+H&, C:A6_8,]O&)Q%'&%X"0V_ M!D$]",[@-:I\&Q:O\2;>2L,H5F$B5"X1?@Q62DOZ-WZ>RK; :I[&,O?E6F4L MQ)Y+%T*A?$:W__Z=WZY_.<.T63%MGD/OSV_NQJ,ER?%T"R=4.D7W+.!IND]Z MB]+A0J."C+T:X2$4=.>45B#60,>P%@G=W9AO@-D]T@33%4JKRYZF*2LB.;C.X\4$:9EP$\PQY#4B&">9UD2$[0]OZ"3"PAJ0;-A'=2!AS#$ MP?=K[: #G=KGH.DLA&;)?LNOU_QVQ[E'I>@>28E<0R:D;05DTNH$Y-4B)O>" M$EN@3.$XQ 6T6C9ZN]F&,WJV*CU;_ZSG[7*QG(WA84##9#&A:5RYC':.5[UAL1I> 9"TT-J.TFK\BDPJ01T;V(\&-AM?P7]G MA#O53^ 00(,*6XA@5DVJ="G>Q5Z^4P7W#MI&UL?57?;]HP$'[GKSAEU=1*J/E!H)0!$A2J(E&U M*G1[F/9@D@.L.G9F&VC_^YT3R)A&>2#Q^>[[_-TY=W1W2K^9-:*%]TQ(T_/6 MUN8=WS?)&C-FKE6.DCQ+I3-FR=0KW^0:65J ,N%'0=#R,\:EU^\6>\^ZWU4; M*[C$9PUFDV5,?PQ1J%W/"[W#Q@M?K:W;\/O=G*UPAO8U?]9D^15+RC.4ABL) M&I<];Q!VAK&++P*^<]R9HS6X3!9*O3ECDO:\P E"@8EU#(Q>6[Q#(1P1R?B] MY_2J(QWP>'U@OR]RIUP6S."=$C]X:M<]K^U!BDNV$?9%[1YPGT_3\25*F.() MNS(V#CQ(-L:J; \F!1F7Y9N][^MP!&A_!HCV@*C071Y4J!PQR_I=K7:@732Q MN461:H$F<5RZ2YE935Y..-M_FC^,7V Z&0PGT\E\,I[!Y9PM!)JKKF^)WT7Y MR9YK6')%GW"%$3PJ:=<&QC+%]%\"GX15ZJ*#NF%TEG&$R34TPCI$012=X6M4 MV38*OL9GV=HU:IARMN""6XX&1MPD0IF-1O@Y6!BKZ3/Y=2KUDC@^3>Q:IV-R MEF#/H]XPJ+?H];]^"5O!MS.RXTIV?(Z]/[M[&(]>IV-XNH?_+NR4V+-TI\4. M3$TM@0J.V8)J="@Z,)FZ!9FJ*)XX*EZBJ#F-Q10(2EY8*D%=SN6J P?-M5.: M:Q-)\6ICB-V4Y[@S:N7];%&F2D/./MR7"!?0#D+WJXWXEJ?DK%QALP%A/0[; M)=+ 3="DC78[JLV59>*$YK#>:MY"7 ^);XJ&DMAHC=)"KG0Q)R[#>N,VABNX MC.JM=@.N]E1"R158U-D)T@N(6DUZ%EK@U(W[1RV:H5X5@\A5<"-MV:W5;C7K M!F6+_PTO!^4CTRLN#0A<$C2XOFEZH,OA4QI6Y47#+Y2E\5$LUS2O4;L \B^5 ML@?#'5#] _3_ %!+ P04 " "UGGY6H&*'5F4$ "-"@ &0 'AL+W=O MS,."3]]3TS!A9V"5GM"\SMG.\[5Y_V3LC/*J%4PTO* M,]5Q$JVW]Y6*BA*:$O51;&F&-[&0*=&XE9N*VDI*UE8HY17?=1N5E+#,Z;;M MV4QVVR+7G&5T)D'E:4KDZP/E8M=Q/.=P,&>;1)N#2K>])1NZH'JYG4G<58Y: MUBREF6(B TGCCM/S[A_JYKU]\!>C.W6R!F/)2HC/9C-<=QS7$**<1MIH(/CW M3/N4AT.N_H=?S82PRG2@(LC5=GRNH(,DC M4__ ],&_JG% HX]0]1 M!>:,K!AG^O6R-UHG1I6-5>\[HM&ZZ,'OX2XYI>$V2WA^<,H1_.9P>/MCKFIX M;[KJ?2)[A]4:<*7HZL>BJ_]PT3TNP^4\@/%P,APOQYBQD[ W@EGO4]%0,9>_ M3=W%I=J["GBY]L*$EK1ISK R'U:LO$A@Y\)FC1F!?F0O6(:12+;;&OB;RS!1I1%0"L:E$XW:@)$H.[V(FE<9?C,@K);)HD.9""TTX@IG/O:EK M>UO"7_"P0IHL:5A+;/XC,OL >JP1G:]LD'@@G641A88,&%^?%X/:F,@-0SA.8Q1U/S8Q?64Q_!0;+;9VX%@)C>.+ M728X+U)I'N!]+(0^; S <0+M_@]02P,$% @ M9Y^5NVEF:_U!@ .Q0 M !D !X;"]W;W)K&ULK5AM;]LV$/ZN7W'P@F$# M%%NDWMLD@).XJ[*UA2# 5,\'H]W MY',/3SI[*/BGQLA=J\&@W*Y8=ND[!<[EN/(NN#;1&"7WPW* M'6?)2DW:9@/J.,%@FZ1Y[^),R6[YQ5FQ%UF:LUL.Y7Z[3?CC)Z56" M:7JW$5(PN#C;)7=LQL2'W2W'WJ"VLDJW+"_3(@?.UN>](7EU&4M]I?!;RA[* MQC/(2!9%\4EVQJOSGB,=8AE;"FDAP>:>7;$LDX;0C;^-S5Z]I)S8?*ZLOU&Q M8RR+I&171?8Q78G->2_JP8JMDWTFIL7#6V;B\:6]99&5ZA\>M&X0]&"Y+T6Q M-9/1@VV:ZS;Y;/:A,2%RGIE S02J_-8+*2^O$Y%A???T<"YW6'@U[MH-=E_6)V]79T_>'=""9OX.-P.AW>S&?J9.-AI:C*^3$O4/<4? M(;%-<.F@'\<'KW%_&OYZ$;%#U\,5\>_@OG3>&FEKZE#J?9<.>C9%;1F1&Z& MQK[MQP$* BGH@)Y?0\__:NA-/LQG\^'-]?CFI_KPVM#7:;$=?9.]*$62K_ ( MK3K I)3;T\"/SGA(.)-C&JWE,:C:?+1J# WO&LGF#:ZB 8S'9)#@VOH1YIGE4EM&YYNL0L^B'-=6[\"#52U-"3KN7W M8P)>WW4K>)V $OF-CH5H\E&)HE*%7"DX/%NA!"CM!Q0B+[1]["A)Y&L[LH,Z MO@-N/XB ^HX1HZ39L606H(Y/C_+B.$E4 H#3=S%YG$9.'/=T9'J ]CW2 /Y) M!?TGL.Y <5"C.'@Y@3:@8L/H]]OQ] ^X'LY'@#+LCZ97X]D(;J?CJU$KS#N7 M;(=Y=$7&,='Y0W MU](; ^0#4[]A"[['"@YH:-)3L>*IX4CK??(()%)#KCEW@RS=6).E**33Q/L* M)2=02I[!L0&U::T9VPF] X[F"E]C.7)M%_&D&^OG?<[ T:L%#077-*B0/4)8 MCS> ;EJKWFEC)FPS\S[ARPWFD=%H)N>IWI9Z+L;@ZGB/1S0-5".'5#E<#QW) M$=;)$7YUVJ]C2Z_OR M=HR(%&J!2ZV9*):?H-C)FN90!40>49B2U_;I$YWJ^I=C-+)#W_E"92G]R3*V MLC&=^9JETF:L#[#58E4F4(0L%MS2,G6U!^V5 K5)[-A^Y"(Z)*O6<JXJY M2;.)4(1IMK+BSF]GWZ.ZY-OC?BG-DHIFB62<4W CVR%AZW@DQ\/ =I",#C1= M<;%"#]7<0BNNEHSE^$:#RKJ9(F4I%>18J:/(T91B%02IIF'3UF1=:WFJ #>$ M[BDS-\6]V3VG-B65T!.L/(#@7$RO@QIU#/&;FH+J"L:TUA"/)JN45%%4+TB: ML1V(E7@0>)%)M*>#@8_7T3.$W*#J)X&J820:D^Z-ZT@'Z3IZ)UR\#^4]X9K+ MK54O\O!H]4*FM0Z9?TCZCIR-ZYR-7YBS5Y/WMZ.;V5 B6.(7GT=M^=EI]YD* MB%F<+0LNZQ7-3\MBNV-YJ5\M,?7PF0%G&0KDVV2ADO.>E<*P^S&KR?QLOC"8 MEP))OEWU45O&MD7=N)'&.1HL]B6N6!H6/W+]1-[*E& ;^\0H3)27M?=X!%P)>,$W!M$DH&IGBDI/4X!XT/.EO&[]1G*[QIBGTN]+>=6EI_&1OJ M#T('=?U9#7&.]V0)&5OC5*&UL?551;]I #'[G5UA9-6U2U"0'%-8!$@7: M(JVT MH]'XDAT2YW[.XH[;^?[P*42927Q+[8GS_[;*>S5?J/R1$MO)5"FFZ0 M6[N^CB*3YEARNH MC16%Q"<-9E.67+_?H%#;;I $^X-IL0SO%8WJ/?^MPIEP4W.%#B=Y'9O!NT \APR3?"3M7V'G?Y-!U>JH3Q M3]A6MHUZ .G&6%7NG(E!6?.+"= _.\JT">Y9!;WNMHM07M MK G-"3Y5[TWD"NDN968U?2W(S_8&CY/!:#*?]N?CQPGT)T.X&SW>3?M/]^,! M#/OS/GR;\X5 \[T368KGO*)TAWU38;-/L!,&#TK:W,!(9IC]#Q 1T0-;MF=[ MP\XB#C&]A'H2 HL9.X-7/V1?]WCUS[)7,D5I-?<=TI<9W*%::;[.BQ1A]_9)1[-3',^BG.8XQ5>4&S2UQ3NL=E5X!Z[1=WT&5"";DU((@EL!SS)R M-6A +4%M]*Y949M+F)/=4@D:>&=I??^ H0U#2\3F-,M5)#B*1/6F4-Q9^##O MR+4!='T#=.M8+E#[F]]7H'94@=K8<5,;PV5F?&^X1U+;IW1=>Y:%):29Y9;B M7D S"6-6=T(];+%F;6PT1P$-%K*D!2P)VXTVN1OKLG-\:+>(#'Z$];@)++QJ MM6MS9;GXR.4"DIB%S4:3I%8[9,T$3MUW=#2J5*R57T@&4K61MIK:P^EAY_6K M4?\PKQ;F ]>K0AH0N"37^++5#$!72ZA2K%K[P5\H2S?CQ9SV-FIG0-^72MF] MX@(<_@2]?U!+ P04 " "UGGY6/"\0Y:P$ "N"P &0 'AL+W=OMC=;;JVY791M:$M416\KQ9B5D231^RG57;24EN14JBV[@>5&W)(RWAM>6 M]E$.K\5.%XS3CQ+4KBR)_/.6%F)_T_);+X0Y6V^T(72'UUNRI@NJ'[8?)7YU M:RTY*RE73'"0='73BOVKV\CP6X9'1O?JZ S&DZ407\S')+]I>080+6BFC0:" MKR=K=JD$3P^OVB_L[ZC+TNBZ$@4GUBN-S>M00MRNB*[0L_% M_CT]^-,W^C)1*/N$?<4;(7.V4UJ4!V%$4#)>O2[$':;A1FSE85ZTT@F/<)&6A)=XRE-/#R?UH]B&!-/X5VBE9%E2= M7WR@Y+92$KRAQ _@@^!ZHR#A.*>W#Q>A],GZ8)C"[@W%RE\SG MR=@F*5XLDG0!\?T8II/X=C*=I)-DT03_I(%F^.F&.AI#1%,&/*:4S,-WYI7# M_X HZ1/E.PIGT/-]?/J#P/&CL/WY'*:L9)K8,1*X0>2![T9XBW,!NYXW>N^' M??"COG./@Q5'J$1IO@8L/ 4#-^R'<.'Z4<])A28%K*6A-ZKQ7;\_@$O7OPR= M*57J"AY)L:NPQ"9X!%,";=]S!Y<>G$-[X%X$>+"&FS0&T27T+L+7(3I*C1.7 M0FKV5V4"L\*X)GS-<#:\SBS63<8JKK8?]HSMT!N@Y3F>?XOM1=M-3<62.!?<0IU\K!B/)F MGUT,=5;L8#(R< >#OO/X M;WA-5=A0"_\MP5&=X.B[$SQ/1K/[$0Z&RDFD+-(X?4AG\]]@'J>)#4)R=Y>, MTLEC]?,SY*9 9%G<5C275>THY*)P7.RUP.0MMB'AKNM7K>!=P M_LX>0CS44X]5_]0#6Z_3ZUNVJ!,.#-MH@U,#O>1-E8RE$G7\T KX_4[0,Q)S MJG>2F]_)5HHG9O<^DG_&):@TG0/M"@ @H$M$.=,;#%2[DD=91K M]]J=7N_ $Q@-3>76/=JA2BK7=E-4D(D=U]4Z55/K932N=K!O[-4F^X'(->,* M"KI"4:]S@0-#5MMA]:'%UFYD2Z%QO[/'#2[45!H&O%\)H5\^C(%Z11_^#5!+ M P04 " "UGGY6,92E<.,# #G%0 &0 'AL+W=OO'6C,2*U#F>8%;,?WW(\<^\3N;[CX)M< "CVE228'WEJI_,+W M9;B&E,H3GD.FG\10\,W P][+P"U;K949\(?]G*Y@ 6J9SX7N^15*Q%+().,9$A / MO$M\<47.C4$YXY[!1NZUD4GE@?-OIC.)!E[+1 0)A,I 4/WW"->0) 9)Q_%] M!^I5/HWA?OL%?5PFKY-YH!*N>?(/B]1ZX)UY*(*8%HFZY9O/L$NH8_!"GLCR M%VVVZG+-O^TZ==(?8,2L+)?13INW4<''].1@MIP&Z&:-@<3>97=X%([167$0K^7D[FL^#+'?IC!(JR1/[9]Y6.Q2#ZX<[O MU=8O><,O)FC&,[66*,@BB'X&\'4252;D)9,KXD0<07B"VO@3(BU"''CMJC+M M$N_T#;QQ(3*F"@&(9A$:LR?3ENCK#-('$/^A'VC&,I86:37T6A67(X+3*X+1$;[^1P5SHQ2O4\R7$+;OEMQJDP@[\@X/?TRO\,6RHP6G7T@$3&Q/Y M%4(*VX[B>7F3]\"5XFG97 .-0)@) M^GG,N7KI& ?5W>[P?U!+ P04 " "UGGY6_R\"J'@# !## &0 'AL M+W=O.X%)![9 MNY&6!?%HKU3U@S<9(&IBI[:S;/_]M4U(89=%K82J?L&/S!S/.1Z/ALZ6\6]B M@RCA*4NIZ%H;*?-KVQ;1!C,BKEB.5'U9,9X1J99\;8N<(XF-4Y;:GN,T[(PD MU.IUS-Z4]SJLD&E"<)R=KG*-:!"!RR]',2RTW7:ED0XXH4J9RQ M[2V6A.H:+V*I,+^P+6T="Z)"2):5SBJ"+*&[D3R50APXN(U7'+S2P7ON4'O% MP2\=?$-T%YFA-2*2]#J<;8%K:X6F)T8;XZW8)%1?XUQR]351?K(W']X&H^5= M ),;Z-\O0AB%=\M%^"F >3!6BH . MPX[*8 >[8+U7@G4]&#,J-P("&F-\#& KYA5];T]_X)U%'&%T!;[[ 3S'\TX$ M-/QU=_=,.'YU&[[!\U_!ZU.9Q$E:Z-2&.48%3V2B9 N>HK10C&'%609#EN6% M).89L!4$A-.$K@5,D<-CT)7C6N0DPJZE2H- M_HA6[^T;M^'\I@R(2!7 M$AG+4ZKLCFJ8HW3Y>^SYC:;GN\V._7A(^*6=U_9;GM>N[(ZXU"LN];-;_N.<_HEM"HNK;-< M/A.=]O)LII]%^-V+NQ#8$=EV1;;]5V1Z^Y*"70CL2##7^=FS.'\NU\NSCI*X MUG*;?NU9LI\R])NM]HNZ;Q^T8QGRM>E2!42LH'+7FE2[52?<-_W?L_V![I!- MF_<39M=>CPE?)U1 BBL%Z5PU5:WFNXYUMY L-TW? Y.JA333C>KRD6L#]7W% ME(;E0A]0_6_H_0]02P,$% @ M9Y^5O[,0!SA!@ \S, !D !X;"]W M;W)K&ULM9MK^.^C1--4GUXWL%[6SVJ0.W/S_1/Q8'KP[FA@CJL_1K M$LOE<6?403&=DW4JK]C]G[0ZH+[F12P5Q5]T7[5U.BA:"\FR*ECU($OR\C]Y MJ(38"L"C9P)P%8!W MS>,P%>%>"]-J!7!?1>&]"O HI#[Y;'7@@7$$G&1YS= M(ZY;*YK^4*A?1"N]DEP/E)GDZM=$Q_OCWJ2M4; MS>Q&U9Y/RCWC9_;L8G3&)6?Q.I)HFI?5 M1)^5WTY5(S25-!-_-R6L)/::B;ID?1 K$M'CCJI)@O([VAG__HL[)BT]&WT\255I)GE$D4H+BMGZ1L[7J:J7$5OG4C1EI03V"Z"N M^W?C7K_O.&J0W&WKO=]LL-_NB[3?#?7=?-FM?VLH&!#-D&VQD&UAEFV8KDG UT4N4J*H[3_)$TO>I MJN6QVB!)ODAN4HJ($+1Y, [V1MFNI"^V"*Q=;*LF$,Q0<[A16WM7ELE@6"&DH<; M)0_MYW4>L8PB21[0:7)+TV3)6-RDGQVS4%Y#4H[DDN2H[_R&4AO,M\+:3O&0 ML! (9N3"=>IK:L;V>X-S0<.",\''@[ ][>\;8J0]%,F;>LBVN5.?R^ M3N2CNL*-U'RFIC!TF:IA^^V,:K$;+W#MP+97N*"T )060M',U. Z-1C'YPM(5^N#T@)06@A%,Y-5>V[W$'Z^@+2Y/B@M *6%4#1S*:CVX-CNP?_7 M?&%GMLT.*"T I85X_XZ!ON^]?8O,%+YVY=CNRB?54@:Z)(]$WTS>JF1^L:!) MN8QX]9"9^](ZVR!NGE06@A%,U-:NWD,[^8Q MJ)L'I06@M!"*9B:G=O/8[N;-4XGK4VE%N=Y$%HU7:17OT+@2ZHUV;BDVMAKT M=XR[O6^ME?P9QAW7QAW;C?NT7A$[+5;$IO6*V*18$;.7(U"?#DH+0&DA%,W, M4^W3,;Q/QZ ^'906@-)"*)J9G-JG8[M/OZ+Z\32]AG=?K8*@IU60-)E3M>O& M]?H7J$/T2(GR/0.4%<\,-28%U)Z#TD(HFIF4VL-CNX?_X67_BF];]W^Y26#O M96M-?X95Q[55QW:KWF*V4)>T9ZIEML[L$PBH<0>E!:"T$(IFIJXV[AC>N&-0 MXPY*"T!I(13-?&RQ-NZ>W;A?"ZJ?B-.31>,SBO9HKYPH&A](!+7CH+00BF9J M7GMVS^[96]8R\O!B+;/OL/6SI*#>')060M',U-7>W(/WYAZH-P>E!:"T$(IF M)F?K&6R[-W^IEMFC7==2S& ?KX9]OAK4QG>W7F[(*%\4;Y4(5-QD+-\-V&S= MO+DR*=[7V-E^XG[PR_=/:DSY.LP9X8LD%RBE?E:8E!<# MR@4 ,8D 9 >&PO=V]R:W-H965TA,@C]W22$W@[E9:NZG=[EY,]X5#G,0:8&:;9OWV]Q@HA(9ZC73Z MIN7!YV?[_.'@/V&Z$_*GVC*FR>\X2M1Y9ZMU^K[74^&6Q51U1YSBC7DQYTIE-\V-?Y&PJ,AWQA'V11&5Q3.7]G$5B=]YQ M.P\';OAFJ\V!WFR:T@V[9?I;^D7"7J^BK'C,$L5%0B1;GW!YYF O,6_ MG.W4WC8Q4UD*\=/L7*[..XX9$8M8J V"PK\[MF!19$@PCE\EM%/U:0+WMQ_H M?^>3A\DLJ6(+$7WG*[T][TPZ9,76-(OTC=C]P\H)#0TO%)'*_Y)=T79XUB%A MIK2(RV 80HX")\T1 OPSH/[>'01DP>&[ L S( MI]XKYIXGSJ>:SJ92[(@TK8%F-O+LY]&0+YZ8"^562SC+(4[//GZ^O/Y(%I^O M%\'--7GG,TUYI,@UE9(:"4_(7^3;K4_>O3XAKPE/R->MR!1-5FK:T]"_H?3" MLJ]%T9?W1%^N1ZY$HK>*!,F*K9J '@R\&KWW,/JY9R5>4=DEWO"4>([GM0W( M'NZSL$OZ[I/A_O/#W9;PP!Y^D6VZQ&T-;R2C7TG9SWG])W@W3&F9A3J3/-F0 MA5":@$X$#C-YQ\B/3]">7&H6J_]:!CLOX(-VN*E7[U5*0W;>@8*4$SNSMZ_< MD?.A+>^8,!\3%B#!&@H-*H4&-OKL.]1,HTU(4ZYI9 H:#[EN4\,*.E:- C;, M8>;)<3?K3QS'F?;N]M.,V66 !&ND>5BE>6A-\T489G$64FN("- M]E(\&0Q&CU,\/!!B[ S';K-5@#2P1NY&5>Y&UMSY;*FAS)M* LL!?0K;FD$W MFL#S@)T2I?.TIDR&$!4BPAD)GE4)GUAOFAJ7TWA0K1<0:S$M1^%,J]3V4_V5K[3\[*,3> M\/$#<6'M]MAT8\(")%@CW:Y36P;'FO!YE#%RJZFTUB8[Y-A+'Y7FH]("+%I3 MCCT'Y[YDA2KI6#IATGQ46H!%:^KDU3IY?UJ6BLQ4*2A7=!G!8FJ_5G'6YJCG M=N;1ZGB'3F!TZ 10.PVP:,VTUZ[8M5HZG!6MO8^C92AH9\V%X_"Q"JB^%XO6 M5*%VOJ[=^EX4[P47I?.U/CA0O2\JS4>E!5BTIB:U37:'+_K@0#70J#0?E19@ MT9HZU9;_FZ!2C>FDL6C/%M>=V[:;[ M.]P*3";D(HHX3BZ)X>NV][-T2E&]=U8M.:/7;7Q]NS&VZ?)1FBX!^(T M@W*ER">]LA8I.^_8BQ^5YJ/2 BQ:4YG:@WLOZL$]5 ^.2O-1:0$6K:E3[<$] MNP>?9PJ.*$5H^"OCBAM32!8R?@=C6_,$%BKF:EL+230TV9N2F84Y%%&X$+W^&[.OMA2&8K;* M,@+-KJ@,MZ3O%+^ DW>FI[#L2>P215S'>5.'G'3)_EAHI 1AOU,6:@7=45TV M>_MJXKGC#XJ$5&W7$6BTXU%$EC#$9<2(%L1DA,,JRXS1O*(%/902(<^=^([K M+>&ZH5%^4&0ZCTB8F3_,VO#)6HHX/YQ[^G+B&RFRM-MZ.:.^V\"B%9=S;^\[ MCIC)3?X!#:31O#8J/NFHCE8?Z5SDGZ;TZN;%%SZ@[(:#@!%;0ZC3'<-35Q8? MS10[6J3Y5R%+H;6(\\TMHRLF30,XOQ9"/^R8#JI/EV;_ U!+ P04 " "U MGGY6O>4(F"0& !&*0 &0 'AL+W=O=-FEMP.1GKXV4!KIE:KM>T^ZDF^Z%"VZ"!CBSG625[H\_ MFU"( _$M=\^;-AB>C^VOX;&_X/,-X]_$@E*)?J1))BY:"RF79^VV"!*4 M+6FFSCPSGA*I#OF\+9:.R5QUAJ=YV5W?'3.5C*),WK'D5BE M*>$OES1AFXN6VWHMN(_G"ZD+VJ/S)9G3&96/RSNNCMHE)8I3FHF898C3YXO6 MV#T+<%\'Y%=\B>E&[/Q&NBM/C'W3!]/HHN7H%M&$AE(CB/JWIA.:))JDVO&] M@+;*.G7@[N]7^E7>>=69)R+HA"5_Q)%<7+0&+1319[)*Y#W;?*1%A[J:%[)$ MY'_1IKC6::%P)21+BV#5@C3.MO_)CT*(G0"W?1E?/P8S?68\FP4/,S2>_/XX MO5>GQ[<^NIZ.+Z?7TX>IND2=?[Q1Y6]]*DFE:K6NNQT6+?2W+<0'6NAB=,,RN1 HR"(:F8"VZF[99_S:YTML)7Y: M):?(&;Q'V,%N0X,F]O ;\H(<[V"T;X_V:7B*/#!=KH0J$0*-P^^K6,3YT_OU6I6AJ:2I^*NAB9=;9*<9J5/;F5B2D%ZT5.X2 ME*]I:_3K+V[/^:U);$B8#PD+@&#&N'3*<>G8Z*,)$0NT)"\J)\NFA^;2&G[L M&$#"_/\ 0TWR;SG=G*/GN_6H,QRJ1V;=(&NWE+5KE=4GV9Q)-%L03M'=BH<+ M-'KE\/3@LU$//2+\>E;WULQF'(5S32"8D\)11)AM@FH[QI./JUQ[;G..53NU796MNQ M*D/" B"8H?*@5'D DIS0WZBX=,+2Y4I2+M"UC*S)RUKSL0\)),R'A 5 ,&/X MAN7P#>&3UQ!R7"!A/B0L ((9X^(ZE<=Q_M]BRAY_[# 4M-T4V'6Z S,'^J!U M!E T4^$=%^F"31!VU-%B;VD]VWSC@U890-%,K7&E-;9J?45BCM8D65'$GI&0 M+/R&8B&T_&\Q=MZ[CH>$GD/$NT;YK?2CY<US0=@7N>F[M!@LY\5&94&M;D$S,G2O MMZ\KJ(>%HIFZ5B[6M9HQ/1NRE5IJ($Y#&J_UC-@H,ZAS+6CF#=SIUS(%J"F% MHIE"5[;4M?O2:;962SK&7QKEA32&DX*V*V^GY]9N8U S"D4SU:WLJ&OWHY_E M@G(]T]$#JV904UG0S(EN6,N_H'81BF8*7!E&U^I[1G><+2F7+XAD$:+*-"ZU M0VF4&M0G%C0C(WLU?P)J *%HY@>?R@%BNP/\P%BTB9.D25M[Z+':%C0C#?=K MY@^TS@"*9HI;F3]L-W\/G$04921MG.7LP4?+6[=[[F#H[@:*:\E=_# M=K\WR;\"JTS,:9(OAL4B7C8J#>KL<-W9>:XWW%<:U-E!T4RE*V>'[EVGMO M7]0-%/MROYAN_V[I;)(T?9$ FH$2+;,=Z4],:E6-_G/!57K2*XO4.>?&9.O![J"&ULM91=;YLP%(;_RA&3IE::"B%I-W4$B7RM2$F;A::35NW"@9-@U6!J MFZ3]][,-19G4]&XWX//U^CG@X^# Q9/,$16\%*R40R=7JKIV79GF6!!YP2LL M=63+14&4-L7.E95 DMFB@KF^YUVY!:&E$P;6MQ1AP&O%:(E+ ;(N"B)>1\CX M8>CTG#?'BNYR91QN&%1DAPFJ=;44VG([E8P66$K*2Q"X'3I1[WHT,/DVX8'B M01ZMP72RX?S)&'$V=#P#A Q3912(?NUQC(P9(8WQW&HZW9:F\'C]ICZSO>M> M-D3BF+-?-%/YT/GF0(9;4C.UXH<;;/NY-'HI9](^X=#F>@ZDM52\:(LU04'+ MYDU>VN]P5."?*O#; M]R-QM9R@E1) P$/X PV5K-+&RKMEK#T=+\E$0)':6Z M3H7)^&8Z6<^G<#>#U71\]^,V_CV=P"R*5_ 0S=?3Q$2B))G>)Q"-?Z[CE0Y' MMQ.8Q]$HGL?WL4[1\?5"^\\FJ AE\AS.ED1@J7)4-"7L/'"5AC5;NFD+-FK M_!-@"_(*7O\+^)[? YEK-?FOB*L[[=KUNW9]JSHXH3HAY8XK&/.BJA4*"7.5 MP>,"BPV*/^]!?BAG)N9:5B3%H:-'0J+8HQ-^_M2[\KY_ -OO8/M6O7\"=E1+ M[9$2HO2YII+:8_PXUSZ(%1;R7>#^?P >=,"##[_NC% !>\)J!+X%?7;3)Z!2 MUIB]^P<;X$;RRDJ:*V0?^K[7\_J!NS]&<8_.N+DN%D3L:"F!X587>A=?+QT0 MS0@VAN*5/?8;KO00V66N;RT4)D''MYRK-\-,4G M?E8XIM9FK@@ ,U> 9 >&PO=V]R:W-H965TW M2&:D,!9Z\K)K*YR/='Q C F M)]%.AME/[J(X<-/L;;P9)KM8NNLB*/"'U# FP\#UPL'BK+AV$R_.HGWJ>Z&\ MB4FR#P(W?KR4?O1P/C '3Q>^>)MMFE\8+LYV[D8N9?IU=Q-G[X8U9>T%,DR\ M*"2QO#L?7)BGPIKG <6(WSWYD!R\)OE'N8VBO_,WU^OS@9&O2/IRE>8(-_OO M7EY)W\])V3J^5=!!/6<>>/CZB1_X>W3K?G@]F K.6=N_?3 M+]&#D-4'&N>\5>0GQ;_DH1P[M09DM4_2**B"LQ4$7EC^[_Y3_2(. BA](8!6 M ?1YP/R% *L*L)X'S%X(&%4!HV,#QE7 ^-C/,*D")L<&3*N Z;, <_1"P*P* MF!7?;OEU%-^E[:;NXBR.'DB%DB1]W(_&YQFNS#1,;W+\P3NCD;'C?(:UQ M+:VQ7EKN8Y8CIB2-R.Y)90<2>_%V<%EBQP>+L<;FS#",>CVE:K33]U5->]*1 M8=+6I YR4H:$<21,@&"*<":U<"9'[TFE2M[K=B(MK.].A(392)B#A#$DC"-A M8M*U$UG=.]&T%M14*Z@ZQW*;'"N35!R1XMDY>X2]E^%>=HE+"^XK+B3,1L(< M)(PA87S:VI?G=&P8K8U9@&95!#:K!3;[7P(+94J\NZXU$[1 M5VI(F(V$.4@80\)X"9L<2,TT9EU2 \VJ2&U>2VVNE=JG6DI=&M+&]M40$F8C M80X2QN:M'>8GTYK,S-;WSN[)4<_HK3LDS8;2'"B-06D<2A,5 M37V G$Z['R#-QJ4WM2[LHKJ;7D7!;I]FRB(?TK7^W@KUZ*$T&TISH#0&I7$H M3:!HJ@8;J]X$4[?%*EQJ3+RD#-JTJI#+ID!)H5E5*C<=OZDW^*D-;Y@4C4I>0+C:QE$494INL06U^ M*,V&TAPHC4%I'$H3*)HJQZ8B8,[>(%F#U@"@-!M*M>PH;,Z4!J#TCB4)E T]1QK M4V*@^A+#[ZZ_E\0KQ-4E)GUX7S%5M,,4A!JS42L'L:'3.E :@](XE"90-%5- M3=6 :MW@Q96;;#M5!"T,5+3#+6ELC-L'RVSHM Z4QJ T#J4)%$U54>/Y4[WG M?^,^NK>^S \<1KG]WZDHJ.5?T0[WI:ZG;!LZJP.E,2B-0VD"15,%U9C^5&_Z M?Y'Y'T]YX:8\UQ-G>51537(WG8:%GM=;75#3OZ*IA9'1_-GQUJ-&,>C*.)0F M4#15,XU)3[7FZ]$V1):*?PY"[QOY3:ZV8>1'&R_+SW4FA7[BWN*".OE0F@.E M,2B-0VD"15/%VCCY=(PW*2C4XH?2;"C-@=(8E,:A-(&BJ3ILR@!47P8XWJ30 M@WJ+#UH2J&C*\X79^@.2HT8QZ,HXE"90-%4LC=%/]4;_J]8#U,R'TFS:/LX^ M[7IB<*J!IGEH>5C3D3%N2P5JPD-I D53I=*8\%1_+K]',G;LF5G]C+W5!;7H MH30'2F-0&H?2!(JFJK2QZ.G\#;(PJ%L/I=E0F@.E,2B-0VD"15,;$32>OJ7W M](_/PO2@ON*#TNR*=IA?C>:M^^M1HQAT91Q*$RB:*I;&LK?TEOUK69@^O+=$ MH&?Z*]IA%F:.K'825HU3DK#19-Q.P:#+XU":0-%4G32FO*4WY7ND8+W/6.NG M[JTQZ/E]*,V!TAB4QJ$T@:*I MHHQ@-64$2U]&J'?*7>RMY"ME)SVKM_Z@E8&*IA:4QN;S.^TQHQAT91Q*$RB: MJI?&R;=>;;;S:NU;C^@M$ZAQ;[7[[W3Z8M!9&93&H32!HJF":BQY2V_)OX%U MII^QM_Z@WCV4YD!I#$KC4)I T525-K4 :_H&Z1JT0 "EV5": Z4Q*(U#:0)% M4W78%!HL?:&A7[H&+2% :79%>RU=.V84@ZZ,0VD"15/UTEC^EOY4_DTMD+S) M75R?,ZN\UVP3N]O[_B-9>_X^E>N\N[77[<1"RP!0FEW15)48+2T=,XI!5\:A M-(&BE5H:'O3"#F2\*?JB)V05[<.T;"M<7ZU[KU\4'<>?7;?-4\?LN,[,4UYV M5F_P9:/WCVZ\\<*$^/(NF\HXF68I:%SV3B_?I-&NZ,1]&Z5I%!0OM])=RS@? MD/W\+HK2IS?Y!'4'^\5_4$L#!!0 ( +6>?E;_,0IAAP( &<& 9 M>&PO=V]R:W-H965T$E_[GN-S;N+K>,O%DRP M%'HN*9,CIU"JNG!=F1508GG"*V!Z9<5%B94.Q=J5E0"<6U!)77\P&+HE)LQ) M8CMW+Y*8UXH2!O<"R;HLL?AS"91O1X[G["9F9%TH,^$F<877, >UJ.Z%CMR. M)2L5]9[]K+$DM(.?U!MF"MH"2L>>/GM@Y[ "]\ ^"W /^C@* %!-9HH\S: MFF"%DUCP+1(F6[.9@:V-16LWA)FO.%="KQ*-4\D\O9Y.%K=3='>%QFEZM_C^ M,$>S:3J]>1Q?ZNG#"2A,J#Q"QV@QGZ##@R-T@ A##P6O)6:YC%VE=1@V-VOW MO&SV]-_8,R7U:=Q5H,]U0Q59*M,4-HD?!N%9[&[V[?1DG7K^>9?U M0F?8Z0S?U7D+4B),=:O!+ .DFQ;*>;U4JYIVZOLD-ZS#/3''812]4MR3-.R7 M&W5RH_?+RA6F?65%APS449_2Z-^R!6?GP2NI/5FZN,$KM>Y>&S M^!L6:\(D MHK#2N,')J28035MK L4KVQF67.D^8X>%O@E F 2]ON)<[0+3;+J[)?D+4$L# M!!0 ( +6>?E:X9!!#TP( /0) 9 >&PO=V]R:W-H965TUT$D2*E6J6^B:_=AV@>3'& UL3/; M0/?O=W92#RJ(V@GM2_SZ/+[G?!??8"/DHUH":/*49UP-O:76Q:GOJV0).54- M40#'E;F0.=4XE M?%1)H:D%YYH=!T/5SRK@7#>S8 R"#!)M&"@V:X@ARPP1FO&KXO3CGT^AY)84Y7F9Z*S5>H]'0,7R(R9;]D4^T-/)*LE!9Y M!48+V.3"?QY.)A-+Z!S6,IY!TB"MY@D) M@S#<8U#\>GBSQIR6\W_+\K4/\#FWU?FHEL+D^:DJ: )##Q-9@5R#%[U_U^P& M7_;I.Q+9CMJV4]NV[*U#T5;%T FY%AJPN124*T)Y2LX9ISQA?+$37Y=(0"XT MY&JO8]K'=,R1R'8^_QG;OF(XY$MF.8_K. M,?WCQG8MW5N5]_ZC.R+_6)^C"5- M68'\I2GKH2LJ%PSC(8,Y4@:-'F:G+&N,3*+-A)7.(%3$'=E[="S^R.)2,%,$DX M0P+F0^O4/1E%)KX.>"!0R;4Q,DYFG#^:R54VM!PC""BDRC!@_5K!""@U1%K& M4\MI=2D-<'W\RGY1>]=>9EC"B-.?)%/YT#JR4 9SO*1JPJM+:/V$AB_E5-9/ M5#6QX ?@M0#OHP"_!?BUT499;6N,%4YB MP2LD3+1F,X.Z-C5:NR',G.)4";U+-$XET]'E^?C^^SFZN4!7UP_GUWHA\ M]POR',_K@8\^#G??PFWMN3/N=<:]FL]_A^^*K8 I+E[0F,B4])@EB!E7S^Y$;.MSZW_XGLC7>_\^[O8D\F MN-)W2($@F/:>9 ,/:[CI ZLD"HYC>[5N8#OFZ#CH8M[H"CI=P4Y=_\Y$7S5] M#KI7J#YY#4NTEEHWK6!#W\Y4_05&.VH;=A["G1XN""/Z<\S0@O-,HGT*4B), M=;?$+(6#/COAEIW(&?@;=OJ"(K>_WE&G-=JI]8XK3'6MFZH3Z+T+T?8Y#[QH M0]UV4'0?E9NJ#5T[@, #X4 9 M >&PO=V]R:W-H965T) 6^ M:5M6QPP(#8UA/WDWY<,^BZ5/0YAR).(@(/SW)_#99F!@X_G%'5VNI'YA#OL1 M6<(]R,=HRM7(S%#F-(!04!8B#HN!\1%?C&Q+)R017REL1.$9:2HSQG[JP=5\ M8%BZ(O#!DQJ"J)\UC,#W-9*JXU<*:F1SZL3B\S/Z94)>D9D1 2/F_T?G?4"/ M]V/T[NU[]!;1$#VL6"Q(.!=]4ZI2-*#II=-^VDYK'YAV#-XY!K,(9_O<$=Z^\JX@V!E=K@9&UPZM"S M-B3\X9G_&?J',U&YR+5PQS)_!1BJ(=W*2+=J25^#$!?J./'B(/:)A+DZ!=0, M'B7ZG*EBO<5K)WCZF%P//V#+L?KFNDAG&]4I1MFVY611I6+;6;'M5ZW0+$IXK;9!L: BNUH9NUH=OLJ=+=$V2ONZ/9_9!6KU"Q2]006(D[MG(;8)U0JREX0YUH M"JWN 9''N6W"M'QB.6!#%$O@+C]9ZM*/7 MZ11>!>=F!3NGE&RCWJ4IM'(K<@N#ZSW,\9+==R>]KKLKV?T@W&E;!S2;6QA< M[V$N8QY2Y0P@J?:2/NGG^H.V'O'HQ6H(K+Q"M^Z>)&UGU]!6!;5;!V2;NQA<;V.^PHIZ_I^$6HMQ].HTA%9FG!LBW#NE M4!MU1TVAE:\'$+VDH MD \+E66=NRJ=;R^KM@/)HN2^9\:D9$'RN (R!ZX#U/<%8_)YH*^0LBO#X?]0 M2P,$% @ M9Y^5E(&DW]S @ N04 !D !X;"]W;W)K&ULK51-;]LP#/TK@E<,+=#5L9UF0^<8R->P'MIY:;MA&'90;"86 M*DNN)"?MOQ\E.U[:)<4.N\0BQ??(QXB,-U+=ZP+ D,>2"SWT"F.J"]_760$E MU6>R H$W2ZE*:M!4*U]7"FCN0"7WPUYOX)>4"2^)G2]522QKPYF 5!%=ER55 M3V/@ M!7QCL-$[9V*5+*2\M\9E/O1ZMB#@D!G+0/&SA@EP;HFPC(>6T^M26N#N>;S]#J.;=\F>3:_9)-$SO X*S61I8M M&"LHF6B^]+'MPPX@&!P A"T@? GH'P!$+2!R0IO*G*PI-32)E=P09:.1S1Y< M;QP:U3!A_\4;H_"6( J&,J[)-56* MVDZ?D'?D[F9*CH].R!%A@MP6LM94Y#KV#19BZ?RL33INDH8'D@8AN9+"%)K, M1 [Y&>@B;_#@]>*2?JNAHYONA05Q6. MF3)/IR3E5!B";2*SAYI5^/X-^3E::*/P ?_:U[J&N;^?V0[UA:YH!D,/IU:# M6H.7O'T3#'H?]\G^3V3/FM#OFM!_C1V;BJ09HVYY64#8 [Y=2FJUA M$W3;.OD-4$L#!!0 ( +6>?E9 L*\?SP, *P1 9 >&PO=V]R:W-H M965T@+D2BT'1)KJ])N M%],N3&+ 6A(SVY1MOWYV2/,!(0,MO8$X/N?Q;WTGOW MS._1M8A(@N\9X.LX1NS7)8[HIJ]![>7& UDLA;JA^[T56N I%D^K>R9'>HX2 MDA@GG- $,#SO:P-X,82> M\1!'D4*2/'YDH%J^IG(L7[^@7Z?!RV!FB.,AC;Z04"S[FJ>!$,_1.A(/=/,1 M9P$Y"B^@$4]_P69KVY'&P9H+&F?.DD%,DNT_^IDEHN0 [0,.9N9@'NM@90Y6 M&NB661K6" GD]QC= *:L)9JZ2'.3>LMH2*(>XU0P.4NDG_"GPX]7HZ?)%;B[ M!C=W=Z,OX\D$#&Y'8'S[.+B]&5_*J<%T>O4X!>]&6" 2\??@##Q-1^#=V_?@ M+2 )>%S2-4=)R'NZD)04L!YDRU]NES&&1!'X^@G',\QJ MJZ81XM2J:0FL$JV;1^N^9O>X;>:A);!*'CIY'CK'%B58,,IKWXN=O7J#KF.; M.U599V4[5GU5>CD_KY'?(T,A!K!N'G#W-0NSVV8> M6@*KY $:Q6YO_'MI9ACEJG--S]XIS;]951F6] AL;>O)H,H4;-OQ=HGN6UF> M>Z"'8"$58.,.[ ]3<889>,!1RI OR:JYH9H13ZVDMM"J\1<2 5JOV52P48&< MG(N6T*JY*%0(/%J&-+35OL2 3L?L[I;KW\RJ' LI INUR$F-Y>QS,#KN[NY4 M8]9UW0.2#A8R C;NSBJ;\E@GSWEK%(%[)H^L3/QJ;JQ6M4-;:-7P"_4 .Z_: M6(WBY.1W6&NL+-/<*5:]=)16WS$^(;8@ M"0<1GDLWX[PC_=GVT\!V(.@J/5W/J)#;07JYQ%)?,64@Y^>4BI>!.K#G'VC\ M/U!+ P04 " "UGGY6JS3Q/*P" #@!@ &0 'AL+W=O2^)+9\?%BTP %'I-62:[5J+4^L:V99Q M2N0U7T.F5Y9_ MZ;?-_GS#,X6=/!@C4\F<\Q<3!(NN53.&@$&L3 :B;UNX!<9,(FWCUSZG52*- M\'#\EGV4UZYKF1,)MYQ]I0N5=*V6A1:P)!NFIGQW#_MZ'),OYDSF5[3;[ZU9 M*-Y(Q=.]6#M(:5;O^.1P(,'Y'@/<"G/LN0+G+ 5'$[PB^0\+LUMG,("\U M5VMS-#,O)51"KU*M4WYX>S\JD7 MAL,HO$*C632;ZO#Q:1H%WWM1\#1&PV^3X3@\=]0M'^!U' XBO4:-^A7 -8S0+!^CRXM/?:6Q=9%DI+BO%>=[& M.WGO.%_L*&-(VT)!IDBVHG,&J"6I4#FYRAS#K5]W ML=.QMQ6L9LEJGF,UJUB%RCU@M1UP[E5J'< M_T=Y)*A!5P-81$&/&ULM5AMC]HX$/XK5NYT:J5V M$P>6ESV(Q,NVAP3;56FO'ZK[8,( 5N.8VF;9GOKC:R?9A.P%[[$;OD#L>!X_ M\V3&F4QOS\4WN0%0Z)Y%L>P[&Z6V5ZXKPPTP(B_X%F)]9\4%(TH/Q=J56P%D MF1BQR/4]K^4R0F,GZ"5SMR+H\9V*: RW LD=8T3\&$+$]WT'.P\3'^EZH\R$ M&_2V9 US4)^WMT*/W!QE21G$DO(8"5CUG0&^&N&.,4A6_$UA+P^ND7%EP?DW M,Y@L^XYG&$$$H3(01/_=P0BBR"!I'M\S4"??TQ@>7C^@OTN9L1XS&J?_Y#X3 MXL MXX8^)F!_]B@><2@D1DT$D=39HE;8Z)(T!-\CX19K=',1:)-8JV]H;%Y MC',E]%VJ[53P_L.'\9?)=(H&-V,TN?DTN'D_&4ZOT6 ^O_XT1Z_&H B-)+HA M0A"C^&OT%GV>C]&KWU_W7*49&!PWS'8;IKOY1W;#/IKQ6&TDNHZ7L"P#N)IZ MSM]_X#_TK8AC""]0 []!ON?[%81&_]\<6^@TCR8*F/RG2KT4O%D-;C+Z2FY)"'U'IZP$<0=.\,=O MN.7]6>5Y36 E'9JY#DT;>C!A6T*%3G>%P@T1:Y!5[J88EPF&.6_N J_GWAWZ M8%M1(G:9$[NT$ALP+A3]ER1G"-SKTU!"%;44I76P,6YWNY[WF.!_US6TA(?K M2C1;.:U5%2?43J(=A)6NPA%.J(J-6P]J:%M18E<.R?7MI*;Z2!G.X:^ MSH M0%1&LA7AU$BN":SD;"=WMG/.C.[4J4--8"4=NKD.7>M#SW2($AUHH0,Q M.KPIPG15F4YV[ ;Z 414A??(:OA,E[%7O!R]DR(=_41/Q8,E)^R;G1H,=:&5 MI3FH&_ Y\R)#KTN+FM#*6OB%%OX9<^,)M@:PD1S,C]D^\! M.\3)S_D<-0TNBAK15NGMTA[+^E \6W2OEAPI3A++C= EB#, GU_Q;EZ&)@-\@Y8 M\ M02P,$% @ M9Y^5KB6!',N P V@8 !D !X;"]W;W)K&ULE95M3]LP$,??\RE.V8- 8DD:Z,:@K=0'JE4"5@';7DQ[ MX2;7QL*Q@^VTX]OO[*2ADPK:WK1^NO_][NR[]#9*/Y@'_C.<6-VQN B62CUX":SK!_$#@@%IM8I,/I;XQB%<$*$\=AH!JU+ M9[@[WJI/?>P4RX(9'"OQ@V_FSS\BT'2&"2>NW;D*2?,LD%/JPUH=YK4W,"'ZJT)CDMW M*7=6TRXG.SL8WUY.9O4=#&\F<#6[N82O4VAV#R=H&1<&;IC6 MS*7Q"#[ J#(D9@Q,N60R11BN-")=F(6?UU@L4/]RIS3/5@@C)A^>E]\"EW#- MA:"+,;W(4B .)TH;Z%$-G;P ?#;W00.WQ[]+1-1'MID)&TR M$J][\H+N%,6IBSE@MLG^.DW9A8+\VL?;:UZNE_5E=6Y*5F*_8#J MQJ!>8S!X_Z;S,;YXA?FD93YY3;UE3FOFY9:9W@@OJ@(62I,BERM(&4'0UKX( M:A^=.N&ND->#L[#;B]9[R$Y;LM-7R>:H4WH,5-J.KXFL=X3/5K4LU+UR#V$;VN?9_C 9.R8N)O62IA MF[N 2VH]8!78'"&C GH"MD;M$K)@PI<,D56R9#P#EJW=B@'JG,8RF;DKJV2& MVIN/ID,X3%515A8S<.T,"B5M3IK4E+@Y.N &\-&Q- [?OSE+DOABKJF'PBUA M^87.A?/Y@[H@U2W3*U57YDTX#*$4E8%.V'UW7 ^?72P1G\7=I;QS*L[+-J = MZH,FN'#?ZXYV6I7K^E3**RX-"%Q2CN/P$Z59^"!'S280H+#I:U[QPS0201/SR8<.VWI&4,B7D239NYAW-D"N" &9< M4F#Q6$,/@D RB77\RTBU?$X)W'Y_9;]*Q LQ4\R@1X+?_IQ[':VIH3DL\"K@ M([*YADQ07?+-2,"27[1)8QLB>+9BG(096*P@]*/TB9\S([8 9NT=@)4!K&,! MU0Q0/190RP"UQ)E42N*#BSEVVI1L$)71@DV^)&8F:"'?C^3_/N94C/H"QYUQ M[[KO/@SZZ/X*W=U/^F,T[/[I7@[Z9VC4'W0G?5=TC"8W8N#4!8[]@/U %?0P M=M'IR0]T@OP(33RR8CB:L[;.Q9(DL3[+IK],I[?>F=Z%V3FJFF?(,BRK -X[ M'FX6P-VCX69C%ZX+'W,SK=Q,*^&KOF>F1RBO3("&R(4I1X\#$8!N.(3L;Y$W M*5NMF$UF_ 6+\0PZFDAI!G0-FO/]FVD;/XN<4DGF*B+;<;&:NU@M8WH)B:QN:\=J5=OZ>MN3PQB[N1?CEB[FBU)KN=1:J=0! M,":RG%*(.(K%YA&EL$AKRF*7:CV,J;:,/:VEJ_FBUGJNM5ZNE43+"I>Y42*T ME*)X@:@H&>H?&^9^8:X/S;!S,^Q2,^[$[D;#='.C6TQ%%7V\A7 *M+!0E))] MME"H)',5D>V8V,A-;"@MMPV5+JHD14!R8R_*IE.^S.T$EF:N(;,='TW@[#!I* M,RJC4V2D4C97%=NNE5OG:E-%6F4LV_E@FON?]H(@R][_G!4$->K[F:5OW13D MO4Y\>I9^Q% "X$RSAL"3M.K4MK@)$XN#U/"Q54D>?7$]1*H#!#C"R(49@UY M'\DOK,Y_4$L#!!0 ( +6>?E9C;T_VP 0 )H= 9 >&PO=V]R:W-H M965T)@526%!HW_#@&^GQLA :Q)%O$[ MNO\+R@<:2)Y/HS3_B_9%VV'/0'Z66]!_1= O!?WW"@:E(']TLWCVW#B7<#*;,+I'3+86-'F0NY^KA5]A M(E^4>\[$W5#H^.S.NYX_>"Y:SN\>OJ/;OQ^\>W'\?7YY[:'/+G 21BFZ)8P1 M&= OZ Q]NW?1YT]?T"<4)NAA2[.4)$$Z,;D8C62:?MGS9=&S_4K/&-W0A&]3 MY"4!!!WZQ1MZ6P$PA0V5%_:+%Y>VDNB"?XYZ^"NR+3SL&M"[Y;;=(7??+\<= M;M6+T'4,!2P00Z3,\[C;#0Q'^O>'K? 5K.)IVE$#<<&E6,# MI6.WE$.*=N29K"(0\UI$. 3BG/$0.E.6$G>J?07,J9ECCWLM X_;.*-6&T_3 MH!H..I6#CM+!>9)D)!*IOGSUQ#P *!&VOKC:Y:(2>:J+.F&N3IA7P+!5"YYU M;@T'5?@:C@\KQX=OOK-H6;ZR-X2)6?;'#<0K8)UY5PD[U6N=,%]RF M;[=G/.70/V@,M@X+>DM_QBZ9[5R&1^.61^K.3WT?M=(\7;2F\;5*"BN-SW-# MF*2<9:*2YE_1FL&O#!+_&=$UV@$+:1#Z,@KR=F<4U!TX%HIEQ1,]=U9+2O') MD=%)\W31FI&Q#Y&QE<8MQ23JASOQ593F=Y>K]E&.:'_:"W5')YNLD^;IHC5- M/M2+6%G[S.:^SS*1A*O$HTHW6JO%DE9/RD/_1TT9I6'^I K"X$&TO$ M,_E/F!BXC$ZJKS8ZO&@CFN M+QK;!FDM*;72/%VTIN6'JA(K*R0=ZT5U!V^L%[56EEIIGBY:,S*'XA*KJ\MW MKA>/:\KVI[]0=W2RR3IIGBY:8;)9VX.*@6WRS;\4^31+>+$%4UVM-ACG^;9: MZ_H"7[C%-N$!4^Q:WA"V$=\+BF MD-;Y4%C/BHW XH337;[3M:*&ULK59K3^) %/TK-UVST62U#VB+ M+C11P&BB0@1WLS'[88 +;6P[W9D!]-_O3%LKE8J/] N=QSUGSKF]0V][3=D# M]Q$%/$9AS#N:+T1RHNM\ZF-$^!%-,)8[<\HB(N24+72>,"2S%!2%NF48CAZ1 M(-:\=KHV9%Z;+D48Q#ADP)=11-C3&89TW=%,[7GA-ECX0BWH7CLA"QRAN$N& M3,[T@F461!CS@,; <-[13LV3KID"THA? :[YQAB4E0FE#VIR.>MHAE*$(4Z% MHB#RL<(NAJ%BDCK^Y:1:<:8";HZ?V<]3\]+,A'#LTO!W,!-^1VMI,,,Y68;B MEJXO,#=D*[XI#7GZ"^LLUG$UF"ZYH%$.E@JB(,Z>Y#%/Q ; ;+X!L'* ]5% M(P]'OW5WU M87 .@_%%_Q9N!N/^"(:G?T[/Y/)^#P4)0GX AW WZL'^W@'L01##V*=+3N(9 M;^M"ZE!L^C0_\RP[TWKCS!Y.CZ!A_@#+L*P*>/?C<+,,UZ7[(@56D0(KY6N\ ME0*?,G$X1A9!#R<"[J]D %P*C/C?*G,96[.:35V[$YZ0*78T>:\XLA5JWO=O MIF/\K+):$UG)>*,PWMC%[HVI(&&5PPQFIS#U/[#R3-.QW+:^VI1>$668SDM4 M25.ST-3D*.9=USQC& A+Y8N1=KY*8L3@EB;9KO9*X'>7:JF:J%-J%0GNW M0AHO(*V6&RJ0PY \D4F(52+MK>-M^Y7"[1#+:3K5"IU"H;-3H=+U+ M&*+.) M,Q@MDR0,D,']-4839)6EO9/WLZ5=$UDI!6Z1 K?6.^W6:;PFLI+Q5F&\];4[ MO1-6+0JJS+6V"]9J-JH+]K@0??QNP187"0;"?Z=,=[)]]FW51%8R;AHOGU^C MUD+-Z6KR7A=;V?Q&[V%^K5ASW'M?H(HP]]AJOBI&?:,[4JWI-6&+(.80XES" MC"-7XEG6[64309.T89I0(=NO=.C+#AF9"I#[?E8FB()0KP( "<) 9 >&PO=V]R:W-H965TV@?;? MST[2#+HT:RN^8%_[GL,YUW;L8,OX@X@!)'I,:"JZ1BQE=F::(HHAP>*499"J MF27C"98JY"M39!SP(@-CH$6L,1K*N_8]A)*/Y[FBQ@5^2_:EKF6@:*UD"PIP4I! M0M*BQ8]E'78 =NL5@%,"G+<"W!+@YD8+9;FM 98X##C;(JZS%9ONY+7)TO+F=#M&X][-W MKI*.!R QH>(+.D&SR0 ='WU!1XBD:!JSM<#I0@2F5*HTMQF5"LX+!NQ:-9.]=BP.1[?GV*M_>03>A=TCC!R+;,^Y7QOW&!5>'V*TS M6*#\O3WHM9T7>["1^X/*VY7R]O^4M^J4M_]1[GDO9#<2?U!VIY+=^=BI[[SI MU#>2OU>ZN7.-Z2?$->8KD@I$8:GHK=.V4L.+:[D(),ORFVW.I+HG\VZL7C+ M=8*:7S+UY2@#?5E6;Z/P#U!+ P04 " "UGGY6,E7"E:$* "^F@ &0 M 'AL+W=OA^&O8F5&HXXT2V(' M$N@ 4HN?GU4ZNUJ-]H4A!XB:Q*SMP%2:#[]V" E.S(E=W?NF$/"YSG%L_W#L MOT_/G]/L6_X@1*'\-9\M\HO>0U$\?NSW\]L',4_RH_11+,K?W*79/"G*E]E] M/W_,1#)9-9K/^MI@,.K/D^FB=WF^^EF<79ZGRV(V78@X4_+E?)YDWS^+6?I\ MT5-[KS_X,KU_**H?]"_/'Y-[<2V*/Q[CK'S5WRB3Z5PL\FFZ4#)Q=]'[I'Z, MAUK58+7$/Z?B.7_SO5*MRDV:?JM>.).+WJ :D9B)VZ(BDO++D[@2LUDEE>/X M[QKM;?JL&K[]_E4W5RM?KLQ-DHNK=/:OZ:1XN.B=]I2)N$N6L^)+^FR+]0J= M5-YM.LM7_RK/+\N.RQYOEWF1SM>-R]?SZ>+E:_+7^HUXTV X>*>!MFZ@M6TP M7#<8MFUPO&YPO-- T]YI<+)N<-*VA]&ZP:AM#^-U@W';!J?K!J=M&YRM&YRU M70=U\+KE!JV;;#;V[M9^=UCJZ^96=[?W^TU>-[C:>HNKKYM<;;W-U=>-KK;> MZNKK9E=7V[W_+2?Z;\G/M]7F_*$=4N?W;=>^?7WK7WNG]6CP>*>KP-T4;:)KR MQ[6N?/CY5\59%.)>9 WE3R9VN.+4%9\BY3\O[ MUX2Y7?:N&B9YO[PN^UA;U&^_VK)=(^C"''KWPBY[?]L5C;H< X=&&'AN_M10]I5OSCJ\CFBBYN"N5/OUQ <0HQS__3E'@OVG&S M5IT@?LP?DUMQT2O/ '.1/8G>Y2\_J:/![TUY1V(ZB1DD9I*816(VB3DDYI*8 M1V(^B04D%I)81&(QA-42;KA)N*%,OUS%VK0,S)(NE/*,3S3EFM3HFFLDII.8 M\8)5'TQ*K?H\_G0Y.!J,3\[[3V\3B^S3(C&;Q!P2W_T9^/ZX)V7153US3+#8ZV^D$L.RB,QG\0"$@M)+&K82B>#P4Y>0#W6 M\N)DDQ)>2>;I M2H/!+S22P8 M[9^8J,/1[KL1DGU&)!9#6"UNQINX&4OC9G5)>W6JI,RJY&F*%ZG0-5Y(3"UP:?WOUT+VQK232IW3CM1T5#-0S40U"]5L5'-0S44U#]5\5 O66OUR_7BO MDB!$>XU0+::T>HYIVQR3EH#^T"U".=DYT-!B=%0S4,U$-0O5;%1S4,U%-0_5 M_+7V]A;(\?%N 5HGR&J1:@64UH]SK8EYZJ\YMP7R_E4^9PLODDOLLF5S@F& MEIVCFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!936CWIM@7MU8/?Y#6W8S3R M2$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"VFM'KD;6ORU59%^0<>*)0C MG8/NI+%6X%3;>6I&;[N@@8[/;-NMA79KHYJ#:BZJ>6W?8!_M-D"UL.U*1&BW M<8MNZU&P+6Q7.U2V-Z8 6L>^UFK/S:F[G_+U5DL9Z,C,ACZUCHO5_Z63!WS66YVCH(7K?9(Q6X.'%S$0,=D'N[00CNT4'CX$=IA+.VP?M1OR[E5>3UWVX=QY4SG UT^J.-W'WK5 M?[BE@:Z!^HY$CGH%,;+[(?[]Z@:KF<@8[.;-FKA?9JHYJ# M:BZJ>2W?7Q_M-4"UL.4Z1&BO\>%>ZR&@;4- 7E)M)X]I,IO.#YV'_*.&T\O1X.=68:NY+UUSC!2,U#-1#4+U6Q46BW/JH%J!:B M6H1J,:75XVE;):W)JZ0/ED:NV]>FT=^M![N2=](YE=#9R%'-1#4+U6Q4 MDU=Y7XO;928F2IRE\VF>I]EW)4P/%)_*RQMET<3M]3&:2J3OE1->80S4=U0Q4 M,U'-6FNUB2*TO6?R;;13!]5<5/-0S4>U -5"5(M0+::T>GYMB^>'1/&\'.F< M8.ALZJAFH)J):M9:.ZM5)*BGNP&&EN&CFHMJ'JKYJ!:@6HAJ$:K%E%8/,&T; M8/+"_S?Z8W(L@R>ZGBUR9B;N2'QR- MRYT_F]X_;%X4Z>-%KTS5F[0HTOGJVP>13$16+5#^_BY-B]<7_=)_3K-OJSXN M_P=02P,$% @ M9Y^5@SWK;C2 @ ,@@ !D !X;"]W;W)K&ULK59=;]HP%/TK5E9-K;0VWR'M(%(+5" QM2IT>YCV8)(+ ML>K$F6V@_?>SDS2C$!@/>R'^N.?<]+[\K+' OH,_J#)#+M&:&!$EC@%95/;#."VH^O^6)&1?F+-E5LX!LH M7@G)LAJL%&0DK[[XM:[#%L#V#@"<&N"<"G!K@%L:K925M@98XJC+V09Q':W8 M=*.L38E6;DBN5W$JN9HE"B>C:7\T'#Q/ANCA'CW,1L,G-!G?WHTGX]EX.$7G M Y"84'&!+M'S=(#.SR[0&2(YFJ5L)7">B*XIE0K-9<9UQKLJHW,@XP#B*^3: M7Y!C.4X+O'\ZW/X(-Y7WI@!.4P"GY',/\#W(%#B:$#PGE$@" @V(B"D3*P[H MY^U<2*ZVVJ\VGQ6QUTZLC]^-*' ,/4.=+P%\#4;T^9,=6%_;7/\GL@\U<)L: MN,?8ZQJL(4\81P5^PW,*;88K%K]DT=?#.@HMM0;K;1_'8S[(\QIYWE%Y [(F MB1)W3%K%$&REM7UW1UI+C&>'[=K\1IO_[]*UG@)_+UO'\G<4[BT*PH: M1<%113,F,46L7%+Z=UNW20SVTP?^]8[&_2#//K2BG49CYZC&"0BA;C?.(9>H M8%S?Z&T".WNY+VWWVMM1V!+E!*';+C%L)(8GE)&R?(DD\.RT@H9[F]\)=M=\ M/Z9E%YI;-[I^3;]AOB2Y0!06"F9==12>5R]4U9&L*"_Y.9/JR2B;J7K4@>L M-;]@3+YW]+O1_$V(_@!02P,$% @ M9Y^5@@IELVR P V P !D !X M;"]W;W)K&ULK5=;<]HX%/XK9]S.3CO3QI8!$[+ M#!=GDYDD9(#L/G3Z((P 36V)2B*D^^M7LAUSL3!IMR\@R>=\^L[QN;F]Y>*; M7!&BX"6)F>PX*Z765ZXKHQ5)L+S@:\+TDP47"59Z*Y:N7 N"YZE2$KN^YP5N M@BESNNWT[%%TVWRC8LK(HP"Y21(L?O1)S+<=!SFO!V.Z7"ESX';;:[PD$Z*> MUH]"[]P"94X3PB3E# 19=)P>NAJ@NE%()?ZF9"OWUF!,F7'^S6QNYQW',XQ( M3")E(+#^>R8#$L<&2?/XGH,ZQ9U&<7_]BGZ=&J^-F6%)!CS^A\[5JN-<.C G M"[R)U9AO;TAN4,/@13R6Z2]LJ;5%M;0YEYC1,E]%.J]51W M,K@)AT]W(8RN832]"<=P^W ]&M_WIK>C!QB'=[UI.(3I"$:/X5@?/OP%=V%O M$L*'(5&8QO(C?(:GR1 ^O/\([X$RF*[X1F(VEVU7:8+F&C?*R?0S,OX),LB' M>\[42D+(YF1^".!JRPKS_%?S^GXEXI!$%U!#G\#W?-]":/!V=51!IU9XNY;B MU4[@#7B24*6S0$G0+H*!MI:R)6$1)1*&5$8QEQM!X$MO)I70,?[5YL7LDKK] M$I/X5W*-(])Q=&9+(IZ)T_WC'0J\/VT>^$U@!_ZH%_ZH5Z%WQZ,GP%(2]0GZ M9$D9T\[061EC%A&;X1E:(T4S!>JY6VLT@K;[O&]06:BY$SF@V2AH-BII]A(N M%/T7F\)CHY5I!WLW?D:>YQWQLDFU6G9F0<$LJ&06+A8D+82@*[HN60S(2[3" M.J1 8$6L.1B4>?@E)Y:%D,D &]=FP;59R?661;K12.N+K=3\V8ANEKCK*+FT MD[\LR%_^,OE*33MYL/'^!9RSF=@J[&N]-1-U[3V3AJV2@_U:*=S+0@>Y>L 2 M>;MVY57RO#,O 6**9S2FZL<;ZT8.>D F\)I'C"U2S1/YB?;Z*ZHDK%O(R<"I M5OV)R,F!WA;RR-]Q]_]/=;&:Y%NJ2X"./5V60L$I5^^:*ZKL56?+=*Y^KDY; MQ4X5:K1K=:BZUY4B]WR>H7(K\VOUXU)MD3H([HRONS]="@].N^;L3V=/7S$ M[^MS'B?.<>](V3>^PUC ]RB,>5_;";&_UW4>['"$^!W=XUC>V5 6(2&[;*OS M/<-HG8JB4+<,P]4C1&+-ZZ77ILSKT42$),93!CR)(L1^?,(A/?8U4WNY,"/; MG5 7=*^W1UL\QV*YGS+9TW.7-8EPS F-@>%-7QN8][YI*4$ZX@O!1W[6!I7* MBM)OJO.X[FN&B@B'.!#* LF_ Q[B,%1.,H[_,E,MGU,)S]LO[@]I\C*9%>)X M2,.O9"UV?:VCP1IO4!**&3U^QEE"+>47T)"GOW#,QAH:! D7-,K$,H*(Q*=_ M]#T#<28PG5<$5B:PWBJP,X']5H&3"9R4S"F5E(./!/)ZC!Z!J='23352F*E: MID]BM>YSP>1=(G7"FP\_C_SE> 3/#_"P7"QG(Y@\/CU.EA.8C9X6@S%,!W]/ M9&L.#\\S>)Z.9H/%X]-?,!X-YJ,YO/>Q0"3D'^ C+.<^O'_W =X!B6&QHPE' M\9KW="'C5+/I01;3IU-,UBLQ^3BX ]O\ RS#LBKDP[?+S0JY_W:Y493K$FY. MV,H)6ZF?_8K?D$81$?)5$1PD#QC26)!XB^. 8 X^X4%(><(P_#-8<<'DB_!O M%;+3)$[U)&IWN.=[%."^)E]_CMD!:][OOYFN\6<5P";-_(;,"G#M'*Y=Y^[) M-;*K:)U4K52EMKZ#9YJ&?)8.YQ1JK6^ET)!9@8*34W"N47"J*)Q4[AF%3MLN M0:AUOA5"0V8%"*T<0NL:A%85A-8%!+O;+D&H=;X50D-F!0AN#L&]!L&M@N!> M0##;;@E"K?.M$!HR*T!HYQ#:UR"TJR#4JJIC@JK=\Q=\7@?5D%D!5"<'U:D% MM: "A56D.A>/B]5R.J7GI=;[5@P-F14P=',,W5H,8\RY+%D$EM:B"D?W L=' MZ^)K4CO'K3@:,BO@,(V?-:%1"V2J3&,!!Q0F&.@&-HE0%8JL/TF41!!B66G# M'OU(JYK* L^X?()LI[SC9*/./].V:Y0V9[]B5+N;CRFF>%;VFM?7/$@84WG2 M54BV2)U#JI,Q+]>_ZY37OVJ4:3MF.9O:N'YU:7\6HV9M.>:-:;P%^:2_+.*U MU*W+0LHQG'+JEZ,LRW7+F3=:*.IG9QYU0IT@MB4QEVEMI+UQUY;1L-.A[]01 M=)\>@U94R$-5VMS)@S)F:H"\OZ%4O'34R2H_>GO_ U!+ P04 " "UGGY6 MN0Z7B($$ W&0 &0 'AL+W=OQ_-,9L9/3&?%Q:.<4:K@*8E3V?5F2LW/?%^&,YH0><3G--6_ M/'"1$*5OQ=27"Y"+)"'B^8+& M?-7UD/XY4&X MD(HG:V/M0<+2[)L\K0.Q88#:;QC@M0'>-FB^8=!8&S0LTAR?#N!\_$ ^E_&M\/Q7Y?C M_O!R A\'5!$62Q@3(8@)^"?X'>XF _CXX1-\ );"[8PO)$DCV?&5]L>@^N%Z M[8ML;?S&V@C#B*=J)N$RC6A4!O UD9P-?F%S@9V( QH>00/]!CC N,*A_OO- MD<.=1A[H:_YLG1*T_ 9OEWIZ3!4-)'_5@4O MPVY68YOR/I-S$M*NI^M74K&D7N_77U [^*.*>$U@I3 T\S T7>B]6ZY(#/1) MMQY)JYAFYBUK;OK.4J>&?GS+30(5!$=!ZWC+5^>R>P:[G9-J[T9*4-/-==)!3'6_ T5% M4L7-#8M/(;&U6I5<3M,]^1[G?(^=CMVE<\(B"'F2,&DVERINQZ^2IQUL/3/G M*GMR.,DYG#@YG#\*O:-]&]'DGHK*7N"TW[47U 16HGJ:4ST]8$L\K3,,-8&5 MPH""8M\-G,_<[GSQ,\S)LU9%JGK[#%[E;6,K;=VK[,MB0SV@FEOH&G"KAZ)F MJ[7-S+GROLQPP0P[F=ULM4W;_2H)N7%:CK[I-MV78J%.D'/7[TU(K N1A(_0 M-X7HZC]NI%TKKRZT,N]"CJ#F 7L02URK9_(TCZ(2*J3V9EV#?!;/SVWPT M/_T_MV?>6^,7Z*R?G>$7,-E?"B,BIBR5.B8/&C(X,F?P(CNESVX4G]N#[GNN M%$_LY8R2B HS0?_^P+EZN3$+Y/^5]'X"4$L#!!0 ( +6>?E9! 5N[N , M $<. 9 >&PO=V]R:W-H965TSXP1@I*@M* MOZO)=30V+(4($@B%,D'D8PLS2!)E2>+X41DU:I]*\7#\9/U=05Z261 .,YH\ MQ)%8CXV!@2)8DDTB;NGN/52$"H A37CQCW:EK.\:*-QP0=-*62)(XZQ\DL,$V^D@SL>9HGD40'1LP)>0:M_V$>VIW M6KR"L(<+WE.0A@;\D!R8%LP@M=_8<]ZJ^/W0L:.V+HU6[?+>O!IDRZ (;I$ M.\(8R02_0)\W@@N217&VND!36,59)H=*)@<6TT@7D-*+5WA1^68;8,?+GUW)'-/HUC7XGC8?BC$.$)EM@,F>A^2.P,.: ;E@<@DP/"O! 6:_YS9XZ63P4$_*JTEY9^_-0S5"*_5HGK\2KW<:8VP/K'X#LD;, MQZ[= MJO0?O/V8G?8^"?1-/K]9N?TJF0WVOYC 8U^,&?1QP>\YCI\0Y.0VG) M7P/PJ91[)'4$>5A#'KY0O#OPER[Z!\@&#>RG$K@%.+;V]WT<@Y1K#E2PY:SCNT]3?MYY4->$KJ3 M:^7@: ?< ?:=9H;5"39*S#&)?<''G17VUWMU)B-'DYA.Z>BDW!8J^VJ.SR_G M%1NR2*!>U>+6U&;7=NU3Z!I!>]CO#[T6^/LJCI]5QL_@HJO'3C.I::2\0ZF2 MA7EP)4^!K8I.A:.0;C)1WG+KU;H;FA0]0&-]JKJDXJJ_-U.V6!\)DS<1CA)8 M2I-6SY? 6-FUE!-!\^+BOZ!"MA'%<"T[/6!*0+Y?4BJ>)LI!W3L&_P-02P,$ M% @ M9Y^5I9OH'#Z!0 (R8 !D !X;"]W;W)K&ULO9K9;MLX%(9?A? ,!BW0B20NMMQQ##A+IP'2)$C2R44Q%XQ,VT*U MN"2=I, \_&BA1066J,5N8?QLRCY9A'SD,KDD"\ML>:,SK-&86!!VQY:(?6CP722?7;#IY-X M(P,_8C<8SC[^G!Q?QX8*<9L8!Y,I6@ MR?Q0HH,B9MJP_'ZK_BGK?-*91RK8:1P\^'.Y.AZX S!G"[H) MY&W\_)FI#I%4SXL#D?T'S_FY0S@ WD;(.%2-DPQ"/\I?Z8LJ1*D!JFL 50.8 MY9T'RK(\HY).)SQ^!CP].U%+WV1=S5HGR?E1>E7N)$^^]9-V'?&)/4#\1[\"1XHYS22X-L7%CXR M_N_$DDD*J9#EJ7 G>3A8$\Z!X$L7'(P+O+6"15^G:9- <7DH6BLCYY+%P=*YV#'\6:>NQXD$00C#^Q MP?2/WYRA_9>A)[CH"3:I3V]IM&0@7H#S%\8]7S!PPWV/B0]@LUXG_>+9]X$? M^K(J]5R<9.+I;'^:.O;$>JI(B!0)$6-"#]FD2>HZ>V(\,0%PRX0_W] 7/H+ M!N[6- +O_ C\9)2+]U4YF?5AWA)@$.:C#KI@3G^:1L6P2'UHE+[>2"%I-/>C MY79>"/!?Y:C+,\WEAN7J8=<9(5Q=PE&1QZA;"5]?VZI,"8 MD=##>Y1BRPNJF>"8H=#9C95>N22DOB(:"HZ9"GTJXG:IB,:"8^9"I>]!L^\9 M%7M:!=0 @?8;^AXTTJIO9S1VH!D[>_J>4B\/BN'1F%0/"JC1 HUN?P#?:PBP M]3U8^!YJ\CVH60+-+.GL>TKOE>]!UZXKH\8'[(B/YEFN%%M>4(T":$9!9]^# M%2@PE$2C !XH:$!W;: MN;.O\8UW[KE'U2,":; @\YW)_J[7$&![USW:NI[3Z'I(DP292=+9]91>>8J[ M>$3J?MP@30_4D1[-Q[:Q8!+ZG_M(\1H>V;%OIL1I=T(_(:V MAXUPZML931ULILZ^>RND8DS4H!!KL.".MR&=;:\AP-;VAEO;&S79'M8@P6:0 M=+8]O+N(Y8P<#,I@>[LD,)6$:!*0@Y. M5)&@IB1$DX#TV- 8&FW/K-C3*8@F!GG+#0WR*S8TB*8.^:4;&DJ]U9ZRY@KY MU=L9#0'T=K+=9'>DM!5^X&T,LKMVY=CU/VF(I@8Y^.*54FQU'34 R(%W,4@% M $P5T0 @!P> 4C16Q"H]MQ,ROLR>3A+ BS>1S!_A*3XMGH":Y<_]Z-/SQZ>^ M4+[T(P$"MDB:VD>C)##/GTC*#V2\SIX">HREC,/L[8K1.>/I"?E;)R,-=S 8 *DW 9 >&PO=V]R:W-H M965TH]^+STV"?L_?\K7CL4D PJWKVL'3>[;V=Y<-V'@^,77N5SPZT>KW-O8] MFS'^=3,)Q%$K4UDZ+O-"Q_= P.XN&P/X;DB[44#[L[9I/_=T'EB9$([V%OP[C_\$N;=MN@,4VY+Z;!HL1N(Z7 M_+0?TT+D F#GA0"4!J#] /)" $X#<)QH,K(XK9'-[7XO\'<@B%H+M>A#7)LX M6F3C>-%EG/% _-81<;P_&WX8C[Y^&H.;*_!M,)T.OLQGX.;K?#8??!E=?_GK M#1C_,[F>_@M&@_D8B'/B>#P=7L_&8#*]'HYGX/<1X[:S#O\ ;\&OH 7"E1VP ML-?B8G11'ZU%.I+WR4C0"R,9L4438/@&H#9")>'#UX=#-;PE:I(5!F6%0;$> M?JDP41IOWXL9L@1#WQ7+)K3CB3<( MN[9V(J13*6F'K>X% MNLC:*:,DV2B)=I17[#;8"J<"\YVX1N+"L0?F@?G*WX9BS,]GYSL??/_,W%L6 ME%XT;1^'7C1#8DHY:%8.>N;Y34V6RI"84JI.5JJ.=N:,'S>.F#?"7UE9GOI@ M,>V: %EOP(N^IHT_,C4K2\UZU=(=/[)@X80,3 )G4>[>B1#-+7*T1H\Q8HJHI\G6#S#2K/3QA^;G40NJ,64 M0]PH5:+*"MSS(WUOQV8CJ0@:P2)8Y!VJ>$F:3%4S=922BJ >BVX6W!<^ Z[\ M;#5UD=9 0E&L%SLQ$T"D>FU-1R23R")_%11;28 M@$T B@D2*J(COT(M#N) M(9'2_.K ))2[,V4,DU 1DZR]):SO[-AD)"4A(Y2$BOC3)18M&%)U.W6 A)'D+&>"A5ZN;MITGWEVP=0(0D$"$C0(2*I-/%N'#SNK*9 M.DH)1$@/1!^W8@&1V'DZ>N\\^NZ.32?WV,S,<[,2I!&6@O>3J6JF MCE*"#]:#S\?M^@E8KW >O<[!2ZD.YL&2>?"YF0<;91Y3:FJY)//@DYBG(EI, MLW4 M<4KJP7KJ&;%%\ITK(1]+[S]&R<>4FKI709(/.3?Y$*/D8TI-+9K'9_K.CDU&DA0U0E*TB$BXY'&^OK/#_8I*UJ)5 MK%7M5S<>TUF6OH>#UV MF[-SN[//35G4[/[L.BB+2LJB)U%61?0K+*L.RJ*2 MLJ@QRJ)%RJ+-"[B_T.N@+"HIBQJA+%I"666N98JR6KGWJ**7V 1]WSM>"-;L M3BBWFY:8Y$'R7EARP/U-_&K5K<^Y[\8?5\Q>LB!J('Y_Y_O\^2!Z6RM[.Z__ M/U!+ P04 " "UGGY6UL>(G?(# !K$0 &0 'AL+W=OZA0&.C$,6P^I'VG];CHWY?TN6\O MCV#*D5B'(>4_AQ"P;4_#VNO$H[]?S8@6IYS,2Q>/^*_C$EK\C,J8 1"[[[GESU-$=#'BSH.I"/;/L)=H2L!,]E M@4A_T3:SM96QNQ:2A3MGE4'H1]F5ONP*47# ]A$'LG,@58?6$0=SYV"F1+/, M4EKW5-)^E[,MXHFU0DMNTMJDWHJ-'R5MG$FNGOK*3_9GHT_C^Z__C-'D(YH] M349_H\GTZ?/D88;^>AP\/(WOT>_W(*D?B#_0G^A7I".QHAQ$5YH*AN[M( MPRP2.1()$_2%17(ET#CRP"L#Z"KM/'?RFON0-"+>@WN+3'R#B$%(34*C][OC MAG3,O)1FBF<>P1O_6/OR)_IW,!>2J^7Y7UV-,HA6/42R9^]$3%WH:6I3"N ; MT/J__8)MXT,=ORN!E=BV967&(EIQ&LKH/L]3M@S([+6P==*,QC?KEAQI67COGU[ZL6^_FV1CG M702R0ER.4RJ$DQ?"N4:CX27V>7T!&O%/*(!SL&"(TSZV*SLYO0J003>#5(";P'^D76_BU;L5\!'.Y6 Q/P(?BB.".83EFM:]OJZTR MD[V,PM?44>/T^@:I+*!5R-6JTGE#:)6Y[$44/E-%[3C1>0#E1[7Y'THIW"*& MB4F518VA85O8-(\0V:LE?*%<.HU0NZ;:';O*IL[*LBM4],*Q-02^3$_SZG7. MUI',3H'Y;/[%8)">DROSP^1+0GHUTVID$I#L]X-1FQN'(Q&T2>XS3A^GTA0QGHPD@*LEV_.U[$IC5 M2><30LOP)C'X]G]W?TN[^P,A3I^B^%LR$R(EWQ?S97+6F:7IZEVOETQF8A$D MW6@EEO(W=U&\"%+Y,+[O):M8!-,\:#'O4HL@7'8&I_ES5_'@-'I(Y^%2 M7,4D>5@L@OCYO9A'3V<=N_/RQ'5X/TNS)WJ#TU5P+\8B_;JZBN6CWE9E&B[$ M,@FC)8G%W5GGW'['^U86D(_X(Q1/2>%GDFWE-HJ^90\NIF<=*UN1F(M)FDD$ M\K]',13S>:8DU_'?1K2SG3,++/[\HOXAW[S)BGU]'31['9D)OI3:)YDO]+GC9CK0Z9/"1IM-@$RQ4LPN7Z_^#[QHA"@.V] M$D W ;0AC$L'X^''$?_Z:40N/Y#QS>7P=W)Y=7-Q^67\AHS^NKJX_IOP M\YL1.?_"Y>/1]?!B/")7UQ?#T9C\S$4:A//D%_*6_$AZ))D%L4A.>ZE<5B;> MFVR6\'Z]!/K*$FQ*/D?+=):0T7(JIJI 3^YGNRGZLJGWU*C(Q:1+F/V&4(M2 MS8*&NX?;FG"^>[AEV W;_HE8KL=>^Q-EOKY]+P_N*1E&"WG&)T%^SIS'<;"\ M%_(L3,GM,RF.NPJ>\Z?/GX)X2O[Y)"7)12H6R;^ZO\]Z?D<_?Y9YWB6K8"+. M.C*U)")^%)W!3S_8GO6KSEM,,8XDIOCN;'UW3.J#T7<13\)$D*LXG.@/[+6 MFPMD&?9QX)[V'HMNK$?T"R.Z[:Q5O(*\U/[Q'+[K+29ZCC;=4^8997VHQG7M^502[\E;[LE MS[BE#^(V?I#%B=C^^M0F_WP6BUL1:P]JHU;3@QI3C".)*1[Z6P_](R<3']-W M3#&.)*;XWM_ZWJ]))JM0'KFR1@N=:>9@>>!W\X/^U8)FC&_J$Y*8XM/)UJ>3 MMDGWI)(M[6XY[1HG:>H'DICBAVU!@V:A)7*SE'ZI1'<\;82**9SU+=LO)?I] MYJNWIM"[VH@%P2S6-#.AJG$L-=5("D;2(U>%S0*PS,=4XUAJJOG0WMO&+K:N M--1$U]<<!CLP[1DMO0D]NMFW*[VD[;W5++/31/T]@4)#75%&CU;;Q>WRS5 MI$14NWS?LQ@KEX@]YJNW!I#!WI$9:#\O$;E9JF M'U0UCJ6FN@AX0(^-!Q05#U#5.):::C[@ 6V%!S71\@3HDOP$>#7YFQ4:NW4( M/J# ![0U'] J']"N4TYOJ'R I::: GQ \?B :MX,<*@F_^O&^9H"<(C^GT+_ M3\W]_V\/\^>7-^-J\C]J[X^JQK'45!.A]Z?'[OTI:N^/JL:QU%3SH?>GK7K_ MFFAY_*_?C'X]_:/V_EAJJEG0^]/6O3^M[_W-DS2VY!"]/X/>G^'U_JS:U-O4 M=RO)?\=QW+RT?;<.W3\S=_^7DS22Z7ZW_&_6:GP5!&K_CZ6F^@C]/SMV_\]0 M^W]4-8ZEIII?N/JG5?]?$RU/@9K\;Q9H;-8AVG\&[3]KW?XSW=4VY?;?/$UC M4P[1_C-H_QE>^\\TU^YH7OW1#'.=:O-O7MB^&X?FGYF;_R_18Y[O";-V*0"H M ("JQK'45",! -BQ 8"A @"J&L=24\T' &"M * F6IX#W?SX?[T H ( EIIJ M%@ :PT K'H!D5LM *@(@*6F7L<*".#@(8"C:^TMZI8K@&XVKY; M!P1PS BP+0%T70(<8PDPBS7-0JAJ'$M--1(8P#DV SBH#("JQK'45/.! 9Q6 M#% 3G9< NBD!CM8L5 ; 4E/-*ERVWYH!-@K%UX#L2H)#10 L-=430 '#P$< M#0+(_%]A@!W'O_OC'YFX6:YA]4 M-8ZEIIH(O;][[-[?1>W]4=4XEIIJ/O3^;JO>OR9Z<_W/Y@T 7^L6:O./I::Z M!QJXVP\<%'Q %6-8ZFIY@,>N*WPH"9Z MEPJ!R@=8:JI;P =N:SYP=>\0>.6KA,SS-';E$(#@ 2!X>(#@:3I_1T,(YBD; M5(A]A.J] 8;PZACBF7P(XR0E-T\1N9E%#XDT1SZ0V4NF-/$HEN8[4:"2!:H: MQU)3K06R\(Y-%AXJ6:"J<2PUU7P@"Z\56=1$9V>%N6R8!1J;=0BP\ LO-9@ MX>G XJ2<%%&Y DM--06XPL/C"J_*%4Q7-+"P8A^A>FL*]RHR8T7IVE,S69BU M&BR\%J114VTIK$IA\ ('S#"Q\,(7X,1 M=I^5[SLTU(US->]/FY>V[]8!$WPS)C2M :B@@*K&L=14)PLW-CTV*/BXMS;% MO;?I(4#!!U#P6X%"3?0.-0 5%+#45+, %/S6H.#KKE#J5XH *BA@J:GWQP50 MZ..!0E][>](J*>PXCIN7UG3KO<+M^!?Y M%P;T8/CZ>Q<^!_%]N$S(7-S)4*N;5:MX_54&ZP=IM,IO[G\;I6FTR'^?E:KTO=$I@( -H& 9 M >&PO=V]R:W-H965TS4-M#^^]D.I!0"ZL->B*]][[GGW."3SHKQ M1Y$!2/1F(<=MI YH3#F2"R* O.7/N1LU;5<:[-Q3^:9U!MVV"GQ'&*0#^68 MJ\BN45)2 !6$4<1AUK5Z[F44Z'R3\)/ 2FRMD58R9>Q1!S=IUW(T(<@AD1H! MJ\<2(LAS#:1H/*TQK;JE+MQ>;]"OC':E98H%1"S_15*9=:T+"Z4PPXMPG)A?M&JRCUO62A9",F*=;%B4!!:/?'S>@Y;!6YPH,!;%WB[!8#AQ]# M-+I"\604?4?1Z'8\O(M[DYO1'1K^UNLA.AV Q"07G] 7]! /T.G))W2""$63 MC"T$IJGHV%+1T:!VLF[=KUI[!UJ['KIE5&8"#6D*Z5L 6^FHQ7@;,7WO*.( MDC/DNY^1YWA> Z'H_>7N$3I^/5O?X/D'\(9/"R)?T)_>5$BN_J]_FV940;2: M(?0=OA0E3J!KJ4LJ@"_!"C]^< /G6Y.^_P3V1FVK5MLZAA[&DB6/*&&%,AB! M]1UMDEMAM V&=IAEZ/IZV,MM&?M)7]NO.6_8M6MV[7>P&Y7&.Y8@)*'S)GX5 M2K#-[Z+M[?!K2 H-+._M]9=R5S[["5*Y_B_F<4(%RF"E(Y^Q<4>*5 MDU:!9*4QHRF3RMK,,E,?'^ Z09W/&).;0#>H/V?A/U!+ P04 " "UGGY6 ML*WA/N@/ .R &0 'AL+W=OG:Z MIK1MLZZX^_B!SIJ#KP[F4U3(RRSY/9Z7B_.C MZ1&9R^MHG93OLSLAVP/R:MXL2XKF_^2N+3LY(K-U46;+MG+5@V6<;OZ-OK0? MQ$Z%BC-6\$[M(+?5O /K1"T%8)# M*TS;"M/FV]U\'7%V6E8]K-LYG;6] M>;WIC?U(;RSR2Y:6BX*$Z5S.!^K3/?5M ^"T^FBVGX_]\/F\MHW$M[/RA#C6 M,;$GMC70H4MS]5?KFVWUR=#QF*M3.=M6MP>JAX=7'^H\.[SS0]6YN?I/Z\18 M79BK_YK=GA KJ*M;KN&;=+9*=QJ>\PCO,HF*@F37Y*K,9I_)'S]7[Y,WI5P6 M_QT2Z@;F#L/J*\K+8A7-Y/E1=QH;TH:Q]EAM(&%T _-VOG4GZ BC7\3R M.ZI =HDC80($TU01;%41&%41?EE5=Z'5A>TV2ZI[A"0N[TEULR#K>Y5XN5X. M*<5('*L4)(QN8-9D5P'":N4^:"*C-7'J@@)H^8# M<\B]C/*".&39>"!#(VDSP=L0AK2$/ Z.A D03-.2-5'VV<3XD;V/B\\_D.M< M5D.CM%*4+,KF-#7H?1E18Y4%I=&6IIVAJK&Q%72&02&T60:E<2A-H&BZLG:, M60NG+"-JM+*0--K2NLIR/;NK+&2S#$KC4)I T71EV4I9]@&&U"J/9W)G=#6H M*R-HM*Z0- JEA2WMA39 \[K. +1-#J4)%$T7E7+7+:.'NCE='7BV@GKK4!J% MTL*6UCWW3=R>L*#6.90F4#1=6,H]M_ZV?7Y7!Y1I61#Y1>:SN!@VJ,SMC)8= MU"Z'TL*6MFMG^5.G*SFH&PZE"11-EYPRQ"VS(_YV5<^K*,A-K:I'Q 2UPJ$T MVM+\G:]_ZEK>9-(=<#VAU<%2-9JSGP* M@YKL4!JU!FQV_T57<@-&>T^8#-HQ#J4)%$W7D[+;+;/?_B8M*PT5\6RC'G*= MY>2V&FQ5ZM)T-*@>J/$.I=&6MBL,-^BF- .%?+^O'JBA#J4)%$U7C_+4+;.I M?K6=34#>K?/9(BHD>753#=J7,BW)'[_(Y2>9#TZ',8-':P=JKD-I(93&H#0. MI0D431>C\N&M%\@)61;4EX?2*)060FD,2N-0FD#1]*F=RKRWS>;]F\VP;'O[ MN)G/.B0^,VBL^* T"J6%4!J#TGA+V[VQL0++M3NC3(%J59>5H7P^E42@MA-(8E,9;VG1'3L%)T-72U_#J;>75VV:O/OQS7<]\>)/. MJA%:?"O)NR1*C2,U,W"TMJ">/9060FD,2N-0FD#1=!$J;]^&3IVWH?X^E$:A MM!!*8U :A]($BJ8K4(4 ]IX0H%UI].CL4W/]T9J#FOM06MC2=@=!70<$VB"' MT@2*I@M)6?OV09/=VQ.9Z3(*-?BA- JEA5 :@](XE"90-%U[*@NP?>AE%&KV M0VD42@NA- :E<2A-H&BZ E5Z8)O3@Z^X%,W<\FBU0L,%*"U\"FTP-H5VBT-I M D73A:J""GM/4&$0ZL:E^QM*A4894!J%TL*6MCM4#'IC16A :4)%$T7H0HH M;/-T^/TW'=!( DJC+4W_[GM30 9*V5V!0/,#*$V@:/J& BH_<,SYP;XED>;J M8_4!I=>(:N8B$*Q*#'QZ$T@:+I0E.)@F-.% ;O6LE?9+P[;&YHM"2AR0.4 M%D)I#$KC4)I T71QJHC"L9&WM0XTGX#2*)060FD,2N-0FD#1= 7N[.QC7GNP M=Z#6UM>"8\N:3KW.ZK;+H8*3YC^](!THV!U;[2_"S,E+'O/,'8KX=(RU62 MW4O9OK.=]KA_I 0- * T"J6%4!J#TCB4)E T7:,J '"@ 8 ##0"@- JEA5 : M@](XE"90-%V!*@!P]@0 >T=*4!L?2J,M3;>T;*\[[.J7LJUI=S''92*-$3%X:3031JL.ZJY#:2&4QJ TWM*T"[S3=? $JDU= M3"8W&9E/;\KKW]F9GB; M>Z11?0FET3T'^V$AR:<79!'-246_C;-UD=R30I:D7$C]DVCV M=JA?7>D?&(E*8FUFP=50]6Z9$DT&E0\,&*(U#:0)%TY6N,@G7 MG$GTKO'D+](X<"J&V&PUM#^-,+H!&&VY^T[PW,0 JA MK3(HC4-I D73]:0"#]<<>(@LF- B!TBB4%D)I#$KC4)I T70%JB#$,PS9':N9T%>97.JXMR6JR3LHGH MGG*M-C>7@LV!QE4U MRJNOMD1E> =<5[&_&HS]V6!H= &E,2B-0VD"1=-UJ*(+#QI=>-#H DJC4%H( MI3$HC4-I D73%:BB"\\<7?0F,6QN?$FT+A=9'O_OD8LM-,> TJ@WL&YB:.EK M>&A!!NT?A]($BJ;+1V44GCFC>$P^V;HLJCO8>9S>#.H'FEM :=3KYQ8]Y>PM MPJ!]XE":0-%TS:@2RMPB#]HE#:0)%T^3B MJYS -V].U([57X\:JYN98Q4#I5$H+832&)3&H32!HNDZ5&F!;R''ZCXT (#2 M*)060FD,2N-0FD#1= 6JF, WQP1/&ZN;H:.%"(T#6IJ6'74NGON+,&B?.)0F M4#1=,LJX]\T["CUQ?&ZFCM8,U,#W]^]8M+\(@_:)0VD"1=,UHZQVWVRUCQ^? MFX&CY0+UWOV^]]Z3R]XB#-HG#J4)%$V7B_+2_8.\],MQXW.HEPZE42@MA-(8 ME,:A-(&BZ3I47KH/]=)]J)<.I5$H+832&)3&H32!HND*5%ZZ_S6\=#-TM!"A M7KK?M\B=02_]T((,VC\.I0D439>/\M+]K^*EFZFC]0/UTOV!-0"NVY_X<& Y M!NT=A]($BJ:K1[GJ/MI5-P-'"P?JJOM]RWQ8.(>58]#><2A-H&B:< +EKP=F M?YW&M_%W^(.KD9-+9 M&RV$MLF@- ZE"11-5YARS@/S//N?XS_7\3QJ%HBOFM.4?&1]I!DT6E10TSP8 MV(VGJRBH$PZE<2A-H&BZHI03'IB=\%>S6=XLVG@X=PV*"6I\0VFTI6EB\IRN MG 8*V=T='J']XE":0-%TE2CS.QAE?N^LY3DFK)+:+J=I0D.R?D9A,X4MU>["YU:G[PO?92GELGDXD:")#OGMN3AU?L MR?8.Y;JWM\O=(IXMGK7KI>H=7;)4JKU>9CN;XG_?-%[=(V?+JD>S*$GN']99 M5:/7M*JJK7R)RB=TZME.I\AAG8K39L\:>2O3>D^;:+.Q3=65593>?_O-U+:" M'PNM3OOASI*L:%:2;3]#9Z>SS^HM JI.5IVH%Y U/W93YE%]+YO\1;K+J =/']! !$JC4%H(I3$HC4-I D73 MI:EBEL!#VML!-&"!TBB4%D)I#$KC4)I T70%JH E,-KG!PZZH;$*E$:AM+"E M:1-37KC=T3DT+8'2!(JFRTFE)<$_]AO.YI9'BQ :J4!I84O3?P.@YWY"V^10 MFD#1=!6JT"7XYWZ@V=ST:!E"DQDH+0SZ^4TM0\_I*1$:X$!I D73E:@"G.#0 M &>CR>V]B/%& YKA0&D42@NA- :E<2A-H&B:#J48M'<<2A,HFJX> ME0U-G[9*XO&)$&;@:.% @Z)I?_G#L' .*\>@O>-0FD#1-L(Y+192EC0JHXNS MI954DJF$9;U\91^=]EY_;;V\M 9>I];+L'G]5.$O MSE;1C?PERF_BM"")O*Z:FIS4QDVS%_[#DS);G1]5?R:?LK+,ELW#A8SF,J\+ M5.]?9UGY\*1NX"[+/S>'<_%_4$L#!!0 ( +6>?E;+&-VEQ00 /H5 9 M >&PO=V]R:W-H965TG>.8V _?CQ)EE]BW^9!6_,ATDG' MA^0CDB:O/Q?RJXH0-3RG"5>#1J1U=M9JJ2#"E*FFR)#3FXF0*=.TE-.6RB2R M,!=*DY;G.,>ME,6\,>SGS^[DL"]F.HDYWDE0LS1E ^GD;: M/&@-^QF;X@/JC]F=I%6K0@GC%+F*!0>)DT%CY)[Y;M<(Y#M^CW&NUN[!N#(6 MXJM97(6#AF,LP@0#;2 879[P I/$()$=WTK01J73"*[?+]'?Y\Z3,V.F\$(D MG^)01X-&KP$A3M@LT?=B_BN6#N4&!B)1^7^8EWN=!@0SI45:"I,%:U; 42:;X+A'X#F>M\.>"[OX-5N T\ZEW5W>V*7?X[@)7B\7 M=RS.M*OOT,[QVGOP*&X3-A8%SS BPOD4*;\T,!YNK&]UA!)TQ#AL"GW^0)AP MI3%57W8X=%X8T-EM@*DO9RIC 0X:5$ 4RB=L#%^_XU!4/*TS]G)?QW&]%_M\J[G_DHQN14;72L:%X(H*IJ%@-)58!-SG:TS' M*+_ GW!-&7?!9"(4_-:$&R*'?@&H>B^W[.+'JO'0L*L3S*\);(/IXXKIX^^= M[\=U$E\GF%\3V ;Q)Q7Q)]80OYUSE"J*,\A0!D0P=3>[V+.B',I>G6!^ 7:Z M5DB87Q/8!M.G%=.GWSOQ3^LDODXPOR:P M#>)=9]7J.M8@]W&L3=;'(HP#R(H?_ET$VG$.9;!6-+]$V^@WG/4N8I.O>IY[\DX!6Q;+(YK;=$2#-:7Q M G"+S*,M>5 12Y+V?C#:C>2J%4C"9\5"!9+'"\ @B,<QK6G+4&\5A)[UR_R2XYJO@ACN[+;M >'79UH?HGV(C7W)N=J M.'2M(]#PDYG *2?QF7H6HILHBFDFL7:[+\?'GB6R5@.?:Y_X'BFN%"O.X/Y14-4ZSM6*YI=H6YUQ=XNB MUMIA68IRFA\Z*HJ*&=?%N5GUM#K8'.7'>:W5]N)4])K): 0CTEB89[VJ1$(LK7>=!!"GAEW0!F7PSHRPE M0D[97.<+!B3,06FB8\-HZBF),\WMY&M/S.W0I4CB#)X8XLLT)>Q/'Q*Z[FJF MMET8Q?-(J 7=[2S(''P0D\43DS.]9 GC%#(>TPPQF'6UGGDU:*OX/. YAC7? M&2/E9$KIJYK/WAE,KMU3 W?&6_3KW+KU, M"83.0X_7:.0]>P\3ST?G0Q D3O@%^HXF_A"=GUV@ M,Q1G:!S1)2=9R#NZD)LK"CW8;-0O-L(G-C(QNJ>9B#CRLA#"?0)=JBZEXZWT M/JYE'$)PB2SS&\(&QA6"!O\/-VOD6&4FK9RO<8)O3 5)Y!][!=D2*A-4X.T< MK[ZNE6L:V&[8'7VU*_LXS&EAVRRC]M0U2G6-6G63A]NQ-T3^N#?V_"IQM7!U MEESQ!0F@J\G#@@-;@>9^_6(VC1]5F?\DLCVG=NG4_F ="GQS)\&V+(1U4(:* M*,O!=G49FJ6X9JVX6W_4\^ZJ1-7BWIO_3R+;L^B4%IT/YM\YRFP#8],YR/]Q M%#9;C59U_ENEN%:MN!%P@1YG\B #]$)9$J*?]Y!.@?VJ$EK+]=Z:?!+9GNUV M:;O]P9JTCPZ=MF4WOT. MUOOR>E!T\W\TQ=WBGK!YG'&4P$Q2&I>.E,2*?EU,!%WD+6]*A6R@^3"25QQ@ M*D"^GU$JMA.U07EI?E8USIYHG ( .,& 9 M>&PO=V]R:W-H965T)FMB9[4 G[8^?[804*D![Z$MBG^^^^[[+^1)L&7\4 M&:*$I[*@8FAE4E:7MBV2#$LB>JQ"JDY6C)=$JBU?VZ+B2%(35!:VYS@#NR0Y MM<+ V.8\#%@MBYSBG(.HRY+P/R,LV'9HN=;.L,C7F=0&.PPJLL8[E-^K.5<[ MNT-)\Q*IR!D%CJNA%;F7\87V-PX_"?2 MN![<,BHS 5COC(.XLXQJ0'OOL!/,?SCA"*_S_/\'"+Y1+Y+_@+"]P@K1%&2)-,79N#PPYC M1K&S'ZOU62KZWE^*BB0XM-3%%L@W:(5OW[@#Y\NQ.KT2V$'5^EW5^@;=/U&U M.6=IG4B8T&8>Z9(]?%-.,)%8BJ/B^Z\I_I7 #L1?=.(OSK?,0:=PW2D5,].#5%[;UZH?EN;,2H@8365S0WLK-VD MCLR >F$?J0G>#-QGF&;\WQ*^SJF E<*TNE]5,1X,U*;C625F4I+)E73FV6F M_D+(M8,Z7S$F=QN=H/NOA?\ 4$L#!!0 ( +6>?E9J'6OD?P, !@+ 9 M >&PO=V]R:W-H965TP;A]SB*X6]/!@C$\J<\V]F,EIT M',\0 8-$&0FB_W;0!\:,DN;XIQ1UJC6-X^'X5?TQ#UX',R<2^IS]3A=JW7%B M!RU@2;9,3?C^$Y0!A48OX4SFOVA?VGH.2K92\;1TU@0IS8I_\E(FXL !-\XX M^*6#?ZU#4#H$>: %61[6@"C2;0N^1\)8:S4SR'.3>^MH:&8^XU0)_99J/]6= M]C\-!\_C(?KM$0V&C\/)9#A L]X?J#>=#F=3U/LR0.-1[V$T'LU&PRFZ&8 B ME,E;] $]3P?HYMTM>H=HAF9KOI4D6\BVJS2747>3DN&A8/#/, P@N4,!_A7Y MGN];W/O7N^-C=U=GHTJ)7Z7$S_6",WJC+.$IH!EY00,J$\;E5@#ZLS>72NA= M]Y;D@"'4>?-0EB!T[W_2\X\C[:POV?Q(Z"#ZK@@TOJW4FA M*)'^E.8X@!"PT.=U!]D6;)$7 M3$1*4-;C$=81@O $TV(3A7;*J**,+E)^T5U"]P.A\Y>MD-[G5KBHMG I(P#N,3V+I5"[<".VQ #]N+6Z12;[4[461;$7G#$K:LCKI^I?0LZ>_ M7.0XS4'C) ";5>#%9T(X:*OXBLU[E&A&R9PRJBC8>R2^"M=B=1[WK>7ABTWE MO^R*4BF\6*UL1K5RY1Y<6\R=\3,1*YI)Q&"IO;R[IG87Q36LF"B^R6\R&ULK57;;IM %/R5(QI5 MB=2$BR]Q4XQ$#%8BN4YD[*12U8,QH+H;&1LKBPC1%O,&,B#-68*YV5HQG1*HI7YNBX$B2$I11 MT[&LOIF1-#<\MUR[Y9[+MI*F.=YR$-LL(_S/)5*V'QJV\;0P2]<;J1=,SRW( M&B.4B^*6JYG9L"1IAKE(60X<5T/#MR]&/5U?%MREN!<'8]!.EHP]Z,EU,C0L M+0@IQE(S$'7;X0@IU41*QN^:TVB.U,##\1/[N/2NO"R)P!&C]VDB-T-C8$"" M*[*EB41BMEI:V 2.*YG.V!ZVK%I@=E;TJT%F#$$X#F>S,("Y_P/\* KG$?C3 .[\R<*?7]],P9],;N[]Z2B,X#A 25(J M3N 4%E$ QT8/O.H]9AC GCQ"D(J9,;#G"3W\I)%>OWZ\V M@Q5CMYU1?Y(7HB Q#@WUS0GD.S2\SY_LOO6MS>Y_(GMFOM.8[[S'KIJY0LXQ M :GL$R%0MC[0BJ17DNC$V'FV;3D]U]P=&GE=-1@,_A4]$]AM!';?%7A'Z)94 M44!5%I$\QC:!%4G_X.A3VQI\M5XH;"D;G#M6N\1>(['WKL2I2N'D8WWLO>YC MYV476VKZ+YMH'D2!CN'OA*_37 #%E4)99^<*SJMHJR:2%64Z+)E465,.-^IO M@%P7J/T58_)IH@.G^;]X?P%02P,$% @ M9Y^5I\LO&U9 P -PH !D M !X;"]W;W)K&ULK59=C^(V%/TK5JI65*KR#0Q3 MB,2$H$7:'4; [&Y5]<&37$BZB4UM!V;_?6TGDP4FA#[T);&=>X[/<6S?.SY2 M]HVG *]%CGA$R,58G]O63Q.H<#U;#DF0%$)Y1@AAL)\;4N0\=6P%TQ.<,CORDC925%TJ_JFGG!'$*:?\D2D4Z,.P,EL,5E M+E;T^ %J0WW%%].=H%87+QW#Q<3'=+):/:F2]F6Z>-\O5'V@UW41H^CA#T7P>A9O%YPAM MIE^KX=X,!,YR_NO8$E*2(K;B>OJ':GKWRO2.BSY1(E*.(I) \QMR;==M$13^=[C3(<=KUM?3?-X5O@6):0%H@U_1+.-Q3GG) M /TY?>&"R2W\5]N258Q^.Z,ZU_=\CV.8&/+@[V(/YI PSGB HM24/8=";D.# MHLUUQC327NGT.@6VJ?W XM7,CZ$QF MOY'9[Y2YEO) 20/>IJL;W+-->_ASV]8/;P.]2^"9_D&C?]"]S)3)VXJ@K-IK M5XUTL_1\T^^W&[D!')C>7:>186-DV,D4IICL0/I !YR7N+KG+KKI%J!*!E!@J(]HX=,IS^<_"UO=ID,1>M_ MJ@AE:CS=Y+9M>Q=GH8[S+^.&H_;S,&HDCSHE+T4*K$W8J%W8<' AK)N^YYC> MNQ-S)M2Q?V0ONY,KVFY!%P*=-TM-\DZX[U\(OS&;5.Y>.;+620HN@.UT9<)1 M3$LBJN35C#;5SU3G_(OQ!U45Z=3^@Z8JJ3YAMLL(1SEL):5M#N7]PJHJI>H( MNM>)_H4*63;H9BHK.V J0'[?4BK>.FJ"IE8,_@502P,$% @ M9Y^5F]Q M9>/A @ (0@ !D !X;"]W;W)K&ULK59M;]HP M$/XK5E9-K;0U+T!H.XA$H=/ZH5W5MTV:]L$D![&:V,QV@/[[G1W(TA*BK=H7 MXI>[YY[G;-\Q6 GYI%( 3=9YQM702;5>G+FNBE/(J3H6"^"X,Q,RIQJG&CPR6*G:F!@E4R&> MS.0R&3J>(009Q-H@4/PL80Q99H"0QJ\-IE.%-([U\1;]L]6.6J94P5ADWUBB MTZ%SXI $9K3(]*U8?8&-GI[!BT6F["]9E;:]T"%QH;3(-\[((&>\_-+U)@\U M!W^?0[!Q"%X[=/J,:QLTIWFF) MNPS]='1Y/?YZ=4'N1]_)X00T99DBUU1*:K)[1#Z2A[L).3PX(@>$<7*?BD)1 MGJB!JS&X@7#C3:#S,E"P)Y ?D"O!=:K(!4\@>0G@(NN*>K"E?AZT(DX@/B8= M_P,)O"!H(#3^>W>_A4ZGRF3'XG7V99+'(@=R3]=DPE2<"55((#]&4Z4E7M:? M32DK$;O-B.8!GZD%C6'HX M5()?@1._?^:'WJ4GN?P)[(;Y;B>^VH4?C0DK@ M&N^(38+&)"RD6#+SV)N$EV@]BV8*S3+J] ;NLBZG-> ;Y?0J.;U6.1.8 0I* MZGI@C953 9D"AQG33:I*T+"NRGNEJC7N&U6%E:JP5=4CS0I:%L\,JS?E,1#L M Z;JE6J-3*H4Z,;W'>ZH\[U3[[7 <.=D3_HUHQ?$^Q7Q?BOQ:^QFV+=,4>)S M@B]+D1AKU#.27U&9-)'M[UZPT_X.V=:P_WH:;JT*YR#GMCDA4U%P71;D:K7J M?R-;]MT_YF7SO*)RSK@B&1SH09NU)@<<_F<#%P_?.\ZAFZ4)W3@WI^]_3'/U=4;QUQ/WIV<=.[/ MK[;M9Q5P[GI6TLL]2"\Z'9P80(P\W(]\%S=&W=NDKI:?:B+C>(JY118W':7U MA GF'-O3^?/K-[(%+;)S$WJ=O>JTHTP8L6]/=S/?.F&O[L)A/\U%VXR!:PR: MGV34>2!\X(X(9V/)P"LE&>-+8^Z"89+S7#I*WP4ZH ^6\M' OIG!#5+S9$SD MLHIM(IC?XWKY%K":@4#&>2.PZQK#L%\0I:@4UWI2+:Z,3R"G'M\M"ZUP*LG2 M[UZZK4-UT4'&N4RH;,+X[LHT['.:@AS)IC.XJKSP %0JS_0@862:"U)I6'G4 M TT[H9S?PM/C>[K!O4C7=JYJ"-$,M:!Z:&C,!/C7V0SW.NWEBWB=@CWDZM-< MIR.J.;0:O9$T98MJOD@; 1B[C[.3HN#+CYQ-149-\GL''/;)RL^9Y9(]ZFC0 M*A-MH-)U'JA4;+)N^2E)<4<7:M5.BQ37W#U"S?^VSE,JJ"1\7;3N_4.N\HL5 MUZ_;U]!JSTUG_$$.HI" M^@(?L[@-L3W=U")8IWHE8IGBM ;'7#3SBV+[;6!SPP'8!ZQV(;X\#/67W M"0+854P;=@?C2!QC"/2BO4?#$*E."%_[_F!W21#$L1T!S*X@"# $[D8-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO M8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( +6>?E;@:^7J M" 8 #HR / >&PO=V]R:V)O;VLN>&ULQ9MM;YM($(#_RLJ?U*>SFZ:Y_3B?U[N;])C4?Y2W:2%?.935,6GDT^K;O+ZM MTF1?WZ1I<\SGRF)AS(])5LS./CV=:UO-X9.R27=-5A;R8'O@,DL?ZN?7VZ?L M/JNSZRS/FG]/9]W?>3ICQZS(CMF/='\Z6\Q8?5,^7)15]J,LFB0/=U69YZ>S M9?_"95HUV>[5X;"%C)+KNCO2)-=!(D%.9\9"GO"05773O:,[?R(9[U/YYO[9 M75.NLKQ)*R=ITG55WMUFQ;?V-/);S,'7Z.+P]-@'\6/U?\)8'@[9+G7*W=TQ M+9H^CE6:MX!%?9/=UC-6),?T=&:7]VG5?A_Y 6+??[=&0H%(51\S^4(E]AT> M)4I1EWFVEY^^9^=)GA2[E'4AK &@@@ J;P;(3K8)@%012'5"R+"%:/^A9N6! M^;>#H=802.TM(%O&L"EWWP&DCD#J;Q9).ZEO *2!0!JTD)X5Q0%G_HKY6QY8 MD?"]$)"9")E)2Q;&FXT57+5HH5A[8B5LRXN89=M^[$4"0+Y'(-_30JY]X:V9 M[7LV#SR ] %!^D"+=!Z'PN-A*"/U5RQ"\7)(EPMLB5[0PCV.7L@";G-Q:9V[ M'**A]B#6A_ NN1?YP14$PFRQ)-;%-FBG9'3%+,]A7([E=B,!(1VFB26Q)]:^ M[WP6KMO1"2^RO+60H\FL,.31X'K#/+&D%D7 '1&QE64+5\X$'G:XKIP@[;IB M0TS,%$MB503_8+2$P72V)?A)%O_WGANPX/ MPJ_=.A/!)5#!=*$0ZV(X+Z+ \D++?BDT!;.&0EUTM.KWHCYSZ@9YS?UU8&TO MA,T<"V*BE0>Q2X0GKT7.(NL+),+\H1#[ TWOOBH0$Q.(0BP0'%.%F)A %&*! MC"9]["1*)$;]&Z3$'*(0.V0D^QMEQ&2B$,OD9QHX2H;91"&VR7@^.(J)^40A M]@F>&#+8Y<#4HDZJED%>TX848F)^48G],I)VC8VXBLE%)9;+J_QKE!#M:5$W MM;!$C)U 3$PV*K5L1E*QT5ABJE&IVUI8QC,0MXJY1B5VS7/&,QI!3#$J=6?+ MON!.['8E* \CL>D6HCCDJ]B5TPAB8KY1B7T#,67.(Y@CW#@2EYR%W(X#B(GY M1J6N7] ,38,-:\PW&K%O!IU"=N*D39+E-?.2JI)OOH>8F&\T8M_ 09=9FB\# M^K>\.%>6"-BEY4),3#D:L7)0S,$BI&'>T8B]\XNT_&GP(2:ZFT+M'3C3T0ZM MAIE'(S;/:/GP/)$@)F8>C=@\,)J@FG@$A1;2, MI$UIHI+2 F)B%M#>J>A[# M"3$Q"VG4%@+1'*F X(XD9B&=V$(0;OE:')9N!6R 5IL,5M8!8RR/=VD*[18'DW M, L9$]9"GZT@L#I>6U;J7?L(8F(6,B:TD!]'H92ZTY;$C\@0$[.0,6$M]#.: MS[P0$[.0,:&%NK8A\[=]=;E^&4WT[K()+33 ?,?XERUL=1F8A8P):Z$>4\[] M+??"?N&$F)B%#&H+C?:'?]H28F(6,H@M].M=^PX6WEZ(6H4Y4+J)2]-K"\S^"FA7*(B)2<@DEA#<8WG9T$X',PASD-DY:-Z]N3[[M$\/69'N M/?D)M3R^2_+=MF+M0W>KE*+I[>U2A[L\M^4QOW#+9/_TTX>GGVV<_0=02P,$ M% @ M9Y^5G-\>"Q1 @ ^RP !H !X;"]?A)Q1JA 7/X)GQ#P^%(.S;AO3\-NWPV+S^/A-*RJW3AVO^IZ6._*L1GN MVJZW5=4_OZ6J MGCM(($CF#U((TOF##()L_B"'()\_*" HY@_*$)3G#[J'H/OY@QX@Z&'^H+1$ M&9<$21.L";1.R'4B\#HAV(E [(1D)P*S$Z*="-1.R'8B<#LAW(E [H1T)P*[ M$^*="/06U%L(]!;46PCTELG#-H'>@GH+@=Z">@N!WH)Z"X'>@GH+@=Z">@N! MWH)Z"X'>@GH+@=Z*>BN!WHIZ*X'>BGHK@=XZ>5E"H+>BWDJ@MZ+>2J"WHMY* MH+>BWDJ@MZ+>2J"WHMY*H+>AWD:@MZ'>1J"WH=Y&H+>AWD:@MTU>=A/H;:BW M$>AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z.VHMQ/H[:BW$^CMJ+<3Z.VHMQ/H[:BW M$^CMDX^5!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>@?J'01Z!^H=!'H'ZAT$>@?J M'01Z!^H=!'H'ZAT$>L?D9Q,"O0/U#@*] _4. KT#]0X"O3/JG0GTSJAW)M [ MH]Z90.^,>F<"O3/JG0GTSJAW)M [H][Y)_4>QJ]#&:X]WVN\_D]2/9[/+=?+ M7Y;?.R?W^ 7G^K9B>/H+4$L#!!0 ( +6>?E;.%^TK=B>7OT%&>'OAOBJMBEY+\S M%NL=]3:6SM.05[8N]#;EK^&>>5OO[3TQL5@85KLAT9#F::Q1K)<_:6L?NC3[ M=<@_Q]8-JR)0%XO9C]/&,6M56.^[MK8IK[/'H7F7,G].*//):4_Y0T% M^S!A7/E[P/.YWX\40MO0;&-#NK%]WL4.'8OIV%$LSY?XH$>WW;8U-:Y^Z/.1 M,OI MHD[HM1WY:GHU?GDE&^83I_\XORIS+G O',3G(]Y8H$^'_)Q?VTSPBFQZ7W_';&;_6_V0? J0/"=*' M NE#@_1A0/JH0/KX!M+'-4@??('2"(JH'(54CF(J1T&5HZC*45CE**YR%%@Y MBJP"15:!(JM D56@R"I09!4HL@H4606*K )%5H$BJT215:+(*E%DE2BR2A19 M)8JL$D56B2*K1)%5HLBJ4&15*+(J%%D5BJP*15:%(JM"D56AR*I09%4HLFH4 M636*K!I%5HTBJT:15:/(JE%DU2BR:A19-8JL!D56@R*K09'5H,AJ4&0U*+(: M%%D-BJP&15:#(FN%(FN%(FN%(FN%(FN%(FN%(FOUE;+>.;?_S_'3L^QM.[SD ML^DOONL_4$L! A0#% @ M9Y^5@=!36*! L0 ! M ( ! &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4 " "UGGY6E."+5^T M K @ $0 @ &O 9&]C4')O<',O8V]R92YX;6Q02P$" M% ,4 " "UGGY6F5R<(Q & "<)P $P @ '+ 0 >&PO M=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( +6>?E8S(8.Q'0@ $<\ 8 M " @0P( !X;"]W;W)K&PO M=V]R:W-H965T&UL4$L! A0#% @ M9Y^5CDY?!6B! M#Q@ !@ ("!Q!@ 'AL+W=O?E;_>1ZP?08 -T= 8 " @9P= M !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ M9Y^5D9<5V(S"0 !BP !@ M ("!B2\ 'AL+W=O M?E:^'B_E,0< /D. 8 " @?(X !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% M @ M9Y^5DQ&UL4$L! M A0#% @ M9Y^5JOP >&PO=V]R:W-H965T?E:QK"[^/ , .H& 9 " M@1Q^ !X;"]W;W)K&UL4$L! A0#% @ M9Y^ M5@M]-1EI!0 X L !D ("!CX$ 'AL+W=O&PO=V]R:W-H965T?E:"B[GB0@, %,' 9 " @5V+ !X;"]W;W)K M&UL4$L! A0#% @ M9Y^5G92G$E^!0 0T M !D ("!UHX 'AL+W=O&PO=V]R:W-H965T?E9GX6"_ MA @ (X3 9 " @9"7 !X;"]W;W)K&UL4$L! A0#% @ M9Y^5G%/X>:Q# [B( !D M ("!2Z 'AL+W=O&PO=V]R:W-H965T M?E9R\5Y1"@0 )\( 9 M " @8VQ !X;"]W;W)K&UL4$L! A0# M% @ M9Y^5K=H@0V"!0 8PP !D ("!SK4 'AL+W=O M&PO=V]R:W-H965T?E9XOTA9] , +$( 9 " @7KH M !X;"]W;W)K&UL4$L! A0#% @ M9Y^5D6N MV]S6 P 30@ !D ("!I>P 'AL+W=O&PO=V]R:W-H965T?E:IP1&UL4$L! A0#% @ M9Y^5D3#ZDD+ P @P8 !D M ("!6/8 'AL+W=O" &0 @(&:^0 >&PO M=V]R:W-H965T?E8B^7&:MP( M /@% 9 " @6?] !X;"]W;W)K&UL4$L! A0#% @ M9Y^5KSV/ <= P 40< !D ("! M50 ! 'AL+W=O&PO=V]R:W-H965T?E:@8H=6900 (T* 9 M " @:@& 0!X;"]W;W)K&UL4$L! A0#% M @ M9Y^5NVEF:_U!@ .Q0 !D ("!1 L! 'AL+W=O&PO=V]R:W-H965T M?E;^S$ &UL4$L! A0#% @ M9Y^5IB4%P/*!0 QB0 !D M ("!6BD! 'AL+W=O4(F"0& !&*0 &0 @(%;+P$ >&PO=V]R M:W-H965T?E9J!_Q59 ( !,% M 9 " @;8U 0!X;"]W;W)K&UL M4$L! A0#% @ M9Y^5CBFUF:N" S5X !D ("!43@! M 'AL+W=O&PO=V]R:W-H965T?E:X9!!#TP( /0) 9 M " @?1# 0!X;"]W;W)K&UL4$L! A0#% @ MM9Y^5J]2"="A @ !P< !D ("!_D8! 'AL+W=O&PO=V]R:W-H965T?E92!I-_&UL4$L! A0#% @ M9Y^5D"PKQ_/ P MK!$ !D ("!I5 ! 'AL+W=O&PO=V]R:W-H965T?E9! M!WT1P@, T3 9 " @8Y7 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^5KB6!',N P V@8 !D M ("!AUL! 'AL+W=O&PO=V]R:W-H M965T?E9C;T_VP 0 )H= 9 M " @69B 0!X;"]W;W)K&UL4$L! M A0#% @ M9Y^5J(!WY() P ?PL !D ("!76&PO=V]R:W-H965T?E8R5<*5H0H +Z: 9 " M@8-M 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^ M5@SWK;C2 @ ,@@ !D ("!6W@! 'AL+W=OP$ >&PO=V]R:W-H965T?E8&:2ELK0, (8/ 9 " @4U_ 0!X;"]W;W)K M&UL4$L! A0#% @ M9Y^5KD.EXB!! -QD M !D ("!,8,! 'AL+W=O&PO=V]R:W-H965T?E:6;Z!P M^@4 ",F 9 " @=B+ 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^5LG(PUW,!@ J3< !D M ("!"9(! 'AL+W=O(G?(# !K$0 &0 @($,F0$ >&PO=V]R:W-H965T M?E9M@5V#9PD %QB 9 M " @36= 0!X;"]W;W)K&UL4$L! A0# M% @ M9Y^5JO2]T2F @ V@8 !D ("!TZ8! 'AL+W=O M&PO=V]R:W-H965T?E;+&-VEQ00 /H5 9 " @<^Y M 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^5CD8 M1CK@ @ 0 D !D ("!R[X! 'AL+W=O:)P" #C!@ &0 M @('BP0$ >&PO=V]R:W-H965T?E9J'6OD?P, !@+ 9 " @;7$ 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^5K[@4C&3 @ :P8 !D M ("!:\@! 'AL+W=O&PO M=V]R:W-H965T?E9O<67CX0( M "$( 9 " @<7. 0!X;"]W;W)K&UL4$L! A0#% @ M9Y^5@[W]PEA P SA4 T ( ! MW=$! 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL M4$L! A0#% @ M9Y^5G-\>"Q1 @ ^RP !H ( !A]P! M 'AL+U]R96QS+W=O XML 92 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 93 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 94 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 261 430 1 false 111 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://omniqinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://omniqinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://omniqinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) Sheet http://omniqinc.com/role/StatementOfStockholdersEquityDeficit Consolidated Statement of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash flows Sheet http://omniqinc.com/role/StatementsOfCashFlows Consolidated Statements of Cash flows Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS Sheet http://omniqinc.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://omniqinc.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - BUSINESS ACQUISITIONS Sheet http://omniqinc.com/role/BusinessAcquisitions BUSINESS ACQUISITIONS Notes 10 false false R11.htm 00000011 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://omniqinc.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORY Sheet http://omniqinc.com/role/Inventory INVENTORY Notes 12 false false R13.htm 00000013 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://omniqinc.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 13 false false R14.htm 00000014 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://omniqinc.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 14 false false R15.htm 00000015 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT Sheet http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit CREDIT FACILITIES AND LINE OF CREDIT Notes 15 false false R16.htm 00000016 - Disclosure - RELATED PARTY NOTES PAYABLE Notes http://omniqinc.com/role/RelatedPartyNotesPayable RELATED PARTY NOTES PAYABLE Notes 16 false false R17.htm 00000017 - Disclosure - OTHER NOTES PAYABLE Notes http://omniqinc.com/role/OtherNotesPayable OTHER NOTES PAYABLE Notes 17 false false R18.htm 00000018 - Disclosure - OTHER LIABILITIES Sheet http://omniqinc.com/role/OtherLiabilities OTHER LIABILITIES Notes 18 false false R19.htm 00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://omniqinc.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 00000020 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://omniqinc.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 20 false false R21.htm 00000021 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://omniqinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 21 false false R22.htm 00000022 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA Sheet http://omniqinc.com/role/ConcentrationAndGeographicData CONCENTRATION AND GEOGRAPHIC DATA Notes 22 false false R23.htm 00000023 - Disclosure - INCOME TAX Sheet http://omniqinc.com/role/IncomeTax INCOME TAX Notes 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - BUSINESS ACQUISITIONS (Tables) Sheet http://omniqinc.com/role/BusinessAcquisitionsTables BUSINESS ACQUISITIONS (Tables) Tables http://omniqinc.com/role/BusinessAcquisitions 26 false false R27.htm 00000027 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://omniqinc.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://omniqinc.com/role/AccountsReceivable 27 false false R28.htm 00000028 - Disclosure - INVENTORY (Tables) Sheet http://omniqinc.com/role/InventoryTables INVENTORY (Tables) Tables http://omniqinc.com/role/Inventory 28 false false R29.htm 00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://omniqinc.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://omniqinc.com/role/PropertyAndEquipment 29 false false R30.htm 00000030 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://omniqinc.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://omniqinc.com/role/GoodwillAndIntangibleAssets 30 false false R31.htm 00000031 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables) Notes http://omniqinc.com/role/RelatedPartyNotesPayableTables RELATED PARTY NOTES PAYABLE (Tables) Tables http://omniqinc.com/role/RelatedPartyNotesPayable 31 false false R32.htm 00000032 - Disclosure - OTHER NOTES PAYABLE (Tables) Notes http://omniqinc.com/role/OtherNotesPayableTables OTHER NOTES PAYABLE (Tables) Tables http://omniqinc.com/role/OtherNotesPayable 32 false false R33.htm 00000033 - Disclosure - OTHER LIABILITIES (Tables) Sheet http://omniqinc.com/role/OtherLiabilitiesTables OTHER LIABILITIES (Tables) Tables http://omniqinc.com/role/OtherLiabilities 33 false false R34.htm 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://omniqinc.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://omniqinc.com/role/CommitmentsAndContingencies 34 false false R35.htm 00000035 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://omniqinc.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://omniqinc.com/role/StockholdersEquity 35 false false R36.htm 00000036 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Tables) Sheet http://omniqinc.com/role/ConcentrationAndGeographicDataTables CONCENTRATION AND GEOGRAPHIC DATA (Tables) Tables http://omniqinc.com/role/ConcentrationAndGeographicData 36 false false R37.htm 00000037 - Disclosure - INCOME TAX (Tables) Sheet http://omniqinc.com/role/IncomeTaxTables INCOME TAX (Tables) Tables http://omniqinc.com/role/IncomeTax 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Sheet http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) Sheet http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) Details 39 false false R40.htm 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://omniqinc.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://omniqinc.com/role/GoingConcern 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Sheet http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Details 43 false false R44.htm 00000044 - Disclosure - BUSINESS ACQUISITIONS (Details Narrative) Sheet http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative BUSINESS ACQUISITIONS (Details Narrative) Details http://omniqinc.com/role/BusinessAcquisitionsTables 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 45 false false R46.htm 00000046 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) Sheet http://omniqinc.com/role/AccountsReceivableDetailsNarrative ACCOUNTS RECEIVABLE (Details Narrative) Details http://omniqinc.com/role/AccountsReceivableTables 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF INVENTORY (Details) Sheet http://omniqinc.com/role/ScheduleOfInventoryDetails SCHEDULE OF INVENTORY (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 48 false false R49.htm 00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://omniqinc.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://omniqinc.com/role/PropertyAndEquipmentTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details) Sheet http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details) Sheet http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details) Details 51 false false R52.htm 00000052 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Sheet http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Details http://omniqinc.com/role/GoodwillAndIntangibleAssetsTables 52 false false R53.htm 00000053 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) Sheet http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) Details http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) Notes http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) Details 54 false false R55.htm 00000055 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative) Notes http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative RELATED PARTY NOTES PAYABLE (Details Narrative) Details http://omniqinc.com/role/RelatedPartyNotesPayableTables 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details) Notes http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails SCHEDULE OF OTHER NOTES PAYABLE (Details) Details 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details) Sheet http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details) Details 57 false false R58.htm 00000058 - Disclosure - OTHER NOTES PAYABLE (Details Narrative) Notes http://omniqinc.com/role/OtherNotesPayableDetailsNarrative OTHER NOTES PAYABLE (Details Narrative) Details http://omniqinc.com/role/OtherNotesPayableTables 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details) Sheet http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails SCHEDULE OF OTHER LIABILITIES (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details) Sheet http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Sheet http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Details 61 false false R62.htm 00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://omniqinc.com/role/CommitmentsAndContingenciesTables 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) Sheet http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails SCHEDULE OF WARRANTS ACTIVITY (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) Sheet http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails SCHEDULE OF OUTSTANDING WARRANTS (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) Sheet http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) Details 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details) Sheet http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails SCHEDULE OF STOCK OPTIONS GRANTED (Details) Details 66 false false R67.htm 00000067 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) Sheet http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) Details 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF STOCK COMPENSATION EXPENSE (Details) Sheet http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails SCHEDULE OF STOCK COMPENSATION EXPENSE (Details) Details 68 false false R69.htm 00000069 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://omniqinc.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://omniqinc.com/role/StockholdersEquityTables 69 false false R70.htm 00000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://omniqinc.com/role/RelatedPartyTransactions 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF REVENUES (Details) Sheet http://omniqinc.com/role/ScheduleOfRevenuesDetails SCHEDULE OF REVENUES (Details) Details 71 false false R72.htm 00000072 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative) Sheet http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative) Details http://omniqinc.com/role/ConcentrationAndGeographicDataTables 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details) Sheet http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details) Details 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details) Sheet http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details) Details 75 false false R76.htm 00000076 - Disclosure - INCOME TAX (Details Narrative) Sheet http://omniqinc.com/role/IncomeTaxDetailsNarrative INCOME TAX (Details Narrative) Details http://omniqinc.com/role/IncomeTaxTables 76 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesNoncurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 28, 184, 7259, 10036 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 7230, 7231, 10031, 10032 [dq-0542-Deprecated-Concept] Concept AccountsPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 9494 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 10015, 10016, 10019, 10020, 10027, 10028, 10053, 10065 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentInterestRateStatedPercentage, us-gaap:EffectiveIncomeTaxRateContinuingOperations, us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments, us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:PreferredStockSharesOutstanding - form10-k.htm 183, 185, 191, 192, 193, 194, 218, 219, 220, 221 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorFirmId must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorFirmId fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 6788 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorLocation must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorLocation fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 6974 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorName must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorName fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 6971 form10-k.htm ex21-1.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex4-2.htm omqs-20221231.xsd omqs-20221231_cal.xml omqs-20221231_def.xml omqs-20221231_lab.xml omqs-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 97 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 25, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1023, "http://xbrl.sec.gov/dei/2022": 41 }, "contextCount": 261, "dts": { "calculationLink": { "local": [ "omqs-20221231_cal.xml" ] }, "definitionLink": { "local": [ "omqs-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "omqs-20221231_lab.xml" ] }, "presentationLink": { "local": [ "omqs-20221231_pre.xml" ] }, "schema": { "local": [ "omqs-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 681, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 144, "http://omniqinc.com/20221231": 50, "http://xbrl.sec.gov/dei/2022": 3, "total": 197 }, "keyCustom": 61, "keyStandard": 369, "memberCustom": 72, "memberStandard": 34, "nsprefix": "OMQS", "nsuri": "http://omniqinc.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://omniqinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - BUSINESS ACQUISITIONS", "menuCat": "Notes", "order": "10", "role": "http://omniqinc.com/role/BusinessAcquisitions", "shortName": "BUSINESS ACQUISITIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE", "menuCat": "Notes", "order": "11", "role": "http://omniqinc.com/role/AccountsReceivable", "shortName": "ACCOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORY", "menuCat": "Notes", "order": "12", "role": "http://omniqinc.com/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "13", "role": "http://omniqinc.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "menuCat": "Notes", "order": "14", "role": "http://omniqinc.com/role/GoodwillAndIntangibleAssets", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT", "menuCat": "Notes", "order": "15", "role": "http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit", "shortName": "CREDIT FACILITIES AND LINE OF CREDIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - RELATED PARTY NOTES PAYABLE", "menuCat": "Notes", "order": "16", "role": "http://omniqinc.com/role/RelatedPartyNotesPayable", "shortName": "RELATED PARTY NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - OTHER NOTES PAYABLE", "menuCat": "Notes", "order": "17", "role": "http://omniqinc.com/role/OtherNotesPayable", "shortName": "OTHER NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - OTHER LIABILITIES", "menuCat": "Notes", "order": "18", "role": "http://omniqinc.com/role/OtherLiabilities", "shortName": "OTHER LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "19", "role": "http://omniqinc.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://omniqinc.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "20", "role": "http://omniqinc.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "21", "role": "http://omniqinc.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:GeographicDataTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA", "menuCat": "Notes", "order": "22", "role": "http://omniqinc.com/role/ConcentrationAndGeographicData", "shortName": "CONCENTRATION AND GEOGRAPHIC DATA", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:GeographicDataTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INCOME TAX", "menuCat": "Notes", "order": "23", "role": "http://omniqinc.com/role/IncomeTax", "shortName": "INCOME TAX", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "24", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "25", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DangotComputersLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - BUSINESS ACQUISITIONS (Tables)", "menuCat": "Tables", "order": "26", "role": "http://omniqinc.com/role/BusinessAcquisitionsTables", "shortName": "BUSINESS ACQUISITIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_DangotComputersLimitedMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "menuCat": "Tables", "order": "27", "role": "http://omniqinc.com/role/AccountsReceivableTables", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - INVENTORY (Tables)", "menuCat": "Tables", "order": "28", "role": "http://omniqinc.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "29", "role": "http://omniqinc.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://omniqinc.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "30", "role": "http://omniqinc.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables)", "menuCat": "Tables", "order": "31", "role": "http://omniqinc.com/role/RelatedPartyNotesPayableTables", "shortName": "RELATED PARTY NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - OTHER NOTES PAYABLE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://omniqinc.com/role/OtherNotesPayableTables", "shortName": "OTHER NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - OTHER LIABILITIES (Tables)", "menuCat": "Tables", "order": "33", "role": "http://omniqinc.com/role/OtherLiabilitiesTables", "shortName": "OTHER LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://omniqinc.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "35", "role": "http://omniqinc.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "OMQS:GeographicDataTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Tables)", "menuCat": "Tables", "order": "36", "role": "http://omniqinc.com/role/ConcentrationAndGeographicDataTables", "shortName": "CONCENTRATION AND GEOGRAPHIC DATA (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "OMQS:GeographicDataTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - INCOME TAX (Tables)", "menuCat": "Tables", "order": "37", "role": "http://omniqinc.com/role/IncomeTaxTables", "shortName": "INCOME TAX (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "OMQS:ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "38", "role": "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "OMQS:ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "39", "role": "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails", "shortName": "SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-6", "first": true, "lang": null, "name": "OMQS:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - GOING CONCERN (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://omniqinc.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-6", "first": true, "lang": null, "name": "OMQS:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "menuCat": "Details", "order": "42", "role": "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotSharePurchaseAgreementMember_custom_DangotComputersLimitedMember", "decimals": "-3", "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotComputersLimitedMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "menuCat": "Details", "order": "43", "role": "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "shortName": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotComputersLimitedMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-10-02", "decimals": "INF", "first": true, "lang": null, "name": "OMQS:PurchaseOfAdditionalOptionPercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - BUSINESS ACQUISITIONS (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "shortName": "BUSINESS ACQUISITIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-10-02", "decimals": "INF", "first": true, "lang": null, "name": "OMQS:PurchaseOfAdditionalOptionPercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "menuCat": "Details", "order": "45", "role": "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "shortName": "ACCOUNTS RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF INVENTORY (Details)", "menuCat": "Details", "order": "47", "role": "http://omniqinc.com/role/ScheduleOfInventoryDetails", "shortName": "SCHEDULE OF INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "48", "role": "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_ManufacturingAndLabEquipmentMember", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://omniqinc.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)", "menuCat": "Statements", "order": "5", "role": "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "shortName": "Consolidated Statement of Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "50", "role": "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails", "shortName": "SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details)", "menuCat": "Details", "order": "51", "role": "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-03-25_custom_BusinessFinanceAgreementMember_custom_BridgeBankMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "shortName": "CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-03-25_custom_BusinessFinanceAgreementMember_custom_BridgeBankMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details)", "menuCat": "Details", "order": "54", "role": "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "shortName": "SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "p", "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative)", "menuCat": "Details", "order": "55", "role": "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "shortName": "RELATED PARTY NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "OMQS:RelatedPartyNotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details)", "menuCat": "Details", "order": "56", "role": "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails", "shortName": "SCHEDULE OF OTHER NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:OtherNotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details)", "menuCat": "Details", "order": "57", "role": "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "shortName": "SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_OtherNotePayableMember", "decimals": "-3", "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-11", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - OTHER NOTES PAYABLE (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "shortName": "OTHER NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-11", "decimals": "-3", "lang": null, "name": "us-gaap:LoansPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details)", "menuCat": "Details", "order": "59", "role": "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash flows", "menuCat": "Statements", "order": "6", "role": "http://omniqinc.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details)", "menuCat": "Details", "order": "60", "role": "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails", "shortName": "SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "menuCat": "Details", "order": "61", "role": "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)", "menuCat": "Details", "order": "63", "role": "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails", "shortName": "SCHEDULE OF WARRANTS ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "OMQS:ScheduleOfOutstandingWarrantsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_WarrantMember45030296", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details)", "menuCat": "Details", "order": "64", "role": "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "OMQS:ScheduleOfOutstandingWarrantsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_WarrantMember45030296", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details)", "menuCat": "Details", "order": "65", "role": "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details)", "menuCat": "Details", "order": "66", "role": "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails", "shortName": "SCHEDULE OF STOCK OPTIONS GRANTED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details)", "menuCat": "Details", "order": "67", "role": "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "shortName": "SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_FebruarySeventeenTwoThoudsandTwentyTwoMember", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockOptionPlanExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF STOCK COMPENSATION EXPENSE (Details)", "menuCat": "Details", "order": "68", "role": "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails", "shortName": "SCHEDULE OF STOCK COMPENSATION EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockOptionPlanExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "69", "role": "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - NATURE OF OPERATIONS", "menuCat": "Notes", "order": "7", "role": "http://omniqinc.com/role/NatureOfOperations", "shortName": "NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-04-012022-04-01", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentOfFinancingAndStockIssuanceCosts", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "70", "role": "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-02-28_custom_ConsultingAgreementMember_custom_MrCarlosJNissensonMember", "decimals": "INF", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF REVENUES (Details)", "menuCat": "Details", "order": "71", "role": "http://omniqinc.com/role/ScheduleOfRevenuesDetails", "shortName": "SCHEDULE OF REVENUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "OMQS:GeographicDataTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_country_US", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "p", "OMQS:GeographicDataTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative)", "menuCat": "Details", "order": "72", "role": "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "shortName": "CONCENTRATION AND GEOGRAPHIC DATA (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "OMQS:GeographicDataTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "menuCat": "Details", "order": "73", "role": "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "OMQS:DeferredTaxAssetGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details)", "menuCat": "Details", "order": "74", "role": "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "OMQS:DeferredTaxAssetGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details)", "menuCat": "Details", "order": "75", "role": "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails", "shortName": "SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - INCOME TAX (Details Narrative)", "menuCat": "Details", "order": "76", "role": "http://omniqinc.com/role/IncomeTaxDetailsNarrative", "shortName": "INCOME TAX (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "menuCat": "Notes", "order": "9", "role": "http://omniqinc.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 111, "tag": { "OMQS_AccruedPayableToOwner": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Payable to Owner.", "label": "Accrued payable to owner", "verboseLabel": "Payable to owner" } } }, "localname": "AccruedPayableToOwner", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_ActionCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Action Capital [Member]", "label": "Action Capital [Member]" } } }, "localname": "ActionCapitalMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_AdjustmentsForPostAcquisitionToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for post acquisition to additional paid in capital other", "label": "Post-acquisition adjustment" } } }, "localname": "AdjustmentsForPostAcquisitionToAdditionalPaidInCapitalOther", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_AkronMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Akron [Member]", "label": "Akron [Member]" } } }, "localname": "AkronMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_AmortizationOfOperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of operating lease liability.", "label": "AmortizationOfOperatingLeaseLiability", "negatedLabel": "Amortization" } } }, "localname": "AmortizationOfOperatingLeaseLiability", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_AprilTwentyTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 20, 2025 [Member]", "label": "April 20, 2025 [Member]" } } }, "localname": "AprilTwentyTwoThousandTwentyFiveMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_AssetsObtainedNetOfCashIncludingNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net assets obtained net of cash including noncontrolling interest.", "label": "Net assets acquired in business combination" } } }, "localname": "AssetsObtainedNetOfCashIncludingNoncontrollingInterest", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_BlueStarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Blue Star [Member]", "label": "Blue Star [Member]" } } }, "localname": "BlueStarMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board Of Directors [Member]", "label": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_BridgeBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridge Bank [Member]", "label": "Bridge Bank [Member]" } } }, "localname": "BridgeBankMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_BusinessCombinationConsiderationFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of stock issued.", "label": "Fair value of stock issued (220,103 shares)" } } }, "localname": "BusinessCombinationConsiderationFairValue", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer relationship.", "label": "Customer relationship" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed goodwill.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill", "verboseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed trade name.", "label": "Trade name" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessFinanceAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Finance Agreement [Member]", "label": "Business Finance Agreement [Member]" } } }, "localname": "BusinessFinanceAgreementMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ChangeInTermsOfAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in terms of accounts payable.", "label": "Change in terms of accounts payable" } } }, "localname": "ChangeInTermsOfAccountsPayable", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ConversionOfDebtShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of debt shares.", "label": "Conversion of debt, shares" } } }, "localname": "ConversionOfDebtShares", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer [Member]", "label": "Customer [Member]" } } }, "localname": "CustomerMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_DangotComputersLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dangot Computers Ltd [Member]", "label": "Dangot Computers Ltd [Member] [Default Label]", "verboseLabel": "Dangot Computers Ltd [Member]" } } }, "localname": "DangotComputersLimitedMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/BusinessAcquisitionsTables", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "domainItemType" }, "OMQS_DangotComputersLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dangot Computers Ltd [Member]", "label": "Dangot Computers Ltd [Member]" } } }, "localname": "DangotComputersLtdMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_DangotSharePurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dangot Share Purchase Agreement [Member]", "label": "Dangot Share Purchase Agreement [Member]" } } }, "localname": "DangotSharePurchaseAgreementMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "OMQS_DecemberFourTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December 4, 2027 [Member]", "label": "December 4, 2027 [Member]" } } }, "localname": "DecemberFourTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_DeclaredDividendsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Declared dividends payable.", "label": "Declared dividends payable" } } }, "localname": "DeclaredDividendsPayable", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_DeferredTaxAssetGross": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets.", "label": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetGross", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_DeferredTaxAssetsValuationAllowancesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation allowance for deferred tax assets.", "label": "Valuation allowance for deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowancesCurrent", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_DisclosureConcentrationAndGeographicDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration And Geographic Data" } } }, "localname": "DisclosureConcentrationAndGeographicDataAbstract", "nsuri": "http://omniqinc.com/20221231", "xbrltype": "stringItemType" }, "OMQS_DisclosureRelatedPartyNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Notes Payable" } } }, "localname": "DisclosureRelatedPartyNotesPayableAbstract", "nsuri": "http://omniqinc.com/20221231", "xbrltype": "stringItemType" }, "OMQS_DividendDeclaredToNonControllingInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividend declared to non controlling interest.", "label": "Dividend declared to non-controlling interest" } } }, "localname": "DividendDeclaredToNonControllingInterest", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_EmployeesAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees And Consultants [Member]", "label": "Employees And Consultants [Member]" } } }, "localname": "EmployeesAndConsultantsMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_EquityComponentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity component description.", "label": "Equity component description" } } }, "localname": "EquityComponentDescription", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "OMQS_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Incentive Plan [Member]", "label": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 5 [Member]", "label": "Exercise Price Range 5 [Member]" } } }, "localname": "ExercisePriceRangeFiveMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 4 [Member]", "label": "Exercise Price Range 4 [Member]" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 1 [Member]", "label": "Exercise Price Range 1 [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 6 [Member]", "label": "Exercise Price Range 6 [Member]" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 3 [Member]", "label": "Exercise Price Range 3 [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 2 [Member]", "label": "Exercise Price Range 2 [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExerciseToPurchaseAdditionalDangotAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise to purchase additional dangot acquisition.", "label": "Exercise to purchase additional Dangot shares" } } }, "localname": "ExerciseToPurchaseAdditionalDangotAcquisition", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_FebruarySeventeenTwoThoudsandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 17, 2022 [Member]", "label": "February 17, 2022 [Member]" } } }, "localname": "FebruarySeventeenTwoThoudsandTwentyTwoMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruarySeventeenTwoThoudsandTwentyTwoOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 17, 2022 [Member]", "label": "February 17, 2022 [Member] [Default Label]", "verboseLabel": "February 17, 2022 [Member]" } } }, "localname": "FebruarySeventeenTwoThoudsandTwentyTwoOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruaryTwentyEightTwoThoudsandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 28, 2023 [Member]", "label": "February 28, 2023 [Member]" } } }, "localname": "FebruaryTwentyEightTwoThoudsandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruaryTwentySevenThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February Twenty Seven Thousand Twenty Two [Member]", "label": "February Twenty Seven Thousand Twenty Two [Member]" } } }, "localname": "FebruaryTwentySevenThousandTwentyTwoMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_GeographicDataTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Geographic Data [Text Block]", "label": "CONCENTRATION AND GEOGRAPHIC DATA" } } }, "localname": "GeographicDataTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicData" ], "xbrltype": "textBlockItemType" }, "OMQS_HaimDangotMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haim Dangot [Member]", "label": "Haim Dangot [Member]" } } }, "localname": "HaimDangotMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_HapoalimBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hapoalim Bank [Member]", "label": "Hapoalim Bank [Member]" } } }, "localname": "HapoalimBankMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_HoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Holders [Member]", "label": "Holders [Member]" } } }, "localname": "HoldersMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_IncreaseDecreaseInRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in right of use asset.", "label": "IncreaseDecreaseInRightOfUseAsset", "verboseLabel": "Increase" } } }, "localname": "IncreaseDecreaseInRightOfUseAsset", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_IncreaseDecreasesInOperatingLeaseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decreases in operating lease asset.", "label": "Increase" } } }, "localname": "IncreaseDecreasesInOperatingLeaseAsset", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_IncreaseDecreasesInOperatingLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease liability.", "label": "Decrease" } } }, "localname": "IncreaseDecreasesInOperatingLeaseLiability", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in accounts payable and accrued liabilities, related party.", "label": "IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty", "verboseLabel": "Accrued interest and accrued liabilities, related party" } } }, "localname": "IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_IntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets intangible assets indefinite lived policy.", "label": "Definite-lived Intangible Assets" } } }, "localname": "IntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "OMQS_IsraeliPrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Israeli Prime Rate [Member]", "label": "Israeli Prime Rate [Member]" } } }, "localname": "IsraeliPrimeRateMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_JulySevenTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 7, 2026 [Member]", "label": "July 7, 2026 [Member]" } } }, "localname": "JulySevenTwoThousandTwentySixMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_JulyThirtyOneTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 31, 2023 [Member]", "label": "July 31, 2023 [Member]" } } }, "localname": "JulyThirtyOneTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_JuneFourTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 4, 2026 [Member]", "label": "June 4, 2026 [Member]" } } }, "localname": "JuneFourTwoThousandTwentySixMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_LeumiBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leumi Bank [Member]", "label": "Leumi Bank [Member]" } } }, "localname": "LeumiBankMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_LoansPayableOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans payable outstanding amount.", "label": "Loans payable outstanding amount" } } }, "localname": "LoansPayableOutstandingAmount", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_ManufacturingAndLabEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing and Lab Equipment [Member]", "label": "Manufacturing and Lab Equipment [Member]" } } }, "localname": "ManufacturingAndLabEquipmentMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "OMQS_MarchFirstTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 1, 2027 [Member]", "label": "March 1, 2027 [Member]" } } }, "localname": "MarchFirstTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MarchFirstTwoThousandTwentySevenOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 1, 2027 [Member]", "label": "March 1, 2027 [Member] [Default Label]", "verboseLabel": "March 1, 2027 [Member]" } } }, "localname": "MarchFirstTwoThousandTwentySevenOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MarchTwentyFifthTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March Twenty Fifth Two Thousand Twenty Seven [Member]", "label": "March Twenty Fifth Two Thousand Twenty Seven [Member]" } } }, "localname": "MarchTwentyFifthTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MarchZeroFiveTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 05, 2023 [Member]", "label": "March 05, 2023 [Member]" } } }, "localname": "MarchZeroFiveTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MayEighteenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 18, 2023 [Member]", "label": "May 18, 2023 [Member]" } } }, "localname": "MayEighteenTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MayFirstTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May First Two Thousand Twenty Seven [Member]", "label": "May First Two Thousand Twenty Seven [Member]" } } }, "localname": "MayFirstTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MayFirstTwoThousandTwentySevenOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May First Two Thousand Twenty Seven One[Member]", "label": "May First Two Thousand Twenty Seven One[Member]" } } }, "localname": "MayFirstTwoThousandTwentySevenOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MrCarlosJNissensonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr. Carlos J. Nissenson [Member]", "label": "Mr. Carlos J. Nissenson [Member]" } } }, "localname": "MrCarlosJNissensonMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_NetIncomeAfterNoncommonStockholderDividendsAttributableToNoncontrollingInterest": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net income after noncommon stockholder dividends attributable to noncontrolling interest", "label": "Non-common stockholder dividends attributable to non-controlling interest" } } }, "localname": "NetIncomeAfterNoncommonStockholderDividendsAttributableToNoncontrollingInterest", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "OMQS_NetLossAfterNoncommonStockholderDividends": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net loss after noncommon stockholder dividends", "label": "NetLossAfterNoncommonStockholderDividends", "totalLabel": "Net loss less non-common stockholder dividends" } } }, "localname": "NetLossAfterNoncommonStockholderDividends", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "OMQS_NotePayableMarinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable Marin [Member]", "label": "Note Payable Marin [Member]" } } }, "localname": "NotePayableMarinMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotePayableSecuredSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable Secured Supplier [Member]", "label": "Note Payable Secured Supplier [Member]" } } }, "localname": "NotePayableSecuredSupplierMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotePayableThometMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable Thomet [Member]", "label": "Note Payable - Thomet [Member]" } } }, "localname": "NotePayableThometMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotesPayableOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable Other [Member]" } } }, "localname": "NotesPayableOtherMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "OMQS_NovemberThirtyTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 30, 2023 [Member]", "label": "November 30, 2023 [Member]" } } }, "localname": "NovemberThirtyTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NovemberTwentyThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 20, 2024 [Member]", "label": "November 20, 2024 [Member]" } } }, "localname": "NovemberTwentyThousandTwentyFourMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NumberOfInstallments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of installments.", "label": "Number of installements" } } }, "localname": "NumberOfInstallments", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "integerItemType" }, "OMQS_OctoberFourteenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October Fourteen Two Thousand Twenty Three [Member]", "label": "October Fourteen Two Thousand Twenty Three [Member]" } } }, "localname": "OctoberFourteenTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberSixTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October Six Two Thousand Twenty Four [Member]", "label": "October Six Two Thousand Twenty Four [Member]" } } }, "localname": "OctoberSixTwoThousandTwentyFourMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberThirtyFirstTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 31, 2027 [Member]", "label": "October 31, 2027 [Member]" } } }, "localname": "OctoberThirtyFirstTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberThirtyFirstTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 31, 2023 [Member]", "label": "October 31, 2023 [Member]" } } }, "localname": "OctoberThirtyFirstTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OmniqTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omniq Technologies [Member]", "label": "Omniq Technologies [Member]" } } }, "localname": "OmniqTechnologiesMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Customer [Member]", "label": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OperatingLeaseAssetOfEffectiveForeignExchangeRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease asset of effective foreign exchange rate.", "label": "Effective foreign exchange rates" } } }, "localname": "OperatingLeaseAssetOfEffectiveForeignExchangeRate", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_OperatingLeaseLiabilityEffectiveForeignExchangeRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liability effective foreign exchange rate.", "label": "Effective foreign exchange rate" } } }, "localname": "OperatingLeaseLiabilityEffectiveForeignExchangeRate", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_OtherNotePayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Notes Payable[Member]", "label": "Other Notes Payable[Member]" } } }, "localname": "OtherNotePayableMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails" ], "xbrltype": "domainItemType" }, "OMQS_PaymentForAdditionalOwnershipInSubsidiary": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for additional ownership in subsidiary.", "label": "PaymentForAdditionalOwnershipInSubsidiary", "negatedLabel": "Payment for additional ownership in subsidiary" } } }, "localname": "PaymentForAdditionalOwnershipInSubsidiary", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_PercentageOfPurchaseOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of purchase of shares.", "label": "Purchase of shares, percent" } } }, "localname": "PercentageOfPurchaseOfShares", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_PercentageOfRemainingSharesOnFullyDilutedBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining shares on fully diluted basis.", "label": "Percentage of remaining shares on fully diluted basis" } } }, "localname": "PercentageOfRemainingSharesOnFullyDilutedBasis", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_PercentageOfReserveAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of reserve account.", "label": "Percentage of reserve account" } } }, "localname": "PercentageOfReserveAccount", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_PreferredStockSeriesCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Series C [Member]", "label": "Preferred Stock Series C [Member]" } } }, "localname": "PreferredStockSeriesCMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ProceedsFromRepaymentsOfSaleOfOtherProductiveAssets": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds fom repayments of sale of other productive assets.", "label": "Proceeds from sale (purchase) of other assets" } } }, "localname": "ProceedsFromRepaymentsOfSaleOfOtherProductiveAssets", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_PurchaseOfAdditionalOptionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase of additional option percent.", "label": "Purchase of additional option percent" } } }, "localname": "PurchaseOfAdditionalOptionPercent", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_PurchaseOfPpeWithFinancing": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase of PPP with financing.", "label": "Purchase of PP&E with financing" } } }, "localname": "PurchaseOfPpeWithFinancing", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_RelatedPartyNotesPayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Notes Payable Disclosure [Text Block]", "label": "RELATED PARTY NOTES PAYABLE" } } }, "localname": "RelatedPartyNotesPayableDisclosureTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayable" ], "xbrltype": "textBlockItemType" }, "OMQS_RemainingAcquiredPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining acquired percentage", "label": "Remaining acquired percentage" } } }, "localname": "RemainingAcquiredPercentage", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_RestOfTheWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rest Of The World [Member]" } } }, "localname": "RestOfTheWorldMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "OMQS_ReverseStockSplitPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Stock Split [Policy Text Block]", "label": "Stock-Based Compensation" } } }, "localname": "ReverseStockSplitPolicyTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "OMQS_RightOfUseLeaseAssetOnNonCashInformation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use lease asset on non cash information.", "label": "Right of use asset acquired in exchange for lease liability" } } }, "localname": "RightOfUseLeaseAssetOnNonCashInformation", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_RivalStreetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rival Street [Member]", "label": "Rival Street [Member]" } } }, "localname": "RivalStreetMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SaltLackCityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salt Lack City [Member]", "label": "Salt Lack City [Member]" } } }, "localname": "SaltLackCityMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ScanSourceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scan Source Inc [Member]", "label": "Scan Source Inc [Member]" } } }, "localname": "ScanSourceIncMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Estimated Useful Lives of Property and Equipment.", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT" } } }, "localname": "ScheduleOfEstimatedUsefulLivesPropertyPlantAndEquipmentTableTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "OMQS_ScheduleOfOutstandingWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Outstanding Warrants [Table Text Block]", "label": "SCHEDULE OF OUTSTANDING WARRANTS" } } }, "localname": "ScheduleOfOutstandingWarrantsTableTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "OMQS_ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of warrants outstanding expiry date and exercise prices [Table Text Block]", "label": "SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES" } } }, "localname": "ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "OMQS_SecuredPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Promissory Note [Member]", "label": "Secured Promissory Note [Member]" } } }, "localname": "SecuredPromissoryNoteMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberOneTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 1, 2025 [Member]", "label": "September 1, 2025 [Member]" } } }, "localname": "SeptemberOneTwoThousandTwentyFiveMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberThirtyTwoThousandThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 30, 2030 [Member]", "label": "September 30, 2030 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandThirtyMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberThirtyTwoThousandThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 30, 2030 [Member]", "label": "September 30, 2030 [Member] [Default Label]", "verboseLabel": "September 30, 2030 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandThirtyOneMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "periodEndLabel": "Number of warrants, Exercisable warrants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Exercisable warrants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares.", "label": "Weighted Average Exercise Price, Warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price.", "label": "Weighted Average Exercise Price, Warrants expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.", "label": "Weighted Average Exercise Price, Warrants granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, End of period", "periodStartLabel": "Weighted Average Exercise Price balance, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_SharePurchaseOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Purchase Option Plan [Member]", "label": "Share Purchase Option Plan [Member]" } } }, "localname": "SharePurchaseOptionPlanMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_StockCompensationInExchangeForDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock compensation exchange for debt.", "label": "Stock compensation in exchange for debt" } } }, "localname": "StockCompensationInExchangeForDebt", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodSharesExerciseOfStockOptionsAndWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares exercise of stock options and warrants.", "label": "Exercise of stock options and warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfStockOptionsAndWarrants", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_StockIssuedDuringPeriodSharesWarrantIssuancesNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares warrant issuances net of issuance costs,", "label": "Stock and warrant issuances, net of issuance costs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantIssuancesNetOfIssuanceCosts", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value exercise of stock options and warrants.", "label": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueForDangotAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value for dangot acquisition.", "label": "Dangot acquisition" } } }, "localname": "StockIssuedDuringPeriodValueForDangotAcquisition", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value warrants exercised.", "label": "Stock issued during period, value, warrants exercised" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodWarrantIssuancesNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period warrant issuances net of issuance costs.", "label": "Warrant issuances, net of issuance costs" } } }, "localname": "StockIssuedDuringPeriodWarrantIssuancesNetOfIssuanceCosts", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockOptionVesting": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock Option vesting.", "label": "Stock Option vesting" } } }, "localname": "StockOptionVesting", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_TotalTransactionPricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total transaction price percentage.", "label": "Transaction price percentage" } } }, "localname": "TotalTransactionPricePercentage", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_TradeAndOtherAccountsPayablePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade And Other Accounts Payable [Policy Text Block]", "label": "Accounts Payable" } } }, "localname": "TradeAndOtherAccountsPayablePolicyTextBlock", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "OMQS_TwoThousandTwentyPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Plan [Member].", "label": "2020 Plan [Member]" } } }, "localname": "TwoThousandTwentyPlanMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_UnpaidCommission": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unpaid commission.", "label": "Unpaid commission" } } }, "localname": "UnpaidCommission", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_WarrantExercisePricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercise price percentage.", "label": "Warrant exercise price percentage" } } }, "localname": "WarrantExercisePricePercentage", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_WesternAllianceBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Western Alliance Bank [Member]", "label": "Western Alliance Bank [Member]" } } }, "localname": "WesternAllianceBankMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficit.", "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_YadHarutzimMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Yad Harutzim [Member]", "label": "Yad Harutzim [Member]" } } }, "localname": "YadHarutzimMember", "nsuri": "http://omniqinc.com/20221231", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ISRAEL" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r602", "r604", "r605" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r602", "r604", "r605" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r602", "r604", "r605" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r602", "r604", "r605" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r602", "r604", "r605" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_DirectorMember": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r321", "r581", "r653", "r705" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r414", "r515", "r534", "r560", "r561", "r579", "r584", "r590", "r650", "r698", "r699", "r700", "r701", "r702", "r703" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r414", "r515", "r534", "r560", "r561", "r579", "r584", "r590", "r650", "r698", "r699", "r700", "r701", "r702", "r703" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r321", "r581", "r653", "r705" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r353", "r354", "r355", "r356", "r413", "r414", "r439", "r440", "r441", "r514", "r515", "r534", "r560", "r561", "r579", "r584", "r590", "r643", "r650", "r699", "r700", "r701", "r702", "r703" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r353", "r354", "r355", "r356", "r413", "r414", "r439", "r440", "r441", "r514", "r515", "r534", "r560", "r561", "r579", "r584", "r590", "r643", "r650", "r699", "r700", "r701", "r702", "r703" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r319", "r320", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r580", "r589", "r653" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r319", "r320", "r544", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r580", "r589", "r653" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r634", "r694" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.", "label": "Accrued interest and accrued liabilities, related party" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r184", "r195", "r214", "r628" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts payable, related parties" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "auth_ref": [ "r195", "r213" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Other vendor payable" } } }, "localname": "AccountsPayableTradeCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r235", "r322" ], "calculation": { "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Trade accounts receivable" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r527", "r545" ], "calculation": { "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Total accounts receivable (net)" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r322", "r323" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll and sales tax" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r97", "r227" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Property and equipment, accumulated depreciation", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r39", "r40", "r41", "r236", "r528", "r539", "r540" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Cumulative translation adjustment" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r248", "r249", "r491", "r492", "r493", "r494", "r495", "r496" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r38", "r41", "r169", "r507", "r535", "r536", "r618", "r619", "r620", "r629", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Remaining weighted average lifespan" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r9", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r444", "r445", "r446", "r629", "r630", "r631", "r686" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r448" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Marketing and advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r443" ], "calculation": { "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "totalLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r237", "r324", "r328", "r329", "r330" ], "calculation": { "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedLabel": "Less allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r237", "r324", "r328" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r62", "r84", "r90" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potential shares excluded from diluted net loss per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r62", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Estimated useful lives" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r188", "r205", "r231", "r265", "r309", "r312", "r316", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r480", "r484", "r490", "r588", "r648", "r649", "r696" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r222", "r242", "r265", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r480", "r484", "r490", "r588", "r648", "r649", "r696" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r477", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/BusinessAcquisitionsTables", "http://omniqinc.com/role/GoingConcernDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r147", "r148", "r477", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/BusinessAcquisitionsTables", "http://omniqinc.com/role/GoingConcernDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Business acquisition, description of acquired entity" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Fair value of stock issued shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/BusinessAcquisitionsTables", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Purchase price percentage" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r475", "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business acquisition, pro forma net income (loss)" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r475", "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business acquisition, pro forma revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r151" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedLabel": "Non-controlling interest" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r156", "r157", "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Total consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r161", "r478" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSINESS ACQUISITIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "verboseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r149", "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r149", "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Current liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r149", "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r150" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": { "auth_ref": [ "r144", "r160" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.", "label": "Purchase Accounting and Business Combinations" } } }, "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r542", "r543", "r588", "r612" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash [Default Label]", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r64", "r225", "r563" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r58", "r64", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r58", "r180" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r232", "r233", "r234", "r265", "r285", "r286", "r289", "r291", "r297", "r298", "r326", "r357", "r359", "r360", "r361", "r364", "r365", "r393", "r394", "r397", "r401", "r408", "r490", "r562", "r611", "r624", "r632" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant Exercise Prices", "verboseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Issued warrants shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrant Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r100", "r351", "r352", "r547", "r647" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Shares of Common Stock authorized", "verboseLabel": "Reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r629", "r630", "r686" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r107" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r8", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock; $0.001 par value; 15,000,000 shares authorized; 7,714,780 and 7,459,534 shares issued and outstanding, respectively." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provision for income taxes" } } }, "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r42", "r244", "r246", "r255", "r523", "r531" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss attributable to OmniQ Corp" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r165", "r166", "r172", "r244", "r246", "r254", "r522", "r530" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Less comprehensive loss attributable to non-controlling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r164", "r172", "r244", "r246", "r253", "r521", "r529" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r75", "r76", "r178", "r179", "r321", "r546" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r75", "r76", "r178", "r179", "r321", "r541", "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r75", "r76", "r178", "r179", "r321", "r546", "r706" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r75", "r76", "r178", "r179", "r321" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r75", "r76", "r178", "r179", "r321", "r546" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r167", "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation and Basis of Presentation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r46", "r517" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSoldAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.", "label": "Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)", "verboseLabel": "Cumulative translation adjustment" } } }, "localname": "CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r683" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current income tax provision" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r143", "r460", "r468", "r627" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "negatedLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r74", "r321" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative", "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r67", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of debt", "verboseLabel": "Debt conversion" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r103", "r263", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r382", "r389", "r390", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "OTHER NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r3", "r4", "r5", "r189", "r192", "r203", "r268", "r366", "r367", "r368", "r369", "r370", "r372", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r499", "r574", "r575", "r576", "r577", "r578", "r625" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r181", "r183", "r366", "r499", "r575", "r576" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r29", "r201" ], "lang": { "en-us": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt instrument, frequency of periodic payment" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r28", "r367" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument, interest rate, stated percentage", "terseLabel": "Debt interest rate", "verboseLabel": "Annual interest rate note payable" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r29", "r268", "r366", "r367", "r368", "r369", "r370", "r372", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r499", "r574", "r575", "r576", "r577", "r578", "r625" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r29", "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Principal and accrued interest amount", "verboseLabel": "Debt periodic payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Principal payments" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r62", "r143", "r461", "r467", "r468", "r627" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred income tax expense benefit" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r456" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r681" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r681" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r142", "r682" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r142", "r682" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Foreign deferred tax assets" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": { "auth_ref": [ "r142", "r682" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.", "label": "163(j) Limitation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r142", "r682" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Reserves and deferred revenue" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r457" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 }, "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: Valuation Allowance", "negatedTerseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndValuationAllowancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r136", "r681" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r142", "r682" ], "calculation": { "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Amortization of intangible assets and depreciation" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r62", "r95" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/PropertyAndEquipmentDetailsNarrative", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r62", "r95" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF REVENUES" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r114", "r200" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Accrued dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends payable, amount per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r4", "r6", "r190", "r206" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividend payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r114", "r200" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Dividends" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r256", "r274", "r275", "r276", "r277", "r278", "r282", "r285", "r289", "r290", "r291", "r293", "r488", "r489", "r524", "r532", "r570" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share - basic attributable to common stockholders\u2019 of OmniQ Corp" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r72", "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r689" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of foreign exchange rates on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r266", "r452", "r469" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Federal statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r680", "r684" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r680", "r684" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Foreign income taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r680", "r684" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Return to provision adjustments" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent", "verboseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r680", "r684" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfReconciliationOfStatutoryRateAndEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r107", "r219", "r248", "r249", "r250", "r269", "r270", "r271", "r273", "r279", "r281", "r296", "r327", "r410", "r444", "r445", "r446", "r463", "r464", "r487", "r491", "r492", "r493", "r494", "r495", "r496", "r507", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership percent", "verboseLabel": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r173", "r175" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r176", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedCustomerRelationshipsGross": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date to an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.", "label": "Customer relationships, net of accumulated amortization of $10,762 and $9,660, respectively" } } }, "localname": "FiniteLivedCustomerRelationshipsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r229", "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Other intangibles, accumulated amortization", "verboseLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r91" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r91" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r91" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r91" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r91" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r340", "r341", "r342", "r343", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r89", "r519" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangibles gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r85", "r88" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets [Member]" } } }, "localname": "FiniteLivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r89", "r518" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFinite-livedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTradeNamesGross": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a reasonably expected period of economic benefit.", "label": "Trade name, net of accumulated amortization of $4,458 and $3,863, respectively" } } }, "localname": "FiniteLivedTradeNamesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r62" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of PP&E" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r228", "r336", "r520", "r573", "r588", "r641", "r642" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "GOODWILL AND INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.", "label": "Indefinite-lived Intangible Assets, Including Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r62", "r337", "r338", "r339", "r573" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment charges" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r45", "r265", "r309", "r311", "r315", "r317", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r490", "r572", "r648" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r43", "r186", "r197", "r216", "r309", "r311", "r315", "r317", "r525", "r572" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r266", "r453", "r454", "r459", "r465", "r470", "r472", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r135", "r138" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Income tax Likelihood" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r267", "r280", "r281", "r308", "r451", "r466", "r471", "r533" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTotalLabel": "Total provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r247", "r449", "r450", "r454", "r455", "r458", "r462" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r622" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Accrued payroll and sales taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred tax assets, net" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r622", "r692" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "verboseLabel": "Lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Impairment indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Member]" } } }, "localname": "IndefinitelivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r83", "r87" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangibles, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "verboseLabel": "Impairment indefinite-lived intangible assets" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r182", "r199", "r251", "r307", "r498" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r49", "r386", "r392", "r577", "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Noncash interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r257", "r260", "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r615" ], "calculation": { "http://omniqinc.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods (less allowance)" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r239", "r564", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://omniqinc.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r224", "r238", "r294", "r331", "r332", "r333", "r516", "r567" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r616" ], "calculation": { "http://omniqinc.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r62" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Stock and warrant issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r505" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease month" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r24", "r265", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r481", "r484", "r485", "r490", "r571", "r648", "r696", "r697" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r13", "r194", "r211", "r588", "r626", "r640", "r688" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r27", "r223", "r265", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r481", "r484", "r485", "r490", "r588", "r648", "r696", "r697" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r5", "r192", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "verboseLabel": "Line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r21", "r625" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line of credit, interest rate, description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r21", "r625" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of credit facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r21", "r625" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r3", "r189" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of credit" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Total expense" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r636" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "ACCOUNTS RECEIVABLE" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r5", "r192", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r101", "r268", "r384" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "verboseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r101", "r268", "r384" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails": { "order": 2.0, "parentTag": "us-gaap_OtherNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "verboseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r29" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, less current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r29", "r102" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r36", "r193", "r210", "r265", "r326", "r357", "r359", "r360", "r361", "r364", "r365", "r490" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Non-controlling interests, distributions and other" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r299", "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/NatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r259" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r259" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r58", "r60", "r63" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r44", "r63", "r198", "r215", "r221", "r243", "r245", "r250", "r265", "r272", "r274", "r275", "r276", "r277", "r280", "r281", "r287", "r309", "r311", "r315", "r317", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r489", "r490", "r572", "r648" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income", "totalLabel": "Net loss attributable to OmniQ Corp" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r168", "r171", "r243", "r245", "r280", "r281", "r620" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net income attributable to non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r274", "r275", "r276", "r277", "r282", "r283", "r288", "r291", "r309", "r311", "r315", "r317", "r572" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders\u2019 of OmniQ Corp" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of net loss to net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r67", "r68", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt assumed" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r162", "r410", "r629", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r48" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expenses" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expenses):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r67", "r68", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Equity conversion" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable \u2013 current portion" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r17", "r185", "r628" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesPayableRelatedPartiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes payable, related parties \u2013 current portion", "verboseLabel": "Less current portion" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r184", "r214", "r628" ], "calculation": { "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesPayableRelatedPartiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Total notes payable", "verboseLabel": "Notes payable related parties" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r30", "r184", "r628" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Notes payable, related party, less current portion", "totalLabel": "Long-term portion" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r309", "r311", "r315", "r317", "r572" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r295", "r506" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from operating lease.", "label": "SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE" } } }, "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of future minimum lease payments", "periodEndLabel": "Lease liability, Ending balance", "periodStartLabel": "Lease liability, Beginning balance" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r501" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability \u2013 current portion", "negatedLabel": "Less current obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r501" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability", "verboseLabel": "Long term lease obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r500" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use lease asset", "periodEndLabel": "ROU asset, Ending balance", "periodStartLabel": "ROU asset, Beginning balance" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r623" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of ROU asset", "negatedLabel": "Amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherInformationRelatedToOperatingLeaseDetails", "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r504", "r587" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r503", "r587" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r141" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r187", "r204", "r230" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r241", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r37" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other intangibles, net of accumulated amortization of $1,541 and $1,457, respectively" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInventoryInTransit": { "auth_ref": [ "r617" ], "calculation": { "http://omniqinc.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.", "label": "Inventory in transit" } } }, "localname": "OtherInventoryInTransit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r196" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "totalLabel": "Total other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r25", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities", "negatedLabel": "Less current portion" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "OTHER LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other long-term liabilities", "totalLabel": "Total long term other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "SCHEDULE OF OTHER LIABILITIES" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLongTermNotesPayable": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.", "label": "Long Term Notes Payable" } } }, "localname": "OtherLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r50" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other (expenses) income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayable": { "auth_ref": [ "r5", "r192", "r208" ], "calculation": { "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes payable classified as other.", "label": "Total", "totalLabel": "Total" } } }, "localname": "OtherNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayableCurrent": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Less current portion" } } }, "localname": "OtherNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermBorrowings": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.", "label": "Short term loans" } } }, "localname": "OtherShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilities": { "auth_ref": [ "r4", "r6", "r191", "r207" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.", "label": "Others" } } }, "localname": "OtherSundryLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment to purchase additional shares", "verboseLabel": "Payment of financing and stock issuance costs" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r59" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Monthly payments" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r55" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Dividends paid to non-controlling interest" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r51" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Cash payments", "negatedLabel": "Payment for acquisition, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r52" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r7", "r108" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred stock conversion, description" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "OMQS_NetLossAfterNoncommonStockholderDividends", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Less: dividends attributable to non-common stockholders\u2019 of OmniQ Corp" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r7", "r108", "r109", "r624", "r651" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Liquidation preference" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r7", "r393" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares designated", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r7", "r393" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r7", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r7", "r108" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred stock, voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r240", "r334", "r335", "r565" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r53" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Net proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r54" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from the issuance of notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Net activity on line of credit" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r53" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from ESPP stock issuance" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r621" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from exercise of options and warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r355", "r644", "r645", "r646" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r221", "r243", "r245", "r258", "r265", "r272", "r280", "r281", "r309", "r311", "r315", "r317", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r479", "r482", "r483", "r489", "r490", "r525", "r572", "r585", "r586", "r620", "r648" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "OMQS_NetLossAfterNoncommonStockholderDividends", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StatementsOfCashFlows", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r99", "r548", "r549", "r550" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r96", "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r98", "r212", "r526", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation of $1,030 and $2,203 respectively", "verboseLabel": "Property and equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r98", "r548", "r549" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful life", "verboseLabel": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r635", "r637", "r638", "r639" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r218", "r510", "r511", "r695" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r508", "r509", "r511", "r512", "r513" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r56" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payments on notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of related party debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r134", "r217", "r704" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research & development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r10", "r114", "r209", "r538", "r540", "r588" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r219", "r269", "r270", "r271", "r273", "r279", "r281", "r327", "r444", "r445", "r446", "r463", "r464", "r487", "r535", "r537" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r305", "r306", "r310", "r313", "r314", "r318", "r319", "r321", "r411", "r412", "r517" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfRevenuesDetails", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r252", "r265", "r305", "r306", "r310", "r313", "r314", "r318", "r319", "r321", "r326", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r490", "r525", "r648" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues [Default Label]", "verboseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r321", "r633" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLE" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/AccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r147", "r148", "r477" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/BusinessAcquisitionsTables", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r685" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "SCHEDULE OF STOCK COMPENSATION EXPENSE" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF OTHER NOTES PAYABLE" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF RECONCILIATION OF STATUTORY RATE AND EFFECTIVE TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r85", "r88", "r518" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "SCHEDULE OF GOODWILL AND INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r1", "r14", "r15", "r16" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORY" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "SCHEDULE OF FUTURE MATURITIES OF NOTE PAYABLE" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ConcentrationAndGeographicDataDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF NOTES PAYABLE, RELATED PARTIES" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r344", "r345", "r346", "r347", "r348", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r118", "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK OPTIONS GRANTED" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r104", "r105", "r106", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r232", "r233", "r234", "r297", "r393", "r394", "r395", "r397", "r401", "r406", "r408", "r579", "r611", "r624" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r115", "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANTS ACTIVITY" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r47" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r613", "r614", "r652" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r613", "r614", "r652" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r613", "r614", "r652" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r61" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date", "verboseLabel": "Expiry Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Stock price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility rate maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility rate minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "verboseLabel": "Risk- free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk- free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Number of warrants, Warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Number of warrants, Warrants expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants, Warrants granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r119", "r121" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants, Outstanding, End of period", "periodStartLabel": "Number of warrants, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of stock options, Exercisable stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Exercisable stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of stock options, Stock options expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Number of stock options, Stock options cancelled, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of stock options, Stock options granted", "verboseLabel": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Stock option outstanding", "periodEndLabel": "Number of stock options, Outstanding, End of period", "periodStartLabel": "Number of stock options, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Exercise Prices", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending of period", "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Intrinsic value for vested stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Stock options expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Stock options cancelled, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Range of Exercise Prices, lower range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Exercisable Warrants" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Outstanding Warrants" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Range of Exercise Prices, upper range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Residual Life Span (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotePayableDetails", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "CREDIT FACILITIES AND LINE OF CREDIT" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Accrues average interest" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r71", "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r232", "r233", "r234", "r265", "r285", "r286", "r289", "r291", "r297", "r298", "r326", "r357", "r359", "r360", "r361", "r364", "r365", "r393", "r394", "r397", "r401", "r408", "r490", "r562", "r611", "r624", "r632" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r34", "r107", "r219", "r248", "r249", "r250", "r269", "r270", "r271", "r273", "r279", "r281", "r296", "r327", "r410", "r444", "r445", "r446", "r463", "r464", "r487", "r491", "r492", "r493", "r494", "r495", "r496", "r507", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfRevenuesDetails", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r269", "r270", "r271", "r296", "r517" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfRevenuesDetails", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r7", "r8", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock and warrant issuance for Acquisition, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r33", "r107", "r108", "r114", "r383" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of equity, shares", "verboseLabel": "Stock issued during period, shares, conversion of convertible securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r7", "r8", "r107", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "ESPP Stock Issuance, shares", "verboseLabel": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock and warrant issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r7", "r8", "r107", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issued", "verboseLabel": "Issued shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock-based compensation - options, warrants, issuances, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r7", "r8", "r107", "r114", "r425" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of stock options, Stock options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r34", "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock and warrant issuance for acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r34", "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of equity", "verboseLabel": "Stock issued during period, value, conversion of convertible securities" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r7", "r8", "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "ESPP stock issuance", "verboseLabel": "Value issued" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r7", "r8", "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Value issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Other" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock-based compensation \u2013 options, warrants, issuances" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r34", "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock issued during period, value, stock options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r62" ], "calculation": { "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock compensation" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r8", "r11", "r12", "r80", "r588", "r626", "r640", "r688" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total OmniQ stockholders\u2019 equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r162", "r163", "r170", "r219", "r220", "r249", "r269", "r270", "r271", "r273", "r279", "r327", "r410", "r444", "r445", "r446", "r463", "r464", "r487", "r491", "r492", "r496", "r507", "r536", "r537", "r626", "r640", "r688" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r116", "r264", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r410", "r486" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND VALUATION ALLOWANCES" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r685" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionsDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r77", "r78", "r79", "r300", "r301", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://omniqinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants valued" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Expiry Date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r284", "r291" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted-average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r282", "r291" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r591": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r592": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r593": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r594": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r595": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r596": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r597": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r598": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r599": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r601": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r602": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r603": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r604": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r605": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r606": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r607": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r608": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r609": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 98 0001493152-23-009866-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-009866-xbrl.zip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�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�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end

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�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